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Abbreviation Name  
A Adenosine/Desoxyadenosine (-phosphate) 
Ab  Antibody 
Abl Tyrosine-protein kinase ABL 
Abp1 Actin binding protein 1 
Acm Acetamidomethyl protecting group 
AFAP Actin filament associated protein 
Amp  Ampicillin 
AP Alkaline Phosphatase 
APEG amino PEG (Poly-ethylene-glycol) spacer 
ApR  Ampicillin resistance 
ARVCF Armadillo repeat protein deleted in velo-cardio-facial syndrome 
BCIP 5-bromo,4-chloro,3-indolylphosphate 
BLAST Basic Local Alignment Search Tool 
Boc t-Butyloxycarbonyl protecting group 
bp  Basepair 
BPB  Bromophenol Blue 
BRCT Conserved domain found at C-terminus of the breast cancer 
susceptibility gene  
BSA  Bovine Serum Albumin 
C  Cytidine/desoxycytidine (-phosphate) 
C3G Guanine nucleotide-releasing factor 2 
c-ABL Abelson murine leukemia viral oncogene homolog 1 
CBS Citrate-Buffered Saline 
CD2 T-cell surface antigen CD2 precursor 
CD2BP2 CD2 Cytoplasmic Domain binding protein 
CDC 42 GAP Cdc42 GTPase-activating protein 
CDC42 Cell Division Control protein 42 
cDNA  Complementary DNA 
cfu  Colony Forming Unit 
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DMF N,N- dimethylformamide 
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DNA  DeoxyriboNucleic Acid 
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E. coli  Escherichia coli 
EDTA  Ethylendiamintetraacetate 
EH Eps15 homology domain 
ELISA Enzyme Linked ImmunoSorbent Assay 
ErbB-4 Tyrosine kinase erbB-4  
EVH1 (E) Ena-VASP Homology domain 1 
Ezr Ezrin 
f.c.  Final concentration 
F2Pmp  (phosphonodifluoromethyl)-phenylalanine 
FACS  Fluorescence Activated Cell Sorting 
Fas Apoptosis-mediating surface antigen FAS 
FE65 (F) Amyloid beta A4 precursor protein-binding family B member 1  
FF  A domain with two conserved phenylalanines (F); 
FHA Forkhead-associated; 
Fmoc Fluorenylmethyloxycarbonyl 
Fyn Proto-oncogene tyrosine-protein kinase Fyn  
G  Guanosine/Desoxyguanosine (-phosphate) 
GBF  Gesellschaft für Biotechnologische Forschung 
GST Glutathione S-transferase 
GYF  Glycine-tyrosine-phenylalanine protein domain 
h  Hour 
HAc  Acetic Acid 
HeLa cells  Cell line taken from Henrietta Lacks alias Helen Lane 
hnRNP K  Heterogeneous nuclear ribonucleoprotein F 
HPLC High Performance Liquid Chromatography 
Hrb HIV-1 Rev-binding protein  
HRP  Horse Radish Peroxidase 
HUGE  A Database of Human Unidentified Gene-Encoded Large Proteins 
analyzed by Kazusa human cDNA project 
IL-4 Interleukin-4 
IPTG  Isopropyl-β-D-thiogalactopyranoside 
kb  Kilobase 
KD  Dissociation constant 
KDa  Kilodalton 
KH  Ribonucleoprotein K homology 
KmR  Kanamycin resistance 
L. monocytogenes  Listeria monocytogenes 
L.M.P agarose Low Melting Point agarose 
LB  Luria-Bertina medium 
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Lin1p Protein LIN1 
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min  Minute 
MTT Methylthiazolyldiphenyl-tetrazolium-bromide 
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NUMB Protein numb homolog 
OD  Optical density 
OPAL  Oriented Peptide Array Library  
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p.a. Per analysis 
p130Cas CRK-associated substrate 
PBS  Phosphate Buffer Saline 
PCR  Polymerase Chain Reaction 
PDZ Protein domain also called Discs-large homologous regions (DHR) 
PEG  Polyethylene Glycol 6000 
pfu  Plaque Forming Unit 
PH Pleckstrin homology 
PI3K p85 PI3-kinase p85-alpha subunit 
Pmc 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl protecting group 
PMSF phenylmethanesulfonyl-fluoride 
POD Peroxidase 
PPII  Polyproline Type II helix 
Prp-8 Pre-mRNA splicing factor PRP8 homolog 
PTB Phosphotyrosine-binding 
rpm  Rounds per minute 
RRT  Recombinant RT-loop 
RSV  Rous sarcoma virus  
RZPD German Resource Center for Genome Research  
SDS  Sodium Dodecyl Sulfate 
sec  Second 
SETA Src homology 3 expressed in tumorigenic astrocytes; 
SF 1 Steroidogenic Factor 1 
SH 1, 2, 3 Src homology 1, 2, 3 
Sh3yl1 Sh3 domain YSC-like 1 
Shb Ubiquitously expressed Src homology 2 protein 
SmB snRNP-associated protein 
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TAIS  Target-Assisted Iterative Screening 
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TBST Tris Buffered Saline -Tween 
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Trt trityl protecting group 
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WISE  Whole Interactome Scanning Experiment 
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WWP1 WW domain-containing Protein 1 
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Amino Acid Three Letter One Letter 
Alanine  Ala  A  
Arginine  Arg  R  
Asparagine  Asn  N  
Asparagine/aspartic acid  Asx  B  
Aspartic acid  Asp  D  
Cysteine  Cys  C  
Glutamic Acid  Glu  E  
Glutamine  Gln  Q  
Glutamine/glutamic acid  Glx  Z  
Glycine  Gly  G  
Histidine  His  H  
Isoleucine  Ile  I  
Leucine  Leu  L  
Lysine  Lys  K  
Methionine  Met  M  
Phenylalanine  Phe  F  
Proline  Pro  P  
Serine  Ser  S  
Threonine  Thr  T  
Tryptophan  Trp  W  
Tyrosine  Tyr  Y  
Valine  Val  V  
Brief summary of rules Symbol Brief summary of rules Symbol 
Unknown, other or any amino acid x Phosphorylated amino acid (Tyr) poY 
Sequences flanking ligand core at the 
N-terminus 
fn Sulfated amino acid (Tyr) suY 
Sequences flanking ligand core at the 
N-terminus 
fc O-glycosylated amino acid (Ser) glS 
Hydrophobic amino acid φ N-glycosylated amino acid (Asp) glN 
Aromatic amino acid Ω Methylated amino acid (Arg) meR 
Hydrophilic amino acid ξ Symmetrically methylated Arg smeR 
Positively charged residue [+] Asymmetrically methylated Arg ameR 
Positively charged residue [-] Acetylated amino acid (Lys) acK 
Aliphatic side chains ψ Hydroxylated Proline hyP 
Small chain amino acid π Excluded amino acid (Pro) ∧P 
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1. Introduction 
 
1.1 Peptide and protein repertoires for global analysis of modules 
Protein-protein interactions are responsible for most of the cellular processes and control the 
cell physiology. Cellular processes are thought to be regulated rather by complicated protein 
complexes and protein networks than by single proteins (Fig 1.1.1). Disruption of some 
sensitive connection within interaction network may drive the cell into a pathological state. 
Despite availability of the sequences of entire genomes, the function of many proteins 
remains unknown. Studies concerned with the relationship between proteins within 
complexes may help to address their biological functions, which is a primary goal of 
functional genomics and proteomics. This is supported by high-throughput technologies 
allowing for global analysis of the entire proteomes (Uetz et al., 2000; Ho et al., 2002; Gavin 
et al., 2004).  
Fig 1.1.1: The protein complex network (Gavin et al., 2004) 
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Many proteins, most prominently those of regulatory function, are built from smaller domains, 
which are stably folded structural modules, still displaying their specific functional property. A 
substantial fraction of protein interactions is mediated by these modules, recognizing and 
binding to short peptides in the partner protein. The catalogue of protein domains is rapidly 
growing (kringel, SH2, SH3, PH, EVH1, PDZ, WW, etc. (Cesareni et al., 2004), indicating a 
more general principle utilized by nature. Protein domains are found in proteins involved in 
the regulation of cellular events such as signal transduction, the cell cycle, protein trafficking, 
targeted proteolysis, cytoskeletal organization and gene expression. Therefore 
understanding of module-ligand recognition mechanisms, relationship between interacting 
partners as well as identification and classification of new protein modules is of high 
importance. In this chapter an overview is given on the experimental approaches that have 
been conceived and are being used to search genomes and proteomes for functional protein 
domains and their ligands as well as to assess their recognition specificities and functions on 
a molecular basis. With respect to the empirical nature of search approaches, most of these 
are very much concerned with the intelligent design and sophisticated preparation of 
competent domain and ligand repertoires that are suited to represent natural global pools of 
potential structures and which allow for efficient experimental exploration. A particular 
attention was paid on the experimental design and concepts of the reports considered for 
this chapter, as well as literature reference for more information on the types of domains and 
ligands that have been discovered this way. This section is organized according to the origin 
of the domain/ligand repertoires reported and the principles applied to prepare and screen 
them. This involves cell biology, biochemistry, molecular biology, and chemistry, which 
illustrates the interdisciplinary nature of the work in this field of research. The recent efforts in 
developing non-natural and small molecule drug-like ligands for use in therapeutic 
interference with protein domain function are not covered in this chapter. 
 
1.1.1 Repertoires from cell extracts 
A cell extract is the most natural source for a repertoire of the proteins to be investigated for 
function as modules or ligands. Cell extracts are relatively easy to prepare and their 
advantageous feature is that all proteins are correctly folded and post-translationally 
modified. Moreover, proteins in cell extracts may be easily metabolically labeled, for 
example, with 35S or 32P. Usually, protein extracts are probed with individual module or ligand 
molecules, and binding partners are isolated by affinity chromatography or pull-down of 
complexes via a tag at the probe molecule (Weng et al., 1993; Weng et al., 1994; Ikeda et 
al., 2000) or by immunoprecipitation (Liu et al., 1999). The separated proteins are 
fractionated on polyacrylamide gels (one-or two-dimensional electrophoresis) and identified 
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by mass spectrometric peptide fingerprinting, or they may be blotted and inspected with, e.g., 
antibodies. Such approaches were recently applied in a high-throughput systematic way to 
analyze the entire yeast proteome and yielded impressively comprehensive protein 
interaction networks (Ho et al., 2002; Gavin et al., 2004). These networks obviously include 
many protein module interactions and may reveal novel module/ligand families. 
 
1.1.2 Repertoires of proteins based on expression cloning of DNA libraries  
The major source for global domain and ligand repertoires is heterologous expression of 
coding DNA libraries. A common theme of approaches based on such sources is to construct 
a physical link between the individual member of the protein repertoire and its coding DNA 
fragment, as well as a suitable selection process for the module-ligand complexes. Usually, 
the complex partners are called bait and prey; either one or both may be represented by a 
global library. A “DNA tag” always allows for efficient, easy amplification of even extremely 
minute amounts of module/ligand molecules. Identification is achieved through DNA 
sequence analysis (DNA sequencing or hybridization with respective complementary DNA 
probes). Examples are the yeast two-hybrid system (Allen et al., 1995) and the split-ubiquitin 
analog (Johnsson and Varshavsky, 1994) phage expression library screens (Sambrook et 
al., 1989), the various molecular display systems (Allen et al., 1995; Fish, 2001) used in 
iterative rounds of affinity enrichment (also called biopanning), and more recently, large-
scale expressed protein collections in microtiter plate or microarray formats (Mac Beath, 
2002). cDNA libraries are the most suitable source of global protein repertoires, rarely 
available in full length, but complementing the full proteome in the form of shorter redundant 
libraries of fragments. cDNA libraries can be chosen to represent specific cellular states, 
such as fetal or adult, brain or liver, healthy or oncogenic/pathogenic, etc. Genomic DNA 
libraries have been used only with simple model organisms such as yeast, Caenorhabditis 
elegans, etc. but are not considered for higher organisms, which carry increasing amounts of 
non-coding genetic material. A limitation of heterologous expression is the lack of proper 
posttranslational modification, which in some instances can be overcome by using 
genetically engineered host strains and in others may be introduced in vitro. Recently, global 
studies were reported that investigated the protein interactomes of whole organisms 
nonbiased for domain–ligand interactions. These have established systematic proteome 
interaction maps utilizing large-scale yeast two hybrid screens for yeast itself, nematode, and 
Drosophila (Ito et al., 2001; Giot, 2003). Work on the human interactome is underway. 
Together with the global protein complex analyses mentioned above (Section 1.1.1), 
comprehensive catalogs of protein interactions are currently being assembled. These will be 
mined with bioinformatics tools for known and new module-ligand interactions. 
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1.1.2.1 Ligand repertoires used with the yeast two-hybrid system 
The DNA for a module of interest is cloned into a bait expression plasmid in-frame with the 
gene for the DNA binding domain of a transcription factor, and a library of cDNA or 
fragmented genomic DNA is cloned into a prey expression plasmid in frame with the gene for 
the transcription activation domain of that transcription factor. Yeast transformants resulting 
from transfection or mating which carry both plasmids and produce active interacting 
partners are identified by activation of a reporter gene such as lacZ or a nutritional marker 
under control of the reconstituted transcription factor. Fig 1.1.2 shows the schematic view of 
this process.  
Fig 1.1.2: Schematic representation of the principle of yeast two-hybrid system. Picture source: 
http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/T/Two_Hybrid.gif  
 
Several examples are listed in (Table 1.1.1).Tong et al, exploited yeast two-hybrid screens 
with prey libraries in various formats: a genome-wide array of transformants representing all 
yeast open-reading frame fusions and conventional yeast genomic and cDNA libraries (Tong 
et al., 2002). The screens were used to systematically confirm module–ligand interactions, 
which had been derived from consensus binding motifs and computational network analysis 
based on phage-display screens of random peptide libraries (see sections: 1.1.4.1 and 
1.1.4.2). This approach was applied to yeast SH3 domains and used to verify 59 interactions 
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for 39 proteins by matching a phage-display network of 394 interactions among 206 proteins 
and a yeast two-hybrid network of 233 interactions among 145 proteins. 
 
Table 1.1.1: Screens of ligand repertoires with the yeast two-hybrid system. 
Prey library Bait  Reference  
HeLa cDNA SH2SH3 of c-ABL  Zhu and Shore, 1996 
human fetal brain cDNA all 3 SH3 of Nck Matuoka et al., 1997 
human brain cDNA SH3 of αI spectrin  Ziemnicka-Kotula et al., 
1998  
human placenta cDNA SH3 of p130Cas  Kirsh et al., 1999  
human mammary gland cDNA bovine SF1  Zhu et al., 2000 
p53 - astrocyte cDNA SH3-1 and SH3-23 of 
SETA 
Borinstein et al., 2000 
yeast genomic DNA SH3 of Abp1 Fazi et al., 2002 
mouse skin cDNA SH3 of Sh3yl1  Shimomura et al., 2003 
murine keratinocyte cDNA Fyn  Seykora et al., 2002 
human lung fibroblast cDNA UD/SH2/SH3 of c-Src  Chang et al., 1998 
T-cell cDNA and 11.5-day mouse 
embryo 
human p52 Shc  Schmandt et al., 1999 
human brain cDNA WW1 of YAP  Espanel et al., 2001 
human leukocyte cDNA EVH1of Mena(S) Tani et al., 2003 
 
1.1.2.2 Module repertoires used with the yeast two-hybrid system 
In the reverse approach, when cloning a ligand of interest into a bait plasmid, the same prey 
libraries can be used to select for modules. Several examples are listed in Table 1.1.2. 
 
Table 1.1.2: Screens of module repertoires with the yeast two-hybrid system. 
Prey library Bait Selected 
 domain 
Reference 
LB-EBV cDNA p47phox SH3 Fuchs et al., 1995 
mouse brain cDNA Alix SH3 Chatellard-Causse et 
al., 2002 
rat brain cDNA proline-rich tail (aa 1015-1308) of  
the 145-kDa isoform of synaptojanin 
SH3 Ringstad et al., 1997 
rat brain cDNA N-terminal part (1-65 aa) of Pγ-rod SH3 Morin et al., 2003 
human brain cDNA cytoplasmic region (aa 790-1356) of 
KDR 
SH2 Igarashi et al., 1998 
human fetal brain cDNA P413 to P713 fragment of athrophin-1 WW Wood et al., 1998 
Activated human T  
cell cDNA 
cytoplasmic region (aa 221-327) of CD2 GYF Nishizawa et al., 1998 
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Prey library Bait Selected 
 domain 
Reference 
lung cDNA library 51 aa of the C-terminus of rat CFTR PDZ Cheng et al., 1998 
 
1.1.2.3 Phage expression libraries of ligands 
The genomic or cDNA library is cloned primarily into a lambda expression vector, packaged 
into phage particles, and plated onto a bacterial lawn. The phage plaques producing the 
fusion protein are lifted onto nitrocellulose filters, and these are probed with the labeled or 
tagged protein module of interest. DNA of positive individual phage plaques is then 
sequenced. Table 1.1.3 gives an overview of reported screens. 
 
Table 1.1.3: Screens of phage expression libraries of ligands 
Vector Prey library Bait Reference 
λEXlox 16-day mouse embryo cDNA GST-SH3 of c-Abl, cCrk, c-Src, n-Src Alexandropoulos et 
al., 1995 
λEXlox 16-day mouse embryo cDNA GST-Gads Berry et al., 2002 
λEXlox 16-day mouse embryo cDNA 35S-labled GST-SH3-SH3 of Crk Schumacher et al., 
1995 
λEXlox 16-day mouse embryo cDNA 32P-labelled GST-WW of YAP Chen et al., 1995 
λEXlox 16-day mouse embryo cDNA EH-AP of Intersectin Yamabhai et al., 
1998 
λEXlox 12-, 14-, 16-day mouse embryo cDNA 32P-labelled GST-WW of FE65 Ermekova et al., 
1997 
λgt11 mouse pre-B cell line 22D6 cDNA biotinylated GST-SH3 of Abl Cicchetti et al., 
1992 
λgt11 human spleen cDNA GST-SH3 of CRK Tanaka et al., 1994 
λZAP macrophage cDNA GST-SH3 of Nck Rivero-Lezcano et 
al., 1994 
 
1.1.2.4  Phage expression libraries of modules 
The lambda phage-based cDNA libraries mentioned above have also been used to search 
for proteins containing modules, by probing the filter lifts with labeled ligands such as 
synthetic peptides or fragments of proteins that carry functional sites. Several examples are 
listed in Table 1.1.4. 
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Table 1.1.4: Screens of phages expression libraries of modules 
Vector Pray library Bait Selected 
domain 
Reference 
λEXlox 16-day mouse 
embryo cDNA 
biotin-SGSGSRLTQSKPPLPPKPSWVSR-
NH2 Cortactin SH3 ligand from phage library 
(Aparks et al., 1996) 
SH3 a) Sparks et al., 1996 
λEXlox 10.5-day 
mouse limb 
bud embryo 
cDNA 
(His)6-proline-rich fragment of formin 
(518-750 aa)  
SH3, WW Chan et al., 1996 
λEXlox 16-day mouse 
embryo cDNA 
mixture of biotinylated 
DHQpoYpoYNDFPGKEPP, 
DHQpoYYNDFPGKEPP 
DHQYpoYNDFPGKEPP 
DHQYYNDFPGKEPP 
ELFDDSpoYVNIQNLD derived from human 
p52 Shc 
SH2 b) Liu et al., 1998 
λTriplEX human              
brain cDNA 
mixture of biotinylated PGTP4YTVGPGY 
(WBP-1), YVQP4YPGPM (WBP-2A), 
PGTPYP4EFY (WBP-2B), G3FPPLP4YPPLG 
(Ras-GAP) 
WW a) Pirozzi et al., 1998 
λgt11 chicken embryo 
cDNA 
proline rich peptide comprised of three 
tandem copies of the 11-aa from the RSV 
Gag p2b sequence 
WW Kikonyogo et al., 
2001 
a) this approach was termed “cloning of ligand targets” (COLT) 
b) this approach was termed “cloning of receptor targets” (CORT) 
 
1.1.2.5 Bio-Panning with phage displayed protein ligands and domains 
 
Technology 
Since its invention (Smith, 1985) affinity enrichment of peptide/protein binders using phage 
display technology was successfully applied in the immunology, cell biology, drug discovery 
and pharmacology research fields and still remains very attractive, especially when 
combined with high-throughput approaches. Physical connection of the peptide/protein 
displayed by fusing them to a phage capsid protein (phenotype) with the nucleic acid 
genome of the phage particle (genotype) is the principle feature of phage display allowing for 
an easy selection and identification of target specific binders. This is achieved by genetic 
fusion of the nucleotide sequences encoding the proteins/peptides to be displayed, in frame 
to the gene encoding a phage coat protein. Huge repertoires, up to 1011 candidates, can be 
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generated by cloning of e.g. gene fragments, random oligonucleotides and cDNA 
populations into phage chromosome. Typically, ligand specific binders are selected in an 
affinity process called “bio-panning”. This process is usually repeated several times and 
results in enrichment of partners that strongly interact with their ligand. For description see  
Fig 1.1.3. Several different phage-display systems utilizing filamentous (M13) and virulent 
(T7, T4, lambda) phages were developed. A very informative comparison of their particular 
properties was given by Castagnoli (Castagnoli et al., 2001). 
 
Phage display of protein ligands 
DNA libraries are cloned into phage vectors in-frame with one of the phage coat protein 
genes. The resulting phages display the fusion protein on their surface and are used to 
select binding ligands by affinity enrichment on immobilized modules. Several interesting 
reports utilizing this approach are described below; however, it is more extensively used with 
repertoires of small peptide ligands (see section 1.1.4). Ligands for SH3 domains were 
isolated from phage-displayed expression libraries of cDNA from the human epithelial breast 
carcinoma cell line MCF7 and a murine fibroblast NIH 3T3 cDNA using the T7Select1-1b 
system. Both libraries (107 primary recombinants with an average length 0.7–0.8 kb) were 
screened with the human Grb2-GST (GST = glutathione S-transferase) fusion protein as bait 
(Zozulya et al., 1999). A fragmented yeast genomic DNA library expressed and displayed as 
N-terminal fusion to the pVIII protein of M13 phage (108 independent clones representing 
more than 50 times the whole yeast genome and presenting yeast protein fragments of 
average length 40 amino acids) was affinity-selected for ligands bound by the full length 
yeast Abp1 protein, which was expressed as GST fusion and immobilized to glutathione–S-
Sepharose (Fazi et al., 2001). A fragmented human leukocyte cDNA library (108 clones, 0.2–
0.5 kb) was fused to the bacteriophage M13 pIII gene. This library was first depleted of non-
phosphorylated ligands by passage over Sepharose loaded with the SH2 domains of SHP-2, 
then was phosphorylated in vitro with fyn kinase and panned against the tandem SH2 
domains of SHP-2 (Cochrane et al., 2000). Usually, several rounds of panning with 
intermediate amplification of phage eluates by bacterial infection are performed to enrich 
over unspecific binders. Kurakin combined phage display and expression library screening 
formats to overcome this drawback (Kurakin and Bredesen, 2002). After the first panning 
round, eluted phages are plated onto a bacterial lawn, and plaques are transferred onto a 
nitrocellulose membrane. The protein target tagged with a reporter such as alkaline 
phosphatase is then used as a one-step detection reagent to screen for interacting plaques 
on the membrane. They named this procedure TAIS (target-assisted iterative screening). 
Using this method with a normal human brain T7 phage-displayed cDNA library and several 
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bait modules (PDZ domain of PSD95; SH3 domains of Src, Abl, and Crk; third WW domain 
of Nedd4), they identified 12 novel putative and two previously. 
Fig 1.1.3: The phage display cycle (a) A library of variant DNA sequences encoding proteins or 
peptides is created and (b) cloned into phage or phagemid genomes as fusions to a coat protein gene. 
(c) The phage library displaying variant proteins or peptides is exposed to target molecules and 
phages with appropriate specificity are captured. (d) Non binding phages are washed off – although 
some non-specific binding may also occur. (e) Bound phages are eluted by conditions that disrupt the 
interaction between the displayed peptide or protein and the target. (f) Eluted phage are infected into 
host bacterial cells and thereby amplified. (g) This amplified phage population is in effect a secondary 
library that is greatly enriched in phage displaying peptides or proteins that bind to the target. If the 
bio-panning steps (c) to (f) are repeated the phage populated becomes less and less diverse as the 
population becomes more and more enriched in the limited number of variants with binding capacity. 
(h) After several (usually three to five) rounds of bio-panning monoclonal phage populations may be 
selected and analyzed individually, (Willats, 2002). 
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Phage display of protein domains 
Again, in the reverse of the scheme above, protein modules have been searched for by 
panning phage displayed cDNA libraries on immobilized ligand baits. SH3 and WW domains 
were isolated from an expression cDNA library made from human brain displayed on the 
lambda D capsid protein (9.8 x 107 primary recombinants) by panning on a GST fusion 
protein of the proline-rich fragment (residues 1058 – 1119) of synaptojanin 1 (Zuconni et al.,   
2001). WW domains were isolated from a normal human brain T7 phage-displayed cDNA 
library screened with the WW-YAP ligand peptide GTP4YTVG, which was tethered to a spot 
on a cellulose membrane. This method will be further advanced into an automated process 
utilizing SPOT arrays of synthetic peptide libraries as multiple baits to systematically scan 
fragments from hundreds of proteins for interacting modules (Bialek et al., 2003). The 
phosphotyrosine-binding domains SH2 and PTB were isolated from MCF7 and NIH 3T3 
phage-displayed libraries (for details see section 1.1.2.5), which were screened with the 
EGFR- and Shc-derived synthetic phosphopeptides (EGFR-pY1068 biotin-
DDAFLPVPEpoYVNQSVPKR, EGFR-pY1148 biotin–SHQMSLDNPDpoYQQDFFPK, and 
Shc-pY317 biotin– LFDDPSpoYVNVQNL) as baits (Zozulya et al., 1999).  
 
1.1.2.6 Protein arrays as ligand repertoires 
The availability of fully sequenced and annotated genomes of model organisms open up the 
opportunity to prepare comprehensive sets of individually expressed and purified proteins as 
bait or prey repertoires. This has been achieved for 5800 open reading frames of 
Saccharomyces cerivisia and from these a yeast proteome microarray containing 
approximately 80 % of the yeast proteins was constructed. The yeast proteins were fused to 
GST-Hisx6 tags at their N-termini and spotted onto nickel-coated glass slides. These arrays 
were probed e.g. with calmodulin in the presence of calcium. Six of the twelve known 
calmodulin targets were detected. Of the remaining six, two were not present in this 
collection and four were not detectable with anti-GST antibodies. 33 additional potential 
partners for calmodulin were identified. Sequence comparison revealed that 14 of the 39 
calmodulin-binding proteins contain a motif whose consensus is fn(I/L)QxxK(K/x)G[+]fc (Zhu 
et al., 2001).  
 
1.1.2.7 Protein arrays as domain repertoires 
A repertoire of 212 GST fusion proteins and protein domains was collected from different 
sources: 33 WW, 23 SH3, 17 SH2, 23 PH, 23 PDZ, 8 FF, 7 14.3.3, 5 PTB, 4 FHA, 2 KH and 
67 proteins without canonical domain structure. These were arrayed onto nitrocellulose-
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coated glass slides to produce a protein-domain chip. Five peptides, including one with 
methylated arginine residues as an example for a post-translational modification, all with 
known binding specificity to the domains above, were used to confirm that the arrayed 
proteins retain their binding integrity. Extract of human HCF7 cells and antibodies against 
Sam 68 and SmB´, as well as peptides derived from these proteins were used to 
demonstrate distinct and reproducible binding to subsets of this array. In this manner, 
module-specific profiles for cellular proteins were obtained from the binding patterns. These 
were at most similar to those obtained with the respective peptide ligands and only slightly 
broader, which is to be expected since proteins may harbour additional interacting residues 
(Espejo et al., 2002). 65 human WW domains were expressed as GST fusion proteins and 
immobilized onto the surface of the wells of a microtiter plate (Hu et al., 2004). A quantitative 
ELISA-like binding assay was applied to screen these modules sequentially with 1930 
putative synthetic peptide ligands that were selected by searching the Swiss-Prot and 
TrEMBL protein databases. A cross-affinity matrix that represented all the possible 
combinations of interactions between the human WW domains and their peptide ligands was 
established which revealed clear ligand preferences for the WW domains: 31 of them were 
classified to a subgroup that recognize the fnPPxYfc motif (elm:LIG_WW_1), 11 of them 
recognize fnPPLPfc/fnPPRfc (elm:LIG_WW_2/; elm:LIG_WW_3), three bind 
fnPGMfc/fnPPRfc (elm:LIG_WW_3) and four could not be classified to any subgroup. 
 
1.1.3 Mutagenized domain libraries 
Site directed mutagenesis with mutagenic oligonucleotide primers or random mutagenesis by 
error-prone PCR were applied to generate repertoires of domain variants. These repertoires 
were used to investigate the contribution of individual residues to domain activity and/or to 
search for domains with new properties. Obviously, all above listed methods for DNA library 
screens are applicable. 
 
1.1.3.1 Site-directed mutagenesis  
Two bacterial expression libraries of mutated YAP WW1 domains with random sequences at 
the position corresponding either to L190 and H192 together (td = 400) or Q195 alone 
(td = 20) were constructed in the pGEX-2TK. Colony lifts on nitrocellulose filters were 
screened with radiolabeled ligands of YAP (PPXY) or FE65 (PPLP). A single mutation 
L190W of the YAP WW1 domain was found to allow binding to both types of ligands and an 
additional substitution H192G almost completely shifted the selectivity to that of FE65 
(Espanel and Sudol, 1999). A library of Hck SH3 domains (1.3 x 108 recombinant clones) 
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with a random hexapeptide replacement in the RT-loop (termed RRT-SH3) was generated 
by PCR-assisted mutagenesis using a degenerate primer. This library was displayed on the 
surface of M13 bacteriophage and used for panning with HIV-1 Nef and Nef-F90R mutant. 
RRT-SH3 domains that can bind to Nef up to 40-fold more avidly than Hck-SH3 were 
identified. Also RRT-SH3 domains with an opposite specificity for the Arg90 Nef-mutant were 
selected (Hiipakka et al., 1999). A repertoire of 107 different SH3 domains was created by 
grafting the residues that are represented at the binding surfaces of natural SH3 domains 
onto the scaffold of the human Abl-SH3 domain (td ~ 2 x 109). The library was displayed by 
fusion to the C-terminus of the D protein of bacteriophage λ and screened by affinity 
selection with APTYP3LPP and LSSRPLPTLPSP peptides, which are known ligands for 
human Abl and Src SH3 domains respectively. As few as two or three amino acid 
substitutions can lead to dramatic changes in recognition specificity (Panni et al., 2002). 
 
1.1.3.2 Random mutagenesis  
A yeast reverse two-hybrid system (interactions activate a toxic reporter) was used to select 
single amino acid changes that abolish protein-protein interaction. A prey library of the 
mutated fragment (159-437) of the E2F1 transcription factor was prepared by a mutagenic 
PCR and screened with the full-length DP1 protein as bait in a two-step selection process 
which deselected misfolded variants in the second step. A putative helix region that is 
conserved among E2F family members was identified as the essential part of the E2F/DP1 
heterodimerization domain (Vidal et al., 1996). The PDZ domain of mouse AF-6 was mutated 
using error-prone PCR. This library was screened using the Y2H-system with four different 
C-terminal expressed peptides (-FHAALGAV, -FHAALGKYV, -FHTQITRYV and -
SPANIYYKV) as baits. All these peptides do not interact with the native AF-6 PDZ domain. 
The majority of mutations leading to high affinity binding to the new peptide ligands were 
localized in the three secondary structure elements of the PDZ domain that are known to 
make up the peptide binding groove (Schneider, 1999). Four Pex5 protein single point 
mutants that abrogate binding to the SH3 domain of Pex13 were used as baits in Y2H-
screen for suppressor mutants from a randomly mutagenized (error-prone PCR) prey library 
of the Pex13p SH3 domain. Mutations that restore the interaction with the Pex5, were found 
at a new unique site on the Pex13-SH3 domain that is distinct from the classical PXXP-
binding pocket (Barnett et al., 2000).  
 
1. Introduction 
 13
1.1.4 Repertoires of peptide ligands based on expression cloning of 
oligonucleotide libraries 
A typical feature of the protein modules discussed in this section is their action either by 
binding or post-translational modification (including cleavage) on short target sequences 
(functional sites) present in other proteins. Such functional sites can be mimicked by 
respective short peptide sequences of completely synthetic origin. This section recapitulates 
approaches to generate such synthetic repertoires by cloning the corresponding coding 
double-stranded DNA repertoires made from synthetic oligonucleotides. The common codon 
scheme NNK or NNS is used for the chemical synthesis of degenerate oligonucleotide 
sequences where N is an equimolar mixture of A+C+G+T, K of G+T and S of G+C. In this 
way, the codons encoding all 20 amino acids are included and stop codons are restricted to 
TAG only (Adey et al., 1996). A triplet (codon-based) chemical synthesis of random 
oligonucleotide repertoires is feasible and could avoid the expression of many nonsense 
peptides (Sondek et al., 1992), but is only rarely used because the triplet building blocks and 
their chemical assembly are not trivial. Often codons for cysteines are included at predefined 
positions to allow for a cyclization of the expressed peptide structures to form constrained 
loops. These oligonucleotide repertoires are primarily expressed as fusions to larger 
proteins, with the phage display clearly dominating (see also section 1.1.2.5). The majority of 
libraries are based on the filamentous phage M13 with the fusion to the N-termini of either 
the minor coat protein pIII (5 copies at the tip of the phage particle) or the major coat protein 
pVIII (approximately 2700 copies forming the body of the phage particle). These two 
variations are particularly distinct in their exploitation or prevention of avidity effects in the 
selection of weak or high affinity binders. Other types of phages are rarely used for peptide 
display except when constructing fusions to the C-termini of proteins which is a prerequisite, 
for example, when selecting binders to PDZ domains. The D-protein of the lambda phage 
capsid and the 10B coat protein of the T7 phage are two examples. The T7 display system 
was also reported in the context of a novel target assisted iterative screening method (TAIS) 
as described already in section 1.1.2.5. As a result, a novel unconventional SH3 binding 
motif, fnPx(P/A)xxRfc was discovered and further characterized (Kurakin et al., 2003). The 
proper display of peptides at the C-terminus of M13 phage coat protein VIII could be also 
achieved with the help of a special thirteen amino acid long peptide linker. Fusion to the C-
terminus of the Escherichia coli Lac repressor was exploited for a plasmid display system by 
Sticker and collogues (Stricker et al., 1997). Following bacterial expression, the Lac 
repressor protein binds to the lac operator sequence on the same plasmid, thereby linking 
each peptide to the plasmid encoding that peptide. Because of the small particle size, much 
higher diversities of peptides can be screened with such libraries. 
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1.1.4.1 Random peptide libraries 
Random peptide libraries are of a generic nature and applicable to any screening task. 
Therefore, many random libraries of different structure concerning the length of the peptide 
insert and constraints by cysteine bridges that were constructed for other studies were also 
utilized for selecting ligands for protein modules. One example is the M13 pVIII displayed 
nonapeptide library X9 by Felici (Felici et al., 1991), which was widely used by many 
researchers for protein domain-peptide ligand interaction studies. Table 1.1.5 gives an 
overview of several reports found in the literature. The library of Felici was also modified 
through an efficient tyrosine residue phosphorylation using PTK p55fyn and became an 
important tool for studying poY-binding modules. Tong and coleuses (Tong et al., 2002) took 
advantage of this library for a systematic compilation of consensus motifs for 24 predicted 
yeast SH3-domains. This compilation was then used to derive a protein interaction network 
which links each recognition module to all those proteins found in the data base to contain a 
preferred peptide site (see also section 1.1.2.1). 
 
Table 1.1.5: Screens of random peptides repertoires 
Library Domain  Protein  Ligand Reference 
M13 display at N-terminus of phage coat protein III 
GX6G SH3 HSrc RSLPPIPG  Table 1.1.6 
entry 3 
Rickles et al., 1994 
X7, CX7C chromo-
shadow 
HP1 fn(P/L)(W/R/Y)VΦΦfc, linear 
and constr.  
Smothers et al., 2000 
CX9C SH2 Grb2 fnYxNfc, constr. Oligino et al., 1997 
X10C EH frog Intersectin FnNPFfc, constr. Yamabhai et al., 1998 
X10C  β1-syntrophin fnx[+]ETC(L/M)AgxФCfc, 
constr. 
Gee et al., 1998 
X12 WW  hWWP1, 
hWWP2, 
hWWP3, hYAP, 
yRsp5.3, 
mNedd4 
fn(L/P)PxYfc, class I, Table 
1.1.6 entry 7 
Kasanov et al., 2001 
X12 SH3-1, 
SH3-2  
CIN85 fnPx(P/A)xxRfc Kurakin et al., 2003 
X15 SH3 Src fnRPLPxxPfc Cheadle et al. 1994 
X4CX10CX4 SH2 Grb7 fnYxNfc, constr., (see Table 
1.1.6 entry 8) 
Pero et al., 2002 
X2CX14CX2  h14-3-3τ fnWLDLfc, constr. 
X2CX18  h14-3-3τ  fnRSx{1,3}[-]fc, linear, 
constr.  
Wang et al., 1999 
X10(G/C/R/S)G(V/A/
D/G)-X10a), 
X18PGX18a) 
SH3 Src fnRPLPPLPfc, (see Table 
1.1.6 entry 2) 
Sparks et al., 1994 
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Library Domain  Protein  Ligand Reference 
M13 display at N-terminus of phage coat protein VIII 
X9 SH3 h amphiphisin fnRPxRfc 
  h endophilin-2 fnP[+]RPPxPRfc 
Cestra et al., 1999 
X9 EH1-3 mEps15, 
mEps15R 
fnNPF([+]/Φ)fc 
fn(N/H)(P/H)F[+]fc 
Salcini et al., 1997 
EH1 mEps15 fnζNPF([+]/Φ)fc  class 
I 
EH2  fnζNPF([+]/Φ)fc class 
I 
EH3  fnFWfc, fnNPFWfc class 
II 
EH1 mEps15R fnNPFRfc class 
I 
EH2  fnζNPF([+]/Φ)fc class 
I 
EH3  fn(S/T)NPFRQfc class 
I 
EH1 yYBL047C fnYxxx(F/L)WRPfc, 
fnNPFfc 
class 
II 
class 
I 
EH2  fnWWxxADfc 
fnNPFfc 
class 
II 
class 
I 
EH3  fnRxxNPFRfc class 
I 
EH2 yPan1 fnNNPFxDfc class 
I 
X9 
 
EH1 yEnd3 fnSWGxxxWfc 
fnH(T/S)Ffc 
class 
II 
Paoluzi et al., 1998 
X9 WWb) Utrophin fnPPxYfc Di Vignano et al., 
2000 
X9 SH3 hEps8, mEps8, 
hEps8R2, 
mEps8R2 
fnPxxDYfc Mongiovi et al., 1999 
X9 EH frog Intersectin  fnNPFfc Yamabhai et al., 1998 
X9c) PTB Shc fnF/YxNPTpoYxxY/Wfc Dante et al., 1997 
X9c) SH2 Shc, 
Sli, 
Rai 
fnN(I/V)poY(E/G)T(I/V/L)(W/
F)fc 
fn(L/I/V)poY(E/G)T(W/Y/F)fc 
fn(V/I)poY(E/G)(T/Y)(I/L)fc 
Pelicci et al., 1996 
X10, X12, CX8C SH2 hGrb2 fnYxNfc, linear, constr. 
Table 1.1.6 entry 9 
Hart et al., 1999 
M13 display at C-terminus of phage coat protein VIII 
X7 PDZ2 
PDZ3 
MAGI3 kinase fn(T/S)WV 
fnFDI 
class I 
class II 
Fuh et al., 2000 
λ phage display at C-terminus of the D protein 
PDZ1 fn(V/R)ΩWΦ class II 
PDZ2 fnEΩDF class II 
X9 
PDZ3 
hINDAL 
fnΩDΦ, class II 
Vaccaro et al., 2001 
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Library Domain  Protein  Ligand Reference 
fnΩ(D/E) class IV 
PDZ4 fnEΦΩV class II 
PDZ5 fn(S/T)W(V/L) class I 
PDZ6 fnΦSΩV class I 
 
PDZ7 
 
fnSxV class I 
 
The T7 phage display at C-terminus of the 10B phage coat protein 
X16 SH3-1, 
SH3-2 
SH3-3 
CIN85 fnPx(P/A)xxRfc Kurakin et al., 2003 
Plasmid display 
X15d) PDZ3 PSD95 fnE(T/S)xV 
X15d) PDZ NNOS fnDxV 
Stricker et al., 1997 
a) the non-X positions resulted from the cloning strategy used to generate the oligonucleotide library 
b) interaction between peptides and WW domain occurred only in the presence of EF hands and ZZ domain 
c) modified through an efficient tyrosine residue phosphorylation using PTK p55fyn 
d) peptides were fused to the C-terminus of the Escherichia coli lac repressor 
 
1.1.4.2 Dedicated peptide libraries 
The rather short and general consensus motifs identified by screening of the random 
libraries above often failed to explain the specificity of proteins pulled down from cell extracts 
(Rickles et al., 1995). Specially constructed phage libraries displaying peptide ligand 
repertoires biased for particular domains have been constructed for a more detailed analysis 
of ligand preferences. Table 1.1.6 summarizes such experiments which were, in the majority, 
follow-up studies from experiments listed in Table 1.1.5. However, the predominance of such 
analyses was conducted using chemical peptide synthesis (see section 1.1.5). Schmitz et 
al., 1996, prepared a peptide repertoire X3YX4 of eight amino acids at the N-terminus of M13 
pIII to search for tyrosine kinase substrates. Following an enzymatic phosphorylation of the 
phage library, this repertoire was then suitable to study poY binding modules. A similar 
library as that of entry 5 (Table 1.1.6), X4PXXPX4, was used by Tong et al., 2002) in their 
systematic yeast SH3 domain study (see also section 1.1.2.1). 
 
Table 1.1.6: Screens of oriented peptide libraries 
Entry Library Domain Protein  Ligand  Classa) Reference 
M13 display at N-terminus of phage coat protein III 
1 X3YX4b) SH2 Grb2  fnpoY(M/E)NWfc II Gram et al., 1997 
2 8 (aa)c) SH3 Src fnRPLPPLPfc 1 R Sparks et al., 1994 
3 X6PPIPG,  
RSLRPLX6, 
PPPYPPX6 
SH3 hSrc, avian 
Src, 
Fyn, 
Lyn,  
fnRPLPPLPxPfc 
fnRPLPP(I/L)Pfc 
fnRxxRPLPPLPxPfc 
fnRxxRPLPPLPPPfc 
1 R 
1 R 
1 R 
1 R 
Sparks et al., 1996 
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Entry Library Domain Protein  Ligand  Classa) Reference 
P13K, 
MAbl 
fnPPPYPPPP(I/V)Pfc 1 @ 
4 X5RPLPPLPP
P, 
RSLRPLPPL
PX5, 
GAAPPLPPR
X5 
SH3 Src, Fyn, Lyn, 
P13K, Yes 
for details see 
reference  
1 R Rickles et al., 1995 
5 Src fnLxxRPLPxΨPfc 1 R 
 Yes fnΨxxRPLPxLPfc 1 R 
 Abl fnPPxΩxPPPΨPfc 1 @ 
 Cortactin fn[+]PPΨPxKPxWLfc 2 K 
 p53bp2 fnRPXΨPΨR[+]SxPfc 2 R 
 PLCγ fnPPVPPRPxxTLfc 2 R 
 Crk fnΨPΨLPΨKfc 2 K 
 
X6PXXPX6 SH3 
Grb2-N fn[+]ΩxPLPxLPfc I 
Sparks et al., 1996 
6 X6PPX6 WW HYAP, mYAP fnPPPPYPfc I Linn et al., 1997 
7 X6PPX6 WW 
 
hWWP1, 
hWWP2, 
hWWP3, 
hYAP, 
yRsp5.3, 
mNedd4 
fn(L/P)PxYfc I Kasanov et al.,  
2001 
8 X4CX4Y(D/A/
E/X)-NX3CX4 
SH2 Grb7  fnY(D/A/E)Nfc, constr II Pero et al., 2002 
M13 display at N-terminus of phage coat protein VIII 
9 X5YXNX8 SH2 HGrb2 for details see 
reference 
II Hart et al., 1999 
a) when available, sub-classification of SH3 modules is according to Cesareni et al., 2002 
b) modified through an efficient tyrosine residue phosphorylation using a mix of phosphotyrosine kinases Blk, c-
Src and Syk (Rickles et al., 1995) 
c) library containing 8 amino acid long peptides encoded by the DNA sequence ((C/A)NN)8 which restricted the 
amino acid compositions to the following proportions: 6R:4P:4L:3I:2H:2Q:2K:2N:2S:1M 
 
1.1.5 Synthetic peptide repertoires 
Combinatorial and simultaneous parallel chemical synthesis techniques have been 
developed and refined since the early eighties and were applied very successfully to the 
preparation of peptide repertoires for studying molecular recognition events in immunology. 
This concerns the discovery and analysis of immunogenic sites (the “epitopes”) of protein 
antigens recognized by antibodies and T-cells (Liu et al., 2003). Principally, the short 
functional sites recognized by the protein modules can be likewise considered as “linear 
epitopes”. Thus, the sophisticated approaches from immunology for library design and assay 
formats apply directly here. 
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Peptides are assembled through stepwise coupling of amino acid derivatives starting from 
the C-terminus tethered to a solid support material. There is a large variety of support 
materials and formats available with PEG-polystyrene (Rapp-Tentagel), polyethylene pins 
and cellulose membranes dominating the field. In addition to the 20 genetically coded aa, 
any non-natural synthetic derivative can be incorporated. Random positions in a library can 
be freely defined with respect to location and number in the sequence as well as the 
composition of aa residues, easily yielding theoretical diversities from a few hundred to 
several billion peptides. These positions are generated either by coupling a mixture of aa 
derivatives or by mixing together portions of support material from respective single aa 
coupling reactions (“mix and split”). Cysteines are often omitted or left protected (Acm-) to 
avoid random disulfide scrambling. After assembly and deprotection, peptides may be 
cleaved from the support and assayed in solution or are left tethered to the support for in situ 
solid phase binding assays. For more information see Ref. (Chan and White, 2000). 
These synthetic opportunities are exploited to generate and screen peptide libraries in many 
formats (for a review see Frank, 2002), such as: A) selection from the full random pool, B) 
iterative or recursive screening by various sub-library pooling strategies with a combination 
of one or more defined aa positions in a random background, the best hit of one screening 
round is then used as the start for the next round; C) “positional scanning” of all consecutive 
positions by single aa incorporations, or “dual positional scanning” for two neighboring 
positions, respectively; D) orthogonal (self-deciphering) pools; E) epitope mapping (or 
“peptide walking”), the systematic scanning of a protein sequence with overlapping peptide 
fragments, F) replacement analysis, the systematic single substitution of each epitope 
residue by one mock aa (e.g. alanine scan); G) “replacement net” analysis, the systematic 
single substitution of each epitope residue by all other aa residues; H) “motif scanning”, the 
systematic editing of an epitope sequence in an all alanine (A) or all random (X) background 
to define consensus recognition motives; I) finally, large collections of individual peptides 
derived by searching genomic sequences with epitope prediction algorithms (see section 
1.2.1). 
 
1.1.5.1 Soluble peptide libraries as ligand repertoires 
Screening for module binding is achieved by an affinity chromatography selection with an 
immobilized domain/protein of interest. The eluted peptides are sequenced or analyzed by 
mass spectrometry as a mixture. This readily yields the consensus binding motif as result of 
the pool analysis. The random library, however, has to be oriented to one or more residues 
that are decisive for binding in order to avoid phase problems if the interacting residues on 
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different peptides were located at different positions. Table 1.1.7 summarizes some library 
screens reported in the literature. 
 
Table 1.1.7: Screens of soluble peptide libraries. 
Library Specification td Screened 
domain 
Protein of 
origin 
Reference 
APXYSP5  20 SH3 Abl 
APTXSP5  20 SH3 Abl 
APTYSPXP3  20 SH3 Abl 
Santamaria et al., 2003 
MAX4YX4AK3 X – C,W 1.1 x 1010 PTB dNumb Li et al., 1997 
poY-oriented 
G(F2Pmp)XPXS-amide X–C; F2Pmp 
as mimic a poY 
361 SH2 Pl 3-kinase Kelly et al., 1996 
GDGpoYX3SPL3 X – C,W 5832 SH2 22 proteins Songyang et al., 1993 
GAX3poYX3K3 X – C,W 3.4 x 107 PTB Shc, Cbl Songyang et al., 1995 
MAX3NXXpoYXAK2 X – C,W 3.4 x 107 PTB ShcC O’Bryan et al., 1996 
poS/poT-oriented 
MAX3poSX3AKK X – C 4.7 x 107 14-3-3 8 proteins 
MAX4poSXPXXAKK X – C 8.9 x 108 14-3-3 8 proteins 
MAX3RXXRpoSXPAKK X – C 4.7 x 107 14-3-3 8 proteins 
MAXXRXXpoSXPAKK X – C 2.5 x 106 14-3-3 8 proteins 
MASXpoSXXAKK X – C 6.9 x 103 14-3-3 8 proteins 
Yaffe et al., 1997 
ISRSTpoSX3NK X – C 6.9 x 103 BRCT 5 proteins 
KAX3poSX3AK X – C 4.7 x 107 BRCT BRCA1 
Rodriguez et al., 2003 
MAX4poTX4AK3 X – C,W 1.1 x 1010 FHA 6 proteins 
MAX4poTXXIXXAK3 X – C 1.7 x 1010 FHA 3 proteins 
Durocher et al., 2000 
P-oriented 
MAX4PXXPX3AK3 X – C,W 2 x 1011 SH3 amphipysin Grabs et al., 1997 
MAX4PXXPX3AK3 X – C,W 2 x 1011 WW 4 proteins 
MAX4PX4AKK X – C 1.7 x 1010 WW 5 proteins 
MAX4PPRX4AK3 X – C 1.7 x 1010 WW 3 proteins 
MAX4YX4AK3 X – C,Y 1.1 x 1010 WW YAP 
Bedford et al., 2000 
C-terminal-oriented      
KNX8-COOH X – C,W 1.1 x 1010 PDZ 6 proteins 
KNX6(S/T/Y)XX-COOH X – C,W 1.1 x 1010 PDZ 5 proteins 
Songyang et al., 1997 
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1.1.5.2  Bead-bound peptide libraries as ligand repertoires 
A widely applied format of peptide libraries for bio-screening is the One-Bead-One-
Compound (OBOC) combinatorial library format synthesized on resin beads by the mix and 
split technique (for a review see Lam et al., 2003). The beads are of about 100 µm in size, 
carry about 100 pmol of a peptide sequence; one gram of resin contains about 3 x 106 
beads. They are screened by incubation with a domain/protein of interest and bound protein 
is detected by various labels. The positive labeled beads are manually isolated with the help 
of a microscope and tweezers and are then individually sequenced by Edman degradation. 
Several examples of screenings performed using the OBOC combinatorial library format in 
context of various protein domains are described below. A biased combinatorial library of 
peptides having the following form; X3PPXPXX-resin (X – C; td ~ 4.7 x 107) was synthesized 
and about 2 x 106 beads were screened with the fluorescently labeled SH3 domains of PI3K 
and Src (Yu et al.,1994). A combinatorial library AX3poTX3ABBRM-resin (X – C,M + 
norleucine as a substitute for M; td ~ 4.7 x 107) was screened with the biotinylated FHA1 and 
FHA2 domains of yeast Rad53 to determine their binding requirements (Liao et al., 2000). A 
phosphotyrosine-oriented peptide library DEXXpoYX3IBBRM-resin (X – C,M + norleucine 
td = 2.5 x 106) was synthesised and about 2.86 x 106 beads were assayed with the N- and 
C-terminal SH2 domain of SHP-1 (Beebe et al., 2000). 
If much smaller beads (~10 µm) are used, rapid FACS technology can be exploited to 
separate fluorescent positive beads. However, the peptide material per bead is not anymore 
sufficient for sequencing and, thus, other strategies are required to identify the ligands. Pool 
sequencing of the sorted beads was applied to reveal the binding consensus of the Grb2 and 
Syk SH2 domain screened with a phosphotyrosine-oriented peptide library 
EPX6poYX19X7X19X7X6 (the superscript numbers refer to the number of defined amino acids 
that were coupled at each position (td ~ 6.4 x 105); for a detailed matrix representation (see 
Muller et al., 1996). A recursive deconvolution strategy was applied to investigate the Grb2 
SH2 domain with a phosphotyrosine-oriented peptide library ASpoYX4SA (td = 1.6 x 105). 
First, twenty sub-libraries ASpoYO+1X3SA with one of the twenty amino acids fixed at the 
position O+1 were synthesized and incubated with a mixture of differently labeled target 
module and negative reference modules. The number of positive beads sorted for a 
particular aa/module combination was taken as a binding preference scale. In a series of 
synthesis and screening rounds, amino acid preferences for the consecutive random 
positions were determined likewise, taking the best hit of each previous screen. To select a 
high affinity motif the library was screened for beads that bind Grb2 but not the Grb2 R67H 
mutant. To search for the most selective ligand, Grb2 positive beads were sorted that do not 
bind to the SH2 domains of hAbl, Nck, bPl3Kp85-N, bPl3Kp85-C, mSHP-2N, vCrc and Grb2 
R67H, applied as a negative reference mixture (Kessels et al., 2002)  
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1.1.5.3 Peptide arrays as ligand repertoires 
Synthetic peptides displayed at high density as an array on a planar support are a potent 
alternative tool for repertoire screening (for a recent review see Frank, 2002). Currently, the 
major technique for in situ synthesis and screening by this approach is the SPOT method. 
Individual peptide preparations are easily synthesized at different locations on a cellulose 
membrane by distribution of small (< µl) volumes of the respective solutions of activated aa 
derivatives or aa mixtures per spot and peptide elongation cycle (Frank and Owervin, 1996). 
Up to 2000 peptides or peptide pools can be synthesized on a single 8x12cm (MTP) size 
sheet of cellulose paper and probed simultaneously with a domain/protein of interest. 
Positive spots of the probed array immediately indicate the sequence of the peptide(s) 
recognized. Relative intensities of binding signals measured on a SPOT peptide array are to 
a good degree representative for relative complex affinities (Kd´s) as proven by Biacor 
measurements (Hultschig, 2000) and competitive ELISA (Kramer et al., 1999). SPOT 
synthesis is used to construct various types of libraries.  
 
1.1.5.4 Sub-library pools for iterative a priori deconvolution  
A library XXOaObSXV-COO- with X (all combined 20 aa, except C, M and W) and O (all 
individual 20 natural aa) was synthesized as an array of the 400 sub-libraries for the OaOb 
combinations, each with a td of 17³ = 4913. This library was used to determine the aa 
preference of the syntrophin PDZ domain in the -3 and -4 position with respect to the 
essential C-terminal Val residue. For the display of a free carboxy terminus of the peptides, 
the tethering to the support had to be reoriented to the N-terminus! This was achieved first 
by coupling the N-terminus of the finished peptide back to the support in a cyclization 
reaction followed by cleavage of the C-terminal linker. Two descendant libraries XOKESXV-
COO- and XXKESOV-COO- (each sub-library with td = 289) were synthesized to define 
requirements at –1 and –5 positions. Also heptamer sub-libraries of the type X4OaXOb-COO-, 
X5OaOb-COO-, X3OaXXOb-COO-, X3OaXObX-COO- and so forth (each sub-library with 
td ~ 1.4 x 106) were synthesized, but relevant binding affinity could not be detected (Schultz 
et al., 1998). An oriented library AX3(poS/poT)X3A was used to evaluate binding specificity of 
four SH2 domains. The importance of different aa residues at any given position was 
estimated using a positional scanning library format. A total of 19 x 8 = 152 sub-libraries 
were spotted for the AX4(poS/poT)X4A library, each sub-library had a td ~ 1.8 x 109. This 
method was designed as the “Oriented Peptide Array Library” (OPAL) Strategy (Rodriguez et 
al., 2004). 
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1.1.5.5 Protein Scanning Repertoires (Peptide walking)  
With the increasing availability of genomic sequence information, and data from protein 
protein interactions, this approach is becoming more widely used. Libraries are characterized 
by “peptide length/offset” (offset is the number of aa residues by which overlapping peptide 
fragments are shifted along the protein sequence). A 15/6-scan of the L. monocytogenes 
ActA protein sequence (aa 30-614) was probed with radio-labeled VASP and led to the 
identification of the fn[-]FPPPPx[-]fc binding motif of the EVH1 domain (Niebuhr et al., 1997). 
A 15/3 scan of the human zyxin sequence was probed with the EVH1 domain of Mena and 
homologous binding sites were found (Dress et al., 2000). A 15/3-scan of the 140-kDa 
isoform of Mena revealed several binding sites for the FE65 WW domain all containing the 
PPLP sequence (Ermekowa et al., 1997). A 15/1-scan of the C-terminal domain of mGluR5 
(aa 1138-1169) identified the binding site LTPPSPF for the mVesl EVH1 domain, which 
recognizes the reverse of the Mena EVH1motif (Barzik et al., 2001). The binding site 
PSIDRSTKP of the Gads C-terminal SH3 domain on SLP-76 (aa 181-291) was identified 
with a 15/4-scan (Berry et al., 2002). A scan (11/2) of human synaptojanin (aa 1060-1312) 
was probed with the SH3 domains of amphiphysin and endophilin-2; several binding sites 
were identified, some matching the known consensus motifs and others do not (Cestra et al., 
1999). 
 
1.1.5.6 Replacement repertoires  
Once a peptide ligand is identified, the contribution of each single residue to the affinity and 
selectivity of the binding motif can be examined by systematic replacement approaches. 
Several examples are listed in Table 1.1.8 
 
Table 1.1.8: Screens of replacement repertoires- 
Protein-
ligand 
Binding sitea) Replacements Domain Protein Reference 
SLP-76 PSIDRSTKP Alanine scan SH3 Gads Berry et al., 2002 
APP QNGYENPTYKFFEQMQ
N 
Alanine scan PTB Dab1 Howell et al., 1999 
Clone 13 P7LPAP3QP Valine scan WW FE65 Ermekova et al., 
1997 
Clone 13 P7LPAP3QP Net WW FE65 Ermekova et al., 
1997 
APP QNGYENPTYKFFEQMQ
N 
Net (except C) PTB Dab1 Howell et al., 1999 
ActA SFEFPPPPTD Net EVH1 VASP Niebuhr et al., 1997 
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Protein-
ligand 
Binding sitea) Replacements Domain Protein Reference 
mGluR5 LEELVALTPPSPFRD Net EVH1 mVesl Brazik et al., 2001 
WBP-1 GTPPPPYTVG Net WW hYAP Chen et al., 1997  
Pires et al., 2001 
artificial CPKPPKYPKK Net WW hYAP Linn et al., 1997 
SLP-76 PSIDRSTKP Net SH3 Gads Berry et al., 2002 
synaptojanin LPIRPSRAPSR Net SH3 Amphiphisin 
endophilin 2 
Cestra et al., 1999 
synaptojanin LEPKRP4RP Net SH3 amphiphisin 
endophilin 2 
Cestra et al., 1999 
α-subunit 
the skeletal 
muscle 
VGSCs 
GVKESLV Net PDZ syntrophin Schultz et al., 1998 
BACH1 SRSTpoSPTFNK Net (except C) BRCT BRACA1 Rodriguez et al., 
2003 
ActA SFEFPPPPTEDEL Net EVH1 VASP 
ActA EFPPPPTEDELEII Net EVH1 VASP 
Ball et al., 2000 
a) aa positions replaced are in bold 
 
1.1.5.7 Genome/proteome scanning  
Literature and data base searches for functional sites of protein modules are an increasingly 
important and rich source for peptide ligands which can be synthesized and investigated 
using the SPOT method. A repertoire of 70 peptides that were described as SH3 or WW 
ligands was probed with VASP to assess the selectivity of the EVH1 domain (Niebuhr et al., 
1997). An array of all C-terminal heptapeptide sequences of human proteins found in 
Swiss-Prot release 34 (3514 sequences) was synthesized with a free carboxyl end by 
Hoffmüller et al., 1999, and probed with the HRP-labeled PDZ domain of syntrophin. 
Landgraf et al., 2004, took the binding motif cores of eight yeast SH3 domains that were 
obtained by phage display experiments (Tong et al., 2002), to define for each one a less 
selective “relaxed pattern”. The Saccharomyces Genome Database was scanned for 
peptides matching these patterns. Approximately fifteen hundred peptides for each domain 
were selected for synthesis and probed with the corresponding SH3 domains. This 
procedure was called WISE (Whole Interactome Scanning Experiment). They reproduced 
this approach also with the SH3 domains of two human proteins, amphiphysin 1 and 
endophilin 1, for which peptide ligands were selected from the Swiss-Prot/TrEMBL database. 
A total of 3774 peptides were synthesized and tested with these two SH3 domains  
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1.1.5.8 Peptide arrays as domain repertoires 
The WW domain, the smallest of all known protein modules, was the subject of a synthetic 
approach to study structure activity relation. A replacement net repertoire (cysteine excluded) 
of 837 individual variants of the 44 residue large hYAP WW domain was synthesized using 
the SPOT method. This array was probed with peroxidase-labeled EYPPYP4YPSG peptide 
(Ball et al., 2000). Another repertoire of 11 859 variants of the hYAP WW domain was 
assembled by a combination of the SPOT method with native chemical peptide ligation. One 
set of 193 = 6859 WW domains (38-mers) with simultaneous substitutions at positions 30, 32 
and 35 (making up the ligand binding pocket), by any of the 19 proteinogenic amino acids 
(excluding C). A second set of 5000 variants was synthesized bearing combinations of 19 
proteinogenic, 20 non-proteinogenic and phosphorylated amino acids in positions 30, 32 and 
35. These arrays were probed with 22 dye labeled different peptides ligands GTP4XTVG (X–
C but including poY, poS and poT) (Toepert et al., 2003). 
 
1.2 The experimental concept 
All experimental approaches described above using peptide repertoires are more or less 
applied to analyze known families of domain interactions using peptide repertoires built 
around consensus binding motifs. There is missing a genome-wide search for new families 
and principles. This is the primary goal of the experimental concept underlying this thesis.   
Both, Hawlisch et al., 2001 and Bialek et al., 2003 have shown that multiplex bio-panning 
with phage-displayed protein libraries can be carried out with a multitude of peptide targets 
arrayed on a planar surface. The project, thus, aims to utilize the two-dimensional screening 
concept of a library of peptide fragments versus a library of protein domains; both libraries 
should include all relevant components from a biological model system of interest such as a 
microorganism, eukaryotic cell or tissue. Both libraries, thus, are more or less genome 
spanning and considerably large. Peptide fragments will be displayed as immobilized 
synthetic compounds in the format of macroarrays. These are manufactured on planar 
continuous supports by in situ parallel chemical synthesis utilizing the SPOT technique (see 
section 1.2.2). A bacteriophage library displaying protein fragments expressed from a 
randomly fragmented cDNA library cloned into the phage genome to yield fusions with an 
envelope protein will be the source for the protein domains. The screening through large 
numbers of peptides simultaneously (multiplexed) should be possible with only a minimum of 
panning rounds, preferably with only one, to make this approach practicable. Furthermore, 
there will be more than just one, rather a family of protein domains enriched on one peptide 
ligand; members of this family will have different affinities toward the peptide ligand. 
Obviously, this situation requires a very competent analytical tool which can identify the 
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multitude of specifically enriched phages in a huge background of unspecific phages and all 
this in a high-throughput process.   
 
1.2.1 Accessible Surface Scanner 
Proteins interact via surface accessible interaction sites which involve amino acid side chain 
and backbone contacts along a linear segment of the protein chain (linear/continuous 
epitopes) or involve amino acid residues from two or more segments of the protein chain 
brought together by the folded conformation (conformational epitopes). Continuous binding 
sites can be efficiently represented by synthetic peptide fragments (Frank, 2002). Several 
possibilities to generate diverse peptide repertoires were briefly described in the section 
1.1.5. When taking into account that continues epitopes correspond to the surface exposed 
regions of proteins and a large part of a protein determines its core (Atassi, 1979; Atassi and 
Kuriaski, 1984), the synthesis of only the exposed regions that contain potential interaction 
motifs seems reasonable and will reduce the effort of the approach considerably (see Fig 
1.2.1).  
Fig 1.2.1: Drawing showing bio-active “epitopes” exposed on the protein surface (in black). Taken 
from Atassi, 1979.  
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One of the approaches to identify exposed regions without knowing the 3D-strucure involves 
computational scanning of the genomic sequences using epitope predicting algorithms. 
Several algorithms based on hydrophilicity (Kyte and Doolittle, 1982), chain flexibility 
(Karplus and Schultz, 1985), turn prediction (Chou and Fasman., 1978), solvent accessibility 
(Rost, 1996) and surface probability (Emini et al., 1985) have been proposed for prediction of 
the protein exposed regions. Some of these (surface accessibility, chain flexibility and turn 
prediction) have been combined in a computer program, which predicts antigenic index 
(Jameson and Wolf, 1988), claimed to be more powerful than any single predictive 
parameter. For predictions of surface exposed protein regions from genomic sequences and 
convenient generation of peptide repertoires, a software tool, called Accessible Surface 
Scanner (ASS) was developed, which is entirely based on the Emini’s surface probability 
algorithm. Fig 1.2.2 shows interface of the ASS software tool. 
Fig 1.2.2: Picture showing interface of the Accessible Surface Scanner software (ASS, by David 
Lincoln)  
 
The algorithm utilizes the empirical amino acid accessible surface probabilities of Janin 
which are fractional probabilities (0.26 to 0.97) determined for an amino acid found on the 
surface of a protein, based upon structural data from 28 proteins (Janin et al., 1978). For a 
given amino acid sequence, a surface probability for amino acid “n” is a normalized product 
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of the surface probabilities of amino acids in positions n-2 to n+3. For detailed information 
refer to Emini et al., 1985. The surface probability for a random hexapeptide is equal 1.0. 
The probabilities greater than 1.0 indicate an increased probability for the hexapeptide of 
being found on the surface. Large repertoires of peptides can be generated using the ASS 
software, as unlimited number of protein sequences can be scanned simultaneously. Protein 
sequences can be downloaded from genomic and proteomic databases in “fasta” format. 
Software parameters can be easily varied, which allows for more or less stringent surface 
probability predictions. Different length of generated peptide can be defined by typing desired 
number in peptide length window. Peak overlap parameter can be varied in a similar way. 
For example, in the case of setup shown in Fig 1.2.2, an appropriate number of 25 aa 
peptides overlapping with 10 aa will be generated from a surface probable fragment that is 
longer than the defined peptide length. Peak height parameter, defines threshold of surface 
probability. Amino acids with higher surface probability values than the defined threshold are 
considered as surface probable and are proposed peptide fragments to be synthesized. 
Minimum width parameter defines number of amino acids with values greater than the peak 
height threshold that have to be next to each other in order to qualify a particular region for 
peptide generation. Next parameter was introduced for smoothing of surface probability 
values using Savitzky and Golay filters. For detail refer to Savitzky and Golay, 1964. 
Following scanning of multiple protein sequences, resulting output files contain generated 
peptides only. In the case of calculations performed for a single protein sequence, a surface 
accessibility plot and a list of all amino acid residues with their surface accessibility values 
are available also. Advantageously, output peptide files are fully compatible with software 
controlling the automated peptide SPOT synthesis, which allows for convenient and safe 
transfer of data and synthesis of peptide repertoires. 
 
1.2.2 The SPOT synthesis technique 
Arrays of peptides for multiplexed phage-panning will be generated with the SPOT-synthesis 
method. SPOT synthesis belongs to the family of positional addressable solid phase 
methods. It is an easy and very flexible technique for simultaneous parallel chemical 
synthesis on membrane supports (Frank, 1992). In principle, dispensing of a small droplet of 
liquid on a planar surface of a porous membrane results in its absorption and formation of a 
circular spot. When appropriate reagents, dissolved in a low volatility solvent are spotted on 
defined positions, such spots form open reactors for chemical conversions involving the 
reactive functions anchored to the membrane support, e.g. conventional solid phase 
synthesis (Merriefield, 1963). The SPOT technique is especially widely used for generation 
of large repertoires of peptide fragments in a high-density array format. In this case, low 
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volatility solutions of N-terminally and side chain protected amino acids are distributed by 
manual or automated pipetting to defined positions on a modified cellulose membrane and 
are coupled in situ to the previously functionalized solid support see Fig 1.2.3. To prepare 
the membrane supports for chemical peptide synthesis the entire cellulose membranes were 
originally modified by esterification β-alanine (Fmoc-β-Ala) followed by removal of Fmoc 
protection group. Nowadays, specially modified membranes for preparations of either 
immobilized or solution-phase peptides are available commercially (see section 2.2.6). Novel 
types of special safety-catch linkers have been developed to cleave also C-terminally 
unmodified peptide acids or amides directly into neutral aqueous buffers for direct use in 
bioassays. Fmoc-β-Ala is initially distributed on the previously defined positions on the 
membrane generating sites for peptide synthesis. The remaining amino groups on the 
membrane are acylated and therefore no longer accessible for further reactions. Elongation 
of peptide sequence is an iterative process employing several washing steps as well as 
steps of de-protection, coupling and acylation of amino acids. The technical description of 
the entire process is in the material and method chapter (see section 2.2.6). In general, the 
N-terminal protection groups are removed before distribution of different activated amino 
acids to different peptide sites. After coupling reaction is completed, the remaining free 
amino functions are deactivated by acylation. In the next step the protecting groups of 
coupled amino acids are removed and the entire cycle can be repeated. After coupling the 
last amino acid, all peptides are N-terminally acetylated to mimic the backbone of proteins.  
Fig 1.2.3: Schematic illustration of the principle of the SPOT method.  
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Despite several steps during SPOT peptide synthesis must be carried out manually, the 
delivery of the activated amino acids to corresponding reaction sites has been automized 
using the SPOT synthesizer (Fig 1.2.4) developed at ABIMED Analysen-Technik GmbH 
(Langenfeld, Germany). The process automation helped to reduce the size of spots and 
thus, increase the number per area considerably. Currently, 2500 spots can be generated on 
a microtiter plate size sheet. This is definitely helpful in a high-throughput application of this 
technique. SPOT peptide arrays are particularly suited for in situ biological activity screening 
in binding or enzymatic transformation assays. They became a very important tool for 
studying of e.g. protein-protein/peptide interactions, mapping of immunological epitopes, 
studying of binding motifs of protein modules. Several examples of application of SPOT-
peptide arrays for different approaches concerned with protein-protein interactions were 
shown in the previous section. Much wider scope of their applications is reviewed in Frank, 
2002.  
Fig 1.2.4: Picture showing the ABIMED peptide synthesizer delivering activated amino acids on the 
appropriate reaction sites. 
 
1.2.3 T7 and lambda phage display systems  
Several phage display systems are available for the anticipated approach, for a recent 
review refer to Castagnoli et al., 2001. Three most popular phage display systems are based 
on filamentous (e.g. M13) and virulent T7 and lambda bacteriophages. The M13 phage has 
been successfully used for display of peptides (see section 1.1.4) and antibodies or their 
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fragments (Clackson et al., 1991; Hoogenboom et al., 1998). Serious limitations of this 
system derive from the characteristics of the phage life cycle. Filamentous phages are 
released from the host cell without breaking the integrity of the cell membrane, and proteins 
that are eventually assembled to form the capsid must cross the lipid bilayer of the inner 
membrane. Thus, any peptide or protein whose properties prevent it from crossing the 
membrane will stop the correct transfer of the hybrid capsid protein which will not be 
assembled. Finally, other limitations derive from the chemical characteristics of the 
periplasmic environment which may affect the folding and stability of the protein to be 
displayed (Castagnoli et al., 2003). Contrary to this, virulent phages assemble in the 
cytoplasm and lyse bacterial membrane. This is advantageous for display of large proteins, 
which can not be efficiently transported through the lipid bilayer of. Therefore virulent 
bacteriophages seem advantageous for display of various genomic protein libraries and are 
more suitable for genome wide screenings purposed in this work. Several significant 
differences in surface display of proteins were reported for both phage types. This are mainly 
concerned with the number and size of proteins presented as fusions with capsid proteins 
(Castagnoli et al., 2001). Comparison of display efficiencies for both T7 and lambda virulent 
phages is summarized in Table 1.2.1.  
 
Table 1.2.1: Main characteristics of the virulent T7 and lambda display systems. Maximum size refers 
to the size of the heterologous protein successfully fused to the coat protein indicated. Castagnoli et 
al., 2001 
 T7 Lambda 
Protein p10 pV pD 
Copy/capsid 415 192 405 
C/N terminal C C N C 
Density High Low Low High Low High Low 
Maximum size (aa) <50 <900 >1024 ND 286 >300 1024 
 
Both display system presents very similar characteristics with respect to efficient display of 
short peptides at high density. Nevertheless, the gpD capsid protein of lambda phage seems 
more tolerant towards large (>300 aa) proteins displayed at high copy number. Higher 
display efficiency of lambda phage, increases avidity of displayed proteins, which is 
advantageous for selection of weaker interacting candidates of large size. On the other hand, 
the T7 bacteriophage has a shorter life cycle and, as a consequence, the time needed to 
perform multiple panning cycles is substantially decreased. Furthermore, differently from 
lambda, the T7 phage particle is extremely robust and resistant to harsh conditions that can 
be used to elute hybrid phage particles bound to their ligands without affecting phage 
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infectivity (Castagnoli et al., 2001). Large diversity of T7 phage display cDNA libraries 
(T7Select) achieved from different, diseased or healthy tissues of different organisms are 
commercially available from Novagen. Libraries utilizing lambda phages (λgt10 and λgt11) 
can be purchased from Clontech. Protein and peptide libraries displayed on lambda phage 
were also contracted by other researchers (Moriki et al., 1999; Santi et al., 2000; Zucconi et 
al., 2001; Sternberg and Hoess, 1995). 
 
1.3 Aim of this thesis 
The general goal will be to develop a process for the genome-wide interaction mapping 
between protein domains and peptide ligands based on the experimental concept described 
above and which is robust and truly high throughput. To realize this, several different tasks 
will have to be solved, briefly described below.  
As mentioned before, the project is based on two dimensional screening of genome-
complement repertoires of protein domains displayed on phage particles versus SPOT 
peptide-ligands arrayed on a planar surface. Before employing such large repertoires, a set 
of three model protein domains and their respective, known proline-rich peptide-ligands will 
be applied to evaluate technical prerequisites of the concept. Table 1.3.1 lists the properties 
of these domains.  
 
Table 1.3.1: Characteristics of the three model protein domains selected for proof-of-principle studies 
Code Type of 
domain 
Parent 
protein 
Peptide ligand Kd  
(µM) 
DNA 
size 
(bp)a 
Domain 
size 
(aa) 
Reference 
E EVH1 mMena SFEFPPPPTDEELRL-pep-E 5 467 113 Niebuhr et 
al., 1997 
Y WW hYAP GTPPPPYTVG-pep-Y 54 278 64 Chen and 
Sudol 1995 
F WW RFE65 PPPPPPPLPAPPPQP-pep-F n.d. 228 46 Ermekova et 
al., 1997  
a) Size of the PCR product with TS21 and TA20 primers (see Table 2.1.6.1 in section 2.1.6) 
 
The most important features of the model domains for this study are their different affinities 
for the peptide ligands covering lower and higher affinity interactions as well as their 
characteristic difference in the size of the coding DNA to allow for an easy identification by 
PCR and gel electrophoretic sizing. Previously, these model domains were cloned into the 
T7 phage chromosome to be displayed on the phage surface and successfully applied for 
affinity selections on their peptides on spots. Similarly, three other, indifferent proteins Fas 
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antigen (Siegel et al., 2000), Ezrin (Gary and Bretscher, 1995) and Interleukin-4 (Singh, 
2003), were cloned in he same chromosome and used for dilution of model domains in 
selection experiments. These studies were carried out in order to set up the bio-panning 
process and phage recovery from the spots (for details see Bialek et al., 2003).  
Here, the model domains will be cloned also into the chromosome of lambda phage and 
these two different phage display systems will be compared with respect to peptide-specific 
enrichment on peptide arrays containing respective ligands. The major difference between 
these phage vehicles is the density of protein presentation on the phage capsids, which is 
considerably higher for lambda, as described in section 1.2.3. This will result in a higher 
avidity of lambda complexes with the high local density of immobilized peptide ligands on 
spots of the planar surface. It was also reported that the selectivity for high-affinity ligands is 
best with T7 and for low-affinity ligands best with lambda (Castagnoli et al., 2001). Because 
of the differences in binding affinities between the model domains, they are perfect for such 
type of comparison. This will help to chose better performing phage display system for future 
applications.  
Another task will be concerned with an evaluation of the ASS computer software tool 
described in section 1.2.1, which was developed for prediction of surface-exposed peptide 
fragments from protein sequence data. A set of sequences of proteins containing known 
binding motifs for different protein domains will be scanned using different parameters. 
Additionally, computational surface probability predictions will be compared with crystal 
structures of analyzed proteins. The most optimal parameters set deduced from these 
studies will be employed for generation of large peptide repertoires from sequences of native 
proteins. Peptides will be synthesized in the form of spot macroarrays on the cellulose 
membranes. Resulting peptide macroarrays will be used for high-throughput phage panning 
experiments with protein domain repertoire, employing experimentally selected display 
system.  
Obviously, the most important task in this thesis will be the establishment of a robust and 
practicable analytical method allowing for identification and validation of protein domain-
peptide interactions. This method must be competent and sensitive enough to distinguish 
between many different specific and non-specific binding events after only one cycle of 
affinity selection.  
Finally, for purpose of fitting all elements into an automated high-throughput process, affinity 
enrichment tests on a novel structurally modified plastic surface, which is suitable for 
spatially addressable parallel peptide synthesis and phage elution, will be performed. This 
surface is designed to prevent contact of liquids added to different neighbouring peptide 
spots for dissociation of bound phage populations. 
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2. Material and methods  
 
2.1 Material 
2.1.1 Chemicals/reagents, materials, kits and enzymes 
All chemicals used in the context of this thesis were of analytical quality. Aqueous solutions 
were prepared with double deionized (Milli-Q) water. Where applicable, solutions were 
autoclaved. All chemicals, materials, kits and enzymes that are not shown in Table 2.1.1.1 
were purchased from Aldrich, Amersham Pharmacia, Difco, Fluka, GibcoBRL, Merck, 
Millipore, New England Biolabs, Novagen, QIAGEN, Riedel de Haen, Roche, Roth, Sigma, 
Schmidt, Greiner, AB Gene and Stratagene. 
Fmoc derivatives of amino acids and further reagents for peptide synthesis were obtained 
from Bachem, Calbiochem and Alexis. 
 
Table 2.1.1.1: Chemicals/reagents, materials, kits and enzymes 
Product Provider 
Chemicals/Reagents 
Albumin bovine serum  
Betaine, PCR Reagent 
Heparin  
MTT 
Sigma; Steinheim, Germany 
Alkaline Phosphatase-conjugated Streptavidin Dianova; Hannover, Germany 
BCIP Biomol GmbH; Hamburg, Germany 
IPTG C.Roth GmbH; Karlsruhe, Germany 
L.M.P Agarose Invitrogen GmbH; Karlsruhe, Germany 
peq GOLD Universal Agarose peqLab Biotechnologie GmbH; Erlangen, 
Germany 
Skim Milk (Difco) Otto Nordwald KG; Hamburg, Germany 
Proteinase inhibitor cocktail Sigma; Steinheim, Germany 
DNA MB grade from fish sperm Roche Diagnostics GmbH; Mannheim, Germany 
dNTPs New England Biolabs GmbH; Frankfurt am 
Main, Germany 
Cyanine 5-dCTP  
Cyanine 3-dCTP 
Perkin Elmer Life sciences, Inc; Boston, MA, 
USA 
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Material 
Amino-PEG-Cellulose membranes AIMS Scientific Products GmbH; Braunschweig, 
Germany.  
Protran BA 85 membrane 0.45µm, φ 132 mm Schleicher & Schuell; Dassel, Germany 
Amine Silinated Slides Cell Associates Inc; Pearland, Texas, USA 
Super Amine Substrates TeleChem International Inc; Sunnyvale, CA, 
USA 
MultiScreen – PCR Plates Millipore; Eschborn, Germany 
96 well PCR plates Thermo-Fast 96, Skirted 
384 well microarraying plates 
Adhesive PCR film 
Gas permeable adhesive seals 
AB Gene; Epsom, Surrey, UK 
Square 96 well blocks Qiagen; Hilden, Germany 
Dialysis membrane 12 – 14 kDa Meticell International Ltd, London, UK 
Kits 
QIAprep Spin Miniprep Plasmid Kit 
QIAquick Gel Extraction Kit 
PCR Purification Kit 
R.E.A.L Prep 96 plasmid kit 
Qiagen; Hilden, Germany 
Montage 96 plasmid miniprep kit Millipore; Eschborn, Germany 
Nucleobond AX 100 kit Macherey-Nagel; Düren, Germany 
ReadyTo Go Lambda Packaging Kit Amersham Pharmacia; Freiburg, Germany 
Enzymes 
Shrimps alkaline phosphatase  USB cooperation, Cleveland, USA 
HindIII 
EcoRI 
NotI 
SpeI 
XhoI 
Taq DNA Polymerase 
New England Biolabs GmbH; Frankfurt am 
Main, 
Germany 
Taq DNA Polymerase 
T4 DNA Ligase 
Promega GmbH; Mannheim, Germany 
HotGoldstar DNA Polymerase Eurogentec Deutschland GmbH; Köln, Germany 
Pfu polymerase MBI Fermentas GmbH, St. Leon-Rot, Germany 
Self-made (SM) Taq DNA Polymerase  GBF, Braunschweig (see 2.2.1) 
Antibodies 
rabbit anti-Mena PAK 73  Purchased from Dr. Melanie Barzik 
Goat anti-rabbit IgG, POD-conjugated Jackson Immuno-Res, Cambridgeshire, UK  
Rabbit anti-GST, POD-conjugated Sigma; Steinheim, Germany 
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2.1.2 Devices 
 
Table 2.1.2.1: Devices used for this work 
Device Symbol/Description Provider 
SPOT synthesis 
Automated SPOT robot Abimed ASP222 Abimed Analysen Technik; 
Langenfeld, Germany 
Microarray  
Contact printing robot MicroGrid II TAS BioRobotics; Cambridge, UK 
Printing Split Pins Microspot 2500 GeneWorx AG; Oberhaching, 
Germany 
Hybridization station  Lucidea Slide Pro Amersham Biosciences; 
Buckinghamshire, UK 
Biochip Reader ArrayWorx Applied Precision; Issaquah, 
WA, USA 
Biochip Reader GMS 418 Genetic Microsystems; 
Woburn, MA, USA 
Agarose gel electrophoresis 
Agarose gel tanks Agagel Mini, Agagel G45, 
Agagel Maxi 
Biometra Biomedizinische 
Analytik GmbH; Göttingen, 
Germany 
Agarose gel tank Electro-Fast WIDE SYSTEM AB Gene; Epsom, Surrey, UK 
Power supply 
High Voltage Power Pack 
Minicell Power Pack 
P30 
P040-000 
Biometra Biomedizinische 
Analytik GmbH; Göttingen, 
Germany 
Gel documentation 
CCD Camera controlled by 
EASY Image 3.16 software 
UV Transiluminator  
 
 
UVT-20 
Herolab; Wiesloch, Germany 
PCR devices 
MJ Research Peltier Thermal 
Cycler 
MJ Research Thermal Cycler 
PTC 200 
 
Tetrad with 4 alpha blocks 
Biozym Diagnostics GmbH; 
Hess. Oldendorf, Germany 
Centrifuges and rotors 
Sorvall centifuge RC5C Kendro Laboratory Products; 
Bad Homburg, Germany 
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IEC centrifuges Micromax RF 
Centra-GP8R 
Int. Equip Company/Life 
Sciences International; 
Frankfurt, Germany 
Sorval rotors  SS-34 
SLA-1500 
SLA-3000 
Kendro Laboratory Products; 
Bad Homburg, Germany 
Photometers 
RNA/DNA calculator 
UV/Visible Spectrophotometer 
GeneQuant II 
Ultrospec 2000 
Pharmacia Biotech Europe 
GmbH; Freiburg, Germany 
Other equipment 
UV Crosslinker Stratalinker 1800 Stratagene; La Jolla, CA, USA 
pH-Meter CG 840 Schott-Geräte GmbH, 
Hofheim, Germany 
Thermomixer 54 36 Eppendorf; Hamburg, 
Germany 
Incubator Multitron Infros HT GmbH; Einsbach, 
Germany 
Shakers  Rotamax 120 
Duomax 1030 
Heidolph Instruments GmbH 
& Co. KG; Schwabach, 
Germany 
French Press French Pressure Cell Press SLM-Aminco; Rochester, USA 
Electroporator Gene Pulser II  Biorad Laboratories GmbH;  
München, Germany 
Multichannel Electronical Pipet Finnpipette BioControl Labsystems; Helsinki, Finland 
Evaporator centrifuge Univapo 150 H UniEquip; Martinsreid, 
Germany 
Vacuum Manifold MultiScreen Separation System Millipore GmbH; Eschborn, 
Germany 
 
 
2.1.3 Computer software 
Several computer programs were used in the context of this work. Accessible Surface 
Scanner software version 1.0 was used for selection of peptides for SPOT synthesis 
(developed by David Lincoln). Microarray analysis was made with ImaGene 5.5.2 and 
GeneSight 3.5.2 software (BioDiscovery, Inc; Segundo, USA). TAS Application Suite 2.2.2.8 
(BioRobotics; Cambridge, UK) was explored for set-up parameters and printing of microarray 
cDNA biochips. A hybridization protocol was developed with Lucidea Slide Pro 2.0 software 
(Amersham Biosciences; Buckinghamshire, UK). Live Image 1.51.0.42 (Genetic 
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Microsystems; Woburn, MA, USA) and ArrayWorx 2.1.2 software suite (Applied Precision; 
Issaquah, WA, USA) were used for scanning of the microarray biochips. DNA sequencing 
data were evaluated with Segman II a Lasergene module (DNA Star, Inc; Madison WI, USA). 
Oligonucleotide primers were engineered with Vector NTI 3.1 (InfroMax, Inc; Gaitherburg, 
MD, USA). Images were viewed and converted with Jasc Paint Shop Pro 4.1.    
 
2.1.4 Bacteria, bacteriophages and clone libraries 
Different E. coli strains used in this work are shown in Table 2.1.4.1. Bacteriophage lambda, 
λDisplay1 was a kind gift from Prof. Gianni Cesareni, the University of Rome, Italy. Adult 
Human Brain phage-display library, T7select10-3b was purchased from Novagen; Madison, 
USA. The full-length cDNA clone library of human brain amygdala region as well as two 384 
well clone plates selected from the other two libraries were purchased from RZPD; Berlin, 
Germany.  
The amygdala library: Name Hamy 2; No. 761, Plates No. 1, 2, 7 – 20; 6144 clones 
 
Table 2.1.4.1: E. coli strains. 
E. coli - strain Genotype/Phenotype References/Provider 
BB4 3,4 LE392.23 [F´ lacIqZ∆M15 proAB Tn10 (TetR)] Greener, 1993 
Bullock et al., 1987 
Stratagene 
BLT5403 F– ompT hsdSB (rB – mB –) gal dcm pAR5403 
(ApR) 
Novagen 
BLT5615 F– ompT hsdSB (rB – mB –) gal dcm pAR5615 
(ApR) 
Novagen 
DH10B™ F– mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 
recA1 endA1 ara 139 (ara, leu) 7697 galU galK - 
rpsL (StrR) nupG 
Invitrogen 
Grant et al., 1990 
Gene Hogs, 
DH10B™-derived E. 
coli strain 
F- mcrA  mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 
recA1 endA1 araD139 (ara-leu) 7697 galU galK 
rpsL (StrR) nupG 
Invitrogen 
BL21(DE3)pLysS F– ompT hsdSB (rB – mB –) gal dcm (DE3) pLysS 
(CmR) 
Studier et al., 1990 
Novagen 
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2.1.5 Vectors 
All vectors used in this work are briefly described in Table 2.1.5.1. Plasmids/phagemids were 
isolated from library clones obtained from RZPD.  
 
Table 2.1.5.1: Plasmids, phagemids and recombinant vectors engineered for the purpose of this work. 
Plasmid/phagemid Genotype/Phenotype References/Provider 
pSPORT 1 General: Phagemid ds-DNA 4019 BP 
Function: cloning, sequencing 
Promoter: SP6, T7 
Resistance: amp 
Ori: pUC 
Host: E. coli 
Related to: pSPORT series 
Available from Invitrogen, as 
a clone from RZPD 
pCMV-SPORT 6  General: Phagemid ds-DNA 4396 BP 
Function: cloning, eukaryotic expression  
Promoter: SP6, T7 
Resistance: amp 
Ori: pUC, SV40 
Host: E. coli, mammalian 
Related to: pCMV-SPORT series 
Available from Invitrogen 
clone source: RZPD Berlin 
pOTB 7  General: Plasmid ds-DNA 1815 BP 
Function: cloning  
Promoter: SP6, T7 
Resistance: cm 
Ori: pUC 
Host: E. coli 
Related to: pOTB 2 
Link: www.fruitfly.org 
Available as a clone from 
RZPD 
Phage display vectors 
T7Select10-3b T7Select series  Novagen; Rosenberg et. 
al,1996 
λDisplay1 Related to: λpRH825 and λ171 Castagnoli et. al, 2001 
Santi et. al, 2000 
Recombinant vectors engineered for purpose of this work 
pCMV-SPORT 6 + E, 
F, Y, Fas, IL4, Ezr  
Refere to pCMV-SPORT6 This thesis 
pOTB 7 + E, F, Y, 
Fas, IL4, Ezr 
Refere to pOTB7 This thesis  
λDisplay1 + E, F, Y Refere to: λDisplay1 This thesis (3.1.1) 
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2.1.6 Oligonucleotides 
Oligonucleotides were purchased as a lyophilised DNA from: Invitrogen GmbH; Karlsruhe, 
Germany, MWG; Ebersberg, Germany and Biospring; Frankfurt am Main, Germany. Stock 
solutions at a final concentration of 100 pmol/ml and 10 pmol/ml were prepared by 
resuspension of lyophilised DNA in autoclaved Milli-Q water or TE-buffer. Aliquots were 
stored at –20°C. Oligonucleotides shown in Table 2.1.6.1 were used for PCR, cloning and 
sequencing.  
 
Table 2.1.6.1: Oligonucleotides: Recognition sites of endonucleases are underlined 
Primer pair Sequence (5’ → 3’) 
Protein domain specific primers for PCR amplification of DNAs coding for Mena-EVH1, 
WW/FE65, WW/Yap domains and following proteins: Fas antigen, IL-4, Ezrin 
E1 
E2 
CGTGAATTCCATGGCTGAACAGAGT    
GGTAAGCTTCGACGTAGATCCTGTCAAT   
F1 
F2 
TCTGAATTCCGATCTACCGGCTGGA   
ATGAAGCTTCCCCTGTGATGGGGAG   
Y1 
Y2 
GGCGAATTCTTCTTTTGAGATACCTGATGA 
AATAAGCTTCGACTGGTGGGGGCTG   
Fas S 
Fas A 
TACGAATTCAGGCCGCCCGCTGTTTTC 
ACTAAGCTTCCATCATGGGTGGCAGGCTCT C 
IL S 
IL A 
ACGGAATTCAGCTATTGATGGGTCTC 
GCAAAGCTTAAAGCATGGTGGCTCAGTA 
Ez S 
Ez A 
CCCGAATTCTACAGCCGAATAGCCGAGG 
GTAGAAGCTTGGCCCCGTAACTGCTCTTTAAGGGACTGG 
Primers used for PCR amplification and sequencing of T7Select 10-3b cDNA library clones 
TS 21 
TA 20       
GGAGCTGTCGTATTCCAGTCA   
AACCCCTCAAGACCCGTTTA   
Primer used for transfer of DNA inserts from T7Select 10-3b vector into λDisplay1 vector 
T7S 
T7A 
TCAACTAGTATGCTCGGGGATCCGAA    SpeI 
CGTTACCTAGTTACTCGAGTGCGGC 
Primers used for PCR amplification of DNA inserts cloned into λDisplay1 vector 
LS 
LA 
CGGCAATCAGCATCGTTACT 
CGAATTCCTTAGCGGCCG 
Primers used for PCR amplification of DNA inserts cloned into pCMV-SPORT 6 vector 
RZPD T7 
RZPD SP6 
TAATACGACTCACTATAGGG 
ATTTAGGTGACACTATAG 
Primers used for PCR amplification of DNA inserts cloned into pOTB 7 vector 
M13 F (-21) TGTAAAACGACGGCCAGT 
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M13 R (19) GGAAACAGCTATGACCATG 
Primers used for PCR amplification of DNA inserts cloned into the pSPORT1 vector  
(full length cDNA amygdala library) 
M13 for 23 
M13 rev 30  
GACGTTGTAAAACGACGGCCAGT 
ATAACAATTTCACACAGGAAACAGCTATGA 
Random 15-mer primers labelled with Cy3 dye used for quality check of the microarrays  
Cy3Rand15 Cy3 (N) 15 
 
 
2.1.7 DNA-Molecular Weight Markers 
DNA standards most frequently used in this work are shown in Table 2.1.7.1. Depending on 
the agarose gel pocket sizes, different amounts of a particular standard were used and will 
be shown where applicable. 
 
Table 2.1.7.1: DNA-Molecular weight markers. 
Name Mass range Provider 
Smart Ladder 200 – 10.000 bp Eurogentec GmbH; Köln, Germany  
MWM XIII  
MWM X 
50 – 2642 bp 
70 – 12200 bp 
Boehringer Mannheim GmbH; 
Mannheim, Germany 
100 bp DNA Ladder  
1 kb DNA Ladder  
100 – 1517 bp 
500 – 10.000 bp 
NEB GmbH; Frankfurt am Main, 
Germany 
Mass Ruler Ladder 
Low Range 
Mass Ruler DNA 
Ladder Mix 
O’ Range Ruler 
100bp DNA Ladder 
80 – 1031 bp 
 
80 – 10.000 bp 
 
100 – 1500 bp 
MBI Fermentas GmbH, St. Leon-
Rot, Germany 
 
 
2.1.8 Antibiotics  
Stock solutions: stored at –20°C 
Ampicillin (Amp 50 mg/ml): 2.5 g of ampicillin (sodium salt) were dissolved in 50 ml of 70 % 
ethanol.      
Tetracyclin (Tet 20 mg/ml): 1 g of tetracyclin was dissolved in 50 ml of 70 % ethanol.  
Kanamycin (Km 50 mg/ml): 2.5 g of kanamycin were dissolved in 50 ml of H2O and filtered 
through a syringe filter (0.2 µm). 
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Chloramphenicol (Cm 34 mg/ml): 340 mg of chloramphenicol were dissolved in 10 ml of H2O.  
Selection for a suitable resistance marker was achieved by using the following final 
concentrations:  
Ampicillin (50 µg/ml): for culturing of BLT5403 and BLT5615 E. coli strains. 
Ampicillin (100 µg/ml): for culturing of clones from libraries: No.988 and No.761 (E. coli 
strain). 
Chloramphenicol (12.5 µg/ml): for culturing of clones from library No.958 (E. coli strain). 
Chloramphenicol (34 µg/ml): for culturing of E. coli BL21 (DE3) pLysS strain. 
Kanamycin (50 µg/ml): for culturing of E. coli BL21 (DE3) pLysS strain containing pET28a-
Taq DNA polymerase construct. 
Tetracyclin (12.5 µg/ml): for culturing of BB4 E. coli strain. 
 
2.1.9 Media for growth of bacteria 
All media for the culturing of bacteria were sterilized through autoclaving. Heat sensitive 
ingredients (glucose, maltose) were sterilized through filtration with (0.2 µm filters). 
 
Table 2.1.9.1: Liquid and solid media used for growth of bacteria 
Liquid Media 
LB-Medium (1x)   
Bacto tryptone  10 g  
Yeast-Extract  10 g 
NaCl     5 g 
H2O    to 1 L 
Adjust to pH 7.0 with 5N NaOH  
LB-Medium (2x) 
Bacto tryptone  20 g 
Yeast-Extract  10 g 
NaCl    10 g 
H2O    to 1 L 
Adjust to pH 7.0 with 5N NaOH  
SOB-Medium 
Bacto tryptone  2 %  
Yeast-Extract   0.5 % 
NaCl    0.05 % 
KCl    2.5 mM 
MgCl2    10 mM 
SOC-Medium 
SOB-medium 
Glucose  20 mM 
 
 
 
Solid Media 
TOP-Agarose / 100 ml  
Bacto tryptone  1 g  
Yeast-Extract   0.5 g 
NaCl    0.5 g  
Agarose   0.6 g                   
LB-TOP-Agar 
LB-Medium (1x) 1 L  
Agar-Agar   15 g 
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For preparation of Agar plates LB-TOP-Agar was heated in a microwave until the solution 
boiled and the solid agar was completely dissolved. The appropriate antibiotic(s) were 
supplemented after the medium cooled down up to ca. 50°C. After additional mixing, the 
medium was poured into the Petri dishes. 
 
2.1.10   Buffers and solutions  
Standard buffers and stock solutions that are most frequently used in this work are given in 
Table 2.1.10.1. Solutions that are not included in this section are given in the further sections 
in the context of the corresponding technique. 
 
Table 2.1.10.1: Standard buffers and solutions used in this work   
Buffers 
TBS (10x) 
Tris base 30 g 
NaCl    80 g 
KCl   2 g 
H2O   to 1 L 
 
Adjust to pH 7.4 with HCl and autoclave 
 
PBS (10x) 
NaCl    80 g 
KCl    2 g 
Na2HPO4 x 2 H2O 14.4 g 
KH2PO4   2.4 g 
H2O    to 1 L 
Adjust to pH 7.4 with HCl and autoclave 
TBST (1x) 
TBS (1x) with 0.1 % (v/v) Tween 20 
 
Tris-HCl (1 M) 
Tris base  121.1 g  
Adjust pH with HCl and autoclave 
CBS (1x) 
NaCl   8 g 
KCl   0.2 g 
Citric acid  10.5 g 
H2O   to 1 L 
Adjust to pH 7.0 with NaOH and autoclave 
 
TBE (5x) 
Tris base   54 g 
Boric acid   27.5 g 
EDTA (0.5M pH8.0)  20 ml 
H2O    to 1 L 
 
TAE (50x) 
Tris base   242 g 
HAc glacial   57.1 ml 
EDTA (0.5M pH8.0)  100 ml 
H2O    to 1 L 
TE (1x) 
Tris-HCl  10 mM 
EDTA    1 mM 
 
Adjust to pH 8.0 with HCl and autoclave 
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20xSSC 
NaCl    175.3 g 
tri-sodium-citrate  88.2 g 
H2O    to 1 L 
Adjust to pH 7.0 with HCl and autoclave 
 
Buffer A 
Tris-HCl pH 7.9,  50 mM 
Glucose  50 mM 
EDTA    1 mM 
 
Lysis buffer 
Tris-HCl  10 mM 
KCl    50 mM 
EDTA    1 mM 
PMSF    1 mM 
Tween 20   0.5 % 
Nodinet P-40   0.5 %  
pH                7.9 
 
Taq storage buffer 
Tris-HCl pH 7.9  50 mM 
KCl    50 mM 
EDTA    0.1 mM 
DTT   1 mM 
PMSF    0.5 mM 
Glycerol  50 % 
 
T7 phage extraction buffer (PEB) 
Tris-HCl     20 mM 
NaCl,       100 mM 
MgSO4        6 mM 
pH                   8.0 
 
λ phage extraction buffer (LD) 
Tris-HCl    50 mM 
NaCl       100 mM 
MgSO4       8 mM 
gelatine       0.01 % 
pH                  7.5 
 
SM PCR buffer (10x) 
KCl                         100 mM 
(NH4)2SO4                         60 mM 
Tris-HCl  pH 8.8      200 mM  
MgSO4                                20 mM 
Triton X-100             1 % 
BSA                         1 mg/ml   
 
Membrane Blocking Solution (MBS)  
20 ml Casein Based Blocking Buffer 
Concentrate, (Genosys Biotechnologies, 
Cambrige, UK) 
TBST pH 8.0     80 ml  
Saccharose       5 g 
The resulting pH will be 7.0, store at 4°C 
Solutions 
EDTA 0,5 M stock solution 
EDTA    186.1 g 
H2O    to 1 L 
Adjust to pH 8.0 with NaOH and autoclave 
 
IPTG 1M stock solution 
IPTG    2.38 g 
H2O    to 1 L 
Sterilize by filtration (0.2 µM), store at –20°C 
BCIP (stock solution) 
BCIP    60 mg 
DMF    1 ml 
Store at –20°C, protect from light 
MTT (stock solution) 
MTT    250 mg 
DMF 70% in H2O  5 ml 
Store at –20°C, protect from light 
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BCIP/MTT substrate solution for AP 
CBS    20 ml 
MgCl2 (1 M)  100 µl 
BCIP    40 µl 
MTT    60 µl 
 
Sodium azide stock solution (2.5 %) 
NaN3    2.5 g 
H2O    100 ml 
Protected against light 
 
Sodium acetate 3 M stock solution 
NaAc x 3 H2O   408.1 g 
H2O    to 1 L 
Adjust to pH 5.2 with glacial HAc and autoclave  
Betaine 5 M stock solution 
Betaine     58.55 g 
H2O    to 100 ml 
 
 
Alkaline lysis solution I 
Glucose   50 mM 
Tris HCl (pH 8.0)   25 mM 
EDTA (pH 8.0)    10 mM 
Autoclave and store at 4°C 
 
Alkaline lysis solution II 
NaOH    0.2 M 
SDS    1 % 
Alkaline lysis solution III 
Potassium acetate   3 M 
HAc glacial    5 M 
 
Ortho-phenylenediamine solution (OPD) 
OPD  1 mg/ml 
H2O2  10 µl/ml  (0.03 %) 
 
Solutions for SPOT synthesis 
Bromophenol blue (BPB) stock solution 
10 mg BPB / 1 ml DMF 
 
Acetylation mix  
2 % solution of acetic anhydride (p.a) in DMF 
Piperidine (p.a.) 
20 % in DMF 
Deprotection mix 
50 % TFA, 3 % TIBS, 2 % water, 45 % DCM 
 
 
2.1.11 Fmoc-amino acid stock solutions  
Fmoc-amino acid derivatives of all 20 L-amino acids as well as ß-alanine and other special 
amino acid derivatives are available from several suppliers in sufficient quality 
(Novabiochem/Merck Biosciences, or Bachem). Side chain protecting groups should be 
Cys(Acm) or Cys(Trt), Asp(OtBu), Glu(OtBu), His(Trt), Lys(Boc), Asn(Trt), Gln(Trt), 
Arg(Pmc), Ser(tBu), Thr(tBu), Trp(Boc), and Tyr(tBu). HOBt-esters of these amino acid 
derivatives must be prepared in NMP for use throughout in spotting reactions (see 2.2.6 III).  
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2.2 Methods 
2.2.1 Growth of bacteria 
All bacterial strains were grown in LB-medium at 37°C under air agitation conditions with 
supplement of appropriate antibiotics (see 2.1.8). For this purpose, different lab-ware was 
used. Small overnight cultures that originate from a single colony were performed in 10 ml 
Capsenberg tubes containing 5 ml LB-medium and cultured in an incubator with rotation (200 
rpm). Larger cultures were grown in 0.1 ml to 1.0 L baffled flasks containing LB-medium with 
rotation (150 rpm) until required OD600 = 0.5 or 1.0 was reached. The volume of bacterial 
medium didn’t exceed the 1/5 of the total flask volume. Bacteria from clone libraries were 
grown in 96 deep well blocks (Qiagen), at 37°C, overnight with high rotation speed (300 
rpm). For high-throughput growth, the cultures were initiated by inoculation of 1.6 ml of 2 x 
LB medium (in 96 well blocks) with a drop of the bacterial clone directly from a glycerol stock. 
For this purpose the 96-pin plastic replication tools (BioCat) were used. The blocks were 
covered with adhesive gas permeable tape (AB Gene) and incubated under the above 
conditions. The E. coli BB4 (plating bacteria) that is a host for the lambda phages were 
grown up to OD600 = 1.0 with a supplement of maltose and MgSO4 to the final concentrations 
0.2 % and 10 mM respectively. Bacteria were harvested by centrifugation at 4000 x g and 
the resulting pellet was redisolved in 50 % of the original culture volume of 10 mM MgSO4. 
Host strains for T7select10-3b phage were grown as follows. The BLT5615 were grown until 
OD600 = 0.4-0.5 was reached, then supplemented with IPTG (final concentration 1 mM) and 
grown for about 30 minutes (OD600 = 1). The BLT5403 bacteria were grown without IPTG 
supplement, until OD600 = 1.0. The additional information considering culturing that is not 
given here will be specified in the corresponding sections.  
 
2.2.2 Storage of bacteria and phages 
Bacterial colonies were obtained by streaking out onto agar plates using an inoculation loop 
and kept at 4°C for less than one month. Liquid cultures were stored at 4°C for no longer 
than one week. For long time storage, fresh log phase cultures were mixed with sterile 
glycerol (final concentration 20 %) in sterile 1.5 ml cryo-resistant tubes and kept at –70°C. 
Replicas of library clones were stored in 96 well plates covered with cryo-resistant adhesive 
foil. Clarified phage lysates were stored at 4°C approximately up to two months. For 
long-term storage or as a backup, samples of the lysates were combined with 0.1 volume of 
sterile 80 % glycerol and then frozen at –70°C. 
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2.2.3 Molecular biology methods 
 
2.2.3.1 Precipitation of DNA 
DNA precipitation was mediated by high salt concentration and addition of either isopropanol 
or ethanol. Precipitation with ethanol was carried out by addition of sodium acetate up to the 
final concentration 0.3 M (pH 5.2) followed by addition of 2 volumes of the cold 96 % ethanol 
and thorough mixing. After 30 min incubation on ice, the DNA was recovered by 
centrifugation at 15000 x g, 4°C for 30 min. With the supernatant removed, the pellet was 
washed with 70 % ethanol (-20°C) and the centrifugation step was repeated for 15 min. The 
ethanol was removed and the pellet was dried either with air on a sterile bench or using 
vacuum evaporator with rotation but without heating. The DNA was redissolved in an 
appropriate volume of Milli-Q water or TE buffer. For probes where an increase in volume 
was undesirable, precipitation with isopropanol was carried out. The ammonium acetate was 
added to the sample up to the 2.5 M final concentration followed by the addition of 0.7 
volumes of isopropanol. The content was mixed appropriately and incubated at room 
temperature for 30 min. All conditions and centrifugation steps were the same as described 
above for the ethanol procedure. Alternatively, only precipitation with isopropanol was carried 
out. For recovery of plasmid DNA (see 2.2.3.6) and PCR products amplified from human 
brain amygdala clone library, 0.7 – 1.0 volumes of isopropanol were precisely mixed with 
each sample (in 96 well PCR plates or deep well blocks). Then they were incubated for 
45 min – 1 h at room temperature and centrifuged at 3500 x g for 45 min, at room 
temperature. The supernatant was discarded and residual drops of a liquid removed by 
tapping on a paper towel. The DNA was air dried for 30 min, at room temperature and 
redissolved in the appropriate solution.  
 
2.2.3.2 Determination of DNA concentration 
DNA concentration was measured using GeneQuant II RNA/DNA Calculator (Pharmacia 
Biotech) in the 10 µl Hellma quartz suprasil glass cuvette (10 mm). Preceding usage, the 
cuvette was washed several times with Milli-Q water. Milli-Q or appropriate buffer was used 
for the calibration of the photometer. If necessary, samples were diluted and the dilution 
factor was listed in the GeneQuant record. The DNA concentration was obtained by 
multiplying the absorbance (A260 nm) by the factor of dilution, and by the nucleic acid 
conversion factor: 
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DNA Concentration [µg/ml] = A (260 nm) x dilution factor x F 
F = 50 (ds DNA), 33 (ss DNA), 40 (RNA). 
Alternatively, the approximate DNA concentration was determined via AGE analysis, by 
comparison of the fluorescence of sample band with the fluorescence of bands of the correct 
molecular mass marker that was run on the same gel. 
 
2.2.3.3 DNA agarose electrophoresis   
Agarose gels (0.6 – 2 %) were prepared by dissolving 0.6 – 2 g of peq-GOLD universal 
agarose in 100 ml of 1 x TBA or TAE buffer by boiling the mixture at least three times in a 
microwave. For 2 – 3 % preparative gels, the appropriate amounts of the low melting point 
agarose were used. The agarose solution was allowed to cool down to approximately 60°C 
and 5 µl of ethidium bromide solution (10 mg/ml) were added. Agarose was poured into 
appropriate gel chambers containing a comb for the formation of sample pockets and left at 
room temperature for polymerisation. Ready to use gel was transferred into the 
electrophoresis device and covered with a running buffer. Always, the same buffer that was 
used for gel preparation was also used as a running buffer. 
Depending on the comb used for the pockets formation, different volumes of probe were 
applied, ranging from 5 µl to 400 µl. Before application onto the gel, DNA samples were 
mixed with 0.2 vol of 6 x sample loading buffer (40 % sucrose in water, 0.25 % Bromophenol-
blue, 0.25 % of xylene-cyanol FF, optional). Additionally a suitable DNA marker was loaded. 
DNA fragments were separated at 60 – 90 V for long-term runs and 120 – 170 V for short-
term runs. For long-term electrophoresis the TAE buffer was used preferentially. The 
different bands were detected on a transilluminator (302 nm). The gels were documented 
with the Herolab CCD camera connected to a PC and controlled by EASY image 3.16. The 
images were saved as 8 bit TIFF files.  
 
2.2.3.4 DNA extraction from agarose gels 
For isolation of DNA of a particular size from a DNA mixture, the different DNA fragments 
were separated on low melting point agarose gels. The piece of the agarose gel containing 
the desired band was cut out on a transilluminator with a scalpel. The DNA was then 
extracted from the gel with the Qiaquick Gel Extraction kit (Qiagen) according to the 
manufacturer’s guidelines. 
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2.2.3.5 Isolation of phage DNA  
The λDisplay1 phage vector DNA was isolated from the phage lysate using the Nucleobond 
AX-100 kit (Machery-Nagel) according to the manufacturer’s protocol. The DNA of single 
clones or phage DNA mixtures from T7 human brain library was isolated from phage lysates 
(see 2.2.4.2). This preparation was used for isolation of phage DNA that served as a 
template for PCR reactions. The volume of 50 – 200 µl of phage lysate were transferred into 
sterile Eppendorf tubes and mixed with EDTA (final concentration 10 mM) and then placed in 
a thermo mixer at 65°C for 10 min with moderate shaking. The mixture was cooled down to 
room temperature for 3 – 5 min and centrifuged at 14000 x g for 3 min. Either the aliquot of 
2 µl of prepared phage DNA solution was directly used for 100 µl “check-PCR” reaction, or 
the whole supernatant was filtrated through the MultiScreen filter plate (Millipore) and 
washed with sterile water twice, in order to eliminate the EDTA from the mixture. The DNA 
was taken up from the filter by redissolving it in 65 – 100 µl of sterile Milli-Q water.  
 
2.2.3.6 Isolation of PCR products and plasmid DNA  
PCR products were purified and isolated with the QIAquick PCR purification (Qiagen) or 
using the MultiScreen PCR Plates (Millipore) according to the producer’s manual. 
Plasmid DNA was isolated with differing methods, which are all based on the alkaline lysis 
method (Birnboim & Doly, 1979). For the purpose of this work only small-scale preparations 
were performed (up to 20 µg). Ion exchange columns were commonly used for plasmid 
preparation (QIAprep Spin Miniprep Kit, Qiagen). For a larger number of probes two 
commercially available kits were used, R.E.A.L Prep 96 plasmid kit (Qiagen) and Montage 96 
plasmid miniprep kit (Millipore). Plasmids from 6144 clones of the human brain amygdala 
cDNA library (RZPD No 761) were isolated using a shortened alkaline lysis protocol. All 
solutions used for this preparation are described in Table 2.1.10.1 Library clones were grown 
in 96 deep well blocks, as described in 2.2.1. Bacteria were harvested by centrifugation at 
4°C, 3000 x g for 15 min. The supernatant was decanted from the culturing block. The 
residual medium was removed by tapping the block on the paper towel. Using a multi-
channel pipette, 100 µl of alkaline lysis solution I were added. Wells of the block were 
covered with a tight rubber cover and the cell pellet was precisely re-suspended by vortexing. 
The block was kept for 5 min at room temperature. Next, 200 µl of solution II were added and 
mixed very gently. The block was immediately placed on ice for 5 min. After addition of 150 
µl of solution III and intensive shaking, the block was again placed on ice for 5 min, followed 
by centrifugation (as above). The clear supernatant (~ 400 µl) was transferred into the block 
containing 400 µl of isopropanol, mixed exactly with the pipette. Plasmid DNA was 
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precipitated with isopropanol only, as described in 2.2.3.1 and redissolved in 100 µl of Milli-Q 
water.  
 
2.2.3.7 DNA digestion  
DNA was digested with restriction enzymes from New England Biolabs, using the 
recommended buffer. For double digestion the optimal buffer was chosen according to the 
manufacturer’s recommendations. As an option, the digestion was run separately for each 
enzyme with a purification step in between. Amounts of endonucleases used for DNA 
digestion are given in units (“U” according to producer’s definition). Usually 1 U of enzyme 
was used for each µg of DNA. The DNA solution was mixed with 0.1 vol of appropriate 
digestion buffer (10x) and appropriate amount of endonucleases/s. The mixture was 
incubated at 37°C for 1 – 4 h. The total reaction volume was dependent on the amount of 
enzyme/s used for digestion and exceeded 10 times the total volume of enzyme/s. This 
restricted volume was, increased when the sensitive endonucleases were used (e.g. HindIII) 
in order to avoid their star activity. Overnight incubations were applied for digestion of PCR 
products that contained the cleavage sites in a close proximity to the strand termini. The 
amount of required endonucleases was increased as well (10 – 20 U). Usually enzymes 
were inactivated by 20 min incubation at 65°C. According to the future applications and 
fragment size, the digested DNA was purified either by L.M.P gel electrophoresis followed by 
extraction using Qiaquick Gel Extraction kit (Qiagen), using QIAquick spin columns (Qiagen) 
or by alcohol precipitation. To digest the PCR amplified and Cy-dye labelled inserts from the 
human brain phage library that were used as targets for microarray hybridization, 5 U of the 
EcoRI and HindIII enzymes were added directly to the PCR reaction. The mixture was 
supplemented with the 12 µl of the buffer for EcoRV or buffer 2 (NEB) and sterile Milli-Q 
water up to 120 µl. The reaction was run at 37°C, overnight.  
 
2.2.3.8 Dephosphorylation 
Digested DNA fragments that were used for ligation were treated with alkaline phosphatase 
from shrimps (USB cooperation, Cleveland, USA). The alkaline phosphatase removed 5’ 
phosphate groups from the vector or insert and therefore prevented so called self-ligation of 
inserts or vector closure. 0.1 volumes of the alkaline phosphatase buffer were mixed with the 
DNA sample followed by the addition of enzyme (1 U for each pmol of DNA). The mixture 
was incubated for 1 h at 37°C. The alkaline phosphatase was inactivated for 15 min at 65°C. 
The mixture was ready to use for ligation reactions.  
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2.2.3.9 Ligation 
The T4 DNA ligase (Promega) was used for cloning of the DNA sequences coding the model 
protein domains (EVH1, WW/FE65, WW/YAP) into the plasmid vectors. The plasmid vectors 
were previously digested and purified from the L.M.P agarose gel. The appropriate inserts 
were PCR amplified, digested, dephosphorylated and purified from the L.M.P agarose gels. 
The molar ratio of insert to vector used for ligation was 3:1. The amounts of 0.8 – 1.5 µg of 
total DNA mixture were mixed with the 0.1 volumes of appropriate buffer and supplemented 
with 5 U of the T4 DNA ligase. The ligation reaction was carried out at 16°C, overnight in 
10 µl volume. 10 µl of water were added to the reaction and heated up to 65°C for 15 min for 
increased electroporation efficiency (Ymer, 1991). 20 ng of the ligated DNA was taken for 
transformation. Ligation of DNA coding for the model domains with the λDisplay1 phage 
vector was performed as follows. Previously PCR amplified, digested with SpeI and NotI 
endonucleases and purified DNA fragments were ligated with the λDisplay1 vector arms. The 
vector arms were previously separately digested with SpeI and NotI, dephosphorylated and 
purified by precipitation (for cloning strategy refer to 3.1.1). A 15 µl ligation reaction 
contained: 6 U units of T4 DNA ligase, 25 µg/ml acetylated BSA, 10 mM DTT, 1 mM ATP, 
4.2 µg of λDisplay1 vector arms and 11.6 ng of DNA from each domain insert. The ligation 
was carried out overnight at 16°C. 8 µl of the ligation mixture was directly used for phage 
assembly using commercially available “Ready To Go” kit (see Table 2.1.1.1), according to 
the manufacturer’s protocol. 
 
2.2.3.10 Transformation of E. coli cells 
The transformation of the Gene Hogs E. coli cells was performed through electroporation, 
using the Bio-Rad Gene Pulser. 50 µl of the electro competent cells were carefully mixed (by 
agitation) with a ligation mixture (approximately 20 ng of DNA) and incubated on ice for 2 
min. This mixture was transferred into the ice-cold 2 mm electroporation cuvette (Bio-Rad) 
and electroporated with the following parameters: 2.5 kV, 25 µF and 200 Ω, as described by 
Dower et al., 1988. The time constant was 4.5 s. After electroporation the cells were 
immediately mixed with the 200 µl of prewarmed SOC medium (37°C), transferred to the 5 ml 
culturing glass tube and grown at 37°C for 1 h. The aliquots of this culture (10 µl, 100 µl, 
1000 µl) were plated out onto the LB agar plates containing appropriate antibiotics and 
incubated at 37°C overnight. 
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2.2.3.11 Polymerase chain reaction  
PCR was used for amplification of genes flanked by the appropriate restriction sites, for 
analysis of phage clones, for amplification of DNA fragments from clone libraries that were 
used for DNA microarray fabrication and amplification and labeling of phage target DNA used 
for hybridization with the microarray chip. Several different DNA polymerases were used 
including hot start, Taq and pfu as well as the self-made Taq DNA polymerase, expressed 
and purified in the lab (see Table 2.1.1.1) PCR reactions were carried out in a MJ research 
PTC 200 Thermocycler using 0.2 ml strips (AB Gene; Epsom, Surrey, UK) or in a MJ tetrad 
Thermocycler with 4 alpha blocks using 96 well plates (AB Gene). Several different protocols 
were developed for different proposes. All are based on the protocol of Sambrook et al., 
(1989). The most commonly used protocols are described below. The modifications that are 
not described here are given in the context of a corresponding experiment. The different 
primers used for different PCRs are listed in Table 2.1.6.1. 
 
The PCR mixture for amplification of the DNA fragments from the T7Select10-3b phage 
vector. Different polymerases were used, according to availability (Table 2.1.1.1).  
 
 
PCR reaction per 100 µl:                                            final concentration 
DNA-polymerase buffer (10x)           10 µl          1x 
MgCl2 (25 mM)                         6 µl          1.5 mM 
dNTP mix (10 mM)                       2 µl          0.2 mM (each) 
Sense primer TS 21 (10 pmol)              2 µl        20 pmol 
Antisense primer TA 20 (10 pmol)        2 µl         20 pmol 
Taq-DNA-polymerase                 0.5 µl        2.5 U 
H2O to 100 µl                                      dependent on the template volume  
DNA template 2-50 µl                               dependent on the experiment 
 
The PCR program: 
 
1. initial denaturation:            94°C for 2 min 
2. denaturation:                 94°C for 30 s  
3. annealing:                    49°C for 30 s  
4. elongation:                   72°C for 3 min 
2-4:                           35 cycles 
5. final extension:               72°C for 6 min 
6. end                         4°C 
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In the case of HotGoldstar DNA Polymerase usage, the initial activation step was applied 
according to the manufacturer’s recommendations (5 min at 95°C). 
 
The PCR amplification and labeling of the DNA fragments from T7 human brain library was 
carried out using the program described above. The PCR mixture was slightly changed. Self-
made Taq DNA polymerase was used in combination with the pfu DNA polymerase. Both 
enzymes were mixed in an average ratio of 10 : 1 units respectively. The buffer used for PCR 
was made according to Lu & Erickson, 1997 (SM PCR buffer: 100 mM KCl, 60 mM 
(NH4)2SO4, 200 mM Tris-HCl, pH 8.8, 1 % Triton X, 1 mg/ml BSA).  
Final concentrations of the deoxynucleotides: dATP, dGTP, dTTP were 0.2 mM. The dCTP 
was added to the final concentration of 0.19 mM. The PCR mixture was supplemented with 1 
µl of Cy3-dCTP or Cy 5-dCTP (final concentration 0.01 mM). 
 
The PCR mixture for amplification of DNA fragments from the full-length cDNA human brain 
amygdala library:  
 
PCR reaction per 100 µl:                                                 final concentration 
SM PCR buffer (10x)                         10 µl          1x 
MgSO4 (25 mM)                             16 µl          4.0 mM 
dNTP MIX (10 mM)                           4 µl          0.4 mM (each) 
Sense primer M13 for 23 (10 pmol)             2 µl         20 pmol 
Antisense primer M13 rev 30 (10 pmol)          2 µl         20 pmol 
Betaine (5M)                               20 µl          1 M 
SM Taq-DNA-polymerase                    0.3 µl         1.5 U 
pfu DNA polymerase 2.5 U/µl                0.08 µl         0.15 U 
H2O                                       45 µl           
Template (plasmid DNA)                        1 µl          50 – 100 ng 
 
The PCR program: 
 
1. initial denaturation:            94°C for 2 min 
2. denaturation:                 94°C for 30 s  
3. annealing:                   56°C for 30 s  
4. elongation:                   72°C for 2.3 min 
2-4:                           10 cycles 
5. denaturation:                 94°C for 33 s,  
6. annealing:                   56°C for 33 s  
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7. elongation:                   72°C for 2.33 min  
5-7:                           20 cycles 
8. final extension:               72°C for 5 min 
9. end                         4°C 
 
2.2.4 Phage work 
2.2.4.1 Preparation of λDisplay1 phage lysates 
The original λDisplay1 phage lysate was diluted in the LD buffer (see Table 2.1.10.1) in order 
to obtain the appropriate phage concentration of 104 pfu/ml. 400 µl of diluted phages were 
mixed with 400 µl of E. coli BB4 plating bacteria (OD600 = 2.0 in 10 mM MgSO4) and 
incubated for 20 min at 37°C. Then 12 ml of LB-top agarose was added, the mixture was 
poured onto 145/20-mm-large Petri dishes and incubated at 37°C overnight. Phages were 
eluted from the agarose by filling up the dish with 20 ml of SM LD buffer followed by 
incubation for 5 h at 4°C, under gentle agitation on a rocker table. The liquid was decanted, 
supplemented with chloroform (2 % final concentration) and centrifuged at 4°C with a speed 
of 4500 x g. The phage lysate was separated from the pellet and poured into a new tube. 
 
2.2.4.2 Preparation of T7select10-3 phage lysates 
Phages displaying proteins from the normal human brain cDNA library were cultured using 
the BLT5615 E. coli host, whereas phages displaying model protein domains were grown 
using the BLT5403 host (see 2.2.1). An aliquot from the original phage lysate (1:103 volume 
of a future culture) was added to the ready for infection host culture and grown at 37°C with 
agitation (200 rpm), until lysis occurred. An increase of the culture transparency and an 
emergence of the bacterial debris indicated the complete lysis. The lysates were clarified by 
spinning at 10000 x g and 4°C and decanted into sterile tubes. Additionally, the individual 
phages were extracted from a single plaque that was placed in an eppendorf tube with 
50 – 200 µl of the phage extraction buffer (PEB) and incubated for at least 2 h at 4°C. 
 
2.2.4.3 Determination of the T7 and lambda bacteriophage titers 
The phage titer, described in plaque forming units per unit volume (e.g. pfu/ml) is the number 
of phage plaques visible on the plate multiplied by an appropriate dilution and multiplied by 
an aliquot of the volume (e.g.10, to account for the 0.1 ml of dilution plated). For example, if 
the aliquot of 100 µl from the phage dilution 1:106 was poured onto the agar plate and 30 
phage plaques were obtained, then the titer must be calculated according to the following 
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formula: 30 x 106 x 10 = 3 x 108 pfu/ml. To calculate a number of plaque forming units (pfu) in 
1 ml of lysate, a series of dilutions of an appropriate sample were prepared using LB medium 
or LD buffer as the diluent for the T7 phage and the λ phages respectively. The initial 1:100 
dilution was prepared by adding 10 µl of sample to 990 µl of medium (1:102 dilution). Serial 
dilutions were made by adding 100 µl of the 1:102 dilution to 900 µl medium (1:103 dilution), 
100 µl of the 103 dilution to 900 µl medium (104 dilution), and so on. A series of 10 ml sterile 
tubes were prepared by pipetting 250 µl and 100 µl of the host cells for T7 and λ phage 
respectively. Starting from the highest dilution, 100 µl of the phage dilution were mixed with 
the bacteria. 2.5 ml of molten Top-agarose (45°C) were added to each probe, mixed well and 
poured immediately onto a pre-warmed (37°C) agar plate. This step was preceded by 
addition of IPTG (final concentration 0.5 mM) to the mixture, in case of the T7 phages. In 
case of the λ phage addition of Top-agarose was preceded by incubation of phage and 
bacteria mixture for 20 min at 37°C. After the contents were poured out, plates were allowed 
to sit undisturbed for several minutes until the top agarose hardened, then inverted and 
incubated for 3–4 h at 37°C or overnight at room temperature (T7 phage) or overnight at 
37°C (λ phage). The phage plaques were counted and the phage titer was calculated as 
described above.  
 
2.2.4.4 Affinity selection of phages on the SPOT membrane  
A piece of the SPOT cellulose membrane containing 4 peptides with different sequences was 
placed in a 2 ml Eppendorf tube and washed for 1 h with the 70 % ethanol. Ethanol was 
decanted and the membrane was washed 20 times for 5 min with TBS pH 7.4, at room 
temperature under agitation on a rocker table. Then the membrane piece was blocked for at 
least 1 h with 2 ml of blocking solution [5 % skim milk, 50 µg/ml fish sperm DNA, 50 µg/ml 
heparin in 0.1 % TBST pH 7.4, 0.1 % NaN3]. 0.9 ml of phage lysate supplemented with 
protease inhibitor were blocked with 0.1 ml of 5 x concentrated blocking solution for 10 min at 
room temperature under gentle agitation. The membrane was placed in a 2 ml tube and 
incubated with blocked phages overnight at 4°C under gentle agitation. The extensive 
washing steps were performed to eliminate the unspecific or unbound background phages. 
The membrane was washed 10 times for 5 min, with 0.5 x concentrated blocking buffer and 
10 times for 5 min with 1 x TBST pH 7.4 (see Table 2.1.10.1). The individual spots were cut 
out and transferred to 0.5 ml tubes containing 100 µl or 150 µl of the elution reagent, in case 
of the T7 phages 1 % SDS or 1 M guanidine. Elution for the T7 phages was carried out at 
room temperature for 10 min with gentle shaking. Affinity selection of the λ phages on the 
peptide-spot membrane was done in a similar manner, except for the elution step. The λ 
phages were eluted via direct infection of 150 µl of the BB4 host bacteria at 37°C for 20 min. 
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Eluted phages were used for lysate preparation, phage tittering or DNA isolation. T7 human 
brain phage displayed library was panned on the cellulose membrane containing 425 
peptides-spots as described above. Nevertheless a certain alterations regarding the volumes 
of the phage lysate as well as the blocking and washing buffers were introduced. The whole 
membrane was placed in a plastic box, washed with 30 ml of ethanol and TBS as described 
above and blocked with 30 ml of the blocking solution for 1 h at room temperature with 
agitation. Following blocking, 30 ml of the phage displayed library was panned on the spot 
membrane under the same conditions as described above. Washing of the membrane was 
done as above using 30 ml of each solution for each washing step. Finally, the membrane 
was placed in a square dish filled up with the TBST buffer. The peptide spots were cut out 
with a scalpel and phages were eluted as follows. The first row with 25 peptides was 
separated from the whole membrane and placed onto a square plate filled with the TBST 
buffer. The individual spots were cut out one by one and placed in a 96 well plate filled with 
75 µl of TBST. When all 400 spots were separated and placed in the 96 well plates, 75 µl of 
2 % SDS was added and the phages were eluted simultaneously at room temperature for 
10 min, with a gentle shaking. 150 µl of phage eluates were transferred into 96 deep well 
blocks containing 1350 µl of the LB medium. A 10 µl aliquot was taken from each well for 
preparation of the appropriate dilution (1:104). Then 100 µl of this last dilution was poured 
onto the standard Petri agar plates as described in 2.2.4.3.  
 
2.2.4.5 Affinity selection of phages on peptide synthesized on a plastic foil surface  
Control phage panning on peptides synthesized on the new type of plastic foil surface was 
prepared in 2 ml Eppendorf tube as described above for the cellulose spots. T7 phages 
displaying model protein domains (EVH1, WW/FE65, WW/YAP) were diluted in the mixture 
of T7 phages displaying IL4 protein (see section 3.6). The pieces of foil with peptide patches 
as well as the phage mixture were blocked as described for the cellulose spots. The number 
of washing steps during the panning procedure was reduced to 5 times for 5 min for both 
solutions. The elution step, for peptide-patches that were cut out from the foil, was carried 
out using 100 µl of 1 M guanidine solution, as described above. The phage eluates were 
ready for dilution preparation and titering.  
 
2.2.4.6 Target Assisted Iterative Screening (TAIS) 
The human brain T7 phage display cDNA library was panned on the cellulose peptide-spots 
according to the protocol given in 2.2.4.4. Phages were eluted from the peptide-spots with 
100 µl of 1 M guanidine. 1:103 and 1:104 dilutions of post-panning phage populations in LB 
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medium were performed in order to achieve separated phage plaques after plating onto 
145/20-mm-large agar plates (see 2.2.4.3). The dilution is highly dependent on the titer of the 
phage sample eluted from the peptide-spot and must be experimentally established for each 
experiment. For plating, 100 µl of diluted phage eluate was mixed with 750 µl of BLT5615 
host bacteria (ready for plating) and 9 ml of top-agarose followed by the addition of IPTG 
(final concentration 0.5 mM). The plates were incubated for 3 – 4 h at 37°C. Probing of the 
pre-selected library subset on a membrane was done according to a protocol developed by 
Kurakin, (Kurakin and Bredesen, 2002), that was slightly modified. To prevent top-agarose 
from sticking to the nitrocellulose membrane, plates were cooled down at 4°C for 30 min. The 
nitrocellulose “protran” membrane (132 mm φ) (see Table 2.1.1.1) was placed onto the plate 
with a special care taken to avoid trapping air bubbles and left for 5 min at room temperature. 
Three deep holes (coordinate points) were made in two places of the membrane perimeter 
using a red-hot syringe needle. The membrane was placed in a new large Petri dish and 
blocked with 1 % BSA for 1 h at room temperature with gentle rocking. In the meantime, the 
biotinylated peptides were mixed with a streptavidine-alkaline phosphatase conjugate 
(STRAP) at the molar ratio of 4:1, in 100 µl of TBST pH 7.4 and incubated for 15 min at room 
temperature. The target-STRAP conjugate was diluted in 30 ml of TBST containing 0.5 % 
BSA. The blocked membrane was then incubated with this mixture overnight at 4°C with 
gentle rocking. Subsequently, the membrane was transferred into a fresh dish and washed 
3 times for 15 min with 50 ml of TBST, at room temperature on a rocker. After these washing 
steps, 20 ml of an alkaline phosphatase substrate solution BCIP/MTT (see Table 2.1.10.1) 
was freshly prepared and the membrane was incubated at 4°C without shaking in the dark, 
until plaques became visible (up to 3 h). The staining solution was decanted and the 
membrane was washed a few times with TBST and stored at 4°C in the same buffer. With a 
help of the coordination points, the phage plaques on the agar plate, corresponding to the 
positive phage plaques on the membrane (blue signals), were picked up with a sterile tooth 
stick and transferred into a sterile Eppendorf tube containing 200 µl of PEB extraction 
solution. Phages were extracted at 4°C for 2 h (see 2.2.4.2). A 100 µl of the extracted phage 
solution were taken for the DNA isolation purpose (see 2.2.3.5) that was used then as a 
template for PCR. Another 100 µl was used for phage propagation (see 2.2.4.2). 
 
2.2.5 Fabrication and handling of DNA microarray biochips 
The nomenclature used in this work, for the description of the nucleic acids that are either in 
the solution or tethered on the solid support is according to (Phimister, 1999). The nucleic 
acid that is spotted on the glass slide is described as a “probe” and the labeled free nucleic 
acid as a “target”. 
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2.2.5.1 Preparation of DNA samples for printing 
After PCR amplification (see 2.2.3.11) and isopropanol precipitation (see 2.2.3.1), 6144 
genes (amygdala library) to be spotted on the glass slides were recovered by addition of 
12 µl of spotting buffer (3 x SSC, 1.5 M betaine). The plates were centrifuged by a short spin 
and left at 4°C overnight. 10 µl of each DNA solution were transferred from 96 well plates into 
384 well source plates (AB Gene), using a multi channel pipette and the 10 µl, thin pipette 
tips (Labsystems). The source plates were centrifuged by a short spin and stored at 4°C for 
use. 
 
2.2.5.2 Printing of high density DNA microarray 
PCR fragments were printed on amine silanated slides (Cell Associates Inc) and super 
amine slides (TeleChem). For array printing the contact microarrayer “MicroGrid II” 
(BioRobotics) and 16 split pins “MicroSpot 2500” (GeneWorx) were used. The split pins 
“resting” in a printing tool were placed in a small flask with sterile water and cleaned by 
sonication for 30 min. They were then transferred to a second flask containing 70 % p.a 
ethanol. Before DNA spotting was initiated, the pins were primed by test spotting with a 
buffer solution, where each pin struck the glass slide surface over 4000 times. Printing 
conditions were established experimentally and are shown in the appendix 1. The arrays 
were left in the microarrayer or at 22°C for a few hours after printing completion. A label on 
each microarray slide was inscribed with a diamond pen before a slide processing started. 
 
2.2.5.3 Fixation of the DNA features to the slide surface  
The DNA features were re-hydrated by lightly moistening the array face of each slide in the 
vapour of a warm (37°C) water bath for about 15 – 20 s (Bowtel et. al 2003). The slides were 
snap-dried immediately by heating for 1 – 3 s on a clean hot plate (120°C). The DNA was 
fixed to the slide substrate by two times UV cross-linking at 1200 µjoules using the 
Stratalinker 1800 device (Stratagene). The slides were then subjected for a chemical 
blocking or blocking with a BSA solution, as described below. The chemical blocking was 
carried out immediately after the DNA fixation procedure and the ready to use slides were 
stored in a dry, clean plastic box. Blocking with the BSA solution was performed always 
immediately before a microarrays application. Until that time, the biochips were stored under 
the same conditions as described above.  
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2.2.5.4 Washing and blocking the slides with BSA solution 
All biochips that were blocked with this method had to be used for hybridization within the 
time period of 30 minutes after blocking to avoid BSA denaturation on their surface. The 
slides were placed in a slide rack and immersed into a glass jar containing clean, 95°C hot 
water for 2 min and then washed several times with room temperature water, in a similar 
manner. Free amino groups on the slide surface were blocked by incubation of the slides for 
45 min at 42°C in a prewarmed solution containing filtered BSA solution (0.5 % BSA, 5 x 
SSC, 0.1 % SDS). To remove unbound DNA and blocking components (especially SDS), the 
microarray substrates were washed several times in water. The slides were dried with a 
stream of N2 (pressure 1.2 bar), by holding the slide with a forceps and streaming the gas in 
the opposite direction. This process was carried out quickly for both sides of the slide. A slow 
drying process would result in a high background (smear appearing on the glass slides). The 
prepared biochips were used within 15 min for hybridization.  
 
2.2.5.5 Chemical blocking with succinic anhydride 
The blocking solution was freshly prepared by dissolving succinic anhydride in 200 ml of 
anhydrous DCE followed by addition of 2.5 ml of N-methylimidazole (Diehl et.al. 2001). The 
slides were blocked for 1 h at room temperature with gentle rocking and washed briefly in 
200 µl of fresh DCE. Immersing the slides several times in 95 % ethanol washed off the 
DCE. For DNA denaturation, the slides were kept for 2 min in 95°C water, as described 
before. The slides were immediately washed, first in water (10x) then in ethanol (10x) 
followed once again by wash in water (10x) and subsequently dried with a stream of N2 or by 
centrifugation either in the 50 ml falcon tubes or in the centrifugation racks for 5 min at 
1100 rpm. Care was taken not to allow the slides to dry out during the washing steps. The 
slides were stored as described above. 
 
2.2.5.6 Cleaning of cover-slips  
The 24 x 50 mm cover-slips used for hybridization (IDL Biotech AB, Bromma, Sweden) were 
immersed in isopropanol and water several times and cleaned with a special wipe (provided 
with the Telechem slides) that didn’t leave any contaminants. After the last isopropanol wash, 
the cover-slips were dried with a stream of N2. The whole procedure was repeated if any 
contamination was still visible. 
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2.2.5.7 Array quality check hybridization 
To check the quality of the spotted array, hybridization with the Cy3 labeled random primers 
(15mere) was performed. A 3 µl of random primer mixture was mixed with 27 µl of the 
appropriate hybridization buffer (1 x SSC, 0.1 % SDS). The DNA solution was dispensed 
near one of the long ends of the microarray slide. The cover-slip (IDE) was held with forceps 
on the one side and the edge of the second side was placed just behind the drop of the DNA 
solution and held with a second pair of forceps to prevent moving. The cover-slip was 
lowered until the liquid covered the total arrayed area. Care was taken to avoid air bubble 
formation. The biochip was placed in a humidity chamber. A few µl of hybridization buffer 
were deposited in each corner of the chamber to keep the moisture level constant. The 
biochip was tightly locked in the hybridization chamber and the hybridization was carried out 
at room temperature overnight.  
 
2.2.5.8 Target to probe hybridization   
The pre and post panning phage DNA populations were PCR amplified and labeled as 
described above. The DNA concentration for each target was determined as described in 
2.2.3.2. When a two-dye system was used, the same quantity (ng) of post panning (Cy3) and 
pre panning (Cy5) targets were mixed together and supplemented with 400 ng of the control 
DNA (Fas), also labeled with Cy5 and Cy3 and mixed in a 1:1 ratio. This DNA mixture was 
applied on a microarray biochip for hybridization. In the case of a one-dye system, both 
targets were labeled with the Cy5 dye and the same quantities (ng) of the pre and post 
panning samples were mixed separately with the Cy5 labeled control Fas DNA (400 ng). Two 
separate targets were applied onto the two biochips for hybridization. The quantities of single 
targets to be hybridized with a biochip ranged from 2 to 4 µg. The target DNA mixtures were 
supplemented with water (if necessary) and 1 vol of 2x concentrated hybridization buffer (5 x 
SSC, 0.2 % SDS). The total volume of sample that was ready for hybridization was 200 µl. 
The hybridization was carried out in the Lucidea Slide Pro hybridization station (Amersham). 
Before each hybridization run, the chambers and pipes of the device were cleaned twice with 
hot Milli-Q water using a wash protocol designed for cleaning. A 180 µl out of 200 µl of the 
hybridization mixture was injected into the hybridization chamber containing a microarray 
biochip inside, using a Hamilton syringe. Hybridization was carried out for 16 hours at 42°C 
with mixing every 15 min (mixing: volume 30 µl, speed 10 µl/s). Pipes and chambers were 
cleaned with twice with 500 µl of water (speed 150 µl/s) followed by cleaning with isopropanol 
under the same conditions (x4). Microarrays were washed as described below. For a manual 
hybridization using cover-slip, the mixture of target DNA was dried out using a evaporator 
(without heating) and redissolved in 30 µl of the hybridization buffer (2.5 x SSC, 0.1 % SDS), 
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overnight at 4°C. The target DNA solution was deposited on the microarray biochip as 
described in 2.2.5.7 and the hybridization was carried out at 42°C for 16 h. Before each 
hybridization procedure, the DNA was additionally denaturized by heating at 95°C for 2 min 
and then cooled down to room temperature.  
 
2.2.5.9 Post hybridization slide processing  
Microarray slides were processed immediately after the hybridization procedure was 
completed. Special care was taken to avoid the drying out of the slides at any stage during 
the washing procedure. Hybridization was performed in the Lucidea Slide Pro station. The 
slides were removed from the hybridization chambers and placed in a glass jar containing 
washing solution I (2 x SSC, 0.1 % SDS), pre-warmed to 42°C, then washed 3 x 5 min with 
this solution by immersing a few times and rocking. Subsequently they were, washed 3 x 5 
min with 0.2 x SSC at room temperature followed by wash with water. Each biochip was 
shortly immersed in a glass jar with isopropanol and dried with a stream of N2 (see 2.2.5.5).  
Slides that were hybridized using the cover-slips were removed from the hybridization 
chamber and placed in a glass jar containing pre-warmed solution I. Gentle agitation was 
applied until the cover-slips detached themselves. All additional processing steps were done 
as described above.  
 
2.2.5.10 Biochips scanning 
Two different devices were used for the scanning of the microarray biochips: the ArrayWorx 
Biochip Reader (Applied Precision) controlled by the ArrayWorx 2.1.2 software suite and the 
GMS 418 Biochip Reader (Genetic Microsystems) controlled by the Live Image 1.51.0.42 
software. Scanning parameters: Scan Area: 39.20 x 20.57 mm, Channel 1: EX 540 / EM 595 
nm, 0.100 sec, gain 9.00, Channel 2: EX 635 / EM 685 nm, 0.300 sec, gain 9.00, Resolution: 
10.0000 µm. 
 
2.2.6 Peptide SPOT synthesis on cellulose membranes 
SPOT synthesis was performed according to Frank, 1992 with the Abimed ASP 222 
Automated SPOT Robot. Chemically modified membranes used for peptide synthesis were 
purchased from AIMS Scientific Products. The APEG ACS01 amino cellulose was used for 
synthesis of probes covalently bound to this support, subsequently applied for phage affinity 
selections. The Fmoc-pro-C540 membrane was used for synthesis of soluble N-terminally 
biotinylated peptides that were cleaved from the solid support and released into the solution 
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after the synthesis was completed and used for TAIS screens. These peptides were 
extended with two additional ß-Ala amino acids followed by biotin. 
 
 
I. Preparation of the Fmoc-pro-C540 support for peptide synthesis: 
 
1. Cleavage of the Fmoc protecting group on the amine of proline by washing the 
membrane in 20 ml 20 % piperidine in DMF for 5 min on a rocker (under a hood).  
2. Washing in 100 ml DMF (1 x 30 s, 4 x 5 min)  
3. Washing in 100 ml ethanol (1 x 30 s, 3 x 2 min)  
4. Drying in between a folder of 3MM paper with cold air from an airgun.  
 
 
II. Generation of the SPOTs array 
 
To generate the spots array, the anchor compounds Fmoc-ß-Ala-OH and Boc-Lys[Fmoc]-OH 
were spotted in the first step on the APEG ACS01 and Fmoc-pro-C540 membranes, 
respectively, as described in steps below.  
 
1. Preparation of the anchor amino acid derivatives for spotting: 
 
ß-Ala / Ac-Ala (1 : 10) 
Fmoc ß-Ala-OH          20 µl   stock solution: 0.2 M amino acid, 0.25 M HOBt in NMP 
Ac-Ala-OH               180 µl  stock solution: 0.2 M amino acid, 0.25 M HOBt in NMP 
BPB / DMF               4 µl   stock solution: 10 mg BPB in 1 ml DMF 
DIC                     8 µl   (ca. 0.25 M, 4 µl /100 µl vial) 
Vortex, 30 min activation at room temperature 
 
Boc-Lys[Fmoc] 
Boc-Lys[Fmoc]-OH      200 µl  stock solution: 0.2 M amino acid, 0.25 M HOBt in NMP 
BPB / DMF               4 µl   stock solution: 10 mg BPB in 1 ml DMF 
This solution was divided in two vials (100 µl) and activated with 4 µl of DIC, 30 min before 
the usage.  
 
2.   Both membranes were placed on the platform of the synthesizer.  
3.  Vials containing activated amino acids were placed in a synthesizer rack and a spotting 
protocol was initiated. The synthesizer dispensed 0.1 µl of activated amino acid solution onto 
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a single spot on the cellulose membrane. For the Fmoc-pro-C540 membrane the spotting 
procedure of Boc-Lys (Fmoc) was repeated again after 30 min reaction, in order to obtain 
better yields.  
Both filters, with the arrays of SPOTs, were covered with a glass plate and left for 3 h to 
complete reaction. Because of the presence of the BPB indicator, all spots were light blue 
due to their current basic pH. As the reaction proceeded, the spots become yellow indicating 
formation of non-basic peptide bond. 
The acetylation step called “capping” was performed to block all remaining free amino 
functions between spots. Both membranes were washed separately for 30 s in 100 ml of a 
capping solution, AC2O (2 % acetic anhydride in DMF), followed by reaction overnight in 100 
ml of a fresh AC2O on a rocker.  
5. Both membranes were washed with 100 ml DMF, (1 x 30 s, 2 x 2 min).  
6. The Fmoc amino protecting groups were removed through 5 min reaction in 20 % 
piperidine / DMF solution. 
7. The membranes were washed again with 100 ml DMF (1 x 30 s, 4 x 5 min)  
8. The spots were stained light blue by 5 min incubation in 100 ml of 1 % BPB / DMF 
solution. Repeat if traces of remaining piperidine turn into a dark blue solution. 
9. The filters were washed with 100 ml ethanol (1 x 30 s, 4 x 5 min) 
10. Dried as described above (I. 4).    
 
III. Assembly of peptides on spots 
 
HOBt-esters of Fmoc amino acid derivatives (2.1.11) must be prepared in NMP for use 
throughout in spotting reactions. Dissolve 1 mmol of each Fmoc-AA in 5 ml NMP containing 
0.25 M HOBt to give 0.2 M Fmoc-AA stock solutions. These are kept in 10 ml plastic tubes 
that are closed tightly, flash frozen in liquid nitrogen, and stored at -70 C.  
 
1. A set of 0.2M Fmoc amino acid stock solutions was removed from the freezer and thawed 
to room temperature followed by activation of the desired aliquots with DIC (4 µl / 100 µl 
of stock aa). The activation reaction was carried out at room temperature for 30 min. Vials 
with the activated amino acids were placed in the synthesizer rack.  
2. The membranes prepared above, were placed onto the platform of the synthesizer for 
spotting. 
3. Solutions of activated amino acids were pre-spotted on a separate 3 MM paper in order 
achieve regular spot sizes during peptide elongation. 0.2 µl of amino acid solutions were 
dispensed on a single spot during three consecutive repetitions, each separated by 10 
min reaction time. During this step, all spots became yellowish or greenish in color. 
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The spotted membranes were covered with glass plates and left on the spotter for 2 h or 
overnight. 
 
All additional steps were performed as described above (see II. 6-12). After completion of the 
entire process, the membranes were used directly for a next spotting cycle carried out in 
exactly the same manner or stored in at -20°C until use.  
After the final cycle, all peptides were N-terminally acetylated as described in II.6, washed 
with DMF, ethanol and dried (see above II. 9, 11, 12). 
 
IV. Side-chain deprotection 
 
The deprotection of amino acid side-chains was performed for both membranes according to 
different procedures. 
 
Immobilized peptides on the APEG amino cellulose membrane: 
The dried membrane was immersed in a reaction trough containing 40 ml of deprotection mix 
(82 % TFA, 10 % DCM, 3 % TIBS, 5 % H2O, under a hood) and reacted overnight with gentle 
agitation. The trough was covered very tightly.  
 
Subsequently, the membrane was washed with following solutions (100 ml each): 
  
4 x 2 min DCE  
3 x 2 min DMF 
2 x 2 min ethanol  
3 x 10 min acetic acid (1 M) 
4 x 2 min ethanol 
The filter was dried with cold air, sealed with a foil and stored at –20°C. 
 
Liquid phase peptides from the Fmoc-pro-C540 membrane: 
The dried membrane was immersed in 20 ml of a deprotection mix (50 % CH2Cl2, 3 % TIBS, 
50 % TFA, 2 % H2O) for 1 h in a tightly closed trough with gentle agitation (under a hood). 
The deprotection mix was exchanged and the reaction was carried out for the next hour.  
Subsequently, the membrane was washed with following solutions (100 ml each): 
 
4 x 10 min CH2Cl2  
3 x 20 min methanol / H2O + HCl (1+1+0.1 %) 
3 x 20 min acetic acid (1 M) 
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The membrane was dried overnight in a drying chamber under vacuum followed by drying 
with cold air until the smell of acetic acid was no longer detectable. Peptides were cleaved off 
from the solid support into the liquid phase according to the following procedure: 
1. The identical peptide spots were cut out from the membrane with a scalpel and collected 
into an Eppendorf tube containing 500 µl of the TAEB (0.1 M) / 20 % ethanol mixture and 
cleaved off overnight with shaking.  
2. The supernatant was transferred in a new Eppendorf tube and the peptide spots were 
treated with the same mixture again followed by reaction for an additional 2 h with 
shaking.  
3. Supernatants were pooled together and dried in a vacuum centrifuge overnight. Peptides 
were stored at –20°C. 
 
The purity of peptides was determined with analytical HPLC and their masses were 
determined by MALDI-MS. 
 
2.2.7 Protein - SPOT peptide binding assay 
Binding assays were carried out using spots containing peptides of different length and GST-
Mena-EVH1 fusion protein as well as GST protein alone (see section 2.3.5, Fig 2.3.5.25 and 
Fig 2.3.5.26). Spots were washed sequentially with 70 % ethanol / 1 h, 20 times for 5 min 
with TBS pH 7.4, at room temperature under agitation on a rocker table and blocked 
overnight at 4°C with MBS (see Table 2.1.10.1). Next, spots were washed ten times 5 min 
with TBST pH 7.4 and incubated for 1h at room temperature with 1-2 µg of GST-Mena-EVH1 
or 1 µg GST protein followed by TBST wash as above. Two antibodies, primary anti-Mena 
PAK 73 Ab (dilution 1:1000 and 1:3000) and secondary, POD conjugated anti-rabbit IgG 
(dilution1:2000) were used in the case of GST-Mena-EVH1 fusion. In the case of GST 
protein alone, only POD conjugated rabbit anti-GST antibody was used (dilution 1:2000). 
Spots were incubated for 1 hour at room temperature with corresponding antibodies. 
Washing procedure with TBST (see above) was repeated after incubation with each 
antibody. Color reaction was indicating interaction was developed using OPD, substrate 
solution for peroxidase (see Table 2.1.10.1).   
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2.2.8 Expression and purification of high-activity Taq DNA polymerase 
The protocol for DNA Taq polymerase purification was adapted from (Pluthero, 1993). The 
composition of all buffers used here is described in Table 2.1.10.1. An overnight culture 
containing 100 ml LB medium, 34 µg/ml chloramphenicol and 50 µg/ml kanamycin was 
initiated with a single colony of BL21 (DE3) pLysS strain containing pET-Taq construct and 
grown at 37°C (200 rpm). The next day, 25 ml of the overnight culture were used to initiate 
three 800 ml cultures. Bacteria were grown at 37°C with 150 rpm agitation until OD600 = 0.4. 
Production of polymerase was induced by addition of IPTG to a concentration of 1 mM. 
Bacteria were grown at the same conditions for the additional 5 – 6 h. The cells were 
harvested by centrifugation at 2800 x g for 15 min at room temperature and the resulting 
pellet was washed with the buffer A, (100 ml / 1 L culture). The cell recovery was obtained by 
another 30 min centrifugation step followed by the addition of 50 ml buffer A, re-suspension 
and the addition of an equal volume of the lysis buffer. Addition of the lysis buffer and 
sufficient mixing caused cell breaking and the lysate became viscous. Alternatively, the 
washing step can be omitted and the cell pellet can be re-suspended directly after first 
centrifugation step in 50 ml of the buffer A. Additionally the cells were efficiently broken by 
high-pressure homogenization using a French press device, according to manufacturer’s 
guidelines. A glass flask with the lysate was placed in a water bath at 75°C for 1 h. Most of 
the proteins except thermo-stable DNA Taq polymerase got denaturized and fell out of the 
solution as white flocculent debris. The debris was isolated by centrifugation at 10000 x g, 
4°C for 20 min. The yellowish clear supernatant was transferred to a glass flask. The 
polymerase was recovered at room temperature by gradual addition of well-powdered 
ammonium sulphate (30 g / 100 ml of supernatant) under rapid stirring. It is very important to 
add the ammonium sulphate stepwise in small amounts and to dissolve it well before addition 
of the next portion. The protein precipitate was harvested by centrifugation at 13 000 x g, 4°C 
for 15 min. The polymerase was visible as a surface precipitate, floating on the surface of the 
liquid. The supernatant was discarded very gently and the pellet re-suspended well in buffer 
A, (20 ml / 100 ml of supernatant). The protein was dialyzed for 24 h at 4°C against two 
changes of the storage buffer (500 ml). The buffer was changed after about 12 h. The 
dialyzed DNA Taq polymerase was stored at –20°C and was ready to use.                                                     
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3. Results and discussion 
 
3.1 Lambda and T7 phage display systems 
 
3.1.1 Construction of lambda phages presenting model protein domains 
The DNA of the phage vector, λDisplay1 was isolated as described in 2.2.3.5. Coding DNA 
sequences of the three model domains (see Table 1.3.1 in section 1.3), were transferred 
from the T7Select10-3b constructs (obtained from Krzysztof Bialek, GBF Braunschweig) to 
the λDisplay1, as shown in Fig 3.1.1. The purified λDisplay1 vector was digested with SpeI 
and NotI endonucleases, analyzed by agarose gel electrophoresis for complete cleavage 
(Fig 3.1.2), and subsequently dephosphorylated followed by ethanol precipitation. The DNA 
inserts coding for the model domains were PCR amplified. The T7Select10-3b constructs 
were used as a DNA template for the amplification reaction. Two oligonucleotide primers 
T7S and T7A were specifically designed for the purpose of PCR (see Table 2.1.6.1.1). The 
sense primer introduced a SpeI restriction site at the 5’ end of the insert. The second SpeI 
restriction site, present at the 3’ end of the multi cloning site (MCS) of the T7Select10-3b 
vector, was eliminated by a single T/G point mutation. The NotI restriction site was taken 
from the T7Select10-3b vector (Fig 3.1.1). Before cloning, the PCR amplified sequences 
were analyzed by agarose gel electrophoresis (Fig 3.1.3). After purification, digestion with 
both restriction enzymes and ethanol precipitation, appropriate amounts of the inserts and 
vector DNAs were mixed together in order to perform the ligation reaction as described in 
(2.2.3.9). The inserted sequences were extended by 21bp and 7bp from the 5’ and 3’ end 
respectively in comparison the parent T7Select10-3b constructs. The lambda phages 
presenting protein domains were assembled using a commercially available packaging kit 
(see 2.2.3.9). Phage extracts were poured onto the agar plates in order to obtain single well-
isolated phage plaques. Twenty phage clones were chosen for PCR analysis to confirm the 
presence of the DNA sequences coding the model protein domains (Fig 3.1.4). PCR was 
performed using a universal primer set, designed for the λDisplay1 vector arms (LS and LA) 
as well as the three primer sets (E1, E2, F1, F2, Y1, Y2), where each set is specific for the 
respective model domain (see Table 2.1.6.1.1). 
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Fig 3.1.1: Cartoon drawing showing the cloning strategy used for the construction of lambda phages 
presenting model protein domains. A) Section of the T7Select10-3B vector and its multiple cloning site 
with a protein domain (blue) inserted between EcoRI and HindIII cloning sites. B) PCR primers: T7S 
that introduce a SpeI site (purple, underlined) into the appropriate position of the vector (orange, 
underlined) and T7A that introduce a single point mutation T/G in the second SpeI restriction site 
flanking the 3’ end of the insert. C) PCR product with the 5’ introduced SpeI restriction site (purple) 
and the 3’ NotI restriction site (pink). D) SpeI and NotI digested PCR product. E) Section of the 
λDisplay1 vector and its MCS. F) PCR product cloned between SpeI and NotI restriction sites at the 3’ 
end of the phage lambda gene D coding the capsid protein gpD.    
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Fig 3.1.2: Ethidium bromide stained 0.7 % AGE analysis of the λDisplay1 vector digested with SpeI 
and NotI endonucleases. In lane 1: DNA marker X; 2: SpeI and NotI digested λDisplay1 vector arms; 
3: DNA SMART marker.  
Fig 3.1.3: Ethidium bromide stained 1 % AGE analysis of the PCR products amplified from 
T7Select10-3b constructs with T7S and T7A primers. A) In lane 1: EVH1, 417bp; 2: WW/FE65, 178bp; 
3: WW/YAP, 228bp; 4: control PCR sample without DNA template with visible primer oligomerysation 
products; 5: DNA marker MXIII. B) DNA marker MXIII (Boehringer Mannheim). 
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Fig 3.1.4: Ethidium bromide stained 1 % AGE analysis of the PCR products corresponding to the DNA 
inserts cloned into the λDisplay1 vector. A) In line 1: DNA marker MXIII; 2-21: PCR products of 20 
randomly chosen phage clones obtained after phage assembly amplified with LS and LA primers 
(Table 2.1.6.1.1). Expected sizes: (EVH1 (E)-422bp; WW/FE65 (F)-183bp; WW/YAP (Y, 233bp); 22: 
DNA marker MXIII. B) PCR of selected phage clones presenting model domains. Sequences were 
amplified using domain specific primers. In line 1: DNA marker MXIII; 2-3: WW/FE65, 138bp; 4-5: 
WW/YAP, 192bp; 5:EVH1, 339bp. C) DNA marker MXIII (Boehringer Mannheim). 
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3.1.2 Comparison of T7 phage with lambda phage 
Both phage display systems were then analyzed with respect to their performance in 
enrichment of domain-presenting phages on the peptide SPOT membranes. The main goal 
of these studies was a comparison of the efficiencies for the same proteins displayed on both 
phage types. The phages displaying the three protein domains were used as a model for 
these studies. Peptide ligands corresponding to these model domains are shown in Table 
1.3.1 in section 1.3. Additionally a control peptide that is not a binding ligand for the studied 
domains (NRPPPAVGPQPAP) was used for monitoring the unspecific phage enrichment. 
Several different phage mixtures were prepared, that were characterized by high, moderate 
or low abundance of model phages. Phages displaying model domains were diluted with a 
mixture of T7 phages displaying IL-4, Fas antigen, ezrin and correspondingly with the wild 
type lambda phages, lacking an insert. These three T7 phage constructs were engineered 
previously as described in Bialek et al., 2003. Before an appropriate phage mixture was 
prepared, phage stocks used as a diluent agent, as well as the model phages were poured 
onto the agar plates and the titers (pfu/ml) were calculated as described in 2.2.4.3. With both 
types of phages, the same panning conditions were applied except for the elution step, which 
had to be carried out by direct infection of bacteria in the case of lambda phages due to their 
instability for elution reagents that were applied for T7 phages (see 2.2.2.4).  
Initially, the 1:100 dilutions of phages presenting model domains were prepared (Table 
3.1.1). After a single round of panning, on the peace of cellulose membrane containing four 
domain specific peptide-spots, the PCR and agarose gel electrophoresis were used to 
identify the number of inserts matching the respective peptide ligands (Fig 3.1.5). The same 
experiments were carried out twice. The amounts of phages eluted from each peptide SPOT 
as well as the percentage of correct inserts and the enrichment factors are shown in Table 
3.1.2. True enrichment factors were calculated from the ratio of positively verified to the 
analyzed phages divided by the initial ratio of model to total phages (in this experiment 
1:100) 
 
Table 3.1.1: An example showing the preparation of the phage mixture containing the model lambda 
phages diluted 1:100 in the wild type lambda phages (WT). 
Phage displaying domain Titer pfu/ml Dilution ratio 1:100 µl 
EVH1 1.9x109 9.4x107 49.4 
WW/FE65 3.65x109 9.4x107 25.8 
WW/YAP 6.25x109 9.4x107 15 
WT  9.4x109 9.4x109 up to 1000 
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Fig 3.1.5: Ethidium bromide stained 1 % AGE analysis of the PCR products corresponding to the DNA 
of phages recovered from the peptide-spot ligands. Dilution ratio of model phages: 1:100. Short name 
code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); Ezrin (Ezr); Interleukin-4 (IL-4),lambda wild type (WT); 
DNA marker XIII (M1). A) Analysis of 20 randomly chosen lambda clones corresponding to each 
peptide ligand. B) Analysis of 20 randomly chosen T7 clones corresponding to each peptide ligand. C) 
DNA marker MXIII (Boehringer Mannheim). 
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Table 3.1.2: Comparison of the enrichment efficiencies of the lambda and T7 phage display systems, 
after a single round of panning on membrane bound peptides. Phages presenting model protein 
domains were diluted 1:100.   
Domain Peptide Lambda T7 
  Experiment 1 Experiment 2 Experiment 1 Experiment 2 
  Titers of eluted phages 
EVH1 pep-E 2.8x105 1.6x105 3.4x104 2.1x105 
WW/FE65 pep-F 4.8x105 4.7x105 1.4x105 1.5x105 
WW/YAP pep-Y 3.1x105 2.7x105 1.6x105 1.5x105 
 control 3x104 3.6x104 4.9x104 1.9x104 
  Percentage of correct inserts among 20 analyzed clones a) 
EVH1 pep-E 35 50 100 90 
WW/FE65 pep-F 95 85 80 80 
WW/YAP pep-Y 40 35 90 95 
  Enrichment factors 
EVH1 pep-E 35 50 100 90 
WW/FE65 pep-F 95 85 80 80 
WW/YAP pep-Y 40 35 90 95 
a) 5 % = 1 insert 
 
In the case of the lambda display system, high affinity enrichment to the corresponding 
peptide SPOTs was observed only for phages presenting WW/FE65 while the two other 
model phages showed a two or three fold lower representation within the eluted population of 
phages. On the other hand, the panning experiment with T7 phages indicated very good 
affinity enrichment for all model phages on their corresponding peptide ligands. However, it 
was found that the enrichment of the WW/FE65 presenting phages was slightly better in the 
case of lambda system when compared with the T7 system (see Table 3.1.2).  
Since the dilution ratios of model phages applied for the above experiments were relatively 
low, these phages were already quite enriched within the working phage solution. Therefore, 
a more realistic dilution ratio (1:104) was applied for the next experiment that allowed a better 
investigation of the enrichment efficiencies of both types of phages, especially with respect to 
the WW/FE65 presenting phages. Panning experiments and clone analysis were performed 
in the same uniform way as described for the experiments above. The data related to the T7 
pannings (1:104), that were used for comparison of both systems were kindly provided by 
Krzysztof Bialek (GBF Braunschweig, personal communication), (Bialek et al., 2003;). The 
agarose gel electrophoresis images are shown in Fig 3.1.6. The enrichment efficiencies of 
both systems after one round of affinity selection are compared in Table 3.1.3.  
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Fig 3.1.6: Ethidium bromide stained 1 % AGE analysis of the PCR products corresponding to the DNA 
inserts of the phage populations recovered from the peptide SPOT ligands. Dilution ratio of model 
phages: 1:104. Short name code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); Ezrin (Ezr); Interleukin-4 (IL-
4), lambda wild type (WT); DNA marker XIII (M1); DNA marker SMART (M2). A) Analysis of 20 
randomly chosen lambda clones corresponding to each peptide ligand. B) Analysis of 20 randomly 
chosen T7 clones corresponding to each peptide ligand. The AGE image B), was provided by 
Krzysztof Bialek). C) DNA marker MXIII (Boehringer Mannheim). D) DNA marker SMART 
(Eurogentec). 
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Table 3.1.3: Comparison of the enrichment efficiencies of the lambda and T7 phage display systems, 
after a single round of panning on membrane bound peptides. Phages presenting model protein 
domains were diluted 1:104 
Domain Peptide Lambda T7 
  Single experiment Average values from two experiments 
  Titers of eluted phages 
EVH1 pep-E 3.3x103 6.5x103 
WW/FE65 pep-F 8.4x103 2.6x103 
WW/YAP pep-Y 3.2x103 6.5x103 
  Percentage of correct inserts among 20 analyzed clones a) 
EVH1 pep-E 15 52.5 
WW/FE65 pep-F 65 7.5 
WW/YAP pep-Y 10 44 
  Enrichment factors 
EVH1 pep-E 1500 5250 
WW/FE65 pep-F 6500 750 
WW/YAP pep-Y 1000 4400 
a) 5 % = 1 insert 
 
With respect to the lambda display system, results obtained from the experiment that utilized 
the higher dilution of model phages, confirmed those of the previous investigation. Better 
enrichment efficiency was observed again for the phages presenting the WW/FE65 model 
domain. The affinity enrichment of the other two domains was again much less. Contrary to 
this, in the case of the T7 display system, the WW/FE65 phages once more showed the 
lowest enrichment efficiency, whereas the two other model phages were represented in 
relatively high yields with the EVH1 presenting phages as favorites. This difference was not 
as clear visible after a 1:100 dilution. Obviously these two display systems behave opposite 
to each other. Additional experiments with the model phages diluted 1:106 were performed 
for the lambda display system. First, only one round of phage panning was carried out. 
Subsequently the second experiment was done in which the phages enriched after the first 
round, were propagated and subjected to a second round of selection. The data obtained 
from both tests were compared with the data acquired from the same type of investigations 
for the T7 phages, where the model phages were diluted 1:105 and 1:106 (Bialek et al., 
2003). Analysis of 40 (1:105) and 20 (1:106) phage clones that were randomly chosen from 
populations eluted from each peptide SPOT (Table 3.1.4) was completed exactly as before 
(AGE images not shown).  
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Table 3.1.4: Comparison of the enrichment efficiencies of the lambda and T7 phage display systems, 
after one and two consecutive rounds of panning on membrane bound peptides. Phages presenting 
model protein domains were diluted 1:105 and 1:106 (T7) and 1:106 (lambda). 
Domain Peptide Lambda T7 
  Single experiment Average values from two experiments 
  1:106 1:105 1:106 
  1 round a) 2 rounds a) 1 round b) 2 rounds a) 
  Percentage of correct inserts among analyzed clones c) 
EVH1 pep-E 0 25 15 95 
WW/FE65 pep-F 10 40 2.5 12.5 
WW/YAP pep-Y 0 0 0 22.5 
  Enrichment factors 
EVH1 pep-E n.d 250 000 15 000 950 000 
WW/FE65 pep-F 100 000 400 000 2500 125 000 
WW/YAP pep-Y n.d n.d n.d 225 000 
a) 20 clones analyzed 
b) 40 clones analyzed 
c) 5 % = 1 insert 
 
This last set of experiments addressed the capacity of the method to identify proteins that 
are only low expressed in the tissue/cells from which the cDNA for the phage library 
originates. The experiments with the lambda system showed that after a single selection 
round, only the WW/FE65 domain could be identified, among all verified clones. Its 
enrichment was four times better than that observed for the corresponding T7 phages 
isolated also after one panning only (dilution 1:105) and comparable to that achieved after 
two consecutive rounds of T7 selection (dilution 1:106). Additionally, when two consecutive 
lambda phage selection rounds were completed, the abundance of the WW/FE65 module 
increased four times and was almost four times higher than the abundance of the T7 phages 
displaying the same domain enriched after two rounds. This confirms once again a better 
performance of lambda phage system presenting this particular domain in comparison to T7 
phages. From the other two domains only the EVH1 could be identified among 20 verified 
clones achieved after two rounds of panning. Distinct from lambda, the T7 system showed 
the highest selection performance for the EVH1 domain. It was enriched after a single round 
of panning and its representation increased evidently after two consecutive pannings, 
indicating very high enrichment efficiencies of this domain when presented on the T7 phage. 
The WW domain of YAP was not identified among analyzed clones after one selection 
round; however, it was sufficiently enriched after two rounds. The comparison of enrichment 
efficiencies for the model phages, achieved from all experiments performed from both 
display systems is summarized in Fig 3.1.7. 
3. Results and discussion 
 76
0.0
20.0
40.0
60.0
80.0
100.0
120.0
A LB A T7 B LB B T7 C LB C T7 D LB D T7
EVH1 domain
WW/FE65 domain
WW/YAP domain
 
 
Fig 3.1.7: Affinity enrichment preferences of the lambda (LB) and T7 phages, displaying model protein 
domains. Comparison of data obtained from four independent experiments utilizing different dilution 
ratios of model phages: A (1:100); B (1:104); C (1:105), one round of panning; D (1:106), two rounds of 
panning 
 
The T7Select10-3b display system was designed for middle density display of large proteins 
with capacities 5-15 copies per phage particle (Rosenberg et al., 1996). Therefore, the 
T7Select10-3b system is more efficient when strong binders are to be isolated in affinity 
enrichment experiments. A weak affinity of some proteins must be compensated with higher 
valence in order to increase the avidity. It was reported that in some cases the display 
densities of the T7Select10-3b are not enough to achieve the satisfactory phage enrichment 
(Zucconi et al., 2001). These observations are in agreement with the experimental results 
described above. In the T7Select10-3b case, the EVH1 domain was always preferentially 
enriched whereas the WW/YAP domain was less enriched but still better than the WW/FE65 
domain. The observed enrichment efficiencies correlate well with the binding constants of the 
corresponding protein-peptide complexes, 5 µM and 54 µM for the EVH1 and WW/YAP 
respectively. A binding constant for the WW/FE65 complex is not reported. Its behaviour 
however, with reference to the other two model domains indicates a weaker affinity. The 
λDisplay1 system was designed for high copy display of proteins (Castagnoli et al., 2001). Its 
high display density (up to 405 copies) was advantageous for affinity isolation of weaker 
binders that couldn‘t be efficient isolated with the T7 system, as reported by Zucconi et al., 
2001.  
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Contrary to the T7 system, the data obtained from all experiments clearly revealed the 
highest enrichment efficiency for the WW/FE65 when displayed by lambda phages. 
According to the observations reported for low affinity proteins (Zucconi et al., 2001), it was 
deduced that the WW/FE65 domain belongs most probably to the weaker binding domains. 
Its high enrichment efficiency was a result of the avidity increase caused by a high-density 
display. Surprisingly, the enrichment of the two other modules was much less as compared 
to the T7 system. Why were the EVH1 and WW/YAP model phages, despite their higher 
affinities for the peptide ligands, less represented within the recovered lambda phage 
populations? It could be suggested that the high display valence strongly increased their 
overall binding avidity to the high-density peptide SPOTs. As a result of the strong binding, 
these two model phages may not be sufficiently infective during the applied elution 
procedure based on direct infection of bacteria. However, the chance that the bacteria reach 
the peptide bound phage and become infected should be similar for all three phages 
displaying model domains. An explanation for this experimental result remains obscure. It 
can be only tentatively suggested that some structural changes important for infection are 
required during the docking process of bacteria to phage and that the increased binding 
affinity of the phage to its peptide SPOT does not allow for these changes. An experimental 
proof for this speculation could be reached by utilizing lower densities of peptides on the 
membrane spots in order to decrease the binding avidity of these phages. An alternative 
explanation for the lower enrichment of the EVH1 and WW/YAP domains could be an 
inefficient folding of these domains when fused to the C-terminus of the lambda capsid 
protein gpD, causing reduced affinities to their peptide ligands. This may be corroborated by 
e.g. plasmon resonance measurements (BiaCore) with immobilized peptides and the 
domain-presenting phages compared to the free protein domains. Although the lambda 
display system has proven to be preferable when weak protein-peptide interactions are to be 
identified, the overall performance of the T7 display system proves to be more reliable and 
general. Additionally, the higher stability against different elution reagents, shorter life cycle, 
more convenient handling, as well as the availability of many commercial cDNA libraries are 
other advantages that support the choice of the T7 display system for the goal of this thesis.  
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3.2 Accessible surface scanner software tool 
The objective of the work in this section was an evaluation of a computer software tool that 
was developed for prediction of surface-exposed protein regions based on a published 
algorithm (see section 1.2.1). This tool was subsequently utilized for peptide generation. 
Several model protein sequences were analyzed that contain continuous epitopes, which 
were proven to be ligands for diverse protein modules. The resulting output files were 
examined for the presence of these epitopes. Additionally, selected sequences that belong to 
proteins of known structure were scanned with the software tool and the output peptides 
were checked for their appearance in the surface-exposed regions, deduced from the protein 
structure. 
3.2.1 Predictions of surface probability for model ligands  
The preliminary tests were performed with four proteins that are well-characterized, natural 
binding partners for the model protein domains studied in this thesis: the WBP1 and WBP2, 
ligands of the WW/YAP, as well as Mena and ActA, interacting with the WW/FE65 and EVH1 
respectively. The initial parameters applied for the following peptide selections were: peak 
height threshold 2.0, minimum width 1.0 and smoothing 2.0. The peptide length was defined 
as 25 aa with the overlap of 10 aa concerned for those surface regions, which were longer 
than 25 aa. The original sequences and the output peptide files, as well as surface 
probability plots for these proteins are shown in Fig 3.2-1 – 3.2-4. Comparison of the input 
and output sequences showed that the motifs responsible for interaction with their 
corresponding modules were present among selected peptide fragments in the all four 
cases. Moreover, the overall, possible number of peptides that would be required for a 
systematic sequence scanning was reduced by about 70 % after a computational analysis 
with the ASS software (see Table 3.2.1).  
 
Table 3.2.1: Comparison of results obtained after computer analysis with the ASS software and the 
systematic peptide scan of the ActA, Mena, WBP1 and WBP2 protein sequences.  
Protein 
domain  
Binding 
protein 
Size 
(aa) 
Binding 
core 
motifs 
Total 
No. of  
motifs 
No. of 
motifs in 
the output 
file 
No. of peptides 
(systematic 
scan)  
25 aa 
No. of 
peptides 
(ASS scan)  
25 aa 
EVH1 ActA 639 FPPPP/
PPIP 
4 3 42 12 
WW FE65 Mena 802 PPLP 6 4 54 15 
WW YAP WBP1 304 PPPPY 1 1 20 6 
WW YAP WBP2 261 PPPPY 3 3 17 5 
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Additionally, for the ActA, WBP1 and WBP2, the residues that were scored as surface-
probable were found directly within the cores of binding motifs, whereas such residues were 
located outside the motif in the case of Mena (see A1-D1, turquoise). 
Fig 3.2.1: A computer analysis of the ActA protein sequence with the ASS software tool. A1) 
Comparison of the input protein sequence with the output file showing selected peptides. Green: 
bolded sequences indicate binding motifs for the EVH1 domain. Turquoise: residues determined to be 
surface-exposed, A2) Surface probability plot. Horizontal lines illustrate selected protein fragments 
that were used for generation of peptides. Green lines indicate the binding motifs. Selection 
parameters: peak height threshold 2.0, minimum width 1.0 and smoothing 2.0, peptide length 25 aa. 
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 A2 
;spP33379 ActA OUTPUT PEPTIDES 
.pep 
TDEWEEEKTEEQPSEVNTGPRYETA (40-64) 
LKEKAEKGPNINNNNSEQTENAAIN (93-117) 
SAAEIKKRRKAIASSDSELESLTYP (141-165) 
DSELESLTYPDKPTKVNKKKVAKES (156-180) 
QLLTKKKSEEVNASDFPPPPTDEEL (250-274) 
PATSEPSSFEFPPPPTDEELRLALP (290-314) 
ATSEPSSFEFPPPPTEDELEIIRET (326-350) 
FTDDENSETTEEEIDRLADLRDRGT (409-433) 
KNPSQPLNVFNKKTTTKTVTKKPTP (479-503) 
ATKPQETVLRENKTPFIEKQAETNK (515-539) 
QKEATESDKEEMKPQTEEKMVEESE (551-575) 
RSAGIEEGKLIAKSAEDEKAKEEPG (585-609) 
spP33379 ActA INPUT SEQUENCE 
MGLNRFMRAMMVVFITANCITINPDIIFAATDSED 
SSLNTDEWEEEKTEEQPSEVNTGPRYETAREVSSR 
DIKELEKSNKVRNTNKADLIAMLKEKAEKGPNINN 
NNSEQTENAAINEEASGADRPAIQVERRHPGLPSD 
SAAEIKKRRKAIASSDSELESLTYPDKPTKVNKKK 
VAKESVADASESDLDSSMQSADESSPQPLKANQQP 
FFPKVFKKIKDAGKWVRDKIDENPEVKKAIVDKSA 
GLIDQLLTKKKSEEVNASDFPPPPTDEELRLALPE 
TPMLLGFNAPATSEPSSFEFPPPPTDEELRLALPE 
TPMLLGFNAPATSEPSSFEFPPPPTEDELEIIRET 
ASSLDSSFTRGDLASLRNAINRHSQNFSDFPPIPT 
EEELNGRGGRPTSEEFSSLNSGDFTDDENSETTEE 
EIDRLADLRDRGTGKHSRNAGFLPLNPFASPVPSL 
SPKVSKISAPALISDITKKTPFKNPSQPLNVFNKK 
TTTKTVTKKPTPVKTAPKLAELPATKPQETVLREN 
KTPFIEKQAETNKQSINMPSLPVIQKEATESDKEE 
MKPQTEEKMVEESESANNANGKNRSAGIEEGKLIA 
KSAEDEKAKEEPGNHTTLILAMLAIGVFSLGAFIK 
IIQLRKNN 
 A1 
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Fig 3.2.2: A computer analysis of the WBP1 protein sequence with the ASS software tool. B1) 
Comparison of the input protein sequence with the output file showing selected peptides. Green: 
bolded sequence indicates binding motifs for the WW/YAP domain. Turquoise: residues determined to 
be surface-exposed. B2) Surface probability plot. Horizontal lines illustrate selected protein fragments 
that were used for generation of peptides. Green lines indicate binding motifs. Selection parameters: 
peak height threshold 2.0, minimum width 1.0 and smoothing 2.0, peptide length 25 aa. 
 
 
 
 
;spP97764 WBP1 OUTPUT PEPTIDES 
.pep 
RASSRNSSEEAWGSLQAPQQQQSPA (3-27) 
IWRRAGTQTRALDTILYHPQQSHLL (35-59) 
FRHRRAKLRLQQQQRQREINLLAYH (110-134)
FKPPAYEDVVHHPGTPPPPYTVGPG (157-181)
HQEGEPRAGLSPVHIPPSCRYRRLT (220-244)
PDSSEGEPLKEARASASQPDLEDHS (255-279)
spP97764 WBP1 INPUT SEQUENCE
MARASSRNSSEEAWGSLQAPQQQQSPAASSLEGAI
WRRAGTQTRALDTILYHPQQSHLLRELCPGVNTQP
YLCETGHCCGETGCCTYYYELWWFWLLWTVLILFS
CCCAFRHRRAKLRLQQQQRQREINLLAYHGACHGA
GPVPTGSLLDLRLLSAFKPPAYEDVVHHPGTPPPP
YTVGPGYPWTTSSECTRCSSESSCSAHLEGTNVEG
VSSQQSALPHQEGEPRAGLSPVHIPPSCRYRRLTG
DSGIELCPCPDSSEGEPLKEARASASQPDLEDHSP
CALPPDSVSQVPPMGLASSCGDIP 
  B1 
0 100 150 200 250 300
Sequence Position - spP97764 WBP1
Peak Height = 2.00, Minimum Width = 1
Peptide Length = 25, Peak Overlap = 10
Smoothed with a 5-point quadratic convolution
S
ur
fa
ce
 A
cc
es
si
bi
lit
y 
E
m
in
i c
al
cu
la
tio
n 
 B2 
1
2
3
5
 4
50
3. Results and discussion 
 81
 
 
 
Fig 3.2.3: A computer analysis of the WBP2 protein sequence with the ASS software. C1) 
Comparison of the input protein sequence with the output file showing selected peptides. Green: 
bolded sequences indicate motifs that bind to the WW/YAP domain. Turquoise: residues determined 
to be surface-exposed, dark green: peptide in the forward orientation (PPPY), light green: peptide in 
the reverse orientation. C2) Surface probability plot. Horizontal lines illustrate selected protein 
fragments that were used for generation of peptides. Green lines indicate binding motifs in forward 
(dark) and reverse (light) orientations. Selection parameters: peak height threshold 2.0, minimum 
width 1.0 and smoothing 2.0, peptide length 25 aa. 
 
 
 
 
 
 
;spP97765 WBP2 OUTPUT PEPTIDES 
.pep 
LNKNHSEGGGVIVNNTESILMSYDH (3-27) 
TFNDMKNVPEAFKGTKKGTVYLTPY (31-55) 
GMYPCPPGYPYPPPPPEFYPGPPMM (162-186) 
YVQPPPPPYPGPMEPPVSGPSAPAT (192-216) 
PGNPHNVYMPTSQPPPPPYYPPEDK (234-258) 
spP97765 WBP2 INPUT SEQUENCE
MALNKNHSEGGGVIVNNTESILMSYDHVELTFNDMKNVP
EAFKGTKKGTVYLTPYRVIFLSKGKDAMQSFMMPFYLMK
DCEIKQPVFGANFIKGIVKAEAGGGWEGSASYKLTFTAG
GAIEFGQRMLQVASQASRGEVPNGAYGYPYMPSGAYVFP
PPVANGMYPCPPGYPYPPPPPEFYPGPPMMDGAMGYVQP
PPPPYPGPMEPPVSGPSAPATPAAEAKAAEAAASAYYNP
GNPHNVYMPTSQPPPPPYYPPEDKKTQ 
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Fig 3.2.4: A computer analysis of the Mena protein sequence with the ASS software. D1) Comparison 
of the input protein sequence with the output file showing selected peptides. Green: sequences 
indicate motifs that bind to the WW/FE65 domain. Turquoise: residues determined to be surface-
exposed, bold: core of the binding motifs, normal: consecutive polyproline stretches preceding the 
core motifs, underlined: not selected motifs D2) Surface probability plot. Horizontal lines illustrate 
selected protein fragments that were used for generation of peptides. Green lines indicate binding 
motifs. Selection parameters: peak height threshold 2.0, minimum width 1.0 and smoothing 2.0, 
peptide length 25 aa. 
;spQ03173 Mena OUTPUT PEPTIDES 
.pep 
DDANKKWVPAGGSTGFSRVHIYHHT (17-41) 
CGPTLPRQNSQLPAQVQNGPSQEEL (135-159) 
VQNGPSQEELEIQRRQLQEQQRQKE (150-174) 
QLQEQQRQKELERERMERERLERER (165-189) 
MERERLERERLERERLERERLEQEQ (180-204) 
LERERLEQEQLERQRQEREHVERLE (195-219) 
QEREHVERLERERLERLERERQERE (210-234) 
RLERERQERERERLEQLEREQVEWE (225-249) 
QLEREQVEWERERRMSNAAPSSDSS (240-264) 
TVPRPLNKNSRPSSPVNTPSSQPPA (342-366) 
PPTSGPAAPPPPPPPPPPPPPPPLP (434-458) 
PGPPPPPPLPSTGPPPPPPPPPPLP (565-589) 
PPPPPPPPLPNQAPPPPPPPPAPPL (580-604) 
PPPPPPAPPLPASGIFSGSTSEDNR (595-619) 
ARRRRIAEKGSTIETEQKEDRNEDA (685-709) 
AKAPSTSTPEPTRKPWERTNTMNGS (714-738) 
WERTNTMNGSKSPVISRPKSTPSSQ (729-753) 
EGLDYDRLKQDILDEMRKELAKLKE (762-786) 
spQ03173 Mena INPUT SEQUENCE 
MSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRV
HIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKY
NQATQTFHQWRDARQVYGLNFGSKEDANVFASAMM
HALEVLNSQEAAQSKVTATQDSTNLRCIFCGPTLP
RQNSQLPAQVQNGPSQEELEIQRRQLQEQQRQKEL
ERERMERERLERERLERERLERERLEQEQLERQRQ
EREHVERLERERLERLERERQERERERLEQLEREQ
VEWERERRMSNAAPSSDSSLSSAPLPEYSSCQPPS
APPPSYAKVISAPVSDATPDYAVVTALPPTSTPPT
PPLRHAATRFATSLGSAFHPVLPHYATVPRPLNKN
SRPSSPVNTPSSQPPAAKSCAWPTSNFSPLPPSPP
IMISSPPGKATGPRPVLPVCVSSPVPQMPPSPTAP
NGSLDSVTYPVSPPPTSGPAAPPPPPPPPPPPPPP
PLPPPPLPPLASLSHCGSQASPPPGTPLASTPSSK
PSVLPSPSAGAPASAETPLNPELGDSSASEPGLQA
ASQPAESPTPQGLVLGPPAPPPPPPLPSGPAYASA
LPPPPGPPPPPPLPSTGPPPPPPPPPPLPNQAPPP
PPPPPAPPLPASGIFSGSTSEDNRPLTGLAAAIAG
AKLRKVSRVEDGSFPGGGNTGSVSLASSKADAGRG
NGPLPLGGSGLMEEMSALLARRRRIAEKGSTIETE
QKEDRNEDAEPITAKAPSTSTPEPTRKPWERTNTM
NGSKSPVISRPKSTPSSQPSANGVQTEGLDYDRLK
QDILDEMRKELAKLKEELIDAIRQELSKSNTA 
 D1 
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To investigate the influence of parameter variations on the surface probability prediction 
process, additional studies were carried out using the above protein sequences. Only one 
out of three parameters was altered before each scanning procedure was initiated. Their 
values ranged from 1.5 to 3.5 for peak height threshold, from 1.0 to 6.0 for minimum width 
and from 0 to 5.0 for smoothing, (see Table 3.2.2).  
 
Table 3.2.2: Influence of the variable selection parameters on the number of peptides and binding 
motifs in the output files. Bold: variable parameter, blue: parameters and results from the previous 
analysis, red: values obtained without smoothing function.  
Results Selection parameters 
No. of peptides in the output file No. of binding motifs in the 
output file 
Peak 
height 
Min. 
width 
Smoothin
g 
ActA WBP1 WBP2 Mena ActA WBP
1 
WBP
2 
Mena    
21 7 6 20 4 1 3 4 1.5 1.0 2.0 
12 6 5 15 3 1 3 3 2.0 1.0 2.0 
9 5 4 8 1 1 3 0 2.5 1.0 2.0 
6 2 2 7 1 0 2 0 3.0 1.0 2.0 
3 2 1 5 1 0 1 0 3.5 1.0 2.0 
12 6 5 15 3 1 3 3 2.0 2.0 2.0 
12 6 5 14 3 1 3 3 2.0 4.0 2.0 
11 5 4 13 3 1 3 3 2.0 6.0 2.0 
17 7 5 13 4 1 3 1 2.0 1.0 0 
13 5 4 13 3 1 3 3 2.0 1.0 3.0 
12 5 5 10 3 1 3 2 2.0 1.0 4.0 
10 4 3 11 1 1 3 2 2.0 1.0 5.0 
 
Variation of the peak height threshold parameter revealed having a major effect on the 
amounts of generated peptides and preservation of the proper binding motifs in the output 
files. Its increase caused a dwindling of the peptide quantities for all studied proteins, but 
frequently at the expense of the correct ligands. For the ActA and Mena, rise of the peak 
height threshold from 1.5 to 2.0, indicated a loss of only one binding motif, however, this 
became critical when further heightened from 2.0 to 2.5, causing a reduction of the majority 
or all binding motifs respectively. In the case of the WBP1 and WBP2, their core motifs 
responsible for binding to WW domains were located within higher scored regions, as 
deduced from the surface probability plots (Fig 3.2.2 and Fig 3.2.3). Therefore, elimination of 
binding motifs in these cases was observed only when the peak height threshold value was 
increased up to 3.0 or higher (Table 3.2.2). Apart from the peak height threshold, the other 
two parameters didn’t seriously affect surface predictions for these two proteins. The 
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omission (0) or application (2.0) of the smoothing function however, revealed to have 
different influence on the ActA and Mena (Table 3.2.2, blue and red). This omission was 
advantageous for the ActA, resulting in selection of the fourth binding sequence (FPPIP), 
which was also found when the peak height threshold was reduced to 1.5. The total number 
of generated peptides however, was higher in this case than that recorded for the analysis 
with the smoothing 2.0. A detailed investigation of surface probabilities (Fig 3.2.5, A1, A2), 
revealed that the non-smoothed value for residue H373 (2.269) was higher than the defined 
peak height threshold (2.0). Therefore a fragment containing this residue was scored as a 
surface-probable. Nevertheless, this value turned out to be smaller (1.739) than the defined 
threshold, when calculated with the smoothing 2.0, which resulted in elimination of the entire 
fragment from the output file. An opposite effect was observed for Mena protein, where 
smoothing (2.0) resulted in an increase of the number of binding core motifs from one to four. 
Analysis of surface-probability values for residues from an example fragment (F1) of Mena 
revealed a slight increase of the value for residue P452 (from 1.927 to 2.005), when 
smoothing 2.0 was applied (Fig 3.2.5, B1, B2). This qualified the P452 as a surface exposed 
and promoted peptide generation process. 
Fig 3.2.5: The influence of smoothing function on fragment generation process. Selection parameters: 
peak height threshold 2.0, minimum width 1.0, peptide length 25 aa. A1) Section of ActA protein 
sequence. B1) Section of Mena protein sequence. Surface probability values of the residues H373 
and P542: blue bold-no smoothing, red bold-smoothing 2.0. Violet bold: binding motifs, green: 
selected region. A2 and B2) Surface probability plots for the ActA and Mena. Blue plot: (no 
smoothing), red plot (smoothing 2.0). Horizontal lines: blue; regions selected with smoothing 
parameters 2.0 and 0.0, green; regions selected with smoothing (ActA) or without smoothing (Mena).  
A1      Surface Probability 
       Smooth 0 Smooth 2.0 
373 H > |2.269    1.739 
374 S > |1.222    1.486 
375 Q   |0.836    0.926 
376 N   |1.026    0.857 
377 F   |0.663    0.756 
378 S   |0.592    0.583 
379 D   |0.569    0.535 
380 F   |0.461    0.511 
381 P   |0.532    0.446 
382 P   |0.459    0.593 
383 I   |0.919    0.812 
384 P   |1.029    1.055 
ActA A2 
B1       Surface Probability    
        Smooth 0 Smooth 2.0 
446 P > |1.927    1.927 
447 P > |1.927    1.927 
448 P > |1.927    1.927 
449 P > |1.927    1.927 
450 P > |1.927    1.927 
451 P > |1.927    1.927 
452 P > |1.927    2.005 
453 P > |1.927    1.696 
454 P > |1.028    1.259 
455 P   |1.028    0.951 
456 P   |1.028    1.028 
457 L   |1.028    1.069 
F1
B2  Mena
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The F1 region contains a strain of eight proline residues having the same surface probability 
value (1.927), which is only slightly smaller than defined peak height threshold (2.0). Despite 
the entire F1 region was not scored as surface probable when scanned without smoothing 
and above parameters, it could be considered as moderately surface exposed and would be 
definitely selected if lower peak height threshold was employed. 
 
3.2.2 Predictions of surface probability for different domain-ligands  
The above investigations demonstrated that variations of the peak height threshold and 
activation or deactivation of the smoothing function had somewhat different effects on 
diverse protein sequences. The need for uniform selection parameters that would be 
beneficial for generation of relatively low quantities of peptides while preserving the 
occurrence of protein binding motifs was a goal of the auxiliary tests. In order to evaluate the 
accuracy of the prediction with the ASS software, additional 21 proteins, which interact with 
the SH3, GYF, EH and PDZ domains were examined. In a similar fashion, the resulting files 
were checked for occurrence of the appropriate binding motifs. Initially, 25mer peptides were 
generated and the peak height threshold (2.0) and smoothing (2.0) were applied, as they 
provided satisfactory results in the previous calculations. Subsequently, the same 
calculations were carried out with reduced peak height threshold (1.5), in order to verify 
whether this change would reinstate those motifs that were lost after the first scanning run. 
The results of these calculations are shown in Table 3.2.3. All tests revealed that the 
predominance of motifs relevant for binding was preserved after surface probability analysis 
carried out with the more restrictive peak height threshold (2.0). Nevertheless, for some 
isolated proteins (AFAP, Abl, Sos-1, Shb), this computing approach appeared to be less 
beneficial, suffering up to 50 % loss of known epitopes. In addition, multiple NPF binding 
motifs present in the Hrb (4) and Epsin-1 (3), were not found in the resulting files. However, 
all these motifs for the Hrb and one for the Epsin-1 were reinstate after reduction of the peak 
height threshold to 1.5. This change restored also a minimal core sequence for the fourth 
motif in the SOS-1 protein, which was only partially selected when the peak height threshold 
was 2.0. These three proteins were the only examples showing an improvement with 
reference to the number of the desired motif sequences in the output files, as a response to 
the peak height threshold reduction. Analogously, as observed for the previous calculations, 
reduction of this threshold resulted in an increase of total amounts of output peptides, for all 
studied proteins. General difficulties were observed with recovery of two PDZ binding motifs 
located at the C-terminus of the ARVCF and ErB4 proteins using the above as well as 
several other parameter variations. However, a similar motif from the Frizzled protein that is 
located internally was successfully selected even after scanning with the most restrictive 
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thresholds. Difficulties with the positive selections of sequences located at the N- and C-
termini are related to the algorithm performance. To calculate a surface probability value for 
a certain amino acid (n) the values of surrounding amino acids (n-2 and n+3) are necessary. 
Unfortunately, such calculations are not possible for the first 2 and last 3 residues. Surface 
probability values for these terminal residues are always equal 0, (Emini et al., 1985). 
Therefore motifs binding to PDZ domains, which include the last three C-terminal residues 
couldn’t be positively scored by the ASS tool (see 3.2.5). 
 
Table 3.2.3: Comparison of the ASS selected binding motifs with motifs present within input 
sequences. The protein domains, their interaction partners and binding motifs, as well as numbers of 
motifs and peptides present in the output files are shown. Selection parameters: peptide length 25 aa, 
peak height thresholds 2.0 and 1.5, minimum width 1.0, smoothing 2.0. The quantities of peptides 
obtained for peak height thresholds are shown. Green: binding motifs selected by the ASS tool with 
the peak height threshold 2.0, black: full motifs or their fragments that were not selected via the 
software tool, blue: residues from the binding motifs, which were selected with the peak height 
threshold 1.5, bold: key residues necessary for interaction. Motifs with missing key residues were not 
accepted as valuable binding partners. 
Protein/ 
Domain 
Binding motifs  
(aa) 
No. of motifs 
nature/ASS 
No. of output  
peptides 
Reference 
 
Binding  
protein 
 P.H a) 
2.0 
P.H a) 
1.5 
P.H a) 
 2.0 
P.H a) 
1.5 
 
Src/SH3 
class I 
Hs AFAP PPQMPLPEIPQQ 
PPDNGPPPLPTS 
2/1 2/2 20 26 Flynn et al., 1993 
 Hs CDC42 
GAP 
TAPKPMPPRPPL 1/1 1/1 7 7 Barfod et al., 
1993 
Hs hnRNP K PLPPPPPPRGG 1/1 1/1 8 12 Weng et al., 1994 
Hs Dynamin GGAPPVPSRPG 
GPPPQVPSRPN 
RAPPGVPSRSG 
3/3 3/3 20 24 Gout et al., 1993 
Hs PI3K p85 QPAPALPPKPP 1/1 1/1 19 25 Kapeller et al., 
1994 
Src/SH3 
class II 
Hs Shb GGPPPGPGRRG 
TKSPPQPPRPD 
2/1 2/1 14 19 Karlsson et al., 
1995 
Hs Abl QAPELPTKTR 
VSPLLPRKER 
EKPALPRKRA 
3/2 3/2 30 39 Ren et al., 1994 Crk/N SH3 
Hs C3G PPPALPPKKR 
TPPALPEKKR 
KPPPLPEKKN 
PPPALPPKQR 
4/4 4/4 26 35 Knudsen et al., 
1994 
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Protein/ 
Domain 
Binding motifs  
(aa) 
No. of motifs 
nature/ASS 
No. of output  
peptides 
Reference 
 
Binding  
protein 
 P.H a) 
2.0 
P.H a) 
1.5 
P.H a) 
 2.0 
P.H a) 
1.5 
 
Hs SOS-1 PVPPPVPPRRR 
DSPPAIPPRQP 
ESPPLLPPREP 
IAGPPVPPRQS 
4/2 4/3 34 44 Rozakis-Adcock 
et al., 1993 
Grb2/N 
SH3 class 
II 
Rn Synapsin-1  NLPEPAPPRPS 
PPGPAGPIRQA 
2/2 2/2 24 31 McPherson et al., 
1994 
Endophilin/
SH3 
Synaptojanin-1 PKRPPPPR 1/1 1/1 39 58 Zucconi et al., 
2001 
NUMB NPF 1/1 1/1 13 21 Salcini et al., 
1997 
Hrb 4 x NPF 4/0 4/3 9 21 Yamabhai et al., 
1998; Lucke et 
al., 2005 
Epsin-1 3 x NPF 3/0 3/1 8 19 Chen et al., 1998 
Eps15/EH 
Synaptojanin-1 3 x NPF 3/3 3/3 39 58 Haffner et al., 
1997 
CD2 SHRPPPPGHRV 1/1 1/1 6 12 CD2BP2/ 
GYF SmB GMPPPGMR 
RPPPPGMR 
2/2  4 8 
Kofler et al., 2004 
Lin1p/GYF Prp-8 PPPPGF 
PPPPGY 
PPPPGL 
3/3 3/3 55 71 Bialkowska et al., 
2002 
Erbin/PDZ ARVCF DSWV- C term 1/0 1/0 27 40 Laura et al., 2002 
PSD95/ 
PDZ 
ErbB-4 TVV- C term 1/0 1/0 30 55 Garcia et al., 
1999 
Dvl1/PDZ Frizzled GKTLQSWRRFYH 
internal PDZ motif 
1/1 1/1 12 16 Wong et al., 2003 
a) Peak height threshold 
 
In the second stage of these studies, the same 21 protein sequences were subjected for 
analysis using various parameters. Initially, the same calculations as above with the peak 
height threshold 2.0 were carried out with and without smoothing in order to investigate its 
influence on the process of peptide selection (Table 3.2.4). Similarly as observed previously 
for the ActA and Mena, activation or deactivation of smoothing showed opposite effects on 
the Dynamin-1 and Hrb proteins. The Dynamin-1 contains three poly-proline motifs for the 
Src/SH3 domain. All of them were found within the resulting fragments when smoothing 2.0 
was applied, whereas only two were hit upon its omission (pink). Opposite to this, none of 
the four NPF motifs were obtained in the case of the Hrb protein employing smoothing; 
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however two were recovered after scanning without this function (red). The total number of 
generated sequences was higher for the experiments performed without smoothing 
parameter, which is in agreement with previous observations. Apart from the Dynamin-1 and 
Hrb, no other protein showed a response to smoothing variations in this approach.  
In order to test whether the same motifs will be preserved after reduction of peptide length, 
all 21 proteins were analyzed using the following parameters: peptide length 15 aa combined 
with the peak height thresholds 2.0 and 1.5, with and without smoothing. Loss of several 
appropriate motifs was observed in many cases (see Table 3.2.4). Obviously, surface 
probability values calculated for residues from these motifs were lower than the respective 
peak height thresholds. Since their incorporation into generated peptide depends on its 
defined length, those motifs, which are more distant from the residues scored as surface-
probable were eliminated upon peptide shortening. As expected, this elimination was more 
frequent in the case of calculations with the peak height threshold 2.0. Nevertheless, several 
of those lost motifs could be reinstated when lower peak height threshold (1.5) was 
employed. Only in one case (SOS-1), the shortening of peptide length resulted in scoring an 
additional binding motifs as surface probable (Table 3.2.4 blue). It was observed for all 
proteins that the overall number of peptides in the output files systematically increased (up to 
50 %) after reduction of each parameter. The parameters chosen for future predictions are 
required to provide a minimal number of peptides that have to be chemically synthesized, 
with possible high preservation of the appropriate binding motifs in the resulting file. In this 
case larger numbers of proteins could be spotted in the form of peptides on a single 
membrane allowing for global analysis of protein-peptide interactions. Since the application 
of the peak height threshold 2.0 in combination with the peptide length of 25 aa provided 
satisfactory results with reference to the preservation of binding motifs and total amounts of 
selected peptides, these two values appeared to be the most appropriate for future 
calculations. Both, omission and application of smoothing will be still considered in the future 
studies.  
 
Table 3.2.4: Quantitative comparison of the ASS selected binding motifs and amounts of peptide 
fragments generated with the ASS using different parameters. Peak height threshold 2.0 and 1.5, 
minimum width 1.0, smoothing 2.0 and 0.0, peptide length 25 and 15 aa. 
No. of binding motifs  No. of output peptides 
P.H a) 2.0 
(25 aa) 
P.H a) 2.0 
(15 aa) 
P.H a) 1.5 
(15 aa) 
P.H a) 2.0 
(25 aa) 
P.H a) 2.0 
(15 aa) 
P.H a) 1.5 
(15 aa) 
Nature
Smooth Smooth Smooth Smooth Smooth Smooth 
Domain 
binding 
protein 
 0 2.0 0 2.0 0 2.0 0 2.0 0 2.0 0 2.0 
AFAP 2 1 1 0 0 1 1 23 20 32 29 49 46 
CDC42 GAP 1 1 1 1 1 1 1 7 7 7 8 10 8 
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No. of binding motifs  No. of output peptides 
P.H a) 2.0 
(25 aa) 
P.H a) 2.0 
(15 aa) 
P.H a) 1.5 
(15 aa) 
P.H a) 2.0 
(25 aa) 
P.H a) 2.0 
(15 aa) 
P.H a) 1.5 
(15 aa) 
Nature
Smooth Smooth Smooth Smooth Smooth Smooth 
Domain 
binding 
protein 
 0 2.0 0 2.0 0 2.0 0 2.0 0 2.0 0 2.0 
hnRNP K 1 1 1 1 1 1 1 11 8 18 17 28 28 
Dynamin 3 2 3 1 1 1 1 25 20 30 26 43 38 
PI3K p85 1 1 1 1 1 1 1 24 19 39 32 45 41 
Shb 2 1 1 1 1 1 1 18 14 21 18 30 25 
Abl 3 2 2 1 1 2 2 27 30 46 39 66 44 
C3G 4 4 4 4 3 4 4 29 26 41 37 51 47 
SOS-1 4 2 2 4 3 4 3 37 34 67 55 85 82 
Synapsin-1  2 2 2 1 1 1 1 23 24 32 27 42 38 
Synaptojanin 1 1 1 1 1 1 1 48 39 63 60 92 81 
NUMB 1 1 1 1 0 1 1 17 12 33 22 40 37 
Hrb (NPF) 4  2 0 0 0 2 2 14 9 16 10 30 29 
Epsin-1 
(NPF) 
3  0 0 0 0 1 0 13 8 15 13 27 26 
Synaptojanin 3  3 3 2 1 2 2 48 39 63 60 92 81 
CD2 1 1 1 1 0 1 1 8 6 14 11 25 22 
SmB 2 2 2 2 2 2 2 4 4 5 5 10 7 
Prp-8 3 3 3 2 2 3 3 57 55 101 85 123 126 
ARVCF C-
term 
1 0 0 0 0 0 0 33 27 46 35 60 51 
ErbB-4 C-
term 
1 0 0 0 0 0 0 40 39 66 52 89 80 
Frizzled  1 1 1 1 1 1 1 12 12 16 17 26 23 
a) Peak height threshold 
 
3.2.3 ASS predictions versus protein structure 
Future attempts to evaluate the ASS performance were concerned with a comparison of 
results achieved for a single sub-unit of the pentameric C-Reactive Protein (CRP), (Shrive et 
al., 1996, PDB 1GNH), with its crystal structure. Presence of several surface exposed loops, 
which are a potential source of linear epitopes as well as interesting for analysis β-structures 
and α-helices within the CRP sub-unit, were the main reasons for choosing this protein as a 
model. Calculations were performed with and without smoothing of surface probability 
values, using the following parameters; peptide length 25 aa, peak height threshold 2.0, 
minimum peak width 1.0, overlap 10 aa. Peptide fragments acquired from the computer 
analysis were verified for their appearance in the regions that are exposed on the protein 
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surface. The surface probability plots on Fig 3.2.6, show protein regions predicted as a 
surface exposed (horisontal lines) as well as peaks representing residues having the highest 
surface probabilities. The red colored plot, corresponds to predictions with smoothing 2.0. 
The blue plot shows a surface probabilitiy profile generated without application of this 
function (0). Four 25 aa peptides were generated from the predicted regions in both cases 
(1-4, blue lines). An additional region represented by a single, C-terminally located peptide 5 
(green line), was scored as a surface probable, only when smoothing was avoided. A 
detailed analysis of this fragment revealed that the surface probability value of the highest 
scored residue (L190) was higher than the defined peak height threshold (2.120 > 2.0), 
resulting in its positive selection. In contrast, activation of smoothing function reduced this 
value drastically to 1.515, eliminating this fragment from the output peptide file (Fig 3.2.7). 
Additionally, all residues in this region were much less scored than residues in other selected 
regions, as deduced from the surface probability plots (Fig 3.2.6). Therefore, the entire C-
terminal region of the CRP monomer should be considered here, less surface-probable. 
Fig 3.2.6: Surface probabilities prediction for the CRP. Selection parameters: peak height threshold 
2.0, minimum width 1.0, smoothing 2.0 and 0, overlap 10 aa, peptide length 25 aa. Superimposed 
surface probability plots. Light blue: smoothing = 0, red: smoothing 2.0. Horizontal lines indicate the 
ASS generated 25 aa peptides: blue with smoothing 2.0, green with smoothing 0. 
Sequence Position - spP02741 CRP
50 100 150 200
S
ur
fa
ce
 A
cc
es
si
bi
lit
y 
 E
m
in
i c
al
cu
la
tio
n 
 Peak Height = 2.00, Minimum Width = 1 
 Peptide Length = 25, Peak Overlap = 10 
 Smoothed with a 5-point quadratic convolution (2.0) 
 Smoothing = 0 
 
1 
3 
4 
 
2 
7 
1 2 3 4 5 
3. Results and discussion 
 91
Fig 3.2.7: ASS calculations for the C-terminal sequence of the CRP scanned with and without 
smoothing. Abbreviations: “>” if determined to be on the surface, “I” if included in a generated peptide 
fragment, arrows: directions of the fragments elongation. Bold: surface probability values for L190. 
 
As next, the accuracy of the above calculations was checked by comparison of results with 
the crystal structure of CRP sub-unit. The first four generated peptides were found within the 
surface exposed loops in the protein structure (see Fig 3.2.8, yellow, LP: 1- 4). All residues 
having the highest surface probability values (red) were located within these loops, 
documenting the accuracy of performed predictions. According to the protein structure, the 
C-terminal region (R1) is evidently surface exposed. However, the ASS predictions didn’t 
reveal such high surface probability for this region, as described for the peptide-5 above. 
Moreover, two additional regions, the α-helix (H) and β-sheet (βa), which seems to be 
displayed on the protein surface, were not scored as surface-probable by the software. It can 
be speculated that predictions of such secondary structures is more difficult for the ASS, 
than predictions of extended loop regions. This was supported by the analysis of two 
additional protein sequences (Nef-HIV1 and Crk-SH2) and comparison of acquired 
predictions with their crystal structures (data not shown). Nevertheless, several exposed 
loops were scored as surface probable in both cases. Since the linear binding motifs for 
various protein domains are often located in such loops, generation of peptides from these 
  Surface Probabilities 
 
     peak 2.0, pep 25 aa 
 
Smooth:     0           2.0   
178 G    |0.347       0.412 
179 P    |0.650       0.695 
180 F    |1.057       0.942 
181 S    |0.793       0.769 
182 P    |0.423       0.603 
183 N    |0.785       0.603 
184 V    |0.616       0.758 
185 L    |0.780       0.644 
186 N    |0.490       0.526 
187 W    |0.545       0.708 
188 R  > |1.321       1.046 
189 A  > |1.287       1.689 
190 L  > |2.120 25aa  1.515 
191 K    |0.803       1.337 
192 Y    |1.377       1.207 
193 E    |1.653       1.639 
194 V    |1.431       1.347 
195 Q    |0.678       0.738 
196 G    |0.339       0.435 
197 E    |0.659       0.537 
198 V    |0.761       0.872 
199 F    |1.189       1.076 
200 T    |1.189       1.236 
201 K    |1.321       1.490 
202 P    |1.604       1.162 
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regions is highly desirable. Therefore the general performance of the ASS software tool is 
satisfactory.  
 
Fig 3.2.8: Comparison of the ASS software predictions with the structure of CRP monomer (Shrive et 
al., 1996). Selection parameters: peak height threshold 2.0, minimum width 1.0, smoothing 2.0 (A), no 
smoothing (B), overlap 10 aa. Abbreviations: yellow: superimposed peptide fragments, red: residues 
showing the highest surface probabilities, pink: termini of generated peptides, blue: regions that were 
not selected via the ASS, Lp: loop, H: helix, R: region, β: β-sheet. 
 
3.2.4 Comparison of the surface probability and solvent accessibility 
algorithms 
The final investigations were concerned with comparison of performances of the surface 
probability predicting algorithm (ASS) with the algorithm predicting solvent accessibility 
(software PH-Dacc), which was previously used by another group for studies on the p53 and 
Znf 217 proteins (Pavlik et al., 2003). Using the PH-Dacc software, Pavlik and colleagues 
selected four and two epitopic peptides for both proteins, respectively. These were 
experimentally verified for binding to antibodies that were enriched before from a phage 
display library with the protein as bait. The main goal of studies performed here was a test 
whether the same epitopes could be successfully predicted by the ASS software. Both 
protein sequences were scanned using the peak height threshold 2.0, minimum peak width 
1.0, peptide lengths 25 aa, with and without smoothing of surface values. As an example, the 
B            smoothing 0, pep 25 aa 
N
C
R1 Lp4
H 
Lp3
Lp2 
L190
Lp1
Lp5 
Lp6 
βa 
 
 
A            smoothing 2.0, pep 25 aa 
N 
C 
R1 Lp4
H 
Lp3 
Lp2 
L190 
Lp1 
Lp5 
Lp6 
β a 
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ASS surface probability plots, achieved here for the p53 protein sequence were compared 
with a plot showing solvent accessibility predictions for the same protein (Fig 3.2.9). From 
several algorithms tested by Pavlik, the solvent accessibility was shown as the best 
performance. Therefore the second chain flexibility algorithm used in his studies, which is 
also visible on Fig 3.2.9-A, will not be compared here with the surface probability algorithm. 
Despite visible similarities, several significant differences between both plots were observed 
including regions (R1-R3, pink) containing the four binding epitopes.  
Fig 3.2.9: Comparison of plots achieved for the p53 protein after calculations using the solvent 
accessibility and the surface probability algorithms. A) Chain flexibility and solvent accessibility plots 
(Pavlik et al., 2003, modified). B) Surface probability plots. Scanning parameters: peak height 
threshold 2.0, minimum width 1.0, smoothing 2.0 (red) and 0 (blue), overlap 10 aa, peptide length 25 
aa. Horizontal lines indicate the ASS generated peptides (blue, smoothing = 2.0, green: smoothing = 
0). Regions R1-R3, show differences in probability calculations between different algorithms (pink). 
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Then, the peptides acquired using the ASS software, were checked for the presence of the 
epitopes described by Pavlik. Scanning of p53 protein sequence using smoothing of surface 
probability values, resulted in generation of three peptides containing the epitopic sequences 
see (Table 3.2.5). Omission of smoothing resulted in the recovery of peptide containing the 
fourth epitope. Nevertheless, only one fragment (3) contained a full length binding motif. The 
remaining three sequences were up to three residues shorter than the corresponding 
peptides selected with the PH-Dacc software. Additional calculations were performed using 
the same parameters with peptides length of 15 aa. This reduction resulted in even stronger 
shortening of the desired epitopic sequences for all peptides with exception of the peptide 
No.3 (see Table 3.2.5),  indicating that the majority of peptides selected as solvent 
accessible by Pavlik, were not fully scored as surface probable with the ASS. These 
sequences were however incorporated into the 25 aa long fragments due to peptide 
extension process. 
 
Table 3.2.5: Comparison of peptides achieved from the p53 sequence after application of algorithms 
calculating surface probability (ASS) and solvent accessibility (Pavlik et al., 2003). Several different 
selection parameters applied for the ASS calculations are shown. Red: epitopic residues, which were 
predicted with the ASS, blue: epitopic residues, which were not predicted with the ASS. 
p53 protein 
Surface probability algorithm (ASS) Solvent accessibility algorithm 
pep 25 aa, peak 2.0  
smoothing 2.0  
1 ------------------------- 
2 KGEPHHELPPGSTKRALPNNTSSSP (292-316) 
3 ALPNNTSSSPQPKKKPLDGEYFTLQ (307-331) 
4 SSHLKSKKGQSTSRHKKLMFKTEGP (366-390) 
1 GPDEAPRMPEAAPPV  59-73 
2 KKGEPHHELPPGSTK  291-305 
3 PNNTSSSPQPKKKPL  309-323 
4 RHKKLMFKTEGPDSD  379-393 
without smoothing   
1 SPDDIEQWFTEDPGPDEAPRMPEAA (46-70) 
2 GEPHHELPPGSTKRALPNNTSSSPQ (293-317) 
3 LPNNTSSSPQPKKKPLDGEYFTLQI (308-332) 
4 SSHLKSKKGQSTSRHKKLMFKTEGP (366-390) 
1 GPDEAPRMPEAAPPV  59-73 
2 KKGEPHHELPPGSTK  291-305 
3 PNNTSSSPQPKKKPL  309-323 
4 RHKKLMFKTEGPDSD  379-393 
pep 15 aa, peak 2.0  
smoothing 2.0  
1 --------------- 
2 RTEEENLRKKGEPHH (283-297) 
3 PNNTSSSPQPKKKPL (309-323) 
4 SHLKSKKGQSTSRHK (367-381) 
1 GPDEAPRMPEAAPPV  59-73 
2 KKGEPHHELPPGSTK  291-305 
3 PNNTSSSPQPKKKPL  309-323 
4 RHKKLMFKTEGPDSD  379-393 
without smoothing   
1 WFTEDPGPDEAPRMP (53-67) 
2 TEEENLRKKGEPHHE (284-298) 
3 PNNTSSSPQPKKKPL (309-323) 
4 STSRHKKLMFKTEGP (376-390) 
1 GPDEAPRMPEAAPPV  59-73 
2 KKGEPHHELPPGSTK  291-305 
3 PNNTSSSPQPKKKPL  309-323 
4 RHKKLMFKTEGPDSD  379-393 
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Analogous studies were performed for the Znf 217 protein (plot not shown). Comparison of 
the epitopic peptides selected using the solvent accessibility algorithm with the two 
fragments achieved after surface probability calculations is shown in (Table 3.2.6). 
Regardless of peptide length, both epitopes described by Pavlik were present within the 
resulting ASS peptide file. The epitope sequence of the peptide No.1 was shortened by three 
residues in the case of generation of 15mers. The last three amino acids from the peptide 
No.2 were not incorporated into the peptide because these are the last C-terminal residues 
and their surface probability values could not be calculated by the algorithm, as discussed 
previously for C-terminal PDZ peptides. Predictions of surface probabilities for epitopic 
sequences form the p53 protein seemed to be less satisfactory comparing with the results 
achieved after calculations of solvent accessibility. However, the ASS predictions for the Znf 
217 protein were comparable for both algorithms. In addition to the studies described above, 
more model proteins, containing known binding motifs have to be analyzed with both 
algorithms in order to compare and judge their performances.  
 
Table 3.2.6: Comparison of peptides achieved from the Znf 217 sequence after calculations with 
surface probability (ASS) and solvent accessibility (Pavlik et al., 2003) algorithms. Several different 
selection parameters applied for the ASS calculations are shown. Red: epitopic residues, which were 
predicted with the ASS, blue: epitopic residues, which were not predicted with the ASS. 
Znf 217 protein 
Surface probability algorithm (ASS) Solvent accessibility algorithm 
pep 25 aa, peek 2.0  
smoothing 2.0  
1 TSVSPAPDKTKRPETKLKPLPVAPS (845-869) 
2 HLSNSMAQKRNYENFIGNAHYRPND (1021-1045) 
PDKTKRPETKLKPLP 851-865 
NFIGNAHYRPNDKKT 1034-1048 
without smoothing   
1 TSVSPAPDKTKRPETKLKPLPVAPS (845-869) 
2 HLSNSMAQKRNYENFIGNAHYRPND (1021-1045) 
PDKTKRPETKLKPLP 851-865 
NFIGNAHYRPNDKKT 1034-1048 
pep 15 aa, peek 2.0  
smoothing 2.0  
1 SPAPDKTKRPETKLK (848-862) 
2 NYENFIGNAHYRPND (1031-1045) 
PDKTKRPETKLKPLP 851-865 
NFIGNAHYRPNDKKT 1034-1048 
without smoothing   
1 SPAPDKTKRPETKLK (848-862) 
2 NYENFIGNAHYRPND (1031-1045) 
PDKTKRPETKLKPLP 851-865 
NFIGNAHYRPNDKKT 1034-1048 
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3.2.5 Summary 
The analysis of 25 protein sequences containing continuous binding motifs for different 
protein modules revealed that their majority was successfully predicted as surface probable 
with the ASS software tool. Since none from the existing algorithms is perfect enough to 
predict all possible, surface exposed regions in a protein, the achieved results are fully 
acceptable and satisfactory. In addition, the option to apply various parameters allows for 
more or less stringent calculations. The choice of optimized parameters is a compromise 
between a total number of peptides that have to be chemically synthesized and accuracy of 
predictions observed for different thresholds applied in the model systems. The peak height 
thresholds will eliminate motifs having lower surface probability values than a defined limit. 
High thresholds will decrease the amounts of peptides to be synthesized and will allow for 
generation of peptides only from highly exposed regions. On the other hand, application of 
very restrictive parameters will reduce chances for generation of those potentially bio-active 
motifs, which are less surface exposed. Such motifs can be selected by reduction of peak 
height threshold and generation of longer peptides, if desirable. Nevertheless, this will 
increase the total amounts of peptides in the resulting file.  
A feature of the ASS software, which definitely needs to be improved, is its inability to predict 
surface probabilities for the N- and C-terminal protein sequences. To calculate the value for 
a certain amino acid (n) the algorithm involves values of surrounding amino acids (n-2 and 
n+3). Such calculations are obviously impossible for the first two and the last three residues, 
therefore their value is equal 0 (Emini et al., 1985). This problem was observed for binding 
motifs of PDZ modules, as they usually contain the last C-terminal amino acids. Even in the 
case of the ErbB-4 protein described earlier, where the C-terminal region was scored as 
extremely surface-probable, the last three residues that are important for binding to PDZ 
domains were not incorporated into the generated fragment. As a proposal to overcome 
these problems, the N- and C-termini should be automatically included in the peptide output 
file.  
Comparison of the ASS calculations with protein structures revealed that several regions 
displayed on a protein surface, especially loops connecting other structural motifs, were 
correctly scored by the algorithm. Selections of loop regions increase chances to generate 
peptides with potentially functional, linear epitopes, which are expected to predominantly 
occur within these regions. Nevertheless, to rely on the comparisons of protein structures 
with computational surface probability predictions could be questionable, as the structural 
data are frequently obtained for proteins bound with their ligands. The effects of structural 
changes occurring upon complex formation (Gohlke et al., 2004) are unpredictable using the 
surface probability algorithm and could lead to inappropriate interpretation of results. Most 
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importantly, it was revealed that certain structural motifs like α-helical and β-strands were not 
correctly qualified as surface-probable, despite their evident exposure deduced from a 
protein structure. It could be hypothesized that difficulties with predictions for α-helices could 
be related to their “dual character”, defined by alternating, buried and exposed amino-acid 
residues. Despite certain limitations, the majority of results achieved using the ASS software 
was satisfactory. The ASS can be proposed as a useful tool, helpful in genome spanning 
approaches toward selections of novel binding ligands. Such application will be supported by 
high-throughput performance of the ASS, as hundreds of protein sequences can be analyzed 
simultaneously.  
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3.3 High-throughput affinity selection tests of the phage 
displayed protein library on the SPOT peptide arrays  
The affinity selection experiments described in chapter 3.1 were performed using the model 
phages and the four peptide-ligands only. In order to test the phage enrichment in a more 
complex and realistic situation, a high-throughput panning experiment was carried out, 
employing the entire human brain T7Select10-3b phage library and screening against a 
peptide array containing a total of 400 spots. The primary information to be acquired from 
this experiment was the performance of the developed panning process as judges by the 
quantities and types of phages eluted from each single peptide-spot. It was suspected that 
those peptides which are recognized by expressed protein domains in the phage library will 
trap a higher number of phages and that this feature may be exploited to select only 
appropriate spots for further analysis. Additionally, an effort was taken to answer the 
question whether the analysis by PCR, AGE and clone sequencing is practical for the 
reliable identification of specifically bound phages enriched after only one round of affinity 
enrichment in this high-throughput situation.  
In the first step, the peptide arrays were assembled on cellulose membranes as described in 
section 2.2.6. A set of sequences derived from naturally occurring human proteins expressed 
in brain tissue was used as the source of peptides. A list of 533 proteins that have been 
previously identified from mouse brain by 2D gel electrophoresis and mass-spectrometry 
technologies was provided by the collaborating partner (Klose et al, Charetie Universität 
Klinikum, Berlin, manuscript in preparation). Unknown or hypothetical proteins as well as 
proteins obviously involved in signalling or cell motility events were preferred. From the entire 
list of the mouse brain proteins, 119 were chosen for the search of their human homologues 
by Blast search. From the resulting list of human proteins, 98 sequences were chosen as 
candidates for peptide generation. Additionally, 14 sequences of the large size human brain 
KIAA proteins were chosen from the H.U.G.E database (http://www.kazusa.or.jp/huge/). The 
complete list of the Gene Bank database accession numbers (gi) is shown in Appendix 2. 
The Accessible Surface Scanner software was then applied to the 112 protein sequences to 
predict the exposed protein regions that were subsequently utilized for generation of 
peptides. The scanning parameters (peak height 2.0, minimum width 1.0, smoothing 2.0 and 
peptide length 25 aa) were chosen as described in the previous section. 1200 peptides were 
acquired, which were chemically synthesized on three cellulose membranes. Each 
membrane contained 400 different peptides in 16 lines of 25 spots each plus 25 replicates of 
a control peptide (GTPPPPYTVG), which is a ligand for the WW/YAP module. Membrane 
No.1 (see Appendix 3) was used for the test panning with the human brain T7Select10-3b 
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phage library containing 1.2 x 107 pfu/ml of the primary recombinants, which was previously 
amplified to give higher phage representation (1.1 x 1011 pfu/ml). The other two membranes 
were preserved for future investigations. The blocking and washing of the membrane and 
phages, as well as the detailed panning procedure are described in Section 2.2.4.4. After 
panning was completed, the spots were cut out and placed separately in the wells of 96 deep 
well blocks filled with TBST. In order to preserve the order of spots as it is on the cellulose 
membrane and allow an easy tracking of the peptide sequences, the spots were 
successively cut out, starting from the upper left corner of the membrane (spot No.1) and 
placed in the appropriate position of the deep well block (blocks PL1-PL5). Thus, spot No. 97 
was then placed in the position A1 of the PL2 block (PL2A1). The bound phages were 
simultaneously eluted from the peptide-spots with 1 % SDS solution. In order to determine 
the total numbers of the phages eluted from each peptide-spot, series of dilutions (up to 
1:104) were prepared and phages were poured out on the Petri agar plates with bacterial 
lawn, as described in 2.2.4.3. Phage titers found ranged from 104 pfu to 107 pfu and were 
evidently much higher than those observed in the previous experiments in which only four 
model peptide spots and a much less diverse phage mixture were used (see 3.1.2). The 
comparison of phage quantities recovered from the four control peptides in this experiment, 
with those determined after panning of model phages diluted at ratios 1:102 and 1:104 on the 
same peptide, showed an increase of two and three orders of magnitude for peptide-spots in 
this experiment (Table 3.3.1). Complete set of data showing amounts of phages eluted from 
each peptide from the membrane No.1 are shown in Appendix 3.  
 
Table 3.3.1: Comparison of amounts of phages eluted from the control peptide-spot in the high-
throughput panning and two previously performed model pannings, where the three model phages 
were diluted 1:102 and 1:104 with the Fas, IL-4 and Ezrin phages 
Peptide Total quantities of eluted phages (pfu/spot) 
 High-throughput panning 1:102 (Table 3.1.3) 1:104 (Table 3.1.3) 
GTPPPPYTVG 2.19x106 
1.8x106 
1.31x106 
1.26x106 
4.9x104 6.5x103 
 
 
The surprisingly high page titers obtained suggested that the washing steps and volumes of 
buffers applied were, in this case, inefficient to remove the unspecific bound background 
phages. This is concluded from the calculation of the total volume of buffer (30 ml) used in 
each step during washing of the membrane of which only approximately 75 µl could be 
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addressed to a single spot, whereas the volume used for a single spot wash in the former 
experiments was 250 µl. To investigate whether the volume of washing buffer affects the 
total number of recovered phages, four peptide spots from the membrane No.1 were reused 
for another panning experiment applying the same phage library. The phage panning was 
performed for each spot separately in the 1.5 ml Eppendorf tubes, using 250 µl of blocking 
and washing solutions. It was shown that the overall number of recovered phages could be 
reduced up to one order of magnitude in all four cases, but was still quite high (5.8x105 - 
1.1x106) see Table 3.3.2.   
 
Table 3.3.2: Comparison of the total amounts of phages eluted from peptide-spots washed with 
different buffer volumes.  
Peptide  Spot position in 
96 well plate 
Total quantities of eluted phages 
  Membrane 
(75µl/spot) 
Single spots 
(250µl/spot) 
GTPPPPYTVG 
GTPPPPYTVG 
RSFPDTVYKKLVQREKTLKVRGVDR 
MKTRRTLKGHGNKVLCMDWCKDKRR 
PL5B6 
PL5B7 
PL3G8 
PL3A6 
1.8x106 
1.3x106 
7.0x106 
1.3x107 
5.8x105 
6.3x105 
9.0x105 
1.1x106 
 
 
An additional panning experiment was carried out using a freshly prepared phage library, 
whose titer was reduced (1.5 x 1010 pfu/ml), comparing to that used for the previously 
described experiment. A fresh segment of the membrane No.2, containing the array of 28 
peptide-spots was utilized. Except for the larger volumes of blocking and washing buffers 
(500 µl/spot), the panning procedure was carried out exactly as described for the membrane 
No.1. The quantities of the peptide-spot eluted phages were not as high as those observed 
for the membrane No.1 (106 or 107) and ranged from 104 for control peptides to 105 for the 
remaining 24 peptides. Peptide sequences, mother protein database identification code, as 
well as amounts of phages eluted from each peptide-spot are shown in Table 3.3.3. It is 
concluded that these are typical amounts of phages that can be recovered from the peptide 
spots after panning with the entire library, even when the combination of large volumes of 
buffers and less amplified libraries are utilized.  
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Table 3.3.3: Amounts of phages eluted from each of 28 peptide-spots washed with increased volume 
of buffer (500 µl/spot). 
Protein ID Peptide sequence Amounts of eluted phages 
APPTASPGPERKPPPASAPAPQPAP 1.33 x 105 
VVRSFRPDFVLIRQHAFGMAENEDF 1.09 x 105 
TLGGEKFPLIEQTYYPNHKEMLTLP 1.11 x 105 
gi3386485 
SGNWKTNTGSAMLEQIAMSDRYKLW 2.98 x 105 
KLKKPEAVRWEKLEGQGDVPTPKQF 5.62 x 105 
PTPKQFVADVKNLYPSSSPYTRNWD 2.47 x 105 
gi12654186 
SSSPYTRNWDKLVGEIKEEEKNEKL 1.33 x 105 
VSGRRRLLTVLLQAQKWPFQPSRDM 4.12 x 105 
SPSQLRKGPPVPPPPKHTPSKEVKQ 3.58 x 105 
VTSPVKAPTPSGQSIPWDLWEPTES 1.02 x 105 
gi14424792 
QNPEEQDEGWLMGVKESDWNQHKEL 2.13 x 105 
MSYQGKKNIPRITSDRLLIKGGKIV 3.4 x 105 
YDGQEQDELSFKAGDELTKLGEEDE 5.25 x 104 
TLNKDATKAATAAADFTAKVWDAVS 7.35 x 104 
gi2967518 
VDFTQDSNYLLTGGQDKLLRIYDLN 5.55 x 104 
DKLLRIYDLNKPEAEPKEISGHTSG 4.05 x 104 
TTLKDEGKLLEAKGPVTDVAYSHDG 4.65 x 104 
DGYSENNVFYGHHAKIVCLAWSPDN 6.6 x 104 
gi16356636 
WSPDNEHFASGGMDMMVYVWTLSDP 1.59 x 105 
gi12803340 TLSDPETRVKIQDAHRLHHVSSLAW 1.62 x 105 
KVRVIDPRKQEIVAEKEKAHEGARP 1.96 x 105 
FSRMSERQLALWNPKNMQEPIALHE 1.75 x 105 
gi23221 
NMQEPIALHEMDTSNGVLLPFYDPD 2.05 x 105 
gi5701730 FEITDESPYVHYLNTFSSKEPQRGM 4.27 x 105 
GTPPPPYTVG 4.65 x 104 
GTPPPPYTVG 5.85 x 104 
GTPPPPYTVG 8.7 x 104 
control 
GTPPPPYTVG 1.41 x 105 
 
 
The entire phage population eluted from a single spot will contain specific as well as 
background phages. The next goal of this experiment was the examination whether specific 
binders can be obtained after only one panning round, and can be identified among the 
number of analyzed clones using the PCR-AGE-DNA sequencing methods. For this purpose 
twenty phage plaques obtained from each of the two peptide spots PL3A6 and PL3G8 with 
the highest quantities of eluted phages, 1.3 x107 and 7.0 x106 respectively, were chosen for 
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further analysis. Of these, clones of the same or very similar sizes of the DNA inserts, which 
were represented more than once within the analyzed phage pool (see colour positions, Fig 
3.3.1) were expected to be specifically enriched peptide binders and were selected for DNA 
sequencing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.3.1: Ethidium bromide stained 1 % AGE analysis of DNA inserts of the phage populations 
recovered from the PL3A6 and PL3G8 peptide-spots. Coloured numbers indicate the phage clones 
selected for the DNA sequencing. The same colour indicates inserts showing the same or very similar 
sizes. PL3A6) In line 1: MXIII; 2-21: PCR fragments of 20 chosen phage clones; 22: SMART. PL3G8) 
In line 1-20: PCR fragments of 20 chosen phage clones; 21: SMART; 22: MXIII. MXIII: DNA marker 
(Boehringer Mannheim), SMART: DNA marker (Eurogentec). 
 
The sequence analysis revealed that despite large DNA sizes, none of these sequences 
code for peptides or proteins larger than 65 aa, due to an early stop codon occurrence. 
Moreover single point mutations within phage capsid protein 10b were discovered in three 
cases. The Blast search showed that the majority of inserts represented fragments of non 
characterized genomic origin. Additionally, none of the inserts of the same or similar size 
was shown to code for the same protein or even peptide fragment. These results revealed 
that large numbers of irrelevant phages were present within the amplified library used for the 
panning experiment (Table 3.3.4). 
 
 
PL3A6
PL3G8
    1    2     3     4    5     6     7     8     9    10    11  12  13   14   15   16   17   18   19   20  21  22 
      1    2     3     4    5     6    7     8    9    10  11  12  13   14   15   16   17  18  19  20    21   22 
 SMARTMXIII 
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Table 3.3.4: N-terminal fragments of translated sequences that are displayed on the phages eluted 
from PL3A6 and PL3G8 peptide-spots, whose DNA insert were subjected for sequencing. The 
sequence GDPNS represents C-terminus of the T7 phage coat protein 10b. Blue bold: single 
mutations; Red bold: the last amino-acid (S) of the phage sequence; Asterix: indicates termination 
codon; N.S.S: no significant similarity. 
Fragment of translated aa sequence  Plate position 
/phage clone  
BLAST result 
GNPNSSL*VFS PL3 A6/4 N.S.S 
GDPNSSLNSSGYTNI**Y*N** PL3 A6/6 emb|N59875 
GDPN*AEKLSTL*EHDTTNFIFYHFLE PL3 A6/7 emb|BC038857 
GDPNSTNSLKT*KLH PL3 A6/8 emb|BD130959 
GDPNSNRESGSSSVPLSRALLQQHPVTVSCQNISVCHGCCP
GFSHDNYHCKQKK* 
PL3 A6/11  emb|CAJ04699 
GDPN*AELCLLLFNFFFFF PL3 A6/12 N.S.S 
GDPIKPKRTPTKRQL*QKYAL PL3 A6/15 emb|AX069004 
GDPNSAEMCTQKVQRQxxxPSEAxxPQMRFGLEKLEKGMQD
EL*T 
PL3 A6/19 emb|AC012254 
GDPNSALQVRVFLLIFLVEGREEGEEQGRRV*E PL3 A6/20 emb|AC084170 
GDPNSQDLSIFYNRNVHHELDTSVCPRCCH* PL3 G8/2 emb|CB117181 
GDPN*AVWRGPQFQQSRCSHWPQSRHTCQGLWSRLRL*R PL3 G8/4 emb|BQ440041 
GDPNSA*GGLELP PL3 G8/5 emb|AC024700 
GDPNSAREGWRQTSPVVSKGAMCLIYKVS*  PL3 G8/8 emb|AL138108 
GDPNSSPLVR*VTCIFYKGLGADLDKS* PL3 G8/12 N.S.S 
GDPNSEKAAPKMSTCSPIPEHKLSILGSGFRNHLCGKT* PL3 G8/13 emb|AC141288 
GDPNSARLNTPHFRNTHLLGNF* PL3 G8/14 emb|AC003003 
GDPNYIVMKSDKEIVGTLLGFDDFVNMVLEDVTEFEITPEGRR
ITKLDQILLNGNNITMLVPGGEGPEV* 
PL3 G8/18 emb|BG716585 
GDPNS*DPGKDQHANQCQ* PL3 G8/20 emb|AC069040 
 
 
Based on this result, the quality of the commercial phage library was heavily questioned. 
Therefore, phages from the mother library lysate were poured on a bacterial lawn. 
Subsequently twenty phage plaques were randomly chosen and subjected to DNA 
sequencing. Because of pour sequencing quality of the 5’ ends of the inserts in many cases, 
the identification of cloning sites and correct open reading frames, thus also identification of 
possible stop codons occurring early at the 5’ end of the insert was very difficult. Fifteen 
sequences were subjected for DNA versus DNA, BLAST homology search. Five remaining 
clones failed the sequencing. It was revealed that, only three clones (3, 14, and 15), were 
recognized in the databases as sequences coding for known or hypothetical proteins (Table 
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3.3.5). The remaining sequences were either uncharacterized or represented fragments of 
chromosomal DNA. Therefore, it was suspected that the majority of analyzed inserts code for 
short non-functional peptide fragments due to possible early stop codon occurrence, similarly 
as described in the above studies. The abundance of phages coding short peptide fragments 
is probably even increasing during the library amplification step. 
 
Table 3.3.5: Results of BLAST homology search performed for fifteen randomly chosen phages from 
mother library lysate.  
Clone Description of homologous sequence  Database ID 
1 H.s cDNA clone UI-CF-EN1-aek-c-04-0-UI 3', mRNA sequence emb|CB306201 
2 H.s DNA sequence from clone RP4-590F24 on chromosome 1 emb|AC027074 
3 Tripartite motif protein 2 (RING finger protein 86) emb|BC011052 
4 H.s DNA sequence from clone RP11-262D11 on chromosome X emb|BX119917 
7 H.s mRNA; EST DKFZp686C03165_r1 emb|BX473784 
8 H.s mRNA; EST DKFZp686L13127_r1 emb|BX471489 
9 H.s bone morphogenetic protein receptor, type II (serine/threonine 
kinase), mRNA (cDNA clone IMAGE:5261941) 
emb|BC035097 
 
11 H.s cDNA clone cs02c09 3', mRNA sequence emb|N48055 
13 H.s chromosome 14 DNA sequence BAC R-671J11 of library RPCI-11 
from chromosome 14 (Human) 
emb|AL445363 
 
14 H.s septin 3 isoform C mRNA, complete cds emb|AF285108 
15 H.s mRNA for KIAA1219 protein, partial cds emb|BC047482 
16 wn89d11.x1 NCI_CGAP_Ut1 H.s cDNA clone IMAGE:2453013 3', 
mRNA sequence 
emb|AI922199 
 
17 Sequence 20 from Patent WO9951727. emb|AX015361 
19 H.s 3 BAC RP11-705F7 emb|AC130003 
20 UI-CF-EN1-adg-c-03-0-UI.s1 UI-CF-EN1 H.s cDNA clone emb|CB851025 
 
 
The phage panning, utilizing the entire T7Select10-3b phage library and larger peptide array, 
revealed a much higher complexity than the model pannings described in 3.1., where the 
mixtures of six phages and four peptide-spots only were applied. The elevated amounts of 
phages eluted from peptide-spots observed in the high-throughput panning were obviously 
the result of a higher diversity of this library, which provided more candidates for the specific 
as well as unspecific interactions. The broad range of phage titers (104 pfu - 107 pfu) 
obtained from the individual peptide-spots showed various preferences of different peptides 
for interaction with phage displayed proteins and peptides. This was not as noticeable in the 
earlier performed model experiments. An additional factor increasing the amounts of 
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recovered phages was certainly the inappropriate panning procedure. The increase of buffer 
volumes applied for the panning process (from 75 µl/spot to 500 µl/spot) led to positive 
effects on the elimination of unspecific binders and decreased the phage titers to at least one 
order of magnitude. Nevertheless, the total quantities of recovered phages were still much 
higher than that observed for the model system. Another factor relevant for the affinity 
selection experiments is the quality of the utilized library. The sequencing analysis showed 
that a large fraction of the phage population in the T7Select10-3b library displayed short 
peptide fragments instead of larger functional proteins or protein modules which are the 
expected potential binding partners for the membrane spotted peptides. The same library 
was successfully used for the affinity selection approaches as a source of peptides 
interacting with protein modules immobilized on the solid support (Kurakine and Bredesen, 
2002). Theoretically, only one-third of all cDNA inserts code for protein/peptide sequences 
from the proteome. The construction of the library should favour a correct orientation; two-
thirds then can be considered as “random peptides” originating from frame shifts upon 
ligation and incorrect insert orientation. In reality, however, the fraction of the proteome in the 
library must be much less, due to priming from untranslated regions of mRNA (Kurakine and 
Bredesen, 2002). Additionally, the T7Select10-3b library was reported to contain even rare 
mRNA sequences, which are represented in it with high probability (Rosenberg et al., 1996 
refer also to Soares et al., 1994). 
Since the high-throughput panning over the whole spot-peptide array carried out in this 
section involves only one round of phage selection, a library amplification step preceding the 
panning process was necessary in order to increase the number of rarely represented 
candidates. Such amplification may additionally increase the background phage populations 
that display short irrelevant peptidic sequences, because these may grow faster than other 
phages displaying proteins of larger size and cause phage assembly more difficult. The data 
obtained from the sequence analysis of phage clones eluted from the peptide-spots confirm 
the high abundance of such background phages.  
Classical phage panning on a defined immobilized target involves several rounds of 
enrichment/panning, each round monitored by an ELISA assay for an increase of target 
specific phages. A corresponding practical monitoring of phage eluates in a multiplexed 
situation would be helpful to select those peptide ligands that successfully enrich phages 
from the library. A simple monitoring based on phage titers would be very practical, however, 
because of the too high background found after one panning round, this easy measure was 
not found to be indicative of a successful enrichment. Consequently, the reliable 
identification of specifically enriched phages in a real high-throughput performance would 
require a new appropriate methodology. 
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3.4 Target-Assisted Iterative Screening (TAIS) 
The results described in this chapter are concerned with the evaluation of the Target 
Assisted Iterative Screening (TAIS), an elegant method developed by Kurakin for mapping of 
protein-peptide interactions (Kurakin et al., 2002, Kurakin et al., 2004). TAIS combines 
phage display and expression library screening formats and was successfully applied to 
screen phage libraries of peptides over proteins/domains immobilized on a solid support (i.e. 
Sepharose beads). In the first step, a phage-displayed peptide-size cDNA library in solution 
is incubated with the immobilized target protein. Phages displaying peptides interacting with 
the target protein remain bound, whereas the non-bindings once are washed away during 
the bio-panning process. In the second step, the bound pre-selected phages are eluted and 
plated onto a bacterial lawn. Next, the plaques formed are lifted onto a nitrocellulose 
membrane by blotting the bacterial lawn with the membrane. In the meantime, the target 
protein in solution is biotinylated and complexed with a streptavidin conjugated reporter 
molecule such as i.e. alkaline phosphatase; the complex is used as a detection reagent for 
those plaques, which can bind the displayed peptide on the membrane. Subsequent analysis 
of DNA inserts of positive phage clones allows identification of the displayed peptide. The 
flowchart in Fig 3.4.1 is describing principle of this method. 
Fig 3.4.1: Schematic flowchart explaining the Target Assisted Iterative Screening process (Kurakin et 
al., 2002).  
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Here, a reversed mode of the TAIS technology was applied for screenings of phage 
displayed repertoires of protein domains over immobilized peptide-ligands. For this purpose, 
two sets of peptides having the same amino-acid sequences were chemically synthesized on 
different types of modified cellulose membranes. One set contained peptides that remain 
covalently attached to the solid support for phage affinity selections in the panning step. The 
second set contained N-terminally biotinylated peptides, which were cleaved from the 
membrane through formation of a C-terminal diketopiperazine and released into solution 
phase (see 2.2.6). In order to test the performance of this novel system in combination with 
target peptide arrays, a panning was carried out over three 10-15 aa long peptides that are 
ligands for the three model domains (WW/YAP, WW/FE65, EVH1) (Table 1.3.1 in section 
1.3). The model phages were supplemented to the T7 human brain phage display library at a 
ratio of 1:106.  
Panning was performed as described in 2.2.4.4. Phages enriched in the first selection step 
were separately eluted from peptide-spots using 100 µl of 1 M guanidine buffer. Serial 
dilutions of the eluate were prepared immediately. Aliquot of 100 µl from dilution 1:103 were 
plated on a host bacterial lawn on large Petri dishes (diameter 15 cm). Despite high phage 
dilution applied, large amounts of plaques were obtained on each plate, often fused with 
each other. The phage titers were estimated to be 105 pfu / 100 µl of the eluate. Surprisingly, 
this is at least one order of magnitude higher than titers (103-104) achieved for the same 
peptides in similar panning experiments described in section 3.1.2 (Table 3.1.3). However it 
is comparable to titers (104-105) obtained for the peptide-ligand of the WW/YAP domain, after 
panning on the cellulose membrane containing 28 spots (see Table 3.3.3 in section 3.3). The 
observed variations could be explained by the fact that all of mentioned experiments were 
carried out using different batches of phage lysates. It is possible that the lysate used for the 
above panning contained higher concentration of background phages which are responsible 
for higher phage titer (see discussion in section 3.3).  
In the second step, plaques were transferred onto nitrocellulose membranes. Biotinylated 
peptides in solution were complexed with streptavidin that is conjugated to alkaline 
phosphatase reporter (STR-AP), as described in 2.2.4.6. Theoretically, each streptavidin 
molecule binds four molecules of peptide, as it contains four biotin binding sites. Resulting 
peptide tetramers were incubated with the pre-selected phages blotted on the nitrocellulose 
membranes. After addition of the alkaline phosphatase substrate (BCIP/MMT), distinct color 
signals were expected for peptide specific phage plaques. In the cases of the EVH1 and 
WW/FE65 peptide-ligands, no signals indicating specific interactions of these peptides with 
corresponding protein domains on the phages were observed. Six well visible signals were 
found on the membrane with plaques obtained from panning on the WW/YAP peptide (Fig 
3.4.2). 
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Fig 3.4.2: Schematic view of the entire TAIS process performed using the WW/YAP peptide as a 
ligand. M1) DNA marker SMART (Eurogentec). M2) DNA marker MXIII (Boehringer Mannheim).  
 
Because of difficulties in isolation of single positive plaques, due to their overgrowing with 
other phages, square areas of top-agarose containing the plaques of interest as well as 
surrounding plaques, were cut out from the plate and collected in the same tube. Phages 
were extracted using PEB buffer (see Table 2.1.10.1). After experimentally determining a 
suitable dilution ratio of 1:106, phages were poured again on a plate with the bacterial lawn, 
in order to achieve sufficient plaque separation. Plaque transfer onto a nitrocellulose 
membrane and probing with the peptide-STR-AP tetramer was repeated as described above 
and resulted in identification of a large number of positive plaques (Fig 3.4.2). Twenty of 
these plaques were picked from the agar plate using sterile tooth sticks and placed in 
separate tubes. Phages were eluted from agar pieces and their DNA was extracted, as 
1 
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described in 2.2.3.5. Phage DNAs were used as templates for PCR followed by insert sizing 
by AGE. Subsequently all inserts were chosen for DNA sequencing and sixteen sequences 
were used for BLAST homology search of gene databases. Unexpectedly, homology search 
revealed that none of the selected clones contained DNA encoding the WW domain of the 
YAP protein that was supplemented to the pre-panning phage population. Three verified 
inserts contained DNA sequence coding for the Itchy homolog E3 ubiquitin protein ligase and 
the remaining thirteen inserts code for the Nedd 4 like ubiquitin protein ligase (Table 3.4.1). 
Both proteins belong to the same family of protein ligases, which contain four WW domains 
(class I), which bind the (L/P)PxY (x-any amino-acid) consensus motif. 
 
Table 3.4.1: Results of BLAST search performed for DNA sequences of selected phage clones. 
a) WW domain-containing protein 1; b) Atropin-1 interacting protein 5; c) Atrophin-1-interacting protein 4; 
d) NFE2-associated polypeptide 1 
 
The positive phages identified here, display proteins that contain at least two WW domains 
as deduced from the analysis of DNA inserts. A very efficient enrichment of these multi WW-
domain proteins, displayed in multiple copies on the phage coat, was most probable because 
of the high avidity of binding to several peptides on the spot. In contrast to this, the avidity of 
a single WW domain of the YAP protein should be respectively lower. Moreover, it is 
possible that phages presenting both identified protein ligases are very abundant within the 
WW 
domains 
Clone Protein name Swiss prot  Synonyms 
1, 2, 3 1 Nedd-4-like ubiquitin-protein ligase  Q9H0M0 WWP1a), AIP5b) 
1, 2 2 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 3 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 5 Itchy homolog E3 ubiquitin protein ligase Q96J02 AIP4c) , NAPP1d) 
1, 2, 3 6 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 7 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 9 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 10 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 11 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 12 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2, 3 13 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 14 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 15 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
1, 2 16 Itchy homolog E3 ubiquitin protein ligase Q96J02  
1, 2 18 Itchy homolog E3 ubiquitin protein ligase Q96J02  
1, 2 19 Nedd-4-like ubiquitin-protein ligase  Q9H0M0  
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T7 brain library. High avidity of these phages combined with a high representation within the 
screened population, could result in strong competition with the WW/YAP domain for binding 
to the peptide-ligand. However, the amount of spot localized peptide (~5 nmol) is sufficient to 
select large number of different binders. It is therefore more realistic that the YAP phages 
were strongly under-represented within the post-panning population and could be identified 
only if larger number of phage clones were analyzed.  
Analogously, screening of the entire post-panning phage populations obtained from peptide-
ligands for the EVH1 and WW/FE65 domains, may also allow the identification of these 
model proteins. This would however, drastically increase the number of membranes and 
amounts of reagents that would be necessary to perform such a high-throughput scale 
screening. The average number of separate phage plaques (about 1 mm in size), which can 
be evenly distributed on one large Petri dish, is approximately 1000. Theoretically, a 
screening of the entire post-panning population from one peptide containing 1x105 pfu, would 
then require about 100 plates and membranes. Costs of such approach would definitely be 
too high. Optionally, the two step process as shown in Fig 3.4.2 could be applied, plating all 
phages from the panning (up to 5000 pfu per plate) and selecting individual phages only from 
the secondary plates. Such a procedure can reduce numbers of plates and membranes to 
about 40, according to the following calculations (first screening: 1x105 pfu: 20 plates with 
5000 pfu each, second screening again 20 membranes).  
The TAIS technology was considered here to be used in combination with high-throughput 
panning approach utilizing membranes containing large number of 25mer peptides, as 
described in section 3.3. In addition to the model experiments described above, several 
screenings of the T7 brain library were performed using 25 aa long peptides presented in 
Table 3.4.2, which were selected using the Accessible Surface Scanner software as 
described in chapter 3.2.  
 
Table 3.4.2: Peptides used for TAIS experiments 
No. Peptide sequence Source protein ID 
1 VGNRFQTARFYRDVLGMKVLRHEEF 
2 DLQKSLNYWCNLLGMKIYEKDEEKQ   
3 CPQKELPDLEDLMKRENQKILTPLV 
4 EGSKLLDDAMAADKSDEWFAKHNKP 
gi14250348 
5 GPRSPRSASPGPASTGPRHPQVAEG 
6 CHGRHEACEARGRRPRLLNPGRRGG 
7 QIAARTRRRGGGRMERKGSAAGAKG 
8 RKGSAAGAKGNPSPPAAGEGQRPPP 
9 AHEFKSQGAQCYKDKKFREAIGKYH 
gi1504033 
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No. Peptide sequence Source protein ID 
10 ALLELKGLLPPPGERERDSRAASPA 
11 ERDSRAASPAGALKPGRLSEEQSKT 
12 VNYERVKEYCLKVLKKEGENFKALY  
13 HLGDYDKALYYLKEARTQQPTDTNV 
14 QPTDTNVIRYIQLTEMKLSRCSQRE 
 
15 NSRPGKNGNPVAENFRMEEVYLPDN 
16 SVDPYMRCRMNEDTGTDYITPWQLS 
17 EESKHTNLTKGDFVTSFYWPWQTKV 
18 SFYWPWQTKVILDGNSLEKVDPQLV 
19 TSELGFDAAINYKKDNVAEQLRESC 
20 ISQMNENSHIILCGQISQYNKDVPY 
21 AIQKERNITRERFLVLNYKDKFEPG 
gi21755897 
 
 
As in the cases described above, due to large amounts of post-panning phages, only an 
aliquot of each population (100 µl from a 1:103 dilution) was subjected for probing with the 
corresponding soluble peptide-STR-AP tetramers. None of the resulting filters, however, 
showed clear signals for peptide interacting phages. In several cases, instead, atypical, 
“daunt shaped” signals were observed for all phage plaques of the plate transferred onto the 
nitrocellulose membrane (Fig 3.4.3). These signals were most probably reflecting an 
unspecific interaction of peptide tetramers with the phage and/or displayed proteins. 
 
Fig 3.4.3: A section of nitrocellulose membrane showing phage plaques obtained from peptide No.20 
and showing high unspecific interaction with soluble peptide-STR-AP tetramers. 
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Thus, additionally studies have to be conducted, attempting a reduction of unspecific phage 
background and a reduction of the total number of post-panning phages to be analyzed. This 
could be achieved by testing and application of more stringent bio-panning for cellulose 
spots or by application of other solid supports for chemical peptide synthesis, which could 
“trap” lower number of phages that are irrelevant for interaction with the target. Overcoming 
of this problem would significantly decrease costs of screenings. This would allow using 
TAIS as high-throughput method. Moreover, several steps of this process could be 
automated by application of new robotic technologies. Following high-throughput parallel 
affinity selection, separate phage elution and plating, the whole populations of post-panning 
plaques could be transferred into micro-plates for phage extraction, using colony picking 
robots. Arraying of phages on the nitrocellulose membranes would be carried out using 
automated printing pin tools (96 format or higher). Optionally, phages would be printed on 
agar plates with bacterial lawn and development plaques would be manually lifted onto the 
membranes. Plaques showing positive interaction signals would be isolated manually and 
subjected for DNA analysis. This concept could be applied after reduction of costs of TAIS 
and would allow identifying large number of interacting proteins simultaneously.  
In conclusion, Target Assisted Iterative Screening is an efficient method, definitely showing a 
significant improvement over the type of crude analysis described in the previous section, 
where phage plaques were only randomly picked from the agar plate and subjected for PCR 
and sequence analysis, in order to identify enriched phages within post-panning populations. 
Although possible, complete screening of large post-panning phage populations using this 
technology would require enormous number of expensive membranes and reagents. 
Currently, this economical aspect rules out TAIS as a high-throughput, genome and 
proteome spanning method, which could be utilized in combination with cellulose peptide 
arrays. Other, rapid and cost effective methods must be developed in order to achieve this 
goal. 
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3.5 DNA microarray biochip based screening 
3.5.1 The concept  
The experiments described before as well as studies performed by Bialek (Bialek et al., 
2003) proved that peptides synthesized on cellulose membranes can be successfully utilized 
for affinity selection of phages displaying protein domains. The advantage of SPOTs is a 
high amount of peptides deposited on a small single spot (0.5-5 nmol), resulting in a high 
local peptide concentration and high avidity of peptide-protein binding that increases the 
chance for efficient enrichment of proteins which are less represented within a screened 
library. On the other hand, phage background is quite high due to the porous structure of the 
cellulose, most probably by trapping phages between its fibers. Performed investigations 
showed that, starting from phage populations containing approximately 1010 pfu, the number 
of phages eluted from a single peptide-spot after one round of affinity selection ranged from 
104 to 106 pfu. Only one round of selection was preferred in order to reduce the phage 
competition process, which will otherwise result in a loss of weaker binders and overgrowing 
with the dominant populations as commonly observed during the classical consecutive 
panning procedure. Therefore, identification of specifically bound candidates within such 
diverse mixtures appeared to be very challenging. The standard procedures (PCR, 
sequencing) that are used for phage clone verification after multiple rounds of selection will 
require enormous number of clones to be analyzed in order to “sift” specific binders from 
background phages (see 3.2). Also, a novel protein-protein interaction screening method 
(TAIS) developed by Kurakin (Kurakin et al., 2002) has been shown to be economically 
unfavorable when large numbers of panning experiments were to be performed in parallel 
(see 3.4). Therefore, a high-throughput screening of the entire phage displayed library of 
protein domains versus high density peptide arrays, as anticipated in this work, requires very 
competent and efficient analytical tools for a rapid, automated and sensitive, simultaneous 
analysis of whole populations of phage displayed protein domains, enriched in only a one 
step affinity selection. 
Post-panning phage populations are enriched for target (peptide)-specific binders 
(proteins/genes) and, thus, differ significantly from pre-panning populations. Similar 
differences concerning gene representation can be observed for cDNA pools obtained from 
two cell population that were exposed for different physical conditions or represent different 
physiological states (i.e. healthy and cancer). Variations in transcript level are usually studied 
using expression profiling method utilizing DNA microarray biochips. Microarray biochips 
containing thousands of genes are either commercially available or can be fabricated by 
printing of oligonucleotides or PCR products on a modified glass surface using 
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microarrayers. Expression profiling analysis involves isolation of mRNA from both test and 
reference cells and their separate labeling with different fluorescent dyes (i.e. Cy3-green and 
Cy5-red). Combined labeled cDNA samples are then hybridized to a set of DNA probes 
arrayed on a biochip and subsequently scanned, using laser scanner. Identification of over or 
under-represented genes is possible via computational measurement of relative 
fluorescence intensities emitted by the excited dyes built into the DNA structures (Fig 3.5.1). 
This attractive method was considered here as a powerful and potentially adequate tool that 
could be exploited for multiplexed simultaneous monitoring of pre- and post-panning phage 
representation and thus immediate parallel identification of enriched phages. Therefore, a 
primary goal of this work was the investigation whether this technology could be efficiently 
applied in the context of a high throughput phage panning approach. 
 
Fig 3.5.1: A schematic view showing expression profiling method 
 
The experimental concept involves that after multiplex affinity enrichment, phage populations 
are separately eluted from each peptide-spot (post-panning) phage DNA will be isolated, 
labeled during PCR amplification with the cyanine dyes, Cy3 (green) or Cy5 (red) and mixed 
with an equal amount of correspondingly different labeled reference DNA obtained from the 
original phage library that was used for panning (pre-panning). This mixture will be 
hybridized with a DNA microarray biochip (Fig 3.5.2) .Compared to the pre-panning DNA, 
genes coding for peptide enriched proteins should be over-represented within the post-
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panning DNA. The DNA sequences of the peptide-specific, over-represented genes and thus 
the protein identities are then easily obtained from the gene lists provided with the biochip, 
displaying all DNA probes specific for the ORFs coding for the proteins of interest.  
Fig 3.5.2: Schematic illustration of the experimental concept.  
 
The application of this new methodology for genomic and proteomic approaches, requires 
highly representative DNA microarrays. Several companies, i.e. Affymetrix, offer commercial 
high-density oligonucleotide biochips. These however, can not be successfully applied for 
this screening approach (Bialek, GBF Braunschweig, unpublished data). The reason for this 
is a random priming strategy used for preparation of the cDNA inserts in the T7Select10-3b 
human brain library (Fig 3.5.3). The random primers anneal to various sites on the mRNA, 
providing cDNA fragments of different sizes and locations. The probe sequences, however, 
chosen for the chemical oligonucleotide synthesis are typically from the 3’ end of the 
transcript, near to the poly-(A) tail (Lipshutz et al., 1999; Lipshutz et al., 1995). Use of the 
oligonucleotide arrays for the above approach therefore would bias the insert detection 
possibilities to those that are located on the 3’ end of the transcript only. The only viable 
alternative to the oligonucleotide microarrays is an array containing full length cDNA 
sequences. Such biochips however, are not commercially available and must be self 
fabricated or purchased from custom services. 
 
 
Surface displayed 
fusion protein 
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Fig 3.5.3: Schematic illustration of the OrientExpress random priming strategy used for preparation of 
the cDNA T7Select10-3b human brain library. Image was taken from Novagen’s catalogue.  
 
3.5.2 Proof of principle 
An initial biochip based experiment was performed by Bialek (Bialek et al., 2003), in order to 
test whether the expression profiling method could be exploited to detect more sensitively 
and in a highly parallel mode peptide-specific enrichment of phages. Simple microarray 
slides were prepared by contact printing of cDNAs that correspond to the three model 
domains (EVH1, WW/FE65, WW/YAP) plus a heavy chain of a mouse antibody as a control. 
The human brain T7Select10-3b library was doped at the ratio 1:104 with phages displaying 
the two model domains EVH1 and WW/FE65. This was then panned over the peptide-spots 
that are ligands for these two domains. Peptide-spot bound phages were eluted and first 
propagated. DNA obtained from the pre-panning phage library and the phage populations 
eluted from each peptide ligand, were labeled with the Cy5 and Cy3 dyes, respectively. 
Additionally, a mouse control DNA was labeled with both Cy5 and Cy3 in two separate 
reactions. One micro-gram each of labeled DNAs from one of the peptide-specific post-
panning phage inserts, of the pre-panning DNA and the two control DNA preparations were 
carefully combined and the mixture was applied to a microarray slide (Fig 3.5.4). 
Hybridization of the DNA mixture obtained from the peptide ligand for the EVH1 domain 
showed (pep-E) that the DNA probe on the slide corresponding to the EVH1 domain emitted 
a green fluorescent signal, indicating that more Cy3 than Cy5 labeled DNA hybridized to this 
probe. This means that DNA coding for the EVH1 domain is more abundant in the post-
panning pool compared to the pre-panning pool. Thus, it clearly indicates enrichment of the 
EVH1 domain presenting phages on the expected target peptide. In contrast, the DNA probe 
corresponding to the WW/F65 domain emitted a red signal, indicating preferential 
hybridization with the Cy5-labeled, pre-panning WW/F65 DNA. This revealed the absence of 
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the WW/FE65 displaying phages within the post-panning population confirming the lack of its 
interaction with the pep-E ligand. 
Fig 3.5.4: Schematic picture showing the panning process for the phage library supplemented with the 
model domain phages, on the peptide ligand for the EVH1 domain (pep-E) and results obtained from 
the differential hybridization of the pre- and post-panning phage library DNA to the DNA probes 
printed onto a glass slide. Short name code: EVH1 (E), WW/FE65 (F); WW/YAP (Y). 
 
The control DNA hybridized to nearly equal amounts of Cy5- and Cy3-labeled DNA resulting 
in a yellow color confirming proper experimental performance. The DNA probe 
corresponding to the WW/YAP domain did not emit any signal, which is in agreement with 
the fact that the phages displaying this domain were not added into the library. It also 
suggests that this domain is not present in the library or only in such a low amount that it 
could not be detected. The panning of the WW/FE65 domain on its target peptide was also 
investigated by using DNA microarray analysis; however, the enrichment signal was much 
lower as compared to EVH1. This can be explained by weaker interaction of the WW/FE65 
domain with its peptide, when compared to the interaction of EVH1 with its ligand (see 
previous chapters).  
The phage propagation step included in this proof-of-principle experiment is quite 
problematic because it could increase number of background phages (see section 3.3). The 
attempts to omit the phage propagation step and to isolate and purify the DNA directly from 
the peptide-spot eluted populations using precipitation with isopropanol and commercial kits 
Fas control DNA labeled with  
Cy3 and Cy5  mixed 1:1 = yellow 
post-panning phage DNA 
labeled with Cy 3  
human brain T7Select10-3b cDNA library 109 phages 
+ 105 phages presenting EVH1, WW/FE65 protein domains
F
E 
panning on the target 
peptide ligand for EVH1 
SFEFPPPPTDEELRL  
 
pre-panning phage DNA 
labeled with Cy 5   
hybridization 
mix  
       E               F 
Control DNA         Y 
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(Millipore), however, gave non-satisfactory results (data not shown). In many cases, none or 
very weak signals indicating phage enrichment were achieved after hybridization with the 
probes on a biochip, suggesting an obvious problem with the direct purification of DNA. Most 
probably, the amounts of phage DNAs, isolated directly from relatively small amounts of 
eluted phages (105 pfu) were not enough to yield the amounts of labeled PCR products 
required for a sufficient fluorescent signal after the hybridization process. It is possible that 
large percentage of the phage DNAs achieved from the post-panning populations is being 
lost during purification steps. Therefore elimination of the propagation step would require a 
more efficient high-throughput method of isolation and purification of large phage DNA 
molecules. Potential problems with this step are treated in section 3.5.9 below. 
An additional experiment was performed in order to evaluate whether the microarray 
approach is sensitive enough to detect protein enrichment, when a higher dilution of model 
phages was applied. For this purpose, phages displaying the three model domains were 
supplemented to the T7Select10-3b library, each at a ratio of only 1 in 106 pfu. The phage 
mixture was used for one round of affinity selection over the pep-E ligand. The eluted phage 
population was propagated and 200 µl of the post- and pre-panning mixtures were taken for 
a phage DNA template preparation as described in 2.2.3.5. The aliquots of 65 µl of both 
templates were taken for PCR labeling reaction. The pre- and post-panning DNA inserts 
were labeled with the Cy5 and Cy3 dyes, respectively. Additionally, PCR labeling of a control 
DNA insert coding for the Fas antigen was carried out in two separate reactions for Cy3 and 
Cy5. A simple DNA microarray biochip was prepared using a contact printing microarrayer 
(see 2.2.5.2). DNA inserts coding for the three model domains, control Fas and two other 
irrelevant DNA inserts (Interleukin-4 and Ezrin), each concentrated to 140-160 ng/µl, were 
printed onto super amine slides (Telechem). The hybridization mixture was prepared by 
mixing equal amounts of labeled pre- and post-panning DNA (2 µg, each) and 500 ng of 
each of control Fas inserts. The mixture was hybridized to the microarray under a cover-slip 
glass as described in 2.2.5.8. The results achieved for phages isolated from the pep-E, as 
well as a schematic representation of the whole process are shown in (Fig 3.5.5). Although a 
strong dilution of all model phages within the pre-panning population, those, displaying the 
EVH1 domain were significantly enriched on the corresponding peptide, which was detected 
as the green signal emitted from the EVH1 DNA on the microarray. The DNA probes coding 
for the WW/F65 and WW/YAP domains didn’t show a green signal here, which confirms a 
lack of interaction of both domains with this peptide ligand. The lack of a red signal from 
these probes as well as from the EVH1 probe is due to the high dilution of these model 
phages in the pre-panning mixture and thus too little of their Cy5 labeled DNA inserts. This is 
much better visible when the array image was analyzed with inactivation of the channel for 
the green fluorescence (Fig 3.5.6). Nearly equal amounts of Cy5- and Cy3-labeled control 
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Fas-DNA hybridized to its corresponding DNA on the array, resulting in a yellow color (Fig 
3.5.5). DNA probes corresponding to IL-4 and Ezr showed no signals because such phages 
were not supplemented to the pre-panning mixture and were obviously not present or not 
enough abundant in the T7 phage library.  
Fig 3.5.5: Schematic picture showing the panning process for the phage library supplemented with the 
model domain phages, on the peptide ligand for the EVH1 domain (pep-E) and the resulting image 
obtained from the differential hybridization of the pre- and post-panning phage library DNA to the DNA 
probes printed onto a glass slide. Short name code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); Ezrin 
(Ezr); Fas antigen (Fas); Interleukin-4 (IL).  
Fig 3.5.6: The image of Fig 3.5-5, generated using the green and red fluorescent channel separately. 
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3.5.3 Choice of the full length cDNA probe library 
For a successful application of microarrays to the screening format described above, the 
collection of cDNA sequences to be printed on a biochip is ideally a replicate of the 
population of cDNA inserts cloned into the T7 phage chromosome. Several libraries of 
clones containing human cDNA sequences are provided by the RZPD in Berlin. The E. coli 
clone library containing full length cDNA sequences originating from the human brain region 
of amygdala, which were cloned into the pSPORT1 phagemid vector, was considered as the 
most suitable one for this approach. Both, the amygdala library and the T7 phage display 
library were generated from mRNAs isolated from human brain. Therefore a high percent of 
the same genes present in both libraries was expected. Additionally, a length of cDNA 
inserts from the amygdala region (up to 3.6 kb), was expected to cover even the largest 
inserts from the T7 phage library (up to 1.5 kb). Moreover, a large number of cDNA 
sequences present within this library is already sequenced, allowing an easy identification of 
sequences of enriched phages, without sequencing of clones corresponding to a DNA 
printed on a biochip. A part of this library, 6144 bacterial clones in 16 plates (384 wells), was 
purchased from the RZPD. A replica of each micro-plate was prepared immediately after 
receipt to reduce the risk of contamination of the original library. Clones were replicated 
using 96 pin tool into four 96 deep well blocks filled with LB and grown as described in 2.2.1. 
Aliquots of 30 µl were transferred into 96 well cryo-resistant plates, supplemented with 
glycerol (20 % f.c) and frizzed at -80°C. Pins of the replication tool fit into every second well 
of the 384 micro-plate, therefore each from the four 96 replica plates was labeled with 
respect to the corresponding position for the first pin in the left upper corner of the 384 
source plate (i.e. A1, A2, B1, B2; Z-type arrangement). Additionally each replica contained a 
number of the original RZPD plate (i.e. PL1A1= plate 1 position A1).  
 
3.5.4 Comparison of plasmid and PCR probes spotted on a glass surface 
Fabrication of a standard cDNA microarray according to standard literature protocols would 
require a high-throughput PCR amplification of a library of DNA inserts and printing of 
purified PCR products on a glass slide. High-throughput PCR amplification is however the 
most laborious, difficult, time and cost consuming step in the whole procedure of cDNA array 
preparation (Botwell et al., 2002). Thus, a much less complicated process, utilizing plasmid 
preparations for printing, would be very much preferable. The main question to be answered 
was, whether the plasmid array is sensitive enough to detect phages enriched on target 
peptides? Therefore studies comparing the performance of arrayed plasmid and PCR probes 
were carried out. Suitable constructs containing two plasmid vectors and cloned inserts 
encoding the three model domains (EVH1, WW/YAP, WW/FE65), as well as the other three 
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control proteins (Fas, IL-4 and Ezrin), were engineered. Two different plasmids were chosen, 
the pOBT7 and pCMV-sport6, having significantly different sizes, 1815 bp and 4396 bp, 
respectively. Since a lower number of larger DNA molecules can be deposited on a single 
spot compared to smaller DNA molecules, printing of differently sized plasmids was 
expected to elucidate possible problems of probe fluorescence intensities that might be 
caused by different amounts of spot localized DNA molecules. The DNA sequences of 
inserts were transferred to the plasmid vectors from the T7 phage constructs prepared 
previously (see Bialek et al., 2003). Inserts were PCR amplified from the T7Select103b 
phage vector using a suitable set of primers (see Table 2.1.6.1). Plasmids were purified from 
bacterial cultures using Qiagen’s plasmid purification columns. Both were first cut with the 
EcoRI and XhoI restriction enzymes, dephosphorylated (only plasmids), purified and ligated 
(see methods). Subsequently, the E. coli DH10B bacteria were transfected with the 
appropriate constructs and propagated. Plasmids were purified as above. All purified plasmid 
constructs were concentrated to 300 ng/µl and transferred into a 96 well spotting plate. 
Additionally, cloned DNA inserts were PCR amplified from both plasmids, digested with 
EcoRI and HindIII enzymes, L.M.P purified and concentrated using vacuum evaporator. PCR 
probes obtained from pOBT7 plasmid were recovered with the spotting buffer (3 x SSC, 
1.5 M betaine) giving a yield ranging from 250 to 300 ng/µl. Inserts amplified from the pCMV-
sport6 plasmid were recovered in a very low amounts, ranging from 40 to 100 ng/µl for all 
inserts except Fas (190 ng/µl). The reason for that was most probably over-drying of DNA. 
Because of their low concentrations, these probes were not taken into account during final 
analysis of arrayed probes. Both, plasmid constructs and PCR products were printed on the 
amine functionalized glass slides. Phage panning was carried out over the pep-E spot, using 
mixture of T7 phage library (titer 7.3 x 1010 pfu/ml), supplemented with phages displaying the 
three model domains, each containing 7.3 x 105 pfu (dilution ratio 1:105). As described 
before, pre- and post-panning populations were propagated, PCR amplified and labeled with 
Cy3 and Cy5, respectively. DNAs from both mixtures were digested with the EcoRI and 
HindIII restriction enzymes, and purified. Following concentration measurement, both DNA 
populations were mixed together (1.32 µg each). Unlike as described in the above 
experiments, five genes instead of three were used as controls in this case. These include 
DNAs of WW/FE65, WW/YAP, Fas, IL-4 and Ezrin (see below). Two separate PCR 
reactions, each containing mixtures of the five phage templates with the above inserts were 
carried out simultaneously to label them with the Cy3 and Cy5 dyes. The PCR products were 
digested and purified as above. Equal amounts of differentially labeled inserts were mixed 
together in equal amount. An aliquot containing 2 µg of such prepared mixture was added to 
the mixture, which was applied on the PCR-plasmid microarray for hybridization. The results 
of hybridization to the printed PCR probes could be foreseen on the basis of the previous 
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experiments. However, nothing is known about the efficiency of hybridization to plasmid DNA 
probes. Application of as many as five controls thought to help investigating hybridization to 
plasmid probes in the case these were not sensitive enough to detect phage enrichment. 
Theoretically, DNA of externally supplemented controls should be more abundant within the 
hybridization mixture (200 ng each in this case) compared to DNAs of enriched phages. 
Therefore at least these over-represented control genes should efficiently hybridize to the 
plasmid probes. Moreover, sizes of the three standard controls (Fas, IL-4, Ezrin) range from 
500 to 1100 bp, whereas the two additional inserts used here as controls (WW/FE65 and 
WW/YAP) are at least two times smaller, 180 bp and 240 bp respectively. This could help to 
observe a possible relationship between sizes of the inserts and hybridization efficiencies to 
plasmid probes. The results obtained, showed that despite their high concentration, neither 
spots containing the smaller pOBT7 or the bigger pCMVsport-6 plasmids gave sufficient 
fluorescent signals (Fig 3.5.7). 
Fig 3.5.7: Comparison of phage enrichment detection sensitivities using PCR and plasmid arrays. 
Differential hybridization of the pre- and post-panning phage library DNA to the EVH1 domain-specific 
DNA probe printed onto a glass slide. Field 1: contains the pOBT7 plasmid probes and PCR probes 
amplified from pOBT7 constructs. Field 2: contains the pCMV-sport6 plasmid probes and PCR probes 
amplified from the pCMV-sport6 constructs. Short name code: plasmids (PL), PCR products (PCR), 
EVH1 (E), WW/FE65 (F); WW/YAP (Y); Ezrin (Ezr); Fas antigen (Fas); Interleukin 4 (IL). Each set of 
probes is printed in three replicates. 
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As expected, all PCR probes amplified from the pCMV-sport6 constructs that were printed on 
the field 2 (see Fig 3.5.7) didn’t show any significant signals as well, most probably because 
of technical problems as mentioned above. In contrast to these observations, signals 
achieved from the PCR probes amplified from the pOBT7 constructs were well visible and 
satisfactory (see field 1). The affinity enrichment of phages displaying the EVH1 domain on 
its peptide ligand was very well visible as a green signal obtained from the spotted insert 
coding for the EVH1. Spots containing the WW/FE65 and WW/YAP products emitted slightly 
orange signals, showing that more inserts labeled with the Cy5 hybridized to these probes. 
This result can be explained by the fact that beside both WW/FE65 and WW/YAP control 
inserts labeled with both dyes, there were additional inserts present within the hybridization 
mixture, which origin from the pre-panning DNA population. Therefore the Cy5 labeled DNAs 
were more abundant within the entire population, hybridizing to the probes and contributing 
to the fluorescent signal. The other control PCR probes showed yellow color, demonstrating 
an equal hybridization of control inserts labeled with both dyes. The absence of signals form 
the plasmid probes was quite disappointing. Since the cloned inserts represent only a small 
part of the entire plasmid DNA (insert: plasmid ratios from 1:3 to 1:20), the number of 
molecules which are available for hybridization is correspondingly lower than the number of 
PCR probe molecules spotted on the glass slide in the same or similar optically measured 
DNA-concentration. These differences obviously results in a relatively weak signals from the 
plasmid probes. Moreover, due to a super-helical structure of plasmids and their larger size, 
many inserts could theoretically be hidden (i.e. buried) and therefore not available for 
hybridization with the labeled inserts. One of the possibilities to avoid such situation and 
achieve better accessibility of the inserts would be a linearization of plasmids to be spotted 
by application of restriction enzymes. This additional and laborious step however, would 
significantly increase costs of the entire process and therefore was not considered here. The 
comparison experiments performed here clearly showed that only PCR probes can be used. 
Therefore a fabrication of a PCR microarray will be a subject of the following sections. 
 
3.5.5 Large scale preparation and spotting of PCR products 
The next goal then was the establishment of an efficient PCR amplification of inserts varying 
considerably in size (0.5 kbp – 3.6 kbp) applicable top most of the clones of the amygdala 
clone library. The PCR was optimized using a small set of randomly chosen clones, before 
the whole clone library was amplified (data not shown). For this purpose several PCR 
ingredients and their concentrations as well as program parameters were stepwise varied. 
Concentrations of different primers varied from 10 to 20 pmol, magnesium ions (MgCl2 or 
MgSO4) from 1 mM to 4.5 mM, nucleotides from 0.2 to 0.4 mM. Program parameters varied 
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as follows: initial denaturation step (94°C) 1-5 min, primer annealing temperatures (45-65°C), 
annealing times (20-50 s), elongation (1.30-5 min) and number of cycles (20-40). 
Experimentally established primer pair and optimal PCR conditions are shown in 2.1.6.1 and 
2.2.3.11, respectively. Since the high-throughput PCR requires relatively large amounts of 
expensive enzymes, the effort was taken to produce Taq DNA polymerase in-house using an 
E. coli expression system (see 2.2.7). Its quality was proven by PCR amplification of insert 
coding for the EVH1-domain using various dilutions of the enzyme and the primer set (M13 
for 23, M13 rev 30) shown in Table 2.1.6.1. The previously described pCMVsport-6+EVH1 
construct was used as a template for amplification. Similar amplification was carried out 
using a commercially available Taq DNA polymerase, purchased from NEB. It was revealed 
that the performance of self-made polymerase was even better than the performance of the 
commercial enzyme (Fig 3.5.8). 
Fig 3.5.8: Comparison of the performances of commercial NEB and self made (SM) Taq DNA 
polymerases. Ethidium bromide stained 1 % AGE analysis of EVH1 DNA inserts. C) Control PCR 
without template supplement, 1:1-1:8) Enzyme dilutions, M) MassRuler™ DNA Ladder, Low Range, 
ready-to-use (MBI Fermentas). 
 
The most important aspect during preparation of DNA probes to be spotted is the quality and 
yield of amplified inserts. Taq DNA polymerase has been reported to make frequent 
mismatch mistakes when incorporating new bases into a strand (Huang et al., 1992. 
Ayyadevara et al., 2000). An efficient amplification of long DNA fragments can be improved 
via application of high fidelity polymerases or ready to use kits containing mixtures of 
enzymes with different performance provided by several companies (Quiagen, Stratagene, 
Fermentas etc.). The addition of a low amount of a proofreading enzyme (e.g. Pfu DNA 
polymerase) to PCR reaction mixtures has been proposed to improve the performance of 
non-proofreading polymerases (e.g. Taq DNA polymerase) by correcting mismatches 
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introduced during PCR, which otherwise prevent the efficient synthesis of full-length products 
(Barnes, 1994, Cline et al., 1996). Additionally, PCR enhancing additives (DMSO, glycerol, 
BSA, betaine) have been reported to improve amplification of some DNA inserts (Chen and 
Janes, 2002, Frackman et al., 1998). Test PCRs of four randomly chosen amygdala library 
clones of insert sizes ranging from ~1.5 to ~2.5 kb, were carried out in order to check 
whether an enzyme mixture containing self-made Taq DNA polymerase and Pfu DNA 
polymerase (MBI Fermentas), as well as the addition of betaine would increase a yield and 
quality of amplified inserts. Both enzymes were supplemented to a PCR reaction mixture at 
ratio 10 U Taq: 1U Pfu. Three similar reactions were performed as described in 2.2.3.11 in 
which different elongation times were applied (2.0 - 3 min). In comparison to the Taq 
polymerase alone, the combination of both enzymes resulted in higher product yields, 
observed for all three cases (Fig 3.5.9).  
Fig 3.5.9: Performance comparison of the SM Taq DNA polymerase alone and in combination with a 
proofreading Pfu polymerase. Ethidium bromide stained 1 % AGE analysis. 1-4) clone No, A1, A2) 
PCR with elongation time 2.3 min, B1, B2) PCR with elongation time 2 min, C1, C2) PCR with 
elongation time 3 min, M) DNA marker SMART (Eurogentec). 
 
Subsequently, PCRs of the same inserts (2.2.3.11), but using four different concentrations of 
magnesium sulfate were carried out to check whether such variation would improve 
amplification of the most problematic inserts. However, the significant increase in its yield 
was not observed, suggesting that some inserts are difficult to be amplified, even when 
sophisticated conditions are applied (see Fig 3.5.10). Additionally, the influence of betaine 
enhancer was checked by amplification of the other four randomly chosen inserts. The 
reactions were carried out similarly as for the above fragments with and without addition of 
betaine and using different salt concentrations (1 mM and 4 mM). Positive effects were 
noticed for all amplified fragments (Fig 3.5.11). Again, 4 mM concentration of magnesium 
 1    2   3    4     M    1    2    3    4     1    2    3    4   1    2   3     4    M     1    2    3    4     1    2    3    4 
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sulphate resulted in the highest DNA yields. On the other hand the insert No.2 seemed to 
amplify better at lower salt concentration (1 mM). This suggested that uniform high-
throughput amplification of all library inserts is very difficult and most probably a certain 
percent of inserts from the whole library will not be efficiently amplified. 
Fig 3.5.10: Comparison of insert amplification using different concentrations of MgSO4. Ethidium 
bromide stained 1 % AGE analysis. All probes were amplified using Taq/Pfu mix and 1 M betaine. 1-4) 
amplified inserts. M) DNA marker MXII (Boehringer Mannheim). 
Fig 3.5.11: Comparison of insert amplifications with and without addition of betaine. Ethidium bromide 
stained 1 % AGE analysis. All probes were amplified using Taq/Pfu mix. 1-4) amplified inserts. 
 
The above PCR optimization experiments were carried out using purified plasmids as a 
template. Although, this is certainly preferred for PCR application in general (Holloway et al., 
2002), purification of thousands of plasmids from the amygdala library would be challenging 
and costly. Alternative sources of DNA templates are: (i) lysates prepared from fresh 
overnight bacterial cultures, (ii) directly used bacterial culture (1 µl) or (iii) single bacterial 
colony. The lysates are prepared by heating (95°C) mixtures containing 5 µl bacterial in 95 µl 
water, followed by centrifugation. Usage of single colony or bacterial culture requires 
increased time of initial denaturation step during PCR to lyse bacteria in situ (Botwell et al., 
2002). To check whether the alternative templates will be sufficient for PCR amplification, 
 M 
1 mM MgSO4  
 1     2     3     4 
2 mM MgSO4 4 mM MgSO4 4.5 mM MgSO4 
 1     2     3     4  1     2     3     4  1     2     3     4
  1      2        3       4    1      2        3       4  1      2        3       4   1       2        3       4 
   - betaine    - betaine   + betaine   + betaine 
1 mM MgSO4  4 mM MgSO4 1 mM MgSO4 4 mM MgSO4  
3. Results and discussion 
 127
eight randomly chosen amygdala clones were amplified, from centrifuged bacterial lysates 
(i), bacterial cultures (ii) or bacterial colonies (iii) and compared to purified plasmid templates. 
PCRs for plasmids (~50 ng) and bacterial lysates (i), (vol 4 µl), were performed exactly as 
described in section 2.2.3.11. The initial denaturation step was extended up to 5 min for 
colony PCR (iii) and bacterial cultures (ii). Instead of using expensive commercial kits, 
plasmids used in this experiment were purified using the shortened alkaline lysis protocol 
described in 2.2.3.6. Only two products were obtained in the case of lysates (i) and colonies 
(i), similarly, amplification from bacterial cultures (ii) was very weak (not shown). However, all 
inserts amplified from purified plasmids gave satisfactory yields (Fig 3.5.12). This experiment 
proved also that plasmids preparations achieved by shortened alkaline lysis protocol, are 
pure enough to be used for efficient PCR amplification.  
Fig 3.5.12: Comparison of insert amplifications when, centrifuged lysates (i), plasmids and bacterial 
colonies (iii) were used as a source of DNA template. Ethidium bromide stained 1 % AGE analysis. 1-
8) amplified clone inserts, M) DNA marker MXII (Boehringer Mannheim) 
 
Additional PCR tests were performed utilizing centrifuged bacterial lysates, where different 
volumes of fresh bacterial cultures were taken for their preparation (5 µl + 95 µl H2O, 200 µl, 
400 µl). Four micro liters aliquot from each lysate was taken for PCR. No products were 
obtained after amplification from the lysate containing 5 µl of bacteria. Five among eight 
inserts were amplified from lysates containing 200 and 400 µl of bacteria (Fig 3.5.13). 
However, none of the remaining lysates gave as satisfactory results as were obtained from 
purified plasmids above. Finally, plasmid preparations by the shortened alkaline lysis method 
were chosen as a source of templates for future high-throughput amplification of inserts. 
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Fig 3.5.13: Amplifications of inserts using templates obtained from centrifuged lysates containing 
different amounts of bacteria. Ethidium bromide stained 1% AGE analysis. 1-8) amplified clone 
inserts, M) DNA marker MXIII (Boehringer Mannheim). 
 
From the amygdala library clones, bacterial cultures were prepared by transferring the 
inoculums from previously prepared 96 well replica plates into 96 deep well culturing blocks, 
using 96 pin replication tools and growing bacteria overnight (see 2.2.1). The modified 
alkaline lysis protocol was applied for plasmid purification as described in 2.2.3.6. PCRs 
were performed in 96 well plates using MJ Research Thermal Cycler instruments as 
described in 2.2.3.11. Utilization of 96 well plates allowed for a more efficient performance of 
the process by using a multi-channel pipette. Steps for the separation of the DNA fragments 
from enzymes, nucleotides, primers and other PCR components and the adjustment of an 
appropriate concentration for ready to spot fragments were optimized. Amplification of insert 
from each plate was carried out four times giving a total amount of 24,576 reactions. In order 
to reduce PCR purification costs, DNA precipitation with isopropanol was performed as 
described in 2.2.3.1 (Diehl et al., 2002; Sambrook and Russel 2001). Purified inserts were 
collected, precipitated once again, air dried and recovered via addition of 15 µl of spotting 
buffer (3 x SSC, 1.5 M betaine). All PCR products were controlled electrophoretically using 
96 pocket agarose gels. Electrophoresis was carried out with a high-throughput Electro-Fast 
WIDE system (AB Gene). Example images of amplified inserts from library plate No.19 (384 
wells) are shown in Fig 3.5.14. Concentrations of PCR products were estimated 
approximately via comparison of band intensities with intensities of DNA molecular mass 
marker and ranged from 160-250 ng/µl. An average percentage of PCR failure was 
estimated as 15 %, from the number of failures among 96 reactions.  
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Fig 3.5.14: Ethidium bromide stained 1 % AGE analysis of PCR amplified inserts from the amygdala 
library plate No.19 (384 wells = 4 x 96). A-H and 1-12) positions in 96 well PCR plate. M) Molecular 
mass DNA marker MXII (Boehringer Mannheim). 
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Purified PCR fragments were transferred into 384 wells spotting microplates and printed onto 
the super amine and amine silanized slides as described in (2.2.5.2, appendix 1). Quality of 
the printed DNA microarrays was checked via hybridization of a selected slide with 15mer 
random primers labeled with Cy3 dye (Fig 3.5.15).  
Fig 3.5.15: Quality check of amygdala microarray by hybridization with Cy3 labeled random primers. 
Two identical replicas were spotted on the glass slide.   
 
3.5.6 Functional analysis of microarray experiments 
To check detection performance of the amygdala array, panning experiment utilizing phages 
displaying the three model protein domains over the pep-E was carried out. Model phages 
were supplemented to human brain T7 phage display library (5.4 x 1010 pfu) at ratio 1:106 to 
give a final concentration of 5.4 x 104 pfu, each. Following phage elution, propagation and 
DNA labeling, equal amounts of pre and post-panning DNA and Fas control DNA were mixed 
together and hybridized to the amygdala biochip using the automatic Lucidea hybridization 
station (Pharmacia). Despite low signal intensities in general, as well as unsatisfactory 
quality of the array image due to a high Cy3 green fluorescence background, a very strong 
green signals from the EVH1 DNA probe indicating its enrichment and a yellow from the Fas 
control was well visible (Fig 3.5.16). As expected, the remaining model protein domains 
didn’t bind to the pep-E, therefore no other significant signals indicating phage enrichment 
were observed. The overall reddish signals visible on the slide were a result of hybridization 
of Cy5 labeled pre-panning phage DNAs to their complementary sequences printed on the 
glass surface. This demonstrated that the representation of genes on the amygdala array 
correspond well with a major part of genes within human brain T7 phage library. Except for 
3. Results and discussion 
 132
the signals emitted by the EVH1 probes, no other green signals indicating enrichment of any 
other proteins on the pep-E ligand, were observed among the remaining 6144 amygdala 
probes on the array. 
Fig 3.5.16: Results obtained from the differential hybridization of the pre- and post-panning DNA 
populations to the EVH DNA probe present on the amygdala microarray. Short name code: EVH1 (E), 
WW/FE65 (F); WW/YAP (Y); Ezrin (Ezr); Fas antigen (Fas); Interleukin-4 (IL).  
 
Unfortunately, the data form many other experiments could not be evaluated because of a 
high green fluorescence background, which caused difficulties in measuring the true spot 
signals and therefore distorted the microarray analysis. This problem was especially 
observed for slides that were chemically blocked and washed with dichloroethane (DCE). It 
suggested that residuals of the blocking substances on the glass surface are attractive for 
the Cy3 dye. Additionally, many dust particles decreased data quality. Some example array 
sections with high background Cy3 fluorescence are shown in Fig 3.5.17. 
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Fig 3.5.17: Images 1 and 2 showing problematic artifacts with the Cy3-dye fluorescence. 
 
Analysis of the same arrays using separate laser channels showed that Cy5 red background 
fluorescence was much lower in comparison to Cy3 fluorescence. Interestingly, a majority of 
the dust particles present on the array No1 showed fluorescence in the wavelength range of 
the Cy3-dye only. Similarly, contaminating background fluorescence on the slide No2 was 
visible only when the green laser channel was used (Fig 3.5.18). This suggested that the 
application of Cy5-dye only would allow for more correct measurements of even weak 
hybridization signals. Additionally, one dye system would eliminate problems related to 
biases in dye incorporation during PCR labeling procedure (Yu et al., 2002, Richter et al., 
2002), as well as their different environmental stabilities (Fare et al. 2003). 
 
Fig 3.5.18: Images of Fig 3.5.17 generated using the green and red channel separately. 
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Introduction of the one dye detection system required minor modifications of the existing 
protocol. Two microarray biochips had to be used, instead of one only, for separate 
hybridizations with pre- and post-panning DNA populations. The type of analysis based on a 
visual inspection of presence or absence of signals obtained from DNA spots that were 
characteristic for phage enrichment applied so far, only could be applied to a limited set of 
genes. This way, however, is not feasible for comparison of intensities of thousands of genes 
arrayed on the amygdala microarray. Two software packages provided by BioDiscovery 
(ImaGene 5.5.2 and GeneSight 3.5.2) were utilized for microarray image and data analysis, 
respectively. Following the fluorescence measurements made for Cy5 dye at each spot on 
the array, a local spot background subtraction and data normalization, the mean fluorescent 
signal values were acquired and presented in tables. Such data sets were subsequently 
analyzed using the Microsoft Excel software. Values obtained from both pre-panning 
(reference) and post-panning (experiment) microarrays were compared and signal ratios 
(experiment/reference) were calculated. The highest ratio values indicated an over-
representation of post-panning genes that belong to phages enriched during affinity selection 
process. First, a careful enrichment analysis of the model phages on their peptide-ligands 
was performed utilizing both, visual and software driven comparison of hybridization signals 
on the microarray biochips. A standard experiment was carried out using a mixture 
containing the three model phages that were supplemented into the T7 human brain phage 
library (1.6 x 1010 pfu/ml) to achieve their final concentration of 1 x 104 pfu (dilution ratio 1:1.6 
x 106). Phages were selected on the 25 aa long peptide ligands for the three model domains 
(pep: E, F, Y). DNA populations isolated from pre- and post-panning phage mixtures after 
propagation were labeled with Cy5 dye and separately hybridized to the biochips. Control 
Fas DNA, supplemented to all mixtures was shown to hybridize to its complementary DNA 
on all biochips utilized in this experiment. A peptide specific enrichment of phages displaying 
a particular model protein domain was visible as a red fluorescence signal on a post-panning 
biochip, emitted from DNA-spot which code to the displayed protein. Absence of that signal 
on a pre-panning biochip indicated an under-representation of that particular domain within 
pre-panning phage population. Microarray analysis performed after panning on the pep-E 
(Fig 3.5.19), revealed that its DNA was over-represented within the post-panning population. 
A visual comparison of sections of the reference and experimental arrays, as well as signal 
intensity values measured using the software package for the three genes of interest (probes 
E, Y, F) are shown. Similarly, enrichment of phages displaying the WW/YAP domain on its 
peptide-ligand (pep-Y) was well visible on the corresponding biochip (Fig 3.5.20).  
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Fig 3.5.19: Sections of amygdala biochips showing hybridizations with Cy5 labeled pre- and post-
panning DNA populations performed after phage selection over the EVH1 peptide-ligand (pep-E). The 
model phages were diluted with human brain T7 phage library at ratio 1:1.6 x 106. Blue circles and 
fonts indicate the gene coding for the EVH1 protein domain specific for the E target-peptide. Signal 
intensities from pre- and post-panning biochips and calculated rations are shown. Short name code: 
EVH1 (E), WW/FE65 (F); WW/YAP (Y); Fas antigen (Fas). 
Fig 3.5.20: Sections of amygdala biochips showing hybridizations with Cy5 labeled pre- and post-
panning DNA populations performed after phage selection over the WW/YAP peptide-ligand (pep-Y). 
The model phages were diluted with human brain T7 phage library at ratio 1:1.6 x 106. Blue circles 
and fonts indicate gene coding for the WW/YAP protein domain specific for the Y target-peptide. 
Signal intensities from pre- and post-panning biochips and calculated rations are shown. Short name 
code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); Fas antigen (Fas). 
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post-panning (pep-Y)
YEDVVHHPGTPPPPYTVGPGYPWTT 
pre-panning 
   E  F Y Fas 
pre-panning 
EVH1           0.0115 
WW/YAP     0.0140 
WW/FE65    0.0086 
post-panning 
EVH1            0.2463 
WW/YAP      0.3308 
WW/FE65     0.0124 
  E F Y Fas    E F Y Fas 
post/pre-panning ratio 
EVH1          21.417 
WW/YAP     31.807 
WW/FE65    1.4418 
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Phages displaying the WW/FE65 protein domain were not detected within the population 
eluted from the pep-F ligand (Fig 3.5.21). This is in agreement with our previous panning 
experiments (see 3.2.1), which also showed that the enrichment of phages displaying this 
domain was always less efficient than the enrichment of phages displaying the other two 
model domains, because of lower affinity/avidity (see Bialek et al., 2003). Unexpectedly, an 
additional signal obtained from the DNA probe E, was observed on both post-panning 
biochips corresponding to the pep-Y and pep-F ligands. Analysis of signal intensities by the 
software package revealed that this signal was only two times weaker in both cases than that 
obtained from the biochip related to target peptide pep-E. This issue will be discussed later in 
this section (3.5.7). Nevertheless, the successful identification of a specific enrichment of 
highly diluted phages (1:106) displaying the EVH1 and WW/YAP domains on their respective 
peptides-ligands, has proven that the microarray analysis takes an advantage over other 
approaches described previously, which failed to detect such enrichment. Therefore the 
microarray analysis should be considered as a very sensitive and promising method.  
Fig 3.5.21: Sections of amygdala biochips showing hybridizations with Cy5 labeled pre- and post-
panning DNA populations performed after phage selection over the WW/FE65 peptide-ligand (pep-F). 
The model phages were diluted with human brain T7 phage library at ratio 1:1.6 x 106. Blue circles and 
fonts indicate gene coding for the WW/FE65 protein domain specific for the F target-peptide. Signal 
intensities from pre- and post-panning biochips and calculated rations are shown. Short name code: 
EVH1 (E), WW/FE65 (F); WW/YAP (Y); Fas antigen (Fas). 
 
 
 
      E  F Y Fas 
 E  F Y  Fas 
pre-panning 
E  F Y Fas 
 E  F Y Fas 
post-panning (pep-F)
PPPPPPPPPPPPLPAPPPQPQQPHF 
pre-panning 
EVH1           0.0115 
WW/YAP     0.0140 
WW/FE65    0.0086 
post-/pre-panning ratio
EVH1          24.634 
WW/YAP     4.625 
WW/FE65    2.9883 
post-panning 
EVH1            0.5015 
WW/YAP      0.0481    
WW/FE65     0.0257 
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An additional panning was carried out using the 25mer peptide-ligands pep-Y and pep-F to 
look into more detail to their more critical behavior in phage enrichments. The corresponding 
model phages were less than previously diluted within the total phage library 
(ratio 1:1.6 x 105). This additional experiment was expected to explain whether an increased 
concentration of possibly weaker binding WW/FE65 phages could promote a detectable 
enrichment on the corresponding target peptide. It could also be helpful in corroborating 
results observed in the previous screen, concerning the unexpected behavior of phages 
displaying EVH1 domain. The image analyses presented in Figs. 3.5.22 and 3.5.23 revealed 
a successful peptide-specific enrichment of WW/FE65 as well as WW/YAP model phages 
that was well visible on the applied biochips. The binding of EVH1 phage to both target 
peptides as observed before, was also detected in this case. These results support the 
former observations that the interaction of the WW/FE65 domain with its peptide-ligand must 
be weaker than the interaction of the WW/YAP and EVH1 domains with their targets. A 
weaker interaction can be compensated by a higher concentration of binding partners in 
order to detect enrichment, as observed in the case of the WW/FE65. This is also supported 
by enrichment of the WW/YAP domain, which was well visible in both above experiments, 
although the concentration of phages displaying this domain was the same as the 
concentration of phages displaying the WW/FE65. 
Fig 3.5.22: Sections of amygdala biochips showing hybridizations with Cy5 labeled pre- and post-
panning DNA populations performed after phage selection over the WW/FE65 peptide-ligand (pep-F). 
The model phages were diluted with human brain T7 phage library at ratio 1:1.6 x 105. Blue circles and 
fonts indicate gene coding for the WW/FE65 protein domain specific for the F target-peptide. Signal 
intensities from pre- and post-panning biochips and calculated rations are shown. Short name code: 
EVH1 (E), WW/FE65 (F); WW/YAP (Y); Fas antigen (Fas). 
 E  F Y  Fas 
pre-panning post-panning (pep-F)
PPPPPPPPPPPPLPAPPPQPQQPHF  E  F Y  Fas 
  E  F Y Fas  E  F Y Fas 
pre-panning 
EVH1           0.0115 
WW/YAP     0.0140 
WW/FE65    0.0086 
post-/pre-panning ratio
EVH1          94.243 
WW/YAP     11.548 
WW/FE65    33.627 
post-panning 
EVH1            1.0838 
WW/YAP      0.1201 
WW/FE65     0.2892 
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Fig 3.5.23: Sections of amygdala biochips showing hybridizations with Cy5 labeled pre- and post-
panning DNA populations performed after phage selection over the WW/YAP peptide-ligand (pep-Y). 
The model phages were diluted with human brain T7 phage library at ratio 1:1.6 x 105. Blue circles 
and fonts indicate gene coding for the WW/YAP protein domain specific for the Y target-peptide. 
Signal intensities from pre- and post-panning biochips and calculated rations are shown. Short name 
code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); Fas antigen (Fas). 
 
In particular, both experiments indicated a minimum concentration for the WW/FE65 phages 
within a screened library (~105pfu, dilution ratio in this case = 1:105) that is required for a 
sufficient enrichment after only one round of affinity selection. Although the value of binding 
constant for the WW/FE65 protein domain is not determined, all observations suggest that its 
interaction with the peptide-ligand is weaker than interactions of the two other model 
domains with their respective peptides. According to the binding constant values, the EVH1 
(5 µM) is more affine to its peptide than the WW/YAP (50 µM) domain to its corresponding 
peptide. This could be corroborated by the microarray analysis, as the values of signal 
intensities and pre-/post-panning ratios given by the EVH1 probes (Fig 3.5.19) were higher 
than those achieved from the WW/YAP probes (Fig 3.5.20). It is expected that enrichment of 
many proteins showing WW/FE65 like properties will be difficult to detect even using the 
sensitive array methodology. Many protein domains display minute and weak interactions 
with their targets and may be not detectable by this or any other methods in a one step 
panning process. A weak affinity of some proteins must be compensated with higher valence 
in order to increase the avidity and therefore enrichment efficiencies. Lower valence is 
preferable for enrichment of strong binding proteins. Therefore, a parallel utilization of the T7 
and lambda phage systems characterized by low and high display capacities respectively, 
would allow for detection of a larger range of interactions (see 3.1). The studies performed 
pre-panning post-panning pep-Y
YEDVVHHPGTPPPPYTVGPGYPWTT 
 
 E F Y Fas 
 E  F Y  Fas 
  E  F Y  Fas 
E F Y Fas
pre-panning 
EVH1           0.0115 
WW/YAP     0.0140 
WW/FE65    0.0086 
post-/pre-panning ratio
EVH1           34.8 
WW/YAP     26.855 
WW/FE65    4.3255 
post-panning 
EVH1            0.4002 
WW/YAP      0.2793 
WW/FE65     0.0372 
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previously with both systems and the three model domains showed satisfactory enrichment 
of the weaker binding WW/FE65 in the case of the lambda system. However, the high 
valence of this system caused difficulties with elution of phages displaying the other two 
domains due to their strong interaction with the target peptides. The results achieved using 
the T7 system were consistent with the results obtained in the above experiments.  
 
3.5.7 Cross-reactivity of the EVH1 domain 
An explanation for the appearance of EVH1 signals indicating enrichment on both non-EVH1 
ligand peptides stays unclear. There was no literature found, describing an interaction of the 
EVH1 domain from the murine protein Mena, with peptide-ligands for WW domains. 
Additionally, it was demonstrated that a protein from the same family, VASP (vasodilator-
stimulated phosphoprotein) containing an EVH1 domain, didn’t interact with peptides that are 
ligands for the WW/YAP (15 aa) and WW/FE65 (10 aa), (Niebuhr et at., 1997). Therefore, 
specific interaction of the EVH1 from Mena with both 25 aa peptide ligands for WW domains 
utilized in these studies seems rather unlikely. Since the literature data exclude cross-
interaction of both WW peptides with the EVH1 domain, another explanation for the puzzling 
observations from the microarray experiments was needed. The first and simplest one would 
be a too high concentration of the EVH1 phages that were supplemented to the phage 
population caused by mistakes in their titration or the preparation of the panning mixture. The 
over-represented phages would stick to the cellulose membrane and are detected as 
background. However, this hypothesis seems to be unlikely as the different model panning 
experiments were carried out independently, using separately prepared mixtures and freshly 
prepared phage lysates that were tittered separately, which minimized mistake probability. 
Additionally, this hypothesis couldn’t be supported by microarray results achieved previously 
by Bialek (Bialek et al., 2003), where representation of the EVH1 and WW/FE65 phages 
supplemented to the library was one and two orders of magnitude higher (f.c 1 x 106 pfu) 
than their representation in the experiments described here. This experiment showed that, 
despite a high representation of model phages, the enrichment of EVH1 was not observed 
on the pep-F, suggesting different nature of this problem. Another hypothesis that could 
possibly explain the observed behavior of the EVH1 domain assumes the presence of a DNA 
insert within the post-panning population, which is partially homologous to the DNA 
sequence of this domain. In order to be enriched, the hypothetical phage containing such 
insert must bind non-specifically to the pep-F and pep-Y spots, as there is no functional 
EVH1 domain displayed on its surface. The cross-hybridization of this insert to the EVH1-
DNA would be visible as a positive signal on the array, therefore considered as phage 
enrichment. Such enrichment signal must be visible on the biochips corresponding to all 
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peptides in the case if the unspecific phage could bind to the fibers of the cellulose 
membrane, or aggregates with the coat proteins of other phages or with other displayed 
proteins. To check this hypothesis, an additional panning of the human brain phage library 
without a supplement of model phages was carried out on 25mer pep-E and pep-Y ligands. 
In the case of presence of the hypothetical phage containing cross-hybridizing insert, an 
enrichment signal given by the EVH1 DNA spot, would be visible after both pannings. 
However, the post-/pre-panning ratios calculated after microarray analysis, showed that 
there was no enrichment of the EVH1-like phages neither on its target peptide nor on the 
pep-Y (see Table 3.5.1). Ratios obtained after panning with the phage library that was 
supplemented with the model phages (f.c 1 x 104 pfu, see above), were ten-fold higher than 
ratios from the present experiment. Since Mena is a murine protein, its EVH1 domain was 
not expected to be present within the human brain phage library. Additionally, any 
homologous DNA sequences hybridizing to the EVH1 probe on the array have been found 
within the screened mixture, eliminating the cross-hybridization hypothesis discussed before. 
As already mentioned above, the literature records exclude a specific interaction of the EVH1 
domain with peptide-ligands for both WW domains. Therefore the observed enrichment of 
this multi-valent phage on both proline-rich target peptides for WW domains was considered 
as unspecific.  
 
Table 3.5.1: Comparison of fluorescent signal intensities from EVH1 DNA spot on the biochips 
corresponding to pep-E and pep-Y ligands, after affinity selection of T7 human brain phage library 
performed without and with supplement of the model phages  
Peptide / Phage mix Pre-panning Post-panning Post-/pre-panning ratio 
pep-E/ (no supplement) 0.0115 0.0538 4.6782 
pep-Y/ (no supplement) 0.0115 0.0343 2.9826 
pep-E/ (supplement 1x104 )a) 0.0115 0.5015 43.6087 
pep-Y / (supplement 1x104)a) 0.0115 0.2463 21.417 
a) supplement of the EVH1, WW/YAP and WW/FE65 model phages to the T7 phage library 
 
In order to check for cross-binding of the EVH1 domain to the pep-Y and pep-F as well as to 
other indifferent peptides without phage context, a set of simple assays was performed 
utilizing the GST-MenaEVH1 fusion protein. Spots containing cellulose-bound peptides of 
different length (10-15 aa and 25aa), were incubated with the GST fusions, followed by 
incubation with anti-EVH1 antibody and subsequently incubated with a secondary antibody 
conjugated to peroxidase enzyme. Binding was detected by the enzymatic reaction with its 
substrate, as described in section 2.2.4.6. The first two assays were performed using 
different dilutions of primary antibody. Results obtained from both tests showed that in the 
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case of 25aa peptides, EVH1 domain bound to its target peptide (pep-E), but also to the 
poly-proline peptides for both model WW domains (pep-Y, pep-F), as well as to the control 
peptide (pep-K) containing 6 proline residues (Fig 3.5.24). Binding to another randomly 
chosen control peptide (1), with only three dispersed proline residues was not observed. 
Contrary, in the case of the short peptides, binding with the WW/YAP and the control peptide 
was not observed. Only a weak signal was detected on the pep-F spot. A significant 
difference in signal intensities between the spots pep-E and pep-F was well visible in the 
assay 1, with higher concentration of the GST-MenaEVH1 and lower dilution of the primary 
antibody (Fig 3.5.24). To exclude a possible unspecific binding of the protein to cellulose 
(trapping) that might be caused by the high concentration of the fusion protein and primary 
antibody used for the assay, concentrations of both proteins were reduced in the second 
assay. Signals obtained from all peptides were weaker in general when compared with 
signals from the first assay. Nevertheless, the above results were confirmed. The difference 
in signal intensities between pep-E and pep-F was however not as clearly visible as in the 
assay 1. It is possible that the concentration of fusion protein was to low in this case and 
therefore less EVH1 fusion protein was bound to the pep-E spot, resulting in weaker signal 
than observed above. This could also be caused by possible differences in handling of 
membranes. An additional, stronger signal given by the control peptide 2 was observed. This 
could be explained by possible strong non-specific affinity of this peptide to the GST-tag or 
entire fusion protein. The other control peptides, including proline rich peptide 6, didn’t 
indicate any binding (Fig 3.5.24). 
Fig 3.5.24: Binding assays of the GST-MenaEVH1 with various peptide ligands of different length. 
C 
E Y 
F 
E 
F Y 
K 
1 
1.  2 µg GST-EVH1 + anti-Mena PAK 73 Ab (dil. 1:1000) + POD anti-rabbit IgG (1:2000)  
25 aa pep  25 aa pepshort pep Peptides:  25 aa 
1) ALSRDYRNLKPSAVAPQRKMPLDDT (gi20521017) 
E) TSEPSSFEFPPPPTDEELRLALPET 
F) PPPPPPPPPPPPLPAPPPQPQQPHF 
Y) YEDVVHHPGTPPPPYTVGPGYPWTT 
K) WPSPHSNRPPPAVGPQPAPAQYEPF 
short 
E) SFEFPPPPTDEELRL    (15 aa) 
F) PPPPPPPLPAPPPQP    (15 aa) 
Y) GTPPPPYTVG         (10 aa) 
K) NRPPPAVGPQPAP      (control-13 aa) 
 2 3 
 K 
2.  1 µg GST-EVH1 + anti-Mena PAK 73 Ab (dil. 1:3000) + POD anti-rabbit IgG (1:2000) 
 4 5 
6 
Peptides:  
25 aa 
2) RIFQSRFQHKKTVWHIQFTADEKTL  (gi20521041) 
3) LRGHQETVKDFRLLKNSRLLSWSFD  (gi20521041) 
4) GARKPQYDIWGNTVNVSSRMDSTGV  (gi20521045) 
5) GVWRNTEDEILKAAVMKYGKNQWSR  (gi20521049) 
6) VPSRPGASPDPFGPPPQVPSRPNRA  (gi181848)
 short pep 25 aa pep  25 aa pep 
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Signals obtained from both 25mers (pep-F, pep-Y) in both assays, suggested interaction the 
EVH1 fusion protein with these peptide-spots. These results are similar to the results that 
were obtained after panning experiments on the same peptides (see 3.5.6). Analogously, the 
enrichment of the EVH1 phages was detected on both biochips corresponding to both non-
EVH1 peptides. In order to check for a possible non-specific interaction of the GST-tag 
protein with the model peptide-spots, an additional test was performed with this protein (1µg) 
alone. Detection was carried out using rabbit anti-GST antibody (1:2000) with conjugated 
peroxidase enzyme. Interactions were observed for all four control spots (7-10) with strong 
differences in signals intensities (Fig 3.5.25). No signals indicating interaction of the GST-tag 
alone with the short model peptides were detected on these spots. In contrast to this, as 
described before for the assays 1 and 2, the short model peptide (pep-F) showed signal 
indicating interaction with the GST-EVH1 fusion protein (Fig 3.5.24). This comparison 
suggested that the interaction with this peptide must be mediated by the EVH1 alone, not by 
the GST protein. Moreover, interaction of this fusion-tag with the 25mer pep-F was not 
detected as well (Fig 3.5.25). The signals from this peptide were however visible when the 
GST-EVH1 fusion was used (Fig 3.5.24). This suggests again that the observed cross-
interaction was mediated by the EVH1 domain. Additionally, significant signals indicating 
binding of the GST-tag alone to the 25mer pep-E peptide were not observed; relatively weak 
signals were visible on the 25mer pep-Y and control peptides (Fig 3.5.25), demonstrating a 
contribution of the GST-tag in interactions with these peptides. Unfortunately, it was not 
possible on the basis of these experiments to completely prove whether the interaction is 
driven be the GST or the EVH1 itself. Additionally one could suspect that it is driven by both 
these proteins, as the previous experiments utilizing microarrays, where no GST-tag was 
used, showed similar non-specificity. 
Fig 3.5.25: Binding assays of the GST (1µg) protein with various peptide ligands of different length.  
Peptides:  
25 aa 
E)  TSEPSSFEFPPPPTDEELRLALPET 
F)  PPPPPPPPPPPPLPAPPPQPQQPHF 
Y)  YEDVVHHPGTPPPPYTVGPGYPWTT 
K)  WPSPHSNRPPPAVGPQPAPAQYEPF 
7)  PQPMEQGSSGVLGGKEEGGKPERSS  (gi20521013) 
8)  VTLVEELSLQEAMRKEPGESSSRKA  (gi20521013) 
9)  QKAFDNTEGKREGYSADSAQEASPA  (gi20521051) 
10) ADSAQEASPARQNVSSASNPENDSS  (gi20521051) 
 
short 
E)  SFEFPPPPTDEELRL  (15 aa) 
F)  PPPPPPPLPAPPPQP  (15 aa) 
Y)  GTPPPPYTVG       (10 aa) 
K)  NRPPPAVGPQPAP    (control 13 aa) 
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Nevertheless, based on the literature data (Niebuhr et al., 1997; Prehoda et al., 1999; Carl et 
al., 1999; Ball et.al., 2002), showing very high specificity of EVH1 domain to the FPPPP core 
motif flanked by acidic residues, a specific binding of the EVH1 to the 25 aa peptide-ligands 
of WW domains seems rather unlikely. The results obtained here for the EVH1 domain and 
the results achieved previously for the EVH1 phages using microarrays support a higher 
non-specificity of this domain to the 25mer peptides compared to the shorter peptides. 
Nevertheless, comparison of interactions mediated by a single EVH1 domain with the 
multivalent phages might be inappropriate and therefore several additional, independent 
tests must be carried out in order to draw appropriate conclusions concerning these 
observations.  
 
3.5.8 Statistical evaluation of microarray results 
All results presented in this section so far, were obtained from the three protein domains, 
which were used as model proteins in order to test performance of the new microarray 
approach. Since the “home” produced biochips contain a total representation of 6144 
different genes originating from amygdala region of human brain, a simultaneous detection of 
potential binders from human brain library that were enriched on peptide-spots became 
possible. Experiments performed using model phages revealed that the microarray profiling 
was more sensitive and efficient than the other applied systems. Following analysis with the 
gene expression profiling software suite, data filtration and statistical analysis were carried 
out using Microsoft Excel software, in order to select possibly most specific binding 
candidates. Previous microarray analysis performed for the three model domains selected on 
their corresponding peptides, was useful in establishing threshold values and filtration 
methods, which will be uniformly used for analysis of microarray data. Filtration of data sets 
will be achieved by elimination of weak and non readable fluorescent signals due to 
background and other technical problems, as well as those signals, whose intensities are 
equal on both pre- and post-panning microarrays. This process would allow for elimination of 
genes which correspond to phages that were not enriched on peptide-spots and genes 
corresponding to phages equally represented in both pre- and post-panning populations. 
Three important data sets are acquired after each microarray analysis. First data set gives 
mean values of Cy5 signal intensities measured for two replicas of each gene that are 
present on the amygdala biochip. The values for EVH1, WW/YAP and WW/FE65 domains 
acquired after analysis of post-panning biochips, ranged from 0.2 to 0.5. Therefore, the 
threshold value chosen for future analysis was set to larger as or equal 0.1, meaning that all 
values which are lower than 0.1 will not be taken into account. Second set, gives coefficients 
of variance (CV) for two replica gene spots on the biochip. This selection parameter was 
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applied for both pre- and post-panning biochips in order to exclude those spots, which are 
characterized by large CV values. Large CV values are obtained when one of the two replica 
spots is covered by contaminating background or dust particle, which give high fluorescent 
signal. Since fluorescence intensities of these two spots are usually not even similar (low 
correlation), their CV value tend to be very high. The CV values found for the model genes 
ranged from 0.1 to 0.3. Therefore, a general CV threshold level was set to 0.5. The third data 
set contains ratios calculated by dividing mean values of intensities of post-panning signals 
through pre-panning signals. Ratios are calculated for each probe (gene) on the microarray. 
The ratio values indicate phage enrichment on certain peptide. A high value of a post-
panning signal emitted from a certain probe on the array divided by a low value of a pre-
panning signal read out from the same probe gives a high ratio, which means positive phage 
enrichment. The threshold for this data set was also established from ratios obtained in the 
model experiments; EVH1 (43.608), WW/YAP (31.801), WW/FE65 (24.634). A threshold 
filter was chosen that preserved only those gene probes on the array, which were 
characterized by ratio of pre-/post-panning signals equal or higher than 15. A list of data 
explaining filtration process using the values obtained from model panning over the pep-Y is 
shown in Table 3.5.2. Data corresponding to only those genes, for which all the filtration 
requirements were fulfilled (blue + green+ red) will be taken into account in the future 
analysis. 
 
Table 3.5.2: Example showing filtration of microarray data acquired after panning on pep-Y, using 
three experimentally defined threshold values. post-panning spot signal ≥ 0.1, post and pre-panning 
CV ≤ 0.5, ratio ≥ 15  
Data before filtration 
 Spot signal CV value Ratio 
Gene ID Pre-panning Post-panning Pre-panning Post-panning Post-/Pre 
DKFZp761P241Q 0.1753 0.2274 0.1786 0.0092 1.297204792
DKFZp761P2420Q 0.0291 0.0241 0.0909 0.2076 0.828178694
DKFZp761P242Q 0.0538 0.0876 0.0747 0.1029 1.628252788
DKFZp761P248Q 0.0154 0.0282 0.3441 0.146 1.831168831
E 0.0115 0.2463 0.2454 0.2022 21.4173913 
Ezr 0.0063 0.0072 0.5727 0.4483 1.142857143
F 0.0086 0.0124 0.3162 0.354 1.441860465
Fas 1 1 0.1899 0.3179 1 
IL-4 0.0088 0.0059 0.4479 0.7667 0.670454545
Y 0.0104 0.3308 0.3863 0.2491 31.80769231
Empty spot (buffer) 0.0012 0.0047 0.9378 0.7106 3.916666667
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Data after filtration  
 Spot signal CV value Ratio 
Gene ID Pre-panning Post-panning Pre-panning Post-panning Post-/Pre 
E 0.0115 0.2463 0.2454 0.2022 21.4173913 
Y 0.0104 0.3308 0.3863 0.2491 31.80769231 
 
 
The above filtration process has been demonstrated to be useful for the microarray analysis 
of protein interaction data from one enrichment experiment on a peptide-spot. However, 
further statistical analysis is necessary to prove whether a selected protein is a potential 
specific binder. At least two of the same but separate panning “sister” experiments have to 
be performed for each peptide-ligand to provide data for a minimal statistical analysis. In 
order to be included in a pool of potentially specific interaction partners, a phage which was 
selected in one panning experiment must be also selected in the “sister” experiment and can 
not be abundantly appearing in other panning experiments performed on different peptide-
ligands. A phage, which is selected in one “sister” experiment only, will be considered as a 
random background. Other reasons for differences in gene representation between two the 
same data sets could be (i) a strong enrichment of unspecific phages in one panning 
experiment or (ii) possible differences in PCR amplification resulting in over- or under-
representation of genes. According to the rules established for “sister” biochip comparison, 
these candidates which occurred only in one data set have to be eliminated.  
If enrichment of this phage is observed in all performed experiments, this means that such 
candidate should be treated as constant background. It is likely that some phages will bind to 
one peptide-ligand only but in unspecific manner (false positive). Such phages will not be 
deselected and, thus, identified as specific binders. Therefore any result from the microarray 
analysis need to be verified by other independent methods. The discrimination of potentially 
specific and unspecific candidates, based on statistical analysis is demonstrated below, 
using microarray data acquired for the three model phages after affinity selection on their 
target peptides (Table 3.5.3).  
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Table 3.5.3: Example showing identification of specifically and not specifically enriched phages, using 
comparison of statistical data from post-/pre-panning ratios obtained from “sister” and unrelated 
panning experiments. Post-/pre-panning ratios showing: specific enrichment of WW/YAP domain on 
its peptide (red), leak of enrichment of WW/YAP domain on unrelated peptide-ligands (green), specific 
enrichment of EVH1 domain on its peptide-ligand (orange) and unspecific enrichment on unrelated 
peptides (blue). Filtration parameters: signal ≥ 0.1; CV ≤ 0.5; ratio ≥ 15. 
Domain Post-/pre-panning ratio Judged enrichment 
 pep-Y pep-F pep- E  
 Experiment 1 Experiment 2    
EVH1 21.4173 34.8 94.2434 43.6087 non specific 
WW/YAP 31.8076 26.8557 11.5480 4.625 specific 
WW/FE65 (1) 1.4418 4.3255 33.6279 3.3255 specific  
(1) Analysis based on panning experiment with supplement model phage (1 x 105)  
 
Enrichment of the WW/YAP domain was detected in both panning experiments on the 
corresponding peptide ligand (red) but was not detected in the other two experiments on 
different peptides (green), strongly indicating a specific domain-ligand interaction. As 
discussed above, most probably due to a weak interaction with its peptide, the enrichment of 
the WW/FE65 domain was not observed after panning with a library containing 1 x 104 pfu 
(dilution ratio 1:106) of model phages but was detected after supplementing with the 1:105 
pfu (dilution ratio 1:105). Because there was only one experiment performed using this higher 
concentration of model phages, the statistical comparison with “sister” experiment cannot 
apply in this case. However, the fact that this domain was enriched only on its corresponding 
peptide proves a specific binding. Enrichment of the EVH1 domain was observed in all four 
experiments and also in pannings on non-EVH1-peptides (blue). According to the rules 
established, results obtained for EVH1 should be eliminated from the pool of specifically 
binding candidates. This is in agreement with the previously discussed observations of high 
non-specificity of this domain for the 25mer peptides used in this work. The judgment on the 
EVH1 domain seems to be proper in this case, although its reported highly specific 
interaction with peptides containing the FPPPP motif. It also suggests that the statistical 
analysis is very sensitive and restrictive and could be advantageous during analysis of 
unknown peptide interacting proteins. 
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3.5.9 Phage library expansion by infection and propagation in bacteria 
As already discussed in the section 3.3, panning experiments on peptide arrays require large 
volumes of phage library lysates. Since the volume aliquot of the commercially available T7 
human brain library doesn’t exceed 100 µl, an amplification step is necessary before each 
screening. Additionally, each post-panning phage eluate needs to be propagated in order to 
provide enough material for PCR amplification. This is done by infection of host bacteria with 
the phages from the original library and further recovery of resulting phage lysate (see 
2.2.4.2). It is absolutely required, that this step must not change the relative abundances of 
the phages in the library. Otherwise, faster growing phages will be identified as false 
positives. In order to test which phages tend to amplify faster and are therefore over-
represented within the library after its propagation, a simple comparison experiment was 
carried out using the amygdala microarrays. First, an aliquot of 10 µl of the original T7 library 
was used to infect 20 ml of host bacteria and phages were propagated. Another 10 µl aliquot 
of this new phage library was used for a second propagation in the same way. Since the only 
difference between these two libraries is the additional phage amplification step, they were 
called “amplified 1°” and “amplified 2°”. Next, an aliquot of 100 µl from each library was used 
for isolation of phage DNA, which was subsequently used for a direct labeling with the Cy5-
dye during PCR. The same amount of DNA corresponding to each library was hybridized to 
two separate amygdala biochips. Microarrays were analyzed using previously mentioned 
software suite. Signal intensities emitted from of gene probes present on both arrays were 
compared with each other. Correlation coefficient value for both libraries was 89 % 
(r2 = 0.8927). Genes showing similar signal values and therefore indicating similar 
representation of phages for both experiments were preserved. Outstanding genes showing 
large differences in intensities of emitted signal were excluded from the array list, which will 
be subsequently used for all analyses of phage enrichments. The fold change (FC) 
thresholds applied for data cleansing, were set greater than -1.5 and less than 1.5. 
Fig 3.5.26 shows a scatter plot of signal intensities before (A) and after (B) data cleansing. 
Genes chosen as a uniform set for phage enrichment analysis, were located between y = 2x 
and y = 0.5 regression lines. In effect, the cleansing process increased correlation coefficient 
for these genes to 97 % (r2 = 0.9744). According to these results, 33 % of genes printed on 
glass slides were shown to correspond to phages, which seem to propagate faster than other 
library members and most likely therefore contribute to unspecific background. The final 
number of 4098 genes from the array list was taken into account during further microarray 
analysis.  
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Fig 3.5.26: Scatter plots showing relationship between phage libraries which were propagated one 
time (amplified 1°) and two times (amplified 2°) before (A) and after (B) data cleansing. Points placed 
close to the regression line (y = x), represent genes with similar values for both experiments. Points, 
which are far away from this line have low correlation score and were excluded from the gene array 
list. All points within the two-fold borders (y = 2x and y = 0.5) were preserved. Five-fold borders are 
indicated by y = 5x and y = 0.2x respectively. A502 – ID of biochip related to non infected library.  
correlation coefficience r2 =0.8927 (89%) 
correlation coefficience r2 =0.9744 (97%)
A 
B 
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3.5.10 Expanding the interaction screen to other domains and peptides 
Previously, only the three model genes were taken into account for panning experiments and 
during microarray analysis in order to establish rules for data segregation and validation of 
phage enrichment. As the entire biochips were used for hybridization with post-panning DNA 
populations, the data achieved from other gene spots were subsequently used to verify 
possible enrichment of other phages on model peptides. In addition, several screens were 
carried out, using different peptides and the T7 library without supplement of model phages. 
Proline rich peptides were preferred as targets, as proline plays a special role in peptide 
mediated protein-protein interactions and is involved in interaction with many different protein 
domains (Kay et al., 2000; Macias et al., 2002; Sidhu et al., 2003). Peptides were selected 
from native protein sequences using the ASS software tool (see section 3.2). Peptide 
sequences and database codes of their parental proteins are shown in (Table 3.5.4).  
 
Table 3.5.4: Peptides used for phage affinity selection experiments. Peptides were selected using the 
ASS software tool.  
Peptide ID Peptide sequence Protein ID 
EVH1 TSEPSSFEFPPPPTDEELRLALPET spP33379 
WW/YAP YEDVVHHPGTPPPPYTVGPGYPWTT spP97764 
WW/FE65 PPPPPPPPPPPPLPAPPPQPQQPHF spQ03173 
107 RLDLPPYPSYSMLYEKLLTAVEETS gi20520999 
113 TVWDKHSVTAATPPPSPTSGESGDL gi20521017 
148 TQQSSLPPPPPPDSLDQPQPMEQGS gi20521013 
199 PPLPPPPPLPKTPRGGKRKHKPQAP gi20521051 
200 GKRKHKPQAPAQPPQQSPPQQPLPQ gi20521051 
 
 
Each panning experiment was performed in duplicate. Microarray data were filtered using 
previously defined thresholds (signal ≥ 0.1; CV ≤ 0.5; ratio ≥ 15) followed by statistical 
analysis. It was shown that in some cases the number of genes was strongly reduced, 
already after a first filtration process. This was especially true for biochips with overall lower 
signal intensities, which could be caused either by higher background or lower quality of the 
hybridization process. Subsequent comparison of both, more and less reduced sets of genes 
frequently resulted in elimination of majority or sometimes all selected candidates. In the last 
step of analysis, an already reduced set of genes was subjected to another comparison with 
biochips, filtering those, which have tendency to occur in other panning experiments. The 
same genes selected for both “sister” experiments but also found in several other screens, 
were also excluded from list of potential candidates, as they likely correspond to non-
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specifically binding phages. Candidates matching all requirements of statistical comparison 
were considered as potential peptide interacting partners. An example showing the analysis 
of data sets containing various numbers of genes obtained from three parallel pannings is 
described below. These pannings were carried out on the peptide-ligand for the WW/YAP 
domain using the T7 library with and without addition of model phages. The numbers of 
positively selected genes after the first filtration process are listed separately for the three 
experiments in (Table 3.5.5). Except for the two genes corresponding to the model domains, 
their enrichment was already discussed earlier; only one gene (DKFZp761O0120Q) was 
found in all three “sister” experiments. Very high values of post-/pre-panning ratio for this 
candidate suggested its specific interaction with the WW/YAP peptide. 
 
Table 3.5.5: Three data sets obtained after initial filtration of microarray records for panning 
experiments performed on peptide for WW/YAP domain using phage library only and phage library 
supplemented with the three model phages. Filtration parameters: signal ≥ 0.1; CV ≤ 0.5; ratio ≥ 15. 
Genes, which positively passed all three types of selection, are showed in bold blue.  
Exp 1. panning with supplement of model phages (1 x 104 pfu, dilution 1 : 106  ) 
Gene ID Signal intensitie CV value Ratio 
 pre-pan post-pan pre-pan post-pan post-/pre-pan 
DKFZp761O0120Q 0.0032 0.2332 0.3834 0.2309 72.875 
EVH1 0.0115 0.2463 0.2454 0.2022 21.4173913 
WW/YAPY 0.0104 0.3308 0.3863 0.2491 31.80769231 
 
Exp 2. panning with supplement of model phages (1 x 105 pfu, dilution 1 : 105) 
Gene ID Signal intensitie CV value Ratio 
 pre-pan post-pan pre-pan post-pan post-/pre-pan 
DKFZp761C1516Q 0.0063 0.1024 0.127 0.0757 16.25396825 
DKFZp761D2310Q 0.0053 0.1124 0.1534 0.3094 21.20754717 
DKFZp761L2112Q 0.0054 0.1031 0.2239 0.247 19.09259259 
DKFZp761L242Q 0.0071 0.1787 0.1015 0.1962 25.16901408 
DKFZp761O0120Q 0.0032 0.2604 0.3834 0.1645 81.375 
DKFZp761O0216Q 0.0056 0.1036 0.0123 0.1531 18.5 
DKFZp761O2113Q 0.0067 0.1222 0.1153 0.4529 18.23880597 
DKFZp761O2412Q 0.0055 0.1072 0.3061 0.0317 19.49090909 
DKFZp761P198Q 0.0124 0.217 0.6201 0.127 17.5 
EVH1 0.0115 0.4002 0.2454 0.1357 34.8 
WW/YAP 0.0104 0.2793 0.3863 0.1315 26.85576923 
 
Exp 3.  panning with T7 phage library only 
Gene ID Signal intensitie CV value Ratio 
 pre-pan post-pan pre-pan post-pan post-/pre-pan 
DKFZp761F1212Q 0.0305 1.4466  0.1956 47.4295082 
DKFZp761F1510Q 0.0222 3.5795  0.1829 161.2387387 
DKFZp761F1611Q 0.0109 0.4861  0.3487 44.59633028 
DKFZp761O0120Q 0.0032 0.317  0.3834 99.0625 
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Comparison of data sets obtained for all experiments revealed that this gene was also over-
represented in post-panning population, acquired after phage selection on peptide 107B 
(Table 3.5.6). Unfortunately, a comparison with a second “sister” biochip for this peptide was 
impossible due to hybridization failure. Nevertheless, high ratio value for this gene suggested 
a specific interaction of the related phage to this peptide. 
 
Table 3.5.6: Statistical comparison of post-/pre-panning ratios obtained for gene DKFZp761O0120Q 
after all performed panning experiments.  
DKFZp761O0120Q clone 
Peptides used for panning  Post-/pre-panning ratio 
pep-Y exp 1 72.875 
pep-Y exp 2 81.375 
pep-Y exp 3 99.0625 
pep-F 1.9375 
EVH1 1.96875 
200A  1.84375 
200B  2.21875 
148A  1.34375 
148B  0.9375 
199B  0.96875 
pep113A  0.90625 
113B 0.59375 
107B 65.09375 
 
 
Sequencing of the DKFZp761O0120Q gene followed by BLAST homology search revealed 
that it codes for a human Nedd-4-like E3 ubiquitin-protein ligase called also WW domain-
containing protein 1 (WWP1) or Atropin-1 interacting protein 5 (AIP5). This protein contains 
four WW domains (class I), which bind (L/P)PxY motif (x-any amino acid). Interaction of 
WWP1 with the peptide-ligand for WW/YAP containing the PPPY motif was already identified 
previously using TAIS technology (section 3.4). Additionally, this protein was shown here as 
interaction partner for peptide 107. Analysis of the peptide sequence revealed that it contains 
the binding motif LPPY for WW domains of class I, (Kasanov et al., 2001). Moreover, peptide 
107 is a fragment of the Nedd 4-like ubiquitin ligase 1 (NEDL1) encoded by KIAA0322 gene 
and is located in its C-terminal HECT domain. A similar motif, PPYK, was identified in the C-
terminus of WWP1 protein sequence (Fig 3.5.27). The fragment of the nucleotide sequence 
of DKFZp761O0120Q clone as well as amino acid sequences of both proteins are listed in 
appendix 4. Interaction of WWP1 with a peptide originating from NEDL1 and the presence of 
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a similar motif in WWP1 itself, suggests possible interaction of these two proteins with each 
other and likely with other proteins containing WW domains of class I. These speculations 
however, have to be additionally proven by other methods validating in vivo protein-protein 
interactions. It is also not known, whether this finding could be of biological relevance. This 
can now be investigated using the peptide in competition experiments or by mutating the 
corresponding site in the protein by site directed mutagenesis and inspection of the biological 
consequence. Furthermore, this discovery proves also a proper performance of the novel 
Accessible Surface Scanner software tool (ASS), which was applied for selection of the 107 
peptide from the WWP1 protein sequence.  
Fig 3.5.27: Graphical domain representation of WWP1 and NEDL1 proteins. Fragment of peptide 107 
(green). Similar motif found at the C-terminus of WWP1 (blue).  
 
The example above showed that the microarray analysis based on thresholds defined with 
the help of model system is quite restrictive. Apart from the positively enriched gene coding 
for the two described proteins, only one additional gene DKFZp761L0517Q passed the entire 
selection process after analysis of microarray data achieved from all panning experiments. 
Phage corresponding to the above clone was enriched on the ligand for the WW/FE65 
domain (pep-F) in both selection experiments and was not detected in any other experiment. 
Nevertheless, sequencing of this gene revealed that it codes for myelin basic protein (MBP). 
Myelin basic protein is a hydrophilic protein that may function to maintain the correct 
structure of myelin, interacting with the lipids in the myelin membrane by electrostatic and 
hydrophobic interactions (Inouye and Kirschner, 1991). Since FE65 protein binds its proline 
rich peptide through WW domain, one would expect a presence of this domain within the 
NRLDLPPYKSYE 
NRLDLPPYPSY 
WWP1 sp|Q9H0M0 
NEDL1 tr|Q9HCC7 
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identified sequence. However, none of known domains interacting with proline rich peptides 
were found in this protein.  Additionally, the MBP protein is not at all related to FE65. 
Analysis of post-/pre-panning ratios for this gene obtained in both “sister” experiments 
revealed that these were only a little higher than the defined threshold limit (15.4794 and 
15.5616). This observation, together with lack of any relationship of this protein with the 
FE65 protein lead to the conclusion that phages presenting this protein were most probably 
enriched on the peptide-spot as difficult to recognize false positive background. An increase 
of the ratio threshold (i.e. >20) in this case would eliminate this candidate. Thus, a definition 
of uniform thresholds for global analysis seems to be very difficult due to different affinities of 
peptide specific proteins. The nucleotide sequence of the DKFZp761L0517Q clone as well 
as amino acid sequence of MBP protein is shown in appendix 4.  
The fact that no other candidates that were enriched in different pannings were qualified as 
valid peptide-binding partners could suggest that the defined threshold values for filtration of 
microarray data and rules of statistical analysis are too stringent and may eliminate most of 
the binding candidates. On the other hand, comparisons of microarray data, especially 
post-/pre-panning ratios obtained from all above experiments, showed that ratios for 
specifically enriched proteins are usually relatively high, in contrast to those observed for the 
false positive like MBP (Table 3.5.7). A moderate increase of the defined thresholds, thus, 
should not eliminate specific binders. 
Interestingly, comparison of post-/pre-panning ratios revealed certain relationship between 
the value and the affinity of the protein to its target peptide. Very high values observed for 
WWP1 protein are related to multiple WW domains present in this protein. Four binding 
modules within this protein may account for its high avidity, thus, more efficient enrichment 
on the target peptide. This was also observed previously using the TAIS technology. Very 
efficient enrichment of WWP1 protein was found in that case, whereas the single WW/YAP 
domain that was supplemented to the phage library at final concentration 
1 x 104 pfu (dilution 1:106), was not detected (see section 3.4). Assuming that the screening 
of very high diversity phage libraries has to cope with protein-peptide interactions of a wide 
range of binding properties, the maintenance of relatively tolerable thresholds is important, 
even though the risk of isolation of non specific interactions may become higher. In order to 
test whether application of lower thresholds than applied for the above microarray analyses, 
would result in the identification of a higher number of potentially specific interaction 
partners, all data were additionally filtered using another set of signal with CV and variable 
ratio values slightly decreased (signal ≥ 0.1; CV ≤ 0.5; ratio ≥ 5, ≥ 10). Although the 
representation of genes in all experiments became significantly increased, only a few 
candidates occurred in both “sister” experiments and these were usually eliminated when 
comparing with data obtained from other biochips (see appendix 5). These analyses indicate 
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that relaxing the threshold values will not result in an increased number of positive interaction 
candidates. But, it may increase the probability of selecting false positive background phages 
like MBP. This analysis supports again the fact that thresholds applied for data selection 
which were defined on the basis of real model interactions are selective enough to omit most 
unspecific interactions with preservation of potential specific binding candidates.  
 
Table 3.5.7: Comparison of post-/pre-panning ratio values observed for specific interactions and those 
considered as non specific interaction (MBP). 
DKFZp761O0120Q clone 
peptides / panning  Post-/pre-panning ratio 
pep-Y / exp 1 72.875 
pep-Y / exp 2 81.375 
pep-Y / exp 3 99.0625 
107B 65.0937 
WW/YAP model protein 
pep-Y / exp 1 (f.c 1x105) 31.8076 
pep-Y / exp 2 (f.c 1x104) 26.8557 
EVH1 model protein 
pep-E / (f.c 1x104) a) 34.8  
FE65 model protein 
pep-F / (f.c 1x105) 33.627 
MBP (non specific) 
pep-F exp 1 15.5616 
Pep-F exp 2 15.4794 
a) Despite its non-specific interaction with the 25mer peptides (pep-F, pep-Y, pep-K), observed in 
these studies (section 3.5.7), the EVH1 domain was included in this table as its interaction with the 
pep-E ligand is highly specific (Niebuhr et al., 1997) 
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3.5.11 Conclusions 
Studies performed in this section for a selected number of target-peptides, confirmed a high 
potential of the microarray based approach for high-throughput performance of the entire 
process of a genome-wide mapping of peptide-mediated protein-protein interactions. 
Compared to the other approaches, more focused on certain types of peptide ligands (Salcini 
et al., 1997; Sparks et al., 1994; Tong et al., 2002) this approach here is particularly able to 
discover new families of peptide-recognizing protein domains from genome wide screenings. 
Several important requirements have been identified which have to be met in order to 
perform successful screening experiments. These include, highly representative genome 
spanning repertoires of peptide fragments, phage-based cDNA expression systems as well 
as microarray biochips which are optimally matching the screened phage libraries. Peptides 
can be selected from native ORF sequences, as described in this work, using the ASS 
software designed especially for this purpose. This approach narrows the complexity of 
possible peptide ligands down to those occurring in nature. Phage displayed repertoires of 
proteins/domains obtained from different tissues and organisms are offered by various 
companies (e.g. Novagen, NEB). However, studies performed here revealed that large 
percentage of proteins/fragments displayed as fusions with the phage coat proteins, 
corresponds to non coding, nonsense DNA fragments. Such contaminations contribute to 
undesirable high phage background. Therefore the quality issue of the protein repertoire is of 
high relevance and preparation of custom libraries should be carefully controlled. The 
microarrays compatible with the process described here are not available commercially and 
must be fabricated from appropriate full length cDNA libraries. Such libraries are currently 
generated and fully characterized by the cDNA consortium of the German NGFN and 
comprehensive collections will be soon available. The final aspect of the entire high-
throughput approach is the validation, segregation and storage of obtained data. A validation 
and statistical segregation process was developed in the context of this work, however more 
convenient databases and data mining tools must be found or developed in order to analyze 
and mine large amounts of data. 
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3.6 A novel structurally modified plastic surface for peptide 
synthesis and phage affinity selection 
To apply the developed peptide-based phage panning in a systematic genome-wide ORF-
scanning process would require the automation of as many steps as possible. High density 
arrays of peptide ligands attached to cellulose membranes have been successfully employed 
in this work for specific affinity selection of proteins displayed on a phage particle. However, 
utilization of peptides synthesized on such membranes requires separation (by cutting) of 
individual spots after the simultaneous multiple panning process and before the elution step. 
Otherwise, dissociated phages will diffuse to neighbouring spots and mix together. To avoid 
this, a novel structurally modified, non porous plastic surface (foil) was developed, which is 
suitable for spatially addressable peptide synthesis and phage elution (Patent DE 103 40 
429.5: Frank et al.). Hydrophobic barriers, between hydrophilic acrylamide-patches, that 
were graft-polymerized on a planar polypropylene sheet, are designed to prevent contact of 
liquids containing phage populations dissociated from different peptides (Fig 3.6.1). This 
feature will also allow for an automation of the entire selection process using robotic pipetting 
tools of different array formats (i.e. 48, 96) and subsequent robotic transfer and propagation 
of the eluted phage populations in compatible 48 or 96 deep well culturing blocks.  
 
Fig 3.6.1: Pictures showing a novel plastic surface suitable for peptide synthesis and phage affinity 
selection experiments.  
 
 
Aqueous medium for 
multiple affinity enrichment 
Organic medium for 
in situ synthesis 
2 mm 
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The main objective of this section was performance of various selection tests to study the 
binding abilities of phages displaying the three model protein domains (EVH1, WW/YAP, 
WW/FE65) to their corresponding peptides synthesized on this novel plastic surface. A 
series of patch arrays prepared with different chemistries all containing the model ligand 
peptide sequences (see Table 1.3.1 in section 1.3) were kindly provided by Dipl. Chem. Ing. 
Ulrike Beutling (personal communication GBF, Braunschweig). Initially, peptide arrays were 
subjected to phage affinity selection tests in order to choose the best performing one. 
Results described below were achieved using the UB194 array. For the preliminary tests, a 
solution containing high percentage of model phages was prepared by mixing them at a ratio 
of 1:100 with indifferent phages displaying mouse interleukin-4 (IL-4). Due to a high 
concentration of model phages within this mixture, large amounts of specifically bound 
phages were expected to be present within post-panning populations obtained from the 
peptide-patches. Before elution with guanidine solution, patches were cut out with the scalpel 
and placed in separate tubes, as described previously for the cellulose membranes (see 
2.2.4.5). Following plating of the phages on a bacterial lawn, ten clones corresponding to 
each peptide, were randomly chosen for DNA isolation process followed by PCR 
amplification of DNA inserts and analysis of their sizes by AGE (Fig 3.6.2).  
 
Fig 3.6.2: Ethidium bromide stained 1 % AGE analysis of DNA inserts from selected phages that were 
enriched on model peptides synthesized on the patched plastic surface after panning with model 
phages diluted in IL-4 phage at ratio 1:100. Short name code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); 
control (K); Interleukin-4 (IL-4); DNA markers: SMART (M1) (Eurogentec), XIII (M2) (Boehringer 
Mannheim); c/v correct/verified. 
 Pep-E Pep-F 
 Pep-Y Pep-K
E   E  
Y   
IL-4   E  
Array UB194: model phages diluted in IL-4 at ratio 1:100 
Total amounts of eluted phages  
Pep-E   2.5x104  pep-F   230  
Pep-Y   6.1x103           pep-K   250   
c/v 10/10      c/v 0/10   
c/v 10/10   
M2  M1  
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In general, much less phages were recovered from the patches as compared to the cellulose 
spots, which is expected as the resin material on the patches and the amount of immobilized 
peptides is also much less than the peptide/cellulose material of a spot (see Table 3.1.2 in 
section 3.1.2). Successful enrichment goes strict with a ten to one hundred fold increase in 
recovered phages: all phages obtained from the pep-E and pep-Y peptides contained the 
correct inserts. Quantity of phages eluted from the pep-F peptide resembled that from a 
control peptide (pep-K). Instead of the WW/FE65, only phages displaying the EVH1 domain 
were found within the population eluted from this peptide. Regarding the control peptide, 
phages displaying the IL-4 were expected to occur more frequently within the eluted 
population than the model phages, which were two folds of magnitude less represented 
within the pre-panning population. Nevertheless, phages displaying the EVH1 domain were 
also enriched on this patch. This supports the weak non-specific stickiness of the EVH1 
phages, either to peptides or to the plastic support as observed in the previous chapter. 
Nevertheless the fact that the WW/FE65 domain was not enriched on its peptide, even 
despite of its high concentration within pre-panning mixture was surprising and may be a 
result of obscuring the pep-F ligands with the high excess of sticky EVH1 phages. 
In order to test selection performances of the UB194 array when higher dilutions of model 
phages are applied, two additional pannings were carried out. New phage mixtures were 
prepared with the model phages diluted at ratios 1:103 and 1:104 in IL-4-phages. Panning and 
clone analysis were carried out as described above. As expected, higher dilutions of model 
phages resulted in slightly reduced amounts of phages eluted from their corresponding 
peptides, in both experiments. Phages recovered from pep-E, all contained DNA inserts 
characteristic for the EVH1 domain, in both experiments (Fig 3.6.3). Enrichment of phages 
displaying the WW/YAP domain on its peptide became less efficient, but still acceptable and 
is in agreement with previous results (see section 3.1). Eight and five correct inserts were 
found among ten analyzed clones for each experiment, respectively. Again it was observed 
that no WW/FE65 phage was enriched on its pep-F ligand. Analysis of phages recovered 
from panning with the 1:103 mixture on the pep-F revealed seven clones containing inserts 
coding for the EVH1 domain and three clones containing inserts coding for IL-4. Only five 
phages in total, displaying only IL-4, were obtained from this peptide patch in the case of the 
1:104 mixtures. Obviously, the stickiness of the EVH1 phages is strictly concentration 
dependent and falls beyond the detection limit of the clone analysis method used. It is 
assumed that it will be still detectable with the more sensitive differential array method of the 
previous chapter. Only a few phages were eluted from the control peptides in both 
experiments when the sticky EVH1 phages are more diluted (Fig 3.6.3).   
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Fig 3.6.3: Ethidium bromide stained 1 % AGE analysis of DNA inserts from selected phages enriched 
on model peptides (10-15 aa) synthesized on patched plastic surface, after panning with the model 
phages diluted in IL-4 phage at ratios 1:103 and 1:104. Short name code: EVH1 (E), WW/FE65 (F); 
WW/YAP (Y); control (K); Interleukin-4 (IL-4); DNA markers: SMART (M1) (Eurogentec), XIII (M2) 
(Boehringer Mannheim); c/v correct/verified.  
Pep-E  Pep-F Pep-Y Pep-K  
Array UB194: model phages diluted in IL-4 at ratio 1:103 
c/v 10/10   c/v 0/10  c/v 8/10  
Total amounts of eluted phages: 
Pep-E   6.83x103    pep-F   243   
Pep-Y   4.32x103         pep-K   5 
  E    E  IL-4  IL-4   IL-4  
Y  
M1   M1  
M2  M2  
  M2   M1   
 pep-E  pep-F pep-Y     Pep--K  
Array UB194: model phages diluted in IL-4 at ratio 1:104 
c/v 10/10   c/v 0/5  c/v 5/10  
Total amounts of eluted phages: 
Pep-E   4.6x103        pep-F   5    
pep-Y   2.1x103          pep-K   2 
  M2   M2  
M1   M1   
  E   IL-4  
Y  
IL-4   IL-4  
 M1     M2   
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It could be argued that the observed failure in enrichment of the WW/FE65 could be due to 
either incorrect synthesis of its target peptide on the plastic surface or failure in display of 
functional protein domain on a phage particle caused by mutations within the phage 
chromosome. In order to check these possibilities, a similar control panning experiment 
utilizing the same model peptides synthesized on cellulose membrane was carried out as 
previously. Model phages were diluted again in IL-4-phage at ratio 1:103. As expected, 
amounts of peptide-spot eluted phages were higher than those observed for the patch arrays 
(Fig 3.6.4).  
 
Fig 3.6.4: Ethidium bromide stained 1 % AGE analysis of DNA inserts from selected phages enriched 
on model peptides (10-15 aa) synthesized on cellulose membrane, after panning with model phages 
diluted in IL-4 at ratio 1:103. Short name code: EVH1 (E), WW/FE65 (F); WW/YAP (Y); control (K); 
Interleukin-4 (IL-4); DNA markers: SMART (M1) (Eurogentec), XIII (M2) (Boehringer Mannheim); c/v 
correct/verified.  
 
Very efficient and specific enrichment of the EVH1 phages on their peptide-ligand (pep-E) 
was observed as before. Similarly, eight among ten phages achieved from pep-Y contained 
correct WW/YAP inserts. The remaining two phages displayed the EVH1 domain. Seven 
WW/FE65 phages were eluted from pep-F, although, three were presenting the EVH1 
domain which clearly proves that the WW/FE65 domain is correctly displayed on a phage 
particle as a functional protein and rules out a failure of the patch enrichment because of 
non-presentation. The EVH1 phages were also found on the control spot, which confirms 
once more that these phages have some stickiness to other peptides or solid supports when 
occurring in higher concentrations in the panning libraries.  
   M2  Pep-E  Pep-F Pep-Y Pep-K  
 Y  
  E    E  
 Y  
  E   E  
M1   
F  
c/v 7/10  c/v 8/10  c/v 10/10   
Total amounts of eluted phages: 
pep-E   4.1x104   pep-F   2.1x104 
Pep-Y   4.05x104  pep-K   5.12x103 
Cellulose 10-15 aa pep: model phages diluted in IL-4 at ratio 1:103 
  M2   M1   
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The performance of the patch array was compared with the respective experiments on 
cellulose spots by inspection of phage enrichment factors (see Table 3.6.1), calculated for 
the above bio-pannings, 1:103 (patches and cellulose) and 1:104 (patches) and the 1:104 bio-
panning described in section 3.1.2 (Table 3.1.3).  
Except for the WW/FE65 phages, which were not successfully enriched on the patch arrays, 
a comparable enrichment was revealed for peptides pep-E and pep-Y in both cases when 
mixtures 1:103 were applied for screening. In the case of bio-pannings with the mixture 
containing higher diluted model phages (1:104), performance of the patch array seemed even 
better, but more experiments need to be carried out in order to provide a reliable statistical 
comparison. The efficiency of phage enrichment on peptides synthesized on the patch 
support is very satisfactory. The advantage of this new type of non porous support is 
resulting reduction of total number of eluted phages with preservation of their specificity at 
the same time. Obviously, less phages that are irrelevant for binding to peptides are trapped 
on this solid support. This will be beneficial for future applications of such peptide arrays for 
large scale genome and proteome mapping processes.  
 
Table 3.6.1: Comparison of enrichment factors calculated for phages selected on model peptides 
synthesized on acrylamide-patches and cellulose spots  
Domain Peptide Acrylamide-patches UB194 Cellulose spots 
Dilution ratio of model phages   
1:103 1:104 1:103 1:104 (Table 3.1.3)
  enrichment factors 
EVH1 pep-E 1000 10000 1000 5250 
WW FE65 pep-F 0 0 700 750 
WW YAP pep-Y 800 5000 800 4400 
 
 
A further explanation for the failure of enriching WW/FE65 phages on the plastic patch bound 
pep-F could be a lower local density of the immobilized peptide compared to the peptide 
density on a cellulose spot leading to a reduced avidity in binding the multivalent T7 phages. 
Improvement of the process for patch generation, allowing a higher specific functionalization 
is in progress. Apart from the non-successful selection on the peptide-ligand pep-F 
synthesized on UB194 foil, the amounts of eluted phages, as well as selection specificities 
and enrichment factors observed for the two remaining peptides were very promising. A 
general lower amount of eluted phages, especially documented by the control and F 
peptides, suggested a significant reduction of unspecific background on this non-porous 
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surface. Nevertheless, more tests must be performed in order to prove a superior 
performance of this new type of peptide array.  
Some important preliminary tests with a modified phage elution step using small volumes of 
1 M guanidine solutions (2 – 5 µl) (Bialek, personal communication, GBF) added directly to 
the patches on the array, showed that these new peptide arrays are suitable for 
simultaneous parallel elution of phage populations from hydrophilic peptide patches 
separated via hydrophobic barriers. Future optimization of an elution protocol will allow for 
utilization of pipetting robots and high-throughput performance of the entire screening 
process. This promises an important role of the non-porous plastic surface in an automated 
panning process. Most of the other experimental steps in the screening process described in 
this thesis have been now implemented into high throughput screening formats using 
simultaneous parallel array methods and are carried out by only very few operations. These 
include the well established semi-automated peptide-SPOT synthesis method, as well as the 
massive production of cDNA biochips, both provide tools that are necessary for this 
approach and qualified to the repertoire of functional genomics and proteomics approaches. 
Similarly, the spot-wise parallel transfer of enriched phage populations from the peptide array 
sites to the DNA array analysis requires a series of standard operations, which need to be 
carried out by robotic instrumentation and evaluated by appropriate software in order to 
achieve an adequate throughput. Ultimately, a fully automated performance will definitely 
improve the quality and reliability of the whole process. 
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4. Conclusions and future prospects 
This doctoral work aimed to establish a convenient methodology for the genome-wide 
mapping of interactions between protein domains and peptide ligands. The basic concept of 
a peptide array-based multiplexed affinity enrichment of protein domains displayed on 
bacteriophage capsids was successfully applied to three model domains and their respective 
known peptide ligands. Experimental comparisons of enrichment efficiencies of the model 
proteins using two different phage display systems, lambda and T7, clearly favored the T7 
phage as more suitable for purposes of this project. Several different approaches were 
stepwise evaluated during this work, in order to find a suitable methodology for identification 
of phages specifically enriched on target peptides. These steps include the classical analysis 
of phage clones based on PCR, AGE and DNA sequencing, as well as the more 
sophisticated template assisted iterative screening (TAIS) methodology. None of these 
approaches, however, provided a satisfactory performance when used in the context of a 
highly diverse phage display library screened versus an array of peptides immobilized on a 
cellulose membrane. Finally, a combination of three well characterized methodologies led to 
an effective process, entirely based on high-throughput biochip technologies. In the first step 
of this process, a phage display library of protein domains will be “panned” over repertoires 
of synthetic peptides immobilized as arrays on a solid support. Due to the advantageous 
feature of phage display technology, which is a physical linkage of phenotype with genotype, 
displayed proteins/domains will be identified via differential hybridization of their labeled 
pre- and post-panning DNA inserts with an array of complementary DNA-probe sequences 
printed on a modified glass surface. Differences between the amounts of DNA inserts within 
both populations will be reflected by different values of fluorescent signal intensities, 
achieved from DNA spots after the hybridization process. Overrepresentation of certain open 
reading frame (ORF) DNA inserts within the post-panning population with respect to the 
pre-panning population will indicate enrichment of the expressed protein presented on the 
phage capsid. This process was successfully implemented for the three model domains. A 
special mode of microarray data analysis, based on restrictive thresholds and statistical 
biochip comparisons, was developed to distinguish between specifically and non-specifically 
bound candidates. Using this approach, screening of the entire human brain phage display 
cDNA library, succeeded in selection and identification of WW domain containing proteins 
(AIP4, AIP5), interacting specifically with proline-rich target peptides covalently attached to 
the cellulose membrane. Although information obtained from such screenings still needs to 
be validated for real biological evidence by using independent methodologies, the developed 
process was shown to narrow a large population of phage displayed proteins down to a 
sub-set containing meaningful potential binding partners.  
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The developed process can be applied to diverse types of libraries, prepared from DNA or 
cDNA preparations of tissues or organisms of healthy or pathogenic origin, to be screened 
against any type of dedicated or non-dedicated peptide repertoires. Identification of novel 
interactions will support the elucidation of a potential biological function of both interacting 
proteins and could help to address these to certain signaling pathways or biochemical 
processes. Modern bioinformatics tools based on database searching and analysis of protein 
networks greatly enhanced the profiling of potential relations between identified partners and 
other proteins that are part of interaction networks connected to a certain biological process.  
To achieve the anticipated genome-wide mapping of peptide-mediated protein-protein 
interactions, an advanced high-throughput performance of the process is highly desirable. 
One of the requirements of such a process is an optimized design of peptide arrays. Generic 
peptide libraries as well as a genome-wide overlapping peptide scan covering all (e.g. 
human) ORFs would be adequate peptide collections for this approach, but these could be 
too large for paractical work. On the other hand, utilizing combinatorial search strategies, 
less voluminous libraries of partially randomized peptide pools (103-106 components) with 
built-in information about recognition motives could be applied to reduce the number of 
peptide preparations. In this work, a significant reduction of the number of peptides for an 
ORF scanning approach was achieved by application of an Accessible Surface Scanner 
software tool (ASS). The underlying algorithm was developed for prediction of surface 
exposed continuous, peptidic segments which are considered to posess the binding sites 
responsible for interaction with other proteins. Sequences predicted as buried within the core 
of a protein were assumed to be irrelevant for binding to other protein domains and therefore 
eliminated. Analyses of several protein sequence containing known, linear recognition motifs 
responsible for binding to various protein modules revealed that in the majority of cases, 
these motifs were correctly predicted by the ASS software tool as surface exposed. 
Subsequently, in vitro phage selection experiments performed on peptides selected with the 
help this software, proved its acceptable performance. Moreover, ASS allows for rapid 
simultaneous processing of thousands of protein sequences retrieved from data bases. 
Compatibility of peptide output data with the software that is controlling the robotic peptide 
synthesis process is another advantageous feature supporting the high performance of the 
entire process.  
A second requirement for an advanced genome spanning protein interaction screening 
process is its automation. Many steps that are important for preparation of materials 
necessary for screenings are already performed by robotic systems, including SPOT peptide 
synthesis and fabrication of DNA microarray biochips. Thus, the automation of the phage 
affinity selection process would be highly desirable. A first step toward this goal was the 
successful evaluation of a novel structurally modified, non porous plastic surface, which is 
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suitable for a spatially addressable peptide synthesis and simultaneous multiple phage 
panning. The structure of this array provides peptides synthesized on hydrophilic patches 
surrounded by hydrophobic barriers. This allows for automatic post-panning elution of the 
enriched phage populations, excluding contact and mutual contamination of phage 
containing liquids from neighbouring peptide patches. Automation of panning and elution 
steps would result in a rapid increase of process performance and generation of large 
amounts of data. Model peptides synthesized on this new support were successfully used for 
specific phage enrichment. These studies revealed significant advantages of the new 
peptide array over the classical cellulose support for peptide arrays synthesis. Proposals for 
further improvements of this new type of peptide array have been worked out. Finally, design 
and development of suitable databases for data storage, as well as sophisticated 
bioinformatics tools for data mining and comparison are next in the line for the future work 
and have to be advanced in order to reach a fully automated and functional high-throughput 
methodology for peptide-based proteome mapping.  
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6. Appendix 
Appendix 1 
Parameters used for printing the amygdala biochips using Micro Grid II mictoarrayer 
(Biorobotics).  
 
[Parameters] 
RunType=MicroArray 
BarcodesEnabled=0 
HaltBarcodes=1 
CacheBarcodes=0 
ClearBarcodes=0 
WhereBarcodes=1 
ExpectedBarcode1=[Unknown] 
ExpectedBarcode2= 
ExpectedBarcode3= 
ExpectedBarcode4= 
ExpectedBarcode5= 
ExpectedBarcode6= 
ExpectedBarcode7= 
ExpectedBarcode8= 
ExpectedBarcode9= 
ExpectedBarcode10= 
ExpectedBarcode11= 
ExpectedBarcode12= 
ExpectedBarcode13= 
ExpectedBarcode14= 
ExpectedBarcode15= 
ExpectedBarcode16= 
ExpectedBarcode17= 
ReloadPins=1 
NumSourcePlates=17 
WashAfterEveryVisit=1 
WashAfterEverySample=0 
RequestLogInfo=0 
SourcePlate=384standardb.microplate 
ToolType=4x4 384 split.tool 
PromptPlates=0 
PromptPlatesInterval=1 
SourceWiggle=0 
SourceDibble=0 
RemoveOneLid=1 
TargetDip=0 
TargetWiggle=0 
SoftTouchDistance=0.300000011920929 
SoftTouchSpeed=4 
DelayBefore=0 
TargetDwell=0 
DelayAfterSpotting=0 
MultiStrikes=1 
SoftTouch=0 
TargetDepth=0.300000011920929 
ILayout=0 
PrespotRecycle=0 
UseCamera=0 
Microplates=1 
PreSpot=1 
SlideSize=25 
NumSamples=391 
LastPlateVisits=7 
SpotsPerSource=57 
AdapterPlate=slidesvertical extra.adapter 
AdapterPlate2=slidesvertical extra.adapter 
[PinGrid] 
XSpots=20 
YSpots=20 
Line0=385, 386, 387, 388, 389, 390, 134, 154, 174, 194, 214, 234, 254, 274, 294, 314, 334, 354, 374, 0,   
Line1=19, 38, 57, 76, 95, 114, 133, 153, 173, 193, 213, 233, 253, 273, 293, 313, 333, 353, 373, 0,   
Line2=18, 37, 56, 75, 94, 113, 132, 152, 172, 192, 212, 232, 252, 272, 292, 312, 332, 352, 372, 0,   
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Line3=17, 36, 55, 74, 93, 112, 131, 151, 171, 191, 211, 231, 251, 271, 291, 311, 331, 351, 371, 391,   
Line4=16, 35, 54, 73, 92, 111, 130, 150, 170, 190, 210, 230, 250, 270, 290, 310, 330, 350, 370, 390,   
Line5=15, 34, 53, 72, 91, 110, 129, 149, 169, 189, 209, 229, 249, 269, 289, 309, 329, 349, 369, 389,   
Line6=14, 33, 52, 71, 90, 109, 128, 148, 168, 188, 208, 228, 248, 268, 288, 308, 328, 348, 368, 388,   
Line7=13, 32, 51, 70, 89, 108, 127, 147, 167, 187, 207, 227, 247, 267, 287, 307, 327, 347, 367, 387,   
 
Line8=12, 31, 50, 69, 88, 107, 126, 146, 166, 186, 206, 226, 246, 266, 286, 306, 326, 346, 366, 386,   
Line9=11, 30, 49, 68, 87, 106, 125, 145, 165, 185, 205, 225, 245, 265, 285, 305, 325, 345, 365, 385,   
Line10=10, 29, 48, 67, 86, 105, 124, 144, 164, 184, 204, 224, 244, 264, 284, 304, 324, 344, 364, 384,   
Line11=9, 28, 47, 66, 85, 104, 123, 143, 163, 183, 203, 223, 243, 263, 283, 303, 323, 343, 363, 383,   
Line12=8, 27, 46, 65, 84, 103, 122, 142, 162, 182, 202, 222, 242, 262, 282, 302, 322, 342, 362, 382,   
Line13=7, 26, 45, 64, 83, 102, 121, 141, 161, 181, 201, 221, 241, 261, 281, 301, 321, 341, 361, 381,   
Line14=6, 25, 44, 63, 82, 101, 120, 140, 160, 180, 200, 220, 240, 260, 280, 300, 320, 340, 360, 380,   
Line15=5, 24, 43, 62, 81, 100, 119, 139, 159, 179, 199, 219, 239, 259, 279, 299, 319, 339, 359, 379,   
Line16=4, 23, 42, 61, 80, 99, 118, 138, 158, 178, 198, 218, 238, 258, 278, 298, 318, 338, 358, 378,   
Line17=3, 22, 41, 60, 79, 98, 117, 137, 157, 177, 197, 217, 237, 257, 277, 297, 317, 337, 357, 377,   
Line18=2, 21, 40, 59, 78, 97, 116, 136, 156, 176, 196, 216, 236, 256, 276, 296, 316, 336, 356, 376,   
Line19=1, 20, 39, 58, 77, 96, 115, 135, 155, 175, 195, 215, 235, 255, 275, 295, 315, 335, 355, 375,   
NthOrder=1 
PatternFormat=2 
ToolGridIndex=1, 1,   
Splice=0 
Pitch=0.215000003576279 
NumCopies=58 
[SlideLayout] 
BottomMargin=19.7000007629395 
CentreHoriz=0 
CentreVert=0 
TopMargin=0.519999980926514 
LeftMargin=3.45000004768372 
RightMargin=3.45000004768372 
XSpacing=2 
YSpacing=2 
[Wash] 
InterCycleDelay=5.5 
LeftSeconds=2 
RightSeconds=2 
DrySeconds=2 
VacuumEnabled=1 
Cycles=2 
MWSCycles=3 
[RunPrefs] 
PrintReplicatesFirst=0 
SourceDipTop=0 
SourceDipBottom=0 
TargetDipTop=0 
TargetDipBottom=0 
VisionID= 
BioBankID=DEFAULT 
IOControl=0 
Bath12ZOffset=0 
Bath3ZOffset=0 
FeatureOffsetX=0 
FeatureOffsetY=0 
HumidStartRate=63 
HumidRunRate=58 
TargetHumidity=126 
MinHumidity=99 
UseHumidityControl=0 
UseHumidityHEPA=0 
PauseHumidity=0 
EndHumidityOn=0 
PrimeBath=1 
AskLoadTool=1 
WashAtStart=1 
WashAtEnd=1 
AskBioBank=1 
AskTrays=1 
SourceDwellTime=0.5 
TargetDwellTime=1 
SourceWiggles=0 
SourceWiggleSize=0.25 
SourceDips=1 
SourceDipSize=2 
TargetWiggles=0 
TargetWiggleSize=0.25 
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TargetDips=0 
TargetDipSize=2 
SourceDepth=-0.5 
TargetDepth=0 
BathFillTime=2 
BathDrainTime=2.5 
RecirculateAction=1 
RecirculateStatic=0 
RecirculateWiggleSize=2 
RecirculateDipSize=1 
BlotFirstTimes=1 
BlotFirstSlides=10 
CacheBarcodes=1 
HaltNoWater=1 
BathWiggles=4 
BathWiggleSize=0 
HeaterOnTime=0 
HeaterOffTime=0 
HeaterCoolTime=0 
SourceSoftTouchSpeed=4 
TargetSoftTouchSpeed=4 
SourceSoftTouchEnabled=1 
TargetSoftTouchEnabled=0 
SourceSoftTouchDistance=8 
TargetSoftTouchDistance=1 
[PreSpotLayout] 
BottomMargin=1.41999995708466 
CentreHoriz=0 
CentreVert=0 
TopMargin=0.990000009536743 
LeftMargin=3.40000009536743 
RightMargin=3.40000009536743 
XSpacing=0 
YSpacing=0 
ToolGridIndex=1, 2, 3, 4,   
Splice=0 
[PreSpotting] 
Pitch=0.300000011920929 
SoftTouchDistance=0.300000011920929 
SoftTouchSpeed=4 
DelayBefore=0 
TargetDwell=0 
DelayAfterSpotting=0 
MultiStrikes=1 
SoftTouch=0 
TargetDepth=0.300000011920929 
ISoftTouchDistance=0 
ISoftTouchSpeed=0 
IPitch=0 
IDelayBefore=1 
ITargetDwell=1 
IDelayAfterSpotting=1 
IMultiStrikes=1 
ISoftTouch=0 
ITargetDepth=1 
[LogFile] 
Operator_name*=_ 
Library=_ 
Gridding_Number=_ 
Set_Number=_ 
Replica_Number=_ 
Date=_ 
Time=_  
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Appendix 2 
List of 98 human proteins and their mouse homologs, as well as 14 KIAA proteins, chosen 
for peptide preparation using ASS software and chemical synthesis on cellulose membranes. 
 
Mouse Human Mouse  Human Mouse  Human 
gi|10946574 gi|17939432 gi|19527234 gi|12052851 gi|6685763 gi|19264127 
gi|12018296 gi|19684120 gi|19527238 gi|13676377 gi|6685997 gi|3386485 
gi|12746424 gi|12804042 gi|19527258 gi|7160984 gi|20867606 gi|15559431 
gi|12805413 gi|14286219  gi|19527306 gi|1906008 gi|20873704 gi|183369 
gi|12805431 gi|12653340  gi|20341045 gi|563885  gi|20877156 gi|12654186 
gi|12844082 gi|14705275 gi|20341854 gi|12653396  gi|21311919 gi|14424792 
gi|12845889 gi|13278740 gi|20343963 gi|2065176  gi|21312004 gi|297901 
gi|12849017 gi|9963840 gi|20820655 gi|14250498  gi|6753050 gi|19584409 
gi|12850132 gi|12803908 gi|20821322 gi|20521841 gi|6753676 gi|2967518 
gi|12858691 gi|14250078 gi|20830475 gi|12653600 gi|6754974 gi|20521899 
gi|12963653 gi|12804092 gi|20832179 gi|13477172 gi|6755682 gi|16356636 
gi|12963697 gi|12052958 gi|20833478 gi|1869811  gi|6755714 gi|2335046 
gi|13384704 gi|15559275  gi|20833765 gi|19913486  gi|6755995 gi|12803340 
gi|13384746 gi|285902  gi|20837251 gi|15277483 gi|6756039 gi|23221 
gi|13384810 gi|23274139  gi|20840384 gi|18043711 gi|7022124 gi|7022123 
gi|13385500 gi|13938546 gi|20844633 gi|7020550  gi|7305061 gi|18089153 
gi|13386156 gi|183300  gi|20863245| gi|16307524 gi|7656991 gi|5701730 
gi|13592137 gi|24660071  gi|20880590 gi|12654886  gi|7710102 gi|6934239 
gi|13637964 gi|29635 gi|20882495 gi|14250348  gi|8217551 gi|2921407 
gi|13905144 gi|23272131  gi|20889057 gi|14279193 gi|9790219 gi|415586 
gi|13929082 gi|1946348 gi|20901301 gi|3378167 KIAA  
gi|14043149 gi|14043148 gi|20909498 gi|1504033 gi|20520995  
gi|1407651 gi|2407912 gi|20909548 gi|21755897 gi|20520999  
gi|14777622 gi|182190  gi|20910093 gi|2282031 gi|20521017  
gi|15990388 gi|17391416 gi|20912095 gi|19070131 gi|20521013  
gi|16758814| gi|1809264 gi|20912830 gi|312823 gi|20521031  
gi|1730217 gi|2570403 gi|20978553 gi|13278911 gi|20521051  
gi|17390379 gi|15214594  gi|23879 gi|17389605 gi|20521039  
gi|17390865 gi|15082295  gi|2497503 gi|1463025 gi|20521041  
gi|17865671 gi|13529265  gi|3122018 gi|2967518 gi|20521045  
gi|18201867 gi|18448714 gi|3122037 gi|2342485 gi|20521049  
gi|18202285 gi|31107  gi|346651 gi|21104443 gi|20521067  
gi|18490449 gi|15866713 gi|3810884 gi|1944339 gi|20521069  
gi|18702315 gi|1463025  gi|487855 gi|181848 gi|20521071  
gi|14198445 gi|12653166 gi|6679140 gi|21040483 gi|20521075  
gi|19424252 gi|3281993 gi|6679573  gi|190749   
gi|19526884 gi|13938606  gi|6680137 gi|1513314   
gi|19526926 gi|12052735 gi|6680908 gi|13477282   
gi|19527010 gi|13543435 gi|6680924 gi|15126675   
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Appendix 3 
List of peptides from membrane No.1, used for high-throughout panning with T7 phage 
display library as well as average amounts of phages individually eluted from each peptide-
spot.  
 
Plate 
position 
Peptide sequence Gi code Amounts of 
eluted phages 
PL1 A1 SAHNNHMAKVLTPELYAELRAKSTP gi17939432 1.41E+06 
PL1 A2 GDEESYEVFKDLFDPIIEDRHGGYK  3.05E+06 
PL1 A3 IIEDRHGGYKPSDEHKTDLNPDNLQ  3.09E+06 
PL1 A4 KTDLNPDNLQGGDDLDPNYVLSSRV  2.78E+06 
PL1 A5 RVRTGRSIRGFCLPPHCSRGERRAI  5.28E+06 
PL1 A6 YYALKSMTEAEQQQLIDDHFLFDKP  1.44E+06 
PL1 A7 MARDWPDARGIWHNDNKTFLVWVNE  2.25E+06 
PL1 A8 NKTFLVWVNEEDHLRVISMQKGGNM  2.87E+06 
PL1 A9 FCTGLTQIETLFKSKDYEFMWNPHL  8.40E+05 
PL1 A10 KLPNLGKHEKFSEVLKRLRLQKRGT  5.42E+06 
PL1 A11 VVDGVKLLIEMEQRLEQGQAIDDLM  1.08E+06 
PL1 A12 YIDSKFEDYLNAESRVNRRQMPDNR gi19684120 3.00E+05 
PL1 B1 QEHKIKIYEFPETDDEEENKLVKKI  6.45E+05 
PL1 B2 HYENYRSRKLAAVTYNGVDNNKNKG  2.01E+06 
PL1 B3 VDNNKNKGQLTKSPLAQMEEERREH  1.22E+06 
PL1 B4 QKLKDSEAELQRRHEQMKKNLEAQH  7.50E+05 
PL1 B5 QMKKNLEAQHKELEEKRRQFEDEKA  7.05E+05 
PL1 B6 ANWEAQQRILEQQNSSRTLEKNKKK  6.75E+05 
PL1 B7 VLPDKETSLVDAYEKCRGLADPKVC gi12804042 1.71E+06 
PL1 B8 REKGVNSFQMFMTYKDLYMLRDSEL  2.39E+06 
PL1 B9 GIEISRPEELEAEATHRVITIANRT  1.31E+06 
PL1 B10 ETTTAHATLTGLHYYHQDWSHAAAY  2.09E+06 
PL1 B11 HQDWSHAAAYVTVPPLRLDTNTSTY  2.63E+06 
PL1 B12 ASDHRPFTTKQKAMGKEDFTKIPHG  3.14E+06 
PL1 C1 GKMDENRFVAVTSSNAAKLLNLYPR  1.04E+06 
PL1 C2 NLYPRKGRIIPGADADVVVWDPEAT  1.13E+06 
PL1 C3 RSFPDTVYKKLVQREKTLKVRGVDR  7.05E+06 
PL1 C4 KVRGVDRTPYLGDVAVVVHPGKKEM  3.14E+06 
PL1 C5 EMGTPLADTPTRPVTRHGGMRDLHE  4.80E+05 
PL1 C6 MRDLHESSFSLSGSQIDDHVPKRAS  2.10E+05 
PL1 C7 FEYIIAEKRGKNNTVGLIQLNRPKA gi14286219 6.45E+05 
PL1 C8 MQNLSFQDCYSSKFLKHWDHLTQVK  1.80E+05 
PL1 C9 GEKAQFAQPEILIGTIPGAGGTQRL  7.50E+04 
PL1 C10 TRAVGKSLAMEMVLTGDRISAQDAK  1.50E+05 
PL1 C11 AFEMTLTEGSKLEKKLFYSTFATDD  1.20E+05 
PL1 C12 LFYSTFATDDRKEGMTAFVEKRKAN  3.90E+05 
PL1 D1 LVRRPLREVSGLLKRRFHWTAPAAL gi12653340 4.74E+06 
PL1 D2 NQGMDEELERDEKVFLLGEEVAQYD  3.60E+05 
PL1 D3 EEVAQYDGAYKVSRGLWKKYGDKRI  6.90E+05 
PL1 D4 SAAKTYYMSGGLQPVPIVFRGPNGA  4.05E+05 
PL1 D5 LKVVSPWNSEDAKGLIKSAIRDNNP  2.10E+05 
PL1 D6 FEFPPEAQSKDFLIPIGKAKIERQG  1.50E+05 
PL1 D7 RGAGQQQSQEMMEVDRRVESEESGD gi14705275 1.50E+05 
PL1 D8 RRVESEESGDEEGKKHSSGIVADLS  2.10E+05 
PL1 D9 ADLSEQSLKDGEERGEEDPEEEHEL  4.50E+04 
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Plate 
position 
Peptide sequence Gi code Amounts of 
eluted phages 
PL1 D10 EEDPEEEHELPVDMETINLDRDAED  4.20E+05 
PL1 D11 NLEELQSLRELDLYDNQIKKIENLE  5.40E+05 
PL1 D12 GLENNNKLTMLDIASNRIKKIENIS  1.49E+06 
PL1 E1 LKGARSLETVYLERNPLQKDPQYRR  1.61E+06 
PL1 E2 ADSRATAGAYIASQTVKKVIEINPY gi13278740 6.60E+05 
PL1 E3 YELRNKERISVAAASKLLANMVYQY  1.50E+06 
PL1 E4 GWDKRGPGLYYVDSEGNRISGATFS  1.95E+05 
PL1 E5 MDRGYSYDLEVEQAYDLARRAIYQA  1.65E+05 
PL1 E6 DLARRAIYQATYRDAYSGGAVNLYH  7.50E+04 
PL1 E7 LYHVREDGWIRVSSDNVADLHEKYS  6.00E+04 
PL1 E8 RNPRKKAAKELRLQGAEVVQGDQDD gi9963840 6.00E+06 
PL1 E9 NYWESCSQEQEVKQGKLLADLARRL  1.50E+04 
PL1 E10 NIKKLTAGRLAAAHFDGKGEVEEYF  1.31E+06 
PL1 E11 HFLPQKAPDGKSYLLSLPTGDVPMD  1.65E+05 
PL1 E12 LKMPEKYVGQNIGLSTCRHTAEEYA  1.35E+05 
PL1 F1 TKHTRKVVHDAKMTPEDYEKLGFPG  1.86E+06 
PL1 F2 DLANMFRFYALRPDRDIELTLRLNP  1.65E+05 
PL1 F3 DIELTLRLNPKALTLDQWLEQHKGD  9.00E+04 
PL1 F4 AERQEALREFVAVTGAEEDRARFFL gi12803908 2.55E+05 
PL1 F5 LIHDQDEDEEEEEGQRFYAGGSERS  4.50E+04 
PL1 F6 RFYAGGSERSGQQIVGPPRKKSPNE  1.76E+06 
PL1 F7 GAKEHGAVAVERVTKSPGETSKPRP  1.95E+05 
PL1 F8 YRLGAAPEEESAYVAGEKRQHSSQD  2.55E+05 
PL1 F9 DNGELRSYQDPSNAQFLESIRRGEV  1.80E+05 
PL1 F10 DMEDHRDEDFVKPKGAFKAFTGEGQ  3.15E+05 
PL1 F11 SPAQQAENEAKASSSILIDESEPTT  3.30E+05 
PL1 F12 ETVADTRRLITKPQNLNDAYGPPSN gi14250078 1.65E+05 
PL1 G1 KLKESTVRRRYSDFEWLRSELERES  1.46E+06 
PL1 G2 LPFRGDDGIFDDNFIEERKQGLEQF  6.15E+05 
PL1 G3 LAQNERCLHMFLQDEIIDKSYTPSK  3.00E+05 
PL1 G4 DEEKLPPGWEKRMSRSSGRVYYFNH  5.55E+05 
PL1 G5 TNASQWERPSGNSSSGGKNGQGEPA  3.00E+04 
PL1 G6 LVKHSQSRRPSSWRQEKITRTKEEA  3.71E+06 
PL1 G7 SRFWEWGKNIVCVGRNYADHVREMR gi12052958 2.25E+05 
PL1 G8 KPSTAYAPEGSPILMPAYTRNLHHE  2.25E+05 
PL1 G9 DMTARDVQDECKKKGLPWTLAKSFT  3.90E+05 
PL1 G10 SFTASCPVSAFVPKEKIPDPHKLKL  2.55E+05 
PL1 G11 KIPDPHKLKLWLKVNGELRQEGETS  1.05E+06 
PL1 G12 GPVKENDEIEAGIHGLVSMTFKVEK  1.35E+05 
PL1 H1 SRPPPPRVASVLGTMEMGRRMDAPA gi15559275 2.10E+05 
PL1 H2 RAFLERGHTELDTAFMYSDGQSETI  3.30E+05 
PL1 H3 ATKANPWDGKSLKPDSVRSQLETSL  2.10E+05 
PL1 H4 KSNGWILPTVYQGMYNATTRQVETE  1.05E+05 
PL1 H5 LLTGKYKYEDKDGKQPVGRFFGNSW  5.85E+05 
PL1 H6 PVGRFFGNSWAETYRNRFWKEHHFE  1.50E+04 
PL1 H7 SLEQLEQNLAATEEGPLEPAVVDAF  2.70E+05 
PL1 H8 TSKGPEEEHPSVTLFRQYLRIRTVQ gi285902 1.80E+05 
PL1 H9 QYLRIRTVQPKPDYGAAVAFFEETA  4.20E+05 
PL1 H10 KEHWSHDPFEAFKDSEGYIYARGAQ  3.90E+05 
PL1 H11 FVPDEEVGGHQGMELFVQRPEFHAL  4.50E+05 
PL1 H12 FYSERSPWWVRVTSTGRPGHASRFM  5.55E+05 
PL2 A1 AFREKEWQRLQSNPHLKEGSVTSVN  4.95E+05 
PL2 A2 ATMSASFDFRVAPDVDFKAFEEQLQ  9.00E+04 
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PL2 A3 EGVTLEFAQKWMHPQVTPTDDSNPW  2.55E+05 
PL2 A4 AATDNRYIRAVGVPALGFSPMNRTP  1.35E+05 
PL2 A5 LGFSPMNRTPVLLHDHDERLHEAVF  1.50E+05 
PL2 A6 FRKHTQAEGKKLGLVGWVQNTDRGT gi23274139 1.98E+06 
PL2 A7 VRHMQEWLETRGSPKSHIDKANFNN  7.20E+05 
PL2 A8 QGSSDPEEESVLYSNRAACHLKDGN gi13938546 9.00E+04 
PL2 A9 VSAQKRWNSLPSENHKEMAKSKSKE  9.15E+05 
PL2 A10 KEMAKSKSKETTATKNRVPSAGDVE  2.25E+05 
PL2 A11 ARVLKEEGNELVKKGNHKKAIEKYS  2.25E+05 
PL2 A12 LKQYTEAVKDCTEALKLDGKNVKAF  1.50E+04 
PL2 B1 LDGKNVKAFYRRAQAHKALKDYKSS  1.85E+06 
PL2 B2 FADISNLLQIEPRNGPAQKLRQEVK  1.35E+05 
PL2 B3 LEYTDSSYEEKKYTMGDAPDYDRSQ gi183300 8.10E+05 
PL2 B4 GDAPDYDRSQWLNEKFKLGLDFPNL  3.00E+04 
PL2 B5 CGESEKEQIREDILENQFMDSRMQL  4.50E+04 
PL2 B6 QFMDSRMQLAKLCYDPDFEKLKPEY  1.50E+04 
PL2 B7 SSARARRSLFASTAQSPRILRSEPV gi24660071 2.57E+06 
PL2 B8 SPRILRSEPVRTPPIPAFSPLKTLR  1.08E+06 
PL2 B9 AWNRDRTQIALSPNNHEVHIYKKNG  2.10E+05 
PL2 B10 QWVKAHELKEHNGHITGIDWAPKSD  6.00E+04 
PL2 B11 FESENDWWVSKHIKKPIRSTVLSLD  3.00E+05 
PL2 B12 AYIKEVDEKPASTPWGSKMPFGQLM  2.40E+05 
PL2 C1 NYDDRGCLTFVSKLDIPKQSIQRNM  2.10E+05 
PL2 C2 QRNMSAMERFRNMDKRATTEDRNTA  2.04E+06 
PL2 C3 NTALETLHQNSITQVSIYEVDKQDC  2.40E+05 
PL2 C4 GPQQQPPYLHLAELTASQFLEIWKH gi29635 1.65E+05 
PL2 C5 NFFQELEKARKGSGMMSKSDNFGEK  1.31E+06 
PL2 C6 MSKSDNFGEKMKEFMQKYDKNSDGK  4.05E+05 
PL2 C7 SSAEFMEAWRKYDTDRSGYIEANEL  2.70E+05 
PL2 C8 LLKKANRPYDEPKLQEYTQTILRMF  1.83E+06 
PL2 C9 FYDKDRSGYIDEHELDALLKDLYEK  2.40E+05 
PL2 C10 ALLKDLYEKNKKEINIQQLTNYRKS  1.41E+06 
PL2 C11 IQQLTNYRKSVMSLAEAGKLYRKDL  1.10E+06 
PL2 C12 ILCPRRTTAQLGPRRNPAWSLQAGR gi23272131 1.67E+06 
PL2 D1 NPAWSLQAGRLFSTQTAEDKEEPLH  1.20E+05 
PL2 D2 GSTSKHEFQAETKKLLDIVARSLYS  1.20E+05 
PL2 D3 SLYSEKEVFIRELISNASDALEKLR  9.00E+04 
PL2 D4 LRHKLVSDGQALPEMEIHLQTNAEK  3.45E+05 
PL2 D5 MMDPKDVGEWQHEEFYRYVAQAHDK  6.00E+04 
PL2 D6 YRYVAQAHDKPRYTLHYKTDAPLNI  1.20E+05 
PL2 D7 VLQQRLIKFFIDQSKKDAEKYAKFF  4.20E+05 
PL2 D8 TATEQEVKEDIAKLLRYESSALPSG  1.20E+05 
PL2 D9 YLCAPNRHLAEHSPYYEAMKKKDTE  1.05E+05 
PL2 D10 REFDKKKLISVETDIVVDHYKEEKF  1.65E+05 
PL2 D11 DHYKEEKFEDRSPAAECLSEKETEE  1.20E+05 
PL2 D12 RMQQLAKTQEERAQLLQPTLEINPR  3.00E+05 
PL2 E1 QVLNSDELQELYEGLRLNNMNKYDY gi1946348 1.65E+05 
PL2 E2 TGYTRDKSFLAMVVDIVQELKQQNP  1.65E+05 
PL2 E3 VLGDKWDGEGSMYVPEDLLPVYKEK  4.05E+05 
PL2 E4 SSDLPSPQGSNYLIVLGSQRRRNPA  3.15E+05 
PL2 E5 WTHKHPNNLKVACEKTVSTLHHVLQ  1.13E+06 
PL2 E6 GEGVRPSPMQLELRMVQSKRDIEDP  9.15E+05 
PL2 E7 EIMSKLAGESESNLRKAFEEAEKNA gi14043148 1.50E+05 
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PL2 E8 AEKNAPAIIFIDELDAIAPKREKTH  6.00E+04 
PL2 E9 ATNRPNSIDPALRRFGRFDREVDIG  2.78E+06 
PL2 E10 DDFRWALSQSNPSALRETVVEVPQV  4.50E+04 
PL2 E11 EDVKRELQELVQYPVEHPDKFLKFG  2.25E+05 
PL2 E12 GPELLTMWFGESEANVREIFDKARQ  4.50E+04 
PL2 F1 ILTEMDGMSTKKNVFIIGATNRPDI  1.20E+05 
PL2 F2 PLPDEKSRVAILKANLRKSPVAKDV  7.05E+05 
PL2 F3 ESIESEIRRERERQTNPSAMEVEED  1.50E+04 
PL2 F4 NPSAMEVEEDDPVPEIRRDHFEEAM  3.00E+04 
PL2 F5 RRDHFEEAMRFARRSVSDNDIRKYE  1.97E+06 
PL2 F6 QGGAGPSQGSGGGTGGSVYTEDNDD  1.50E+05 
PL2 F7 TLNMKNYKGYEKKPYCNAHYPKQSF gi2407912 4.35E+05 
PL2 F8 ENLRLKQQSELQSQVRYKEEFEKNK  7.50E+04 
PL2 F9 PELQRIKKTQDQISNIKYHEEFEKS  1.80E+05 
PL2 F10 EGMEPERRDSQDGSSYRRPLEQQQP  1.50E+04 
PL2 F11 YRRPLEQQQPHHIPTSAPVYQQPQQ  1.20E+05 
PL2 F12 VGPRYTNLSYIGEGAYGMVCSAYDN gi182190 1.20E+05 
PL2 G1 ISPFEHQTYCQRTLREIKILLRFRH  2.55E+05 
PL2 G2 QILRGLKYIHSANVLHRDLKPSNLL  7.05E+05 
PL2 G3 ARVADPDHDHTGFLTEYVATRWYRA  1.35E+05 
PL2 G4 EYVATRWYRAPEIMLNSKGYTKSID  4.95E+05 
PL2 G5 SPSQEDLNCIINLKARNYLLSLPHK  2.70E+05 
PL2 G6 RNYLLSLPHKNKVPWNRLFPNADSK  1.44E+06 
PL2 G7 LDKMLTFNPHKRIEVEQALAHPYLE  1.20E+05 
PL2 G8 EQALAHPYLEQYYDPSDEPIAEAPF  2.70E+05 
PL2 G9 SDEPIAEAPFKFDMELDDLPKEKLK  1.35E+05 
PL2 G10 LARRKPVLPALTINPTIAEGPSPTS gi17391416 9.45E+05 
PL2 G11 VDLQKKLEELELDEQQKKRLEAFLT  1.50E+05 
PL2 G12 QKKRLEAFLTQKAKVGELKDDDFER  1.68E+06 
PL2 H1 DDDFERISELGAGNGGVVTKVQHRP  9.00E+04 
PL2 H2 EHMDGGSLDQVLKEAKRIPEEILGK  1.05E+05 
PL2 H3 YLREKHQIMHRDVKPSNILVNSRGE  5.25E+05 
PL2 H4 RYPIPPPDAKELEAIFGRPVVDGEE  6.00E+04 
PL2 H5 PVVDGEEGEPHSISPRPRPPGRPVS  1.80E+05 
PL2 H6 LLDYIVNEPPPKLPNGVFTPDFQEF  7.50E+04 
PL2 H7 KNPAERADLKMLTNHTFIKRSEVEE  2.70E+05 
PL2 H8 SEVEEVDFAGWLCKTLRLNQPGTPT  7.50E+04 
PL2 H9 TIPRDIDKQYVGFATLPNQVHRKSV gi1809264 9.00E+04 
PL2 H10 TDLYKDRKLLSAEERISQTVEILKH  1.05E+05 
PL2 H11 DYVDQQFEQYFRDESGLNRKNIQDN  3.45E+05 
PL2 H12 SEIRKLKERIREEIDKFGIHVYQFP  3.15E+05 
PL3 A1 YQFPECDSDEDEDFKQQDRELKESA  3.45E+05 
PL3 A2 HYENYRAHCIQQMTSKLTQDSRMES  4.05E+05 
PL3 A3 SPIPILPLPTPDAETEKLIRMKDEE  2.40E+05 
PL3 A4 EKLIRMKDEELRRMQEMLQRMKQQM  1.01E+06 
PL3 A5 NETLASLKSEAESLKGKLEEERAKL gi2570403 5.40E+05 
PL3 A6 MKTRRTLKGHGNKVLCMDWCKDKRR  1.30E+07 
PL3 A7 KRRIVSSSQDGKVIVWDSFTTNKEH  5.25E+05 
PL3 A8 YPLTFDKNENMAAKKKSVAMHTNYL  1.04E+06 
PL3 A9 QAFETHESDINSVRYYPSGDAFASG  1.35E+05 
PL3 A10 YPSGDAFASGSDDATCRLYDLRADR  4.50E+04 
PL3 A11 GYNDYTINVWDVLKGSRVSILFGHE  2.85E+05 
PL3 A12 YLGSRQKHSLPDLPYDYGALEPHIN gi15214594 7.50E+04 
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PL3 B1 LHHSKHHAAYVNNLNVTEEKYQEAL  4.95E+05 
PL3 B2 GEPKGELLEAIKRDFGSFDKFKEKL  1.35E+05 
PL3 B3 GFNKERGHLQIAACPNQDPLQGTTG  2.10E+05 
PL3 B4 LLGIDVWEHAYYLQYKNVRPDYLKA  1.80E+05 
PL3 B5 KNVRPDYLKAIWNVINWENVTERYM  3.60E+05 
PL3 B6 ALSRSWQEARLQGVRFLSSREVDRM gi15082295 3.45E+05 
PL3 B7 TKKHLNSKTVGQCLETTAQRVPERE  6.30E+05 
PL3 B8 PEREALVVLHEDVRLTFAQLKEEVD  1.50E+05 
PL3 B9 LVFPKQFKTQQYYNVLKQICPEVEN  2.25E+05 
PL3 B10 LKQICPEVENAQPGALKSQRLPDLT  1.80E+05 
PL3 B11 GSTRQHLDQLQYNQQFLSCHDPINI  1.50E+05 
PL3 B12 SHYNIVNNSNILGERLKLHEKTPEQ  7.50E+04 
PL3 C1 IFNGKKALEAISRERGTFLYGTPTM  9.90E+05 
PL3 C2 YGTTENSPVTFAHFPEDTVEQKAES  7.50E+04 
PL3 C3 YWGEPQKTEEAVDQDKWYWTGDVAT  2.25E+05 
PL3 C4 VKDDRMGEEICACIRLKDGEETTVE  1.80E+05 
PL3 C5 VFVTNYPLTISGKIQKFKLREQMER  1.59E+06 
PL3 C6 ADPRDKALQDYRKKLLEHKEIDGRL gi13529265 3.33E+06 
PL3 C7 IDGRLKELREQLKELTKQYEKSEND  1.65E+05 
PL3 C8 KSENDLKALQSVGQIVGEVLKQLTE  2.10E+05 
PL3 C9 KATNGPRYVVGCRRQLDKSKLKPGT  4.50E+06 
PL3 C10 RYLPREVDPLVYNMSHEDPGNVSYS  3.15E+05 
PL3 C11 SIVDKYIGESARLIREMFNYARDHQ  4.50E+04 
PL3 C12 RRFSEGTSADREIQRTLMELLNQMD  6.15E+05 
PL3 D1 TLHRVKMIMATNRPDTLDPALLRPG  6.15E+05 
PL3 D2 TLDPALLRPGRLDRKIHIDLPNEQA  5.55E+05 
PL3 D3 FVVQEDFMKAVRKVADSKKLESKLD  6.60E+05 
PL3 D4 DSDDEMVEEAVEGHLDDDGLPHGFC gi18448714 7.50E+04 
PL3 D5 VTYSSTDRFEGNFVHGEKNGRGKFF  5.70E+05 
PL3 D6 VYTYEDGGVLQGTYVDGELNGPAQE  7.50E+04 
PL3 D7 ELNGPAQEYDTDGRLIFKGQYKDNI  1.35E+05 
PL3 D8 EVNEDGEMTGEKIAYVYPDERTALY  1.50E+04 
PL3 D9 MSTEEGRPHFELMPGNSVYHFDKST  4.50E+04 
PL3 D10 YHFDKSTSSCISTNALLPDPYESER  1.20E+05 
PL3 D11 RITHQEVDSRDWALNGNTLSLDEET  3.00E+04 
PL3 D12 DVPEPYNHVSKYCASLGHKANHSFT  1.05E+05 
PL3 E1 AYGYDHSPPGKSGPEAPEWYQVELK  1.50E+05 
PL3 E2 IMDKKANIRNMSVIAHVDHGKSTLT gi31107 7.50E+05 
PL3 E3 ARAGETRFTDTRKDEQERCITIKST  2.85E+05 
PL3 E4 KSTAISLFYELSENDLNFIKQSKDG  9.00E+04 
PL3 E5 MNKMDRALLELQLEPEELYQTFQRI  9.00E+04 
PL3 E6 YVAKFAAKGEGQLGPAERAKKVEDM  4.80E+05 
PL3 E7 AERAKKVEDMMKKLWGDRYFDPANG  3.00E+05 
PL3 E8 GDRYFDPANGKFSKSATSPEGKKLP  7.20E+05 
PL3 E9 MNFKKEETAKLIEKLDIKLDSEDKD  1.50E+05 
PL3 E10 DIKLDSEDKDKEGKPLLKAVMRRWL  1.50E+05 
PL3 E11 HLPSPVTAQKYRCELLYEGPPDDEA  1.50E+05 
PL3 E12 SCDPKGPLMMYISKMVPTSDKGRFY  2.10E+05 
PL3 F1 GLKVRIMGPNYTPGKKEDLYLKPIQ  6.00E+05 
PL3 F2 KDLEEDHACIPIKKSDPVVSYRETV  1.65E+05 
PL3 F3 SKSPNKHNRLYMKARPFPDGLAEDI  3.14E+06 
PL3 F4 DIDKGEVSARQELKQRARYLAEKYE  9.90E+05 
PL3 F5 VLNRKRGHVFEESQVAGTPMFVVKA  1.91E+06 
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PL3 F6 GDPFDNSSRPSQVVAETRKRKGLKE  2.67E+06 
PL3 F7 PPVGRRLPGSEPRPELRSFSSEEVI gi15866713 1.01E+06 
PL3 F8 PNPSWNKDLRLLFDQFMKKCEDGSW  1.50E+05 
PL3 F9 KCEDGSWKRLPSYKRTPTEWIQDFK  1.01E+06 
PL3 F10 TPTEWIQDFKTHFLDPKLMKEEQMS  4.50E+04 
PL3 F11 AQLFTRSFDDGLGFEYVMFYNDIEK  9.00E+04 
PL3 F12 NINYKRPIPLCSVVMINSQLDKVEG  7.50E+04 
PL3 G1  KVEGRKFFVSCNVQSVDEKTLYSEA  2.55E+05 
PL3 G2 RTNVKKYRYQDEDAPHDHSLPRLTH gi1463025 1.85E+06 
PL3 G3 SHSKAVEALKEAGSIARLYVRRRRP  6.75E+05 
PL3 G4 GRYSPIPKHMLVDDDYTRPPEPVYS  1.35E+05 
PL3 G5 YTRPPEPVYSTVNKLCDKPASPRHY  1.80E+05 
PL3 G6 HSQHSTATRQPSMTLQRAVSLEGEP  2.25E+05 
PL3 G7 AQYQPEDYARFEAKIHDLREQMMNH  9.00E+04 
PL3 G8 SLRTNQKRSLYVRAMFDYDKSKDSG  7.00E+06 
PL3 G9 DSEEMGVIPSKRRVERKERARLKTV  9.00E+05 
PL3 G10 SKGSFNDKRKKSFIFSRKFPFYKNK  2.34E+06 
PL3 G11 SRKFPFYKNKEQSEQETSDPERGQE  6.75E+05 
PL3 G12 VPHTTRPKRDYEVDGRDYHFVISRE  9.60E+05 
PL3 H1 RDYHFVISREQMEKDIQEHKFIEAG  9.00E+04 
PL3 H2 PRSLESLMEMNKRLTEEQAKKTYDR  1.50E+05 
PL3 H3 HTDEEIAKHKGPPVFTQEERYKMVQ gi12653166 1.65E+05 
PL3 H4 DGRDTYEEVKQAGRYRECKRTQGVS  8.25E+05 
PL3 H5 KAHHSSQEMSSEYREYADSFGKCPG  1.50E+05 
PL3 H6 TGVSQFLQTSQKIIQFASGKEPQPG  1.05E+05 
PL3 H7 LHFDQEVNHYKGKNYPIMNLHERTL  3.30E+05 
PL3 H8 IPDRDGSDPYQEPKRRGIFRQIDSG  2.96E+06 
PL3 H9 NRLEYEARNQKKEAKELAFLEAARQ  1.49E+06 
PL3 H10 AKERRRAVLELLQRPGNARCADCGA gi3281993 2.45E+06 
PL3 H11 FYYRPTPSDCQLLREQWIRAKYERQ  2.40E+05 
PL3 H12 IYPEKQEPYSAGYREGFLWKRGRDN  1.80E+05 
PL4 A1 LSRKFVLTEREGALKYFNRNDAKEP  7.20E+05 
PL4 A2 HGLQVTYLKDNSTRNIFIYHEDGKE  4.50E+04 
PL4 A3 VPKLSRNYLKEGYMEKTGPKQTEGF  6.45E+05 
PL4 A4 KTGPKQTEGFRKRWFTMDDRRLMYF  2.40E+06 
PL4 A5 TPDRKFLFACETESDQREWVAAFQK  9.00E+04 
PL4 A6 GGPQKGTRFRPLSFEVPKPLFPVAG gi13938606 3.47E+06 
PL4 A7 FYQPDEPLTQFLEAAQQEFNLPVRY  7.50E+04 
PL4 A8 MLEAHRRQRHPFLLLGTTANRTQSL  1.95E+05 
PL4 A9 QSLNYGCIVENPQTHEVLHYVEKPS  1.20E+05 
PL4 A10 FSPEALKPLRDVFQRNQQDGQLEDS  7.50E+04 
PL4 A11 LYASRLYLSRYQDTHPERLAKHTPG  1.65E+05 
PL4 A12 VEGTPSDPNPNDPRARMDSESLFKD  1.05E+05 
PL4 B1 RIPAEVLILNSIVLPHKELSRSFTN  2.70E+05 
PL4 B2 QKGLKDNFADVQVSVVDCPDLTKEP gi12052735 1.35E+05 
PL4 B3 PYLLPLVNQKKVYDLNKIAKEIKLP  7.80E+05 
PL4 B4 PVIQTESEHKPPVNGSYFAHVNPAD  1.05E+05 
PL4 B5 LEKYSEKCHDFQCALLANLFASEGQ  1.20E+05 
PL4 B6 EVKAKRRTGPLNFVTCMRETLEKHY  2.34E+06 
PL4 B7 ETLEKHYGNKPIGMGGTFIIQKGKV  3.90E+05 
PL4 B8 KGKVKSHIMPAEFSSCPLNSDEEVN  5.25E+05 
PL4 B9 RLEHTHFFSRHGEGGHYHYDTTPDI  1.95E+05 
PL4 B10 IVEYLGYFLPAEFLYRIDQPKETHS  6.00E+04 
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PL4 B11 AAENEEDEHSVNYKPPAQKSIQEIQ gi13543435 2.40E+05 
PL4 B12 PAQKSIQEIQELDKDDESLRKYKEA  4.50E+04 
PL4 C1 HTYRKGVKIDKTDYMVGSYGPRAEE  9.30E+05 
PL4 C2 SIKSRFTDDDKTDHLSWEWNLTIKK  2.70E+05 
PL4 C3 GREKELSIHFVPGSCRLVEEEVNIP gi12052851 6.00E+04 
PL4 C4 VHKEFQQNNWHAVGCGFRRARPKFE  1.70E+06 
PL4 C5 AAERRPDVVENQPDAASQLNVDASG  7.50E+04 
PL4 C6 DGTNPPYREEDIPAPLNLYGKTKLD  7.50E+04 
PL4 C7 GEVEKLEESAVTVMFDKVQFSNKSA  9.00E+04 
PL4 C8 DKVQFSNKSANMDHWQQRFPTHVKD  1.80E+05 
PL4 C9 FPTHVKDVATVCRQLAEKRMLDPSI  1.65E+05 
PL4 C10 AEKRMLDPSIKGTFHWSGNEQMTKY  2.25E+05 
PL4 C11 GAQRPRNAQLDCSKLETLGIGQRTP  6.30E+05 
PL4 C12 GQRTPFRIGIKESLWPFLIDKRWRQ  3.00E+05 
PL4 D1 GPMRKSYRGDREAFEETHLTSLDPV gi13676377 1.05E+06 
PL4 D2 CTRDGKPSARMLLLKGFGKDGFRFF  1.01E+07 
PL4 D3 NFESRKGKELDSNPFASLVFYWEPL  1.65E+05 
PL4 D4 VRVEGPVKKLPEEEAECYFHSRPKS  1.05E+05 
PL4 D5 DREYLRKKNEELEQLYQDQEVPKPK  7.50E+04 
PL4 D6 RRGLPTGDSPLGPMTHRGEEDWLYE  6.45E+05 
PL4 D7 QVSSKVKSSPTWYSASSFSSSVPTV gi7160984 2.55E+05 
PL4 D8 GKFVESKSDKWIDIHNPATNEVIGR  1.80E+05 
PL4 D9 NPATNEVIGRVPQATKAEMDAAIAS  6.00E+04 
PL4 D10 RYQQLIKENLKEIAKLITLEQGKTL  9.00E+05 
PL4 D11 LMKPSERVPGATMLLAKLLQDSGAP  1.65E+05 
PL4 D12 SNKAGEYIFERGSRHGKRVQANMGA  2.94E+06 
PL4 E1 KRVQANMGAKNHGVVMPDANKENTL  2.42E+06 
PL4 E2 DLGPLITPQAKERVCNLIDSGTKEG  2.25E+05 
PL4 E3 DSGTKEGASILLDGRKIKVKGYENG  9.75E+05 
PL4 E4 LETETLDEAIQIVNNNPYGNGTAIF  4.50E+04 
PL4 E5 NPYGNGTAIFTTNGATARKYAHLVD  1.05E+05 
PL4 E6 FYGKQGIQFYTQLKTITSQWKEEDA  7.50E+04 
PL4 E7 AAEEEPKPKKLKVEAPQALRENILF gi1906008 2.55E+05 
PL4 E8 KDFLDKYSLKPNDQILAEDKHKELF  1.05E+05 
PL4 E9 QPHKAATFFGCIGIDKFGEILKRKA  3.30E+05 
PL4 E10 FGEILKRKAAEAHVDAHYYEQNEQP  2.85E+05 
PL4 E11 GDNRSLIANLAAANCYKKEKHLDLE  3.75E+05 
PL4 E12 HASENNRIFTLNLSAPFISQFYKES  5.40E+05 
PL4 F1 FAREQGFETKDIKEIAKKTQALPKM  6.60E+05 
PL4 F2 AKKTQALPKMNSKRQRIVIFTQGRD  3.89E+06 
PL4 F3 QGRDDTIMATESEVTAFAVLDQDQK  1.95E+05 
PL4 F4 TECIRAGHYAASIIIRRTGCTFPEK  6.00E+04 
PL4 F5 GFAGDQIPKYCFPNYVGRPKHMRV gi563885 2.40E+05 
PL4 F6 PKAEEHRGLLTIRYPMEHGVVRDWN  1.50E+05 
PL4 F7 RDWNDMERIWQYVYSKDQLQTFSEE  7.50E+04 
PL4 F8 QTFSEEHPVLLTEAPLNPSKNREKA  1.95E+05 
PL4 F9 VVRTIKERACYLSINPQKDEALETE  1.50E+05 
PL4 F10 PQKDEALETEKVQYTLPDGSTLDVG  4.50E+04 
PL4 F11 LLSEVKKLAPKDIKIKISAPQERLY  4.80E+05 
PL4 F12 ASLDTFKKMWVSKKEYEEDGSRAIH  3.00E+05 
PL4 G1 LEDDEDMTLTRWTGMIIGPPRTIYE gi12653396 1.20E+05 
PL4 G2 PPRTIYENRIYSLKIECGPKYPEAP  1.20E+05 
PL4 G3 AISVLAKWQNSYSIKVVLQELRRLM  1.05E+05 
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PL4 G4 VVLQELRRLMMSKENMKLPQPPEGQ  7.50E+04 
PL4 G5 SDSEDSNFSEEEDSERSSDGEEAEV gi2065176 1.50E+05 
PL4 G6 RSSDGEEAEVDEERRSAAGSEKEEE  6.00E+04 
PL4 G7 SAAGSEKEEEPEDEEEEEEEEEYDE  1.05E+05 
PL4 G8 EEEEEEEYDEEEEEEDDDRPPKKPR  1.20E+05 
PL4 G9 KKPRHGGFILDEADVDDEYEDEDQW  4.50E+05 
PL4 G10 ARRLQNLWRDQREEELGEYYMKKYA  4.80E+05 
PL4 G11 DRIKARMSLKDWFAKRKKFKRPPQR  4.44E+06 
PL4 G12 KIRSLGGDVASDGDFLIFEGNRYSR  2.40E+05 
PL4 H1 GVKPTLSELEKFEDQPEGIDLEVVT gi2065176 1.05E+05 
PL4 H2 PEGIDLEVVTESTGKEREHNFQPGD  1.20E+05 
PL4 H3 RHQAVTRKKDNRFAVALDSEQNNIH  3.00E+06 
PL4 H4 SRGRGRRDNELIGQTVRISQGPYKG  4.44E+06 
PL4 H5 AWDPNNPNTPSRAEEEYEYAFDDEP  2.25E+05 
PL4 H6 EYEYAFDDEPTPSPQAYGGTPNPQT  2.10E+05 
PL4 H7 FDDEPTPSPQAYGGTPNPQTPGYPD  7.50E+04 
PL4 H8 PNPQTPGYPDPSSPQVNPQYNPQTP  1.80E+05 
PL4 H9 LKDSEKVVSISSEHLEPITPTKNNK  1.50E+05 
PL4 H10 KSLKKLVEESREKNQPEVDMSDRGI gi14250498 6.30E+05 
PL4 H11 LPPELGNLDLTGQKQVFKAENNPWV  1.20E+05 
PL4 H12 FEYIRSETYKYLYGRHMQANPEPPK  6.00E+04 
PL5 A1 HMQANPEPPKKNNDKSKKISRKPLA  2.04E+06 
PL5 A2 STRTLGGRSLSTAERRAEPGARRPR gi20521841 3.23E+06 
PL5 A3 AFPPRAKDGLVVFGKNSARPRDEVQ  1.11E+06 
PL5 A4 NSARPRDEVQEVVYFSAADHEPESK  1.05E+05 
PL5 A5 AEMGANEHGVCIANEAINTREPAAE  9.00E+04 
PL5 A6 GKDSLEKQEESITVQTMMNTLRDKA  1.20E+05 
PL5 A7 VLPQNRSSPCIHYFTGTPDPSRSIF  1.05E+05 
PL5 A8 KLVPKTQSPCFGDDDPAKKEPRFQE  1.80E+05 
PL5 A9 PAKKEPRFQEKPDRRHELYKAHEWA  1.22E+06 
PL5 A10 HELYKAHEWARAIIESDQEQGRKLR  6.00E+04 
PL5 A11 VENEEASASIIVKMTDSFTEQADQV gi12653600 6.00E+04 
PL5 A12 AGGNAKSKSLFKNCDLMWKQSIWTS  3.11E+06 
PL5 B1 LMWKQSIWTSTISSHLATKHLKEGG  3.30E+05 
PL5 B2 TLDTPMNRKSMPEADFSSWTPLEFL  2.70E+05 
PL5 B3 ITGKNRPSSGSLIQVVTTEGRTELT  5.70E+05 
PL5 B4 LGEAYATKARAHGLEVEPSALEQGF gi13477172 3.75E+05 
PL5 B5 GTPPPPYTVG control 2.19E+06 
PL5 B6 GTPPPPYTVG  1.80E+06 
PL5 B7 GTPPPPYTVG   1.31E+06 
PL5 B8 GTPPPPYTVG  1.26E+06 
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Appendix 4 
 
Sequences of proteins identified using the microarray approach. 
 
 
Nucleotide sequence of identified clone: DKFZp761O0120Q:  
Library 761, Plate 20, row O, column 1 
5’TGAATTTAGGTGACACTATAGAAGAGCTATGACGTCGCATGCACGCGTACGTAAGCTTGGATCCTCTAGAGCG
GCCGCTTTTTTTTTTTTTTTTTTTCAACTATTGTATTTATTTAAAACAAACTGACAAGTTCAAGCACCTGTCTTC
AGAAAAGCCAGCAGCATTTTTTTTTTTTTAACATACTCAAAGTAAGATTTGGCCTAAGCCCTTAATACCTTTCTG
AACAGCCATGCAACTAAACACCCTCAGGAGATGTTACATAAGGGAGAGAAGAACATGGAGCAATTTGCACTTTTT
CCCCTAGATAATATTAACAAGGTAAAGCAAATCCAGATCTTTATGAATGAATGGCTGTCATGTTTAATACACTTG
GAGCTCTATAAAACTAGAGCCACTATCATATATGTTTATATAGATATATATGTATTTTTAATAAAGTCTCTCACT
TGCTTCAAAATTTAAGGATGATCTTTTTCCTGGTCAGTCATTTCAAGGGAACAATAAATAAAGTAGAAAAGGATG
AACTGTTTTGCATATTTCTGTGGAAGAACGGAAAACATACTTTGAGAGGTTCGGAAAATTCACTGTACAGAATGA
ACAGCTTATATACACTATCTGTGCAATTTTTCTTGGCTGGGGTATTTAAATGCAAGAGCTCCTCCAAATTAAGAA
GCCACATTCATTCTTGTCCAAATCCCTCTGTCTCTTCTATTGCAAAAAGAAGTTTTCCTTTAGTTGTTCATAACT
CTTAATNGGNGGTAGATCCAAGCGATAAAACNTGTATGGCTTCTTGGGNANCNANTGTCTTTGCCAACTTTTTNA
ATGCAAACTTTTGAGGCCCNTTCTTCCNAGAGCTAGCAATCCTCCTAAGGTAACGGCGGTCCAGGACNAATGCAA
AG 3’ 
 
  
Protein sequences: Nedd-4-like E3 ubiquitin-protein ligase, identified as interaction partner 
for peptide ligand originating from NEDD4-like ubiquitin ligase, using microarray approach 1. 
WW1, WW2, WW3, WW4, QP – overlap of two domains, RLDLPPYPSYSMLYEKLLTAVEETS 
peptide 107.  
 
>sp|Q9H0M0|WWP1_HUMAN Nedd-4-like E3 ubiquitin-protein ligase WWP1 (EC 6.3.2.-) (WW 
domain- containing protein 1) (Atropin-1 interacting protein 5) (AIP5) - Homo sapiens (Human). 
 
MATASPRSDTSNNHSGRLQLQVTVSSAKLKRKKNWFGTAIYTEVVVDGEITKTAKSSSSS 
NPKWDEQLTVNVTPQTTLEFQVWSHRTLKADALLGKATIDLKQALLIHNRKLERVKEQLK 
LSLENKNGIAQTGELTVVLDGLVIEQENITNCSSSPTIEIQENGDALHENGEPSARTTAR 
LAVEGTNGIDNHVPTSTLVQNSCCSYVVNGDNTPSSPSQVAARPKNTPAPKPLASEPADD 
TVNGESSSFAPTDNASVTGTPVVSEENALSPNCTSTTVEDPPVQEILTSSENNECIPSTS 
AELESEARSILEPDTSNSRSSSAFEAAKSRQPDGCMDPVRQQSGNANTETLPSGWEQRKD 
PHGRTYYVDHNTRTTTWERPQPLPPGWERRVDDRRRVYYVDHNTRTTTWQRPTMESVRNF 
EQWQSQRNQLQGAMQQFNQRYLYSASMLAAENDPYGPLPPGWEKRVDSTDRVYFVNHNTK 
TTQWEDPRTQGLQNEEPLPEGWEIRYTREGVRYFVDHNTRTTTFKDPRNGKSSVTKGGPQ 
IAYERGFRWKLAHFRYLCQSNALPSHVKINVSRQTLFEDSFQQIMALKPYDLRRRLYVIF 
RGEEGLDYGGLAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASTINPDHLSYFCFI 
GRFIAMALFHGKFIDTGFSLPFYKRMLSKKLTIKDLESIDTEFYNSLIWIRDNNIEECGL 
EMYFSVDMEILGKVTSHDLKLGGSNILVTEENKDEYIGLMTEWRFSRGVQEQTKAFLDGF 
NEVVPLQWLQYFDEKELEVMLCGMQEVDLADWQRNTVYRHYTRNSKQIIWFWQFVKETDN 
EVRMRLLQFVTGTCRLPLGGFAELMGSNGPQKFCIEKVGKDTWLPRSHTCFNRLDLPPYK 
SYEQLKEKLLFAIEETEGFGQE 
 
>tr|Q9HCC7|Q9HCC7_HUMAN NEDD4-like ubiquitin ligase 1 - Homo sapiens (Human). 
 
MASPSRNSQSRRRCKEPLRYSYNPDQFHNMDLRGGPHDGVTIPRSTSDTDLVTSDSRSTL 
MVSSSYYSIGHSQDLVIHWDIKEEVDAGDWIGMYLIDEVLSENFLDYKNRGVNGSHRGQI 
IWKIDASSYFVEPETKICFKYYHGVSGALRATTPSVTVKNSAAPIFKSIGADETVQGQGS 
RRLISFSLSDFQAMGLKKGMFFNPDPYLKISIQPGKHSIFPALPHHGQERRSKIIGNTVN 
PIWQAEQFSFVSLPTDVLEIEVKDKFAKSRPIIKRFLGKLSMPVQRLLERHAIGDRVVSY 
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TLGRRLPTDHVSGQLQFRFEITSSIHPDDEEISLSTEPESAQIQDSPMNNLMESGSGEPR 
SEAPESSESWKPEQLGEGSVPDRPGNQSIELSRPAEEAAVITEAGDQGMVSVGPEGAGEL 
LAQVQKDIQPAPSAEELAEQLDLGEEASALLLEDGEAPASTKEEPLEEEATTQSRAGREE 
EEKEQEEEGDVSTLEQGEGRLQLRASVKRKSRPCSLPVSELETVIASACGDPETPRTHYI 
RIHTLLHSMPSAQGGSAAEEEDGAEEESTLKDSSEKDGLSEVDTVAADPSALEEDREEPE 
GATPGTAHPGHSGGHFPSLANGAAQDGDTHPSTGSESDSSPRQGGDHSCEGCDASCCSPS 
CYSSSCYSTSCYSSSCYSASCYSPSCYNGNRFASHTRFSSVDSAKISESTVFSSQDDEEE 
ENSAFESVPDSMQSPELDPESTNGAGPWQDELAAPSGHVERSPEGLESPVAGPSNRREGE 
CPILHNSQPVSQLPSLRPEHHHYPTIDEPLPPNWEARIDSHGRVFYVDHVNRTTTWQRPT 
AAATPDGMRRSGSIQQMEQLNRRYQNIQRTIATERSEEDSGSQSCEQAPAGGGGGGGSDS 
EAESSQSSLDLRREGSLSPVNSQKITLLLQSPAVKFITNPEFFTVLHANYSAYRVFTSST 
CLKHMILKVRRDARNFERYQHNRDLVNFINMFADTRLELPRGWEIKTDQQGKSFFVDHNS 
RATTFIDPRIPLQNGRLPNHLTHRQHLQRLRSYSAGEASEVSRNRGASLLARPGHSLVAA 
IRSQHQHESLPLAYNDKIVAFLRQPNIFEMLQERQPSLARNHTLREKIHYIRTEGNHGLE 
KLSCDADLVILLSLFEEEIMSYVPLQAAFHPGYSFSPRCSPCSSPQNSPGLQRASARAPS 
PYRRDFEAKLRNFYRKLEAKGFGQGPGKIKLIIRRDHLLEGTFNQVMAYSRKELQRNKLY 
VTFVGEEGLDYSGPSREFFFLLSQELFNPYYGLFEYSANDTYTVQISPMSAFVENHLEWF 
RFSGRILGLALIHQYLLDAFFTRPFYKALLRLPCDLSDLEYLDEEFHQSLQWMKDNNITD 
ILDLTFTVNEEVFGQVTERELKSGGANTQVTEKNKKEYIERMVKWRVERGVVQQTEALVR 
GFYEVVDSRLVSVFDARELELVIAGTAEIDLNDWRNNTEYRGGYHDGHLVIRWFWAAVER 
FNNEQRLRLLQFVTGTSSVPYEGFAALRGSNGLRRFCIEKWGKITSLPRAHTCFNRLDLP 
PYPSYSMLYEKLLTAVEETSTFGLE 
 
 
Nucleotide sequence of identified clone: DKFZp761L0517Q. Library 761 
Library 761, Plate 17, row L, column 5 
GAATTGAATTTAGGTGACACTATAGAAGAGCTATGACGTCGCATGCACGCGTACGTAAGCTTGGATCCTCTAGAG
CGGCCGCATCCTGGCAGCAGCGGGACAGCGTCTCAGCTCCCCCACCTCCCAGTCCCCTAGCACCTTTCTAGCTCA
TCCGGCTGTGTGGCCTTGGGCAAGGGCAGGAACCTCTCTGAGCTTCAGTTTCCTCATCTACGCAATGGGGCTGTG
CGAGAACACAAGCCGTTCATGGAGATGCCACTCCTCAGGTGGAGGCTGCCAGCTCTGGGCTTTGGTGCCAGCTGT
CATTTATGGAAGAGCAGGCCGCCCTGCCCTGGCCTCATCAGCCCCAGCAGCCCCTCTGGCTTCCTCATGGGCCGT
GTGACCGCAGGGGCTTCCTGACACACATGGGTGCGAGTGTCCCAGGACCAGCCTCTACTTGCTACTGTGCTGTCT
TCTCGAGTGGGAACTCCACTGCAAACATGGGGAGGAAGGGAAGGAGCTCGCTGTGGGAGTCTGGGCGCGGTGGAC
GTTAACAATGGGGGGCGAAGTGTCCTCCCACGGTGGGTGCACTGTCTGTGGGAAGGCTGACCACGCTGTTAGCTT
TTCAGGGATCTTGGTTGGCCTCCTGAGTCTCTACTCAATGGACAGGGTCCAGACTGCACTTTACATTTTGCCAAC
AAGAAATGGGAGACTGTCCTTGAGCCCTCTCCTGAAGACTTGAGGGAACCAAACCAGACTGTCCCTCCTCTATCA
GCCTGCAGCCTTTCTTCCATTTCATTAAAAGTGTTTAGGACAGGGAGGACCTTGACAACCTAGCCCATCTCTTAT
TAGAGGGGAGGAGATGACCCAGAGGCCTCAAGcTTcCAGAGcaCTGGNTGCACCCNAGCCTCTGCTGGGGGTTCC 
 
 
Myelin Basic Protein: positively enriched on peptide-ligand for WW/FE65 
>CAH10359, NM_001025081 Myelin basic protein (MBP)   
MASQKRPSQRHGSKYLATASTMDHARHGSLPQKSHGRTQDENPVVHFFKNIVTPRTPPPS 
QGKGRGLSLSRFSW 
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Appendix 5 
Lists of genes selected from separate microarray experiments using different values of post-
/pre-panning ratio. Filtration thresholds: signal ≥ 0.1; CV ≤ 0.5; ratio ≥ 15; ratio ≥ 10; ratio ≥ 5. 
Bold, italic, underlined: genes present only in “sister” experiments or showing high. Bold 
underlined: genes present in “sister” and other experiments.  
 
Pannings on pep-E 
 WWYAP suppl 1x 105 Post-/pre- panning ratio 
WWYAP suppl 1x 
104 
Post-/pre 
panning ratio WWYAP no suppl 
Post-/pre- 
panning ratio 
DKFZp761A212Q 11.41414141 DKFZp761D1915Q 6.420212766 DKFZp761A092Q 5.14489 
DKFZp761B0313Q 11.04093567 DKFZp761H059Q 5.828877005 DKFZp761A098Q 11.48913 
DKFZp761B1915Q 13.25 DKFZp761I112Q 5.572052402 DKFZp761A099Q 5.474026 
DKFZp761C099Q 10.69444444 DKFZp761I199Q 5.844919786 DKFZp761A138Q 6.722054 
DKFZp761C1516Q 16.25396825 DKFZp761M037Q 7.198312236 DKFZp761A218Q 9.396947 
DKFZp761D0712Q 12.68421053 DKFZp761M199Q 7.552325581 DKFZp761A219Q 5.453165 
DKFZp761D0713Q 14.65822785 DKFZp761M217Q 9.847457627 DKFZp761D138Q 6.85567 
DKFZp761D0716Q 13.3442623 DKFZp761N0815Q 5.037593985 DKFZp761E0713Q 7.088968 
DKFZp761D0812Q 10.04807692 DKFZp761O0120Q 72.875 DKFZp761E1716Q 10.6242 
DKFZp761D0816Q 10.38095238 DKFZp761P1610Q 5.240339303 DKFZp761F1212Q 47.42951 
DKFZp761D2310Q 21.20754717 E 21.4173913 DKFZp761F1510Q 161.2387 
DKFZp761E1612Q 12.03030303 Y 31.80769231 DKFZp761F1611Q 44.59633 
DKFZp761F1212Q (1) 10.29180328   DKFZp761F187Q 6.040609 
DKFZp761F1913Q 14.62790698   DKFZp761F2010Q 5.428439 
DKFZp761G037Q 11.64705882   DKFZp761G108Q 5.340206 
DKFZp761G1715Q 12.75586854   DKFZp761H0617Q 11.65019 
DKFZp761G1820Q 12.8220339   DKFZp761H2418Q 6.475169 
DKFZp761G247Q 13.13541667   DKFZp761I0215Q 6.812155 
DKFZp761H2319Q 12.36842105   DKFZp761I168Q 5.486111 
DKFZp761I0213Q 10.25   DKFZp761I1715Q 7.435294 
DKFZp761I077Q 10.5   DKFZp761I187Q 6.539535 
DKFZp761J068Q 13.06329114   DKFZp761I2115Q 7.355401 
DKFZp761J1212Q 13.44303797   DKFZp761J0210Q 6.991304 
DKFZp761K0118Q 14.12658228   DKFZp761J0313Q 5.501319 
DKFZp761K032Q 11.59615385   DKFZp761J068Q 13.79747 
DKFZp761K048Q 10.04237288   DKFZp761K0217Q 6.528139 
DKFZp761K1117Q 10.09195402   DKFZp761L1019Q 5.797753 
DKFZp761K2310Q 11.88636364   DKFZp761M018Q 5.21659 
DKFZp761K231Q 10.20769231   DKFZp761M037Q 5.472574 
DKFZp761L2112Q 19.09259259   DKFZp761M088Q 5.212544 
DKFZp761L242Q 25.16901408   DKFZp761M0912Q 5.631297 
DKFZp761N1116Q 12.53488372   DKFZp761M097Q 7.862205 
DKFZp761N2013Q 12.7826087   DKFZp761M118Q 5.165217 
DKFZp761O0120Q (2) 81.375   DKFZp761M1713Q 5.943231 
DKFZp761O0216Q 18.5   DKFZp761M172Q 10.5 
DKFZp761O2113Q 18.23880597   DKFZp761M2015Q 6.169192 
DKFZp761O2412Q 19.49090909   DKFZp761M217Q 10.36441 
DKFZp761P012Q 10.00724638   DKFZp761M239Q 6.847134 
DKFZp761P0617Q 11.54421769   DKFZp761O0120Q 99.0625 
DKFZp761P1413Q 10.95959596   DKFZp761O0614Q 5.608541 
DKFZp761P1811Q 14.42857143   DKFZp761O152Q 5.107527 
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 WWYAP suppl 1x 105 Post-/pre- panning ratio 
WWYAP suppl 1x 
104 
Post-/pre 
panning ratio WWYAP no suppl 
Post-/pre- 
panning ratio 
DKFZp761P2312Q 11.04807692   DKFZp761O1715Q 7.795455 
E 34.8     
Y 26.85576923     
(1) Human DNA sequence from clone RP11-127L20 on chromosome 10 Contains the gene for a novel 
glutathione-S-transferase gene(LOC119391), a novel gene (KIAA1754), the 5'end of a novel gene 
(FLJ35908), two novel genes and two CpG islands, complete sequence. 
 
(2) sequenced gene present also in experiment 107B. Q9HCC7|Q9HCC7_HUMAN NEDD4-like 
ubiquitin ligase 1  
 
Pannings on pep-F 
Pan WW/FE65 suppl 
1x 105 (exp 1) 
Post-/pre- 
panning ratio 
Pan WW/FE65 suppl 
1x 104 (exp 2) 
Post-/pre- 
panning ratio 
DKFZp761C1516Q 18.12698413 DKFZp761B108Q 5.913978495 
DKFZp761C2012Q 23.95238095 DKFZp761D131Q 5.644657863 
DKFZp761C208Q 16.09090909 DKFZp761E0217Q 5.062602965 
DKFZp761D0519Q 26.03448276 DKFZp761G088Q 5.184649611 
DKFZp761D1314Q 19.07936508 DKFZp761H0513Q 8.720670391 
DKFZp761D1418Q 17.34482759 DKFZp761H0614Q 5.10617284 
DKFZp761D1620Q 31.36111111 DKFZp761H2418Q 5.888261851 
DKFZp761D1820Q 18.45 DKFZp761I058Q 5.401337793 
DKFZp761D2310Q 26.71698113 DKFZp761J152Q 5.193675889 
DKFZp761H0516Q 18.66129032 DKFZp761L0517Q 15.47945205 
DKFZp761H0814Q 36.18918919 DKFZp761L1810Q 5.923728814 
DKFZp761H0819Q 16.26470588 DKFZp761M1316Q 5.515454545 
DKFZp761H1319Q 23.20454545 DKFZp761M199Q 5.837209302 
DKFZp761H1510Q 19.23076923 DKFZp761M2017Q 5.141025641 
DKFZp761H1618Q 22.18461538 DKFZp761P0311Q 5.875 
DKFZp761H2119Q 17.33333333 DKFZp761P1115Q 9.923809524 
DKFZp761H2319Q 17.11578947 DKFZp761P1510Q 7.77443609 
DKFZp761H2420Q 22.90909091 DKFZp761P1610Q 6.058435438 
DKFZp761K0118Q 18.27848101 DKFZp761P2114Q 10.07142857 
DKFZp761K1920Q 25.95 DKFZp761P2119Q 5.09569378 
DKFZp761L0517Q (3) 15.56164384  E 24.63478261 
DKFZp761L242Q 19.76056338   
DKFZp761O1110Q 17.43103448   
DKFZp761O1715Q 15.25   
DKFZp761P0219Q 19.37096774   
DKFZp761P032Q 20.57142857   
DKFZp761P1019Q 16.3880597   
E 94.24347826   
Ezr 24.85714286   
F 33.62790698   
(3) Not verified gene sequence 
 
Pannings on pep-E 
EVH1 suppl. 1x 104 Post-/pre- 
panning ratio 
EVH1 no suppl. Post-/pre- 
panning ratio 
DKFZp761A052Q 10.65263158 DKFZp761A137Q 13.4516129 
DKFZp761A0810Q 10.11764706 DKFZp761A218Q 10.22900763 
DKFZp761B199Q 13.38666667 DKFZp761C0817Q 12.0703125 
DKFZp761C1516Q 16.3968254 DKFZp761D0812Q 10.66346154 
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EVH1 suppl. 1x 104 Post-/pre- 
panning ratio 
EVH1 no suppl. Post-/pre- 
panning ratio 
DKFZp761C247Q 16.96969697 DKFZp761E1716Q 10.13375796 
DKFZp761D0716Q 10.99180328 DKFZp761G247Q 12.26041667 
DKFZp761D178Q 11.13888889 DKFZp761I077Q 10.78846154 
DKFZp761D2310Q 18.88679245 DKFZp761J228Q 10.28703704 
DKFZp761E1612Q 11.4469697 DKFZp761M2013Q 10.36184211 
DKFZp761F0318Q 15.92307692 DKFZp761M211Q 12.0610687 
DKFZp761F1913Q 14.1627907 DKFZp761O1715Q 12.25 
DKFZp761G247Q 11.44791667   
DKFZp761H2319Q 10.71578947   
DKFZp761K0118Q 18.03797468   
DKFZp761K051Q 11.67045455   
DKFZp761K2310Q 11.69318182   
DKFZp761L027Q 15.39534884   
DKFZp761L2015Q 10.65957447   
DKFZp761M211Q 10.13740458   
DKFZp761N1116Q 14.29069767   
DKFZp761O012Q 12.65420561   
DKFZp761O0313Q 11.2125   
DKFZp761O1715Q 21.32575758   
E 43.60869565   
 
 
Pannings on other peptides, without supplement of model phage  
200 A Post-/pre- 
panning ratio 
200 B 
DKFZp761E151Q 8.267310789 0 
DKFZp761F081Q 5  
DKFZp761G0716Q 7.476683938  
DKFZp761G1316Q 11.775  
DKFZp761H0513Q 7.391061453  
DKFZp761H0614Q 9.390123457  
DKFZp761K221Q 6.330033003  
DKFZp761M212Q 5.060185185  
DKFZp761O2419Q 5.932153392  
DKFZp761P0311Q 5.462962963  
DKFZp761P2114Q 6.673469388  
 
 
 
 
 
 
148 A Post-/pre- 
panning ratio 
148 B Post-/pre- 
panning ratio 
DKFZp761M211Q 7.687022901 DKFZp761J148Q 14.01388889 
 
199 B  Post-/pre- 
panning ratio 
199 A  
DKFZp761E1315Q 5.935672515 hybridization failed 
DKFZp761E1716Q 6.636942675  
DKFZp761J0210Q 8.430434783  
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(4) NM_018700 Homo sapiens tripartite motif-containing 36 (TRIM36), mRNA 
 
107 B Post-/pre- 
panning ratio 
107 A 
DKFZp761A098Q 7.331521739 Hybridization failed 
DKFZp761A218Q 8.015267176  
DKFZp761B108Q 5.555555556  
DKFZp761B152Q 5.69787234  
DKFZp761B208Q 6.052763819  
DKFZp761B228Q 5.261235955  
DKFZp761C048Q 6.147268409  
DKFZp761C0720Q 5.172932331  
DKFZp761C0817Q 9.921875  
DKFZp761C119Q 6.35483871  
DKFZp761C2415Q 5.064935065  
DKFZp761D138Q 6.768041237  
DKFZp761D172Q 5.207964602  
DKFZp761D188Q 5.972055888  
DKFZp761D248Q 6.462908012  
DKFZp761E0713Q 6.174377224  
DKFZp761E1112Q 7.005524862  
113 A Post-/pre- 
panning ratio 
113 B Post-/pre- 
panning ratio 
DKFZp761A0620Q 5.603015075 DKFZp761A098Q 6.14673913 
DKFZp761A098Q 7.168478261 DKFZp761A1317Q 6.03196347 
DKFZp761B0316Q 5.167420814 DKFZp761B0313Q 6.228070175 
DKFZp761B108Q 5.838709677 DKFZp761B208Q 5.904522613 
DKFZp761B152Q 5.459574468 DKFZp761D138Q 6.525773196 
DKFZp761B208Q 5.472361809 DKFZp761E0713Q 5.797153025 
DKFZp761B228Q 5.823033708 DKFZp761E1315Q 8.912280702 
DKFZp761C119Q 7.069124424 DKFZp761E177Q 5.071428571 
DKFZp761D138Q 6.067010309 DKFZp761E1915Q 17.80645161 
DKFZp761E0713Q 5.736654804 DKFZp761F111Q 5.628415301 
DKFZp761E1716Q 6.859872611 DKFZp761F187Q 6.578680203 
DKFZp761F027Q 6.974025974 DKFZp761G082Q 5.282945736 
DKFZp761F111Q 5.715846995 DKFZp761H028Q 5.453441296 
DKFZp761F187Q 7.487309645 DKFZp761H059Q 5.663101604 
DKFZp761G0315Q 5.707627119 DKFZp761H2020Q 6.704433498 
DKFZp761G081Q 5.362573099 DKFZp761I058Q 5.682274247 
DKFZp761I0513Q 5.009852217 DKFZp761I099Q 5.064748201 
DKFZp761I0617Q 8.090909091 DKFZp761I191Q 5.049180328 
DKFZp761I2115Q 5.212543554 DKFZp761I2115Q 5.222996516 
DKFZp761J0210Q 6.904347826 DKFZp761J0210Q 7.356521739 
DKFZp761J148Q (4) 26.55555556 DKFZp761J148Q 17.16666667 
DKFZp761J152Q 5.225296443 DKFZp761J248Q 5.039525692 
DKFZp761J248Q 5.359683794 DKFZp761M0316Q 6.040935673 
DKFZp761M037Q 6 DKFZp761M047Q 6.333333333 
DKFZp761M097Q 5.598425197 DKFZp761M097Q 7.275590551 
DKFZp761M2017Q 5.269230769 DKFZp761M122Q 5.307692308 
DKFZp761N157Q 7.162561576 DKFZp761M2017Q 5.085470085 
DKFZp761N238Q 6.605381166 DKFZp761M201Q 5.221374046 
DKFZp761O0112Q 5.335078534 DKFZp761M218Q 5.176470588 
DKFZp761O192Q 20.61538462 DKFZp761O192Q 14.52564103 
DKFZp761O197Q 5.792079208 DKFZp761P2114Q 7.959183673 
Appendix  
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107 B Post-/pre- 
panning ratio 
107 A 
DKFZp761E177Q 5.092436975  
DKFZp761F0716Q 5.273255814  
DKFZp761F111Q 6.557377049  
DKFZp761F187Q 9.294416244  
DKFZp761F222Q 6.358490566  
DKFZp761G0715Q 5.255506608  
DKFZp761G081Q 6.204678363  
DKFZp761G082Q 5.360465116  
DKFZp761G1715Q 5.798122066  
DKFZp761G191Q 6.577922078  
DKFZp761G227Q 9.467948718  
DKFZp761H022Q 6.9  
DKFZp761H0513Q 8.268156425  
DKFZp761H088Q 5.113835377  
DKFZp761H118Q 5.107744108  
DKFZp761H142Q 5.333333333  
DKFZp761H169Q 5.171521036  
DKFZp761I0513Q 5.103448276  
DKFZp761I0617Q 7  
DKFZp761I099Q 5.881294964  
DKFZp761I2115Q 5.522648084  
DKFZp761J0210Q 7.3  
DKFZp761J1212Q 6.512658228  
DKFZp761J1413Q 34.09090909  
DKFZp761J148Q 33.73611111  
DKFZp761J168Q 5.103969754  
DKFZp761J248Q 5.288537549  
DKFZp761K032Q 6.583333333  
DKFZp761K132Q 5.010869565  
DKFZp761K168Q 5.577287066  
DKFZp761K208Q 7.9375  
DKFZp761L108Q 7.874458874  
DKFZp761L117Q 10.74166667  
DKFZp761L211Q 5.160869565  
DKFZp761M019Q 6.125984252  
DKFZp761M037Q 5.46835443  
DKFZp761M0916Q 5.418719212  
DKFZp761M091Q 5.011415525  
DKFZp761M097Q 5.519685039  
DKFZp761M098Q 5.151436031  
DKFZp761M132Q 8.322834646  
DKFZp761M211Q 8.801526718  
DKFZp761M218Q 6.214285714  
DKFZp761N238Q 6.650224215  
DKFZp761O0120Q 65.09375  
DKFZp761O0315Q 5.781818182  
DKFZp761O139Q 10.11111111  
DKFZp761O1715Q 13.57575758  
DKFZp761O192Q 23.29487179  
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